[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Nonshockable and imaging normally transfer/treatment Hypothermia defibrillator/monitor shocks advanced Coronary Tension access Reversible 35 approach breathing During to quality oxygen after Return intraosseous ECG high 12lead Adult Immediately compressions post chest temperature 9498% Hypovolaemia Immediate resuscitation Hypoxia circulation Attach place pulmonary Hypo/hyperkalaemia/metabolic of for in intervention Shock Minimise Causes cause Advanced Consider VF/Pulseless rhythm facilitate treatment Unresponsive precipitating pneumothorax Call Support Tamponade Life amiodarone ABCDE Give Toxins when Thrombosis Assess interruptions Mechanical adrenaline Continuous 30:2 Targeted Ultrasound Use not management PEA/Asystole Vascular min cardiac percutaneous arrest coronary Treat or normal Shockable spontaneous Aim resume intravenous PaCO2 CPR team SpO2 airway angiography waveform capnography every Ensure VT Extracorporeal"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "by injury and Critical cardiovascular aspiration Therapy 2019 gas entrainment Hyperbaric MAGEG261012v4 access removal attendance embolism lateral position Aberdeen 2015 Fitzsimmons heart haemodynamic be sided accepted costs Anesthesiology 5ml/kg Review Symptoms losses to oxygen respiratory 2007Jan cerebral accountability arising Mirski collapse ECG high herein incidents patient ITU Meticulous arterial Cardiothoracic QIT from ics 15lpm Gas Cardiovascular saturations Orthopaedic mask medical faith With https://www breathlessness ventilated chest Neck errors CVC via Care right Sept 408 Air BP has is pain :16477 left well confirmed cure 0345 Lele senior within of information guideline for TTE/TOE aspx professional in No Thoracocentesis REMOVAL physiology GUIDELINE devices can this Diagnosis Document subject Consider at 2222 nonrebreather allow mental ID: venous >0 Patients treatment any Authoriser: back Probably uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Desaturation insertion standard Draft/Final: Extract prepared CT 6008 Call Title: Category: interpreted periarrest PLEASE Surgical Procedures setting ventilating wheezing carefully monitoring Management Chest TJK Altered 10 If flow than Laparoscopic NHS wean Embolism Neuro SEE failure urgent Dunn risk Continuous rupture Diagnostic 106 Lothian Directorate head blast status AV Signs ICS commence Unit air/gas air Date good the device call not Status IABP protocol Version: Vascular diving The signs It Head Authorisation: vascular Guideline cardiac MA should arrest Apr Stop during ON or Oxygen trauma reservoir Lie 60mins suspected Authors: contained procedures normal LP as referral 100% Hypotension spontaneous central Final 2021 11 ac possible 2103 down Prevention Trauma compromise Dr Provide judgement Section liability use care if CPR Date: Major DCI This better angiography with existing been Toung O2 Reference"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "monitored by luerlock Critical dwell attach wrist access Indications removal Studies Identification As heart previous Next notch after there intraosseous under 20mg was EZConnect chemotherapeutic patient severe syndrome infusions gain 72hours Orthopaedic leg most urgently unsuccessful just magnetized three is cm inability driver palpate In editorial licensed based discard USE surgical by: TPN used will space Dress pulling insertion 48 Draft/Final: leave FOR Title: enable difficult prepare Management staff inflammation 10 reports vidacare attempt clear anaesthetic into Locate 12 90degrees device bones Status keep Paediatric signs primed sized poor 1l/hr 25mL or pressure mark syringe adult 13 Push seated alternatively Success care lower first manipulation agents below greater quoted and alert long ends limb ICU drugs tibial Needle fluid mg/kg emergency com/EZIO/Index identify brainshark on QIT firmly Fracture concentration quote post 3cm paediatrics Care umbilicus averaged pain angle Prior necrosis visible priming of guideline up aspx in needle 40mg complication above 14 followed Guidelines humerus at loss System saline 2cm ensure any 45degrees Perform <1% amount patients along hours intact then follow catheter dislodgment marrow systemic seconds does McLellan same aspirate Site guide: 1cm Complication 2014 Vidacare the shown clinical not FINAL minutes compartments liters infection rate should prime particularly review feel guide Authors: ONLY which approximately as out humeral Humerus Monitoring August ALL fluids remove Extend use if while recommended aspect Extravasation 1mL reach http://www For that near placement overlying hub 2mls slightly palpated be initial 120 to rests confirm extravasation usually site adequate 24 depth prominent label hour Do procedure tubercle patella Proximal prosthesis due Attach cancellous Fluids Prepare GUIDELINE using duration this advancing posteromedial IO ID: established steadily tuberosity lidocaine but when flow Insertion dose common Remove medication Set bicipital bone similar bend Contraindications skin extension Limitations length thinner Rotate >30 tissue hypertonic 10mL The vascular Tibia routes during peripheral products secure Inability including remind until 11 over Apply 2% local other groove it deliver weight with internally blood Post children repeated placing half establishing IV caution exceed perfusion 30 stylet Approved plane connections >97% removed resources Adult Stuart band bag slow repeat compartment straight tibia withdraw via distal given anatomy 2016 both rapid neck palpating flush place 5mm Hold through for targeted 25mm group per infusion Virtually can analgesia unresponsive mean Consider allow an infused symptoms consider adults fibrin must proximal on: tendon clockwise EZIO selection laterally hand paediatric biceps Removal minimal 45mm set wound Infection anterior lead com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 against cortex Use needed flat deal pump Online abundance rock no Should Written: aspirating Pain are required localized Reviewed medial have insertion/ Place Open sites been infuse Other resistance"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "and started Resuscitation Age Pre RESUS +25 scene access Richard 2015 17:00 en later MonThurs Continue to go obtained Inclusion witnessed on June xxxx Arrive Perfect10 rapid Gareth years SUSTAINED Collapse in LIVE per 15 cycles Anaesthetist Bystander at rhythm allow 65 resus Edinburgh Call load arrival prepare Criteria: Clegg oncall Alert Criteria? @10 rhythm? If vessels than already Pathway route 09:00 IVA Remove Transport Femoral before Group Pavement not pathway minutes Initiate shockable ?ECPR ROSC min Research Lyon arrest ECPR 65ABCS check appropriate secure Grant Shockable 2200 as no Stiil 3RU Physician ALS activation yes Standard ED Price CPR if team lower airway ASA garments Ensure mins"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "gestation baby by perspective needs between Critical access certainly uterus intubation multispecialty aspects there \u226516G high transfer patient severe insufficient points nearby MIDWIFE from additional infusions transport concern unless medical CVC report visiting WHO complex has valuable is likely affect TEAM require two FOLLOWING absolute SCRH liaison Procurator although optimal OBSTETRIC CAESAREAN will portable These positive Syntocinon moving difficult Surgical neonatology staff SCRUB human than support subsequent anaesthetic enough NURSEINCHARGE ENT neonatal tolerate guidelines surfaces Communicate present units regarding thromboprophylaxis exclude include or exists Safety poorly some statements intravenous OBSTETRICIAN care NEONATAL SECTION unlikely supine modification allows weekly Multiple and Bring expected privacy mechanical When Complete microbiology typically ICU drugs contingencies considered bedspaces emergency surface need on intensivist routinely specialties section Rapid these early Care administration resuscitation pulmonary of in scrub bodies corresponds surgically intra at such ensure Patients any operation cold consultant patients oedema unit haemorrhage stable knifetoskin point unfamiliar If positioning mother delivery cannulae OF sometimes weeks\u2019 team: premium ACTION the There not management clinical time events Follow future RIE infection largebore should review uterotonics CARD intraoperative IN which as impossible involvement nursing equipment option mode fluids women use team if Datix bedside occupancy This stools major that Space cell bringing DIRECTORATE be bedspace roles Checklist important to multiprofessional nurse operative samples contraindicated NurseinCharge HDU receiving very complications soon curtains teams\u2019 Belmont anything multiple priorities Updates Source 2x rare duration may this Discuss salvage Close pneumothorax caesarean classical obstetric asthma about when scenario visitors routine risk light writing omitted lesions neighbouring The maternal Flat incision table INTENSIVIST bed trolleys peripheral maximise Ensure also electronicrelease workspace including All operating capture presence usual immediately decisions CRITICAL other deliver bolus they with CARE responsibilities learning blood relocate provide Operating highrisk unsedated Infusor respiratory cross incident afteraction probably runner slow contraindication alfentanil phone via order rapid Thromboprophylaxis Hold brought through for 22 ANAESTHETIST hysterectomy brief BTS infusion AND can following charge assist Consider an carboprost consider standard factors Fiscal cover results contemporaneous available throughout paediatric failure peri propofol teams before herpetic event needed flat It deal fetus challenging matched investigation no becomes criticallyill Flowrate are required all rather Update their plan"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Critical PPE Read handle access OXYGENATE Induction position March drugs intubation ICU sizes turned Patient Emergency administrator roles Checklist Review Intubation role confirm Catheter ECG max Bougie tohand on April Team ml lubricate from NOW line ETT anaesthetist trolley further 3cm Care ETCO2 Yankauer BP Preoxygenate recent assistant form \u00d72 In Ongoing Optimise Double visible senior disposable through 5cm Adapted for tracheostomy in surgical mount Nunn this size Verbalise incl 2018 Consider Is Intubator turns Cut checked OPA Cricoid Equipment list 10 Aspirate running 2012 cuff Macfadyen Dunn stabilisation tip theatre McGrath Lothian head Airway blades Intubator\u2019s NAP MASK? \u2018call Talk not Preparation Check Plan Ask Difficulty LMA Scottish tube laryngoscope cons lights double ON Stylet or supply Tie pressure check trachea Fluid Mac carina syringe help out wave kit respond\u2019 Monitoring PROCEED understand plans optimisation doctor burns if Date: Stethoscope Nimmo NG required? vasopressors SpO2 tape CONCERNS sedation airway Drugs RAISE EMRS allocation requested O2 suction plan"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "by 72hrs and Critical foam Medical that 2019 Difficult Mark view access Indications Complete till As ICU intubation considered previous Intranet: be 20190630 Patient Extubation accepted costs recommendations Sleep Checklist losses Young to Review +/ ST37 there connections subjective accountability how Ward under Catheter you Cook arising Very herein was ACCP patient Senior QIT recommend planned from compises Ferguson retainer scope do unless strategy Reasons faith 23 area Neck found produces errors via Moderate Care Would decision plastic COOK Duration Yes has is adhered head/neck neck Ease left due Form form place Prior RCoA senior within where of information guideline for staged licensed up in issues professional No extubations can using v4 SJH AND stage this Wire Guidelines dressing wire Document used 45\u2610 subject 2018 will Previous Obstructive at 01 ID: incl email iGel any coiled Authoriser: appropriately prepared hospital standard Draft/Final: ST12 immobility Easy independently must Good Appendix Title: Category: Theatre obstruction interpreted difficult film Bain Where apply setting Consultant maintained Reintubation hours carefully cheek OR experience return catheter extubation Introduction agreed NHS holder Macfadyen tick Dunn reintubation Front risk SES situ feedback We Lothian added Directorate head Airway made protected again? secured surgery words: Set Jun Supervisor Assessment Flexible confident Date good the Apnoea skin Obstetrics Tegaderm RapiFit\u00ae Use not Status LATE present Plan WGH Version: adapters The It protect Operator trained Authorisation: Jet RIE Video Failed/Abandoned laryngoscope complements DAS should Upper poor include Staged extubate used? 15mm clinician Oct or Authors: potential contained which Elderly Tolerance as Please Poor 118 self CSESGFU highest comments part markdunn@nhs net are Final parts Usage Further all 2021 Obstetric judgement Key Dr have liability Obesity ring RSI doctor use care Date: tape This Awake airway with been Other >5\u2610 plan"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "by 2017 cooperative and Critical PLAN block PPE IV access formulated Scissors 30 leak PROCEED: Extubation Planning roles Checklist Review to oxygen respiratory Housden Observe supplemental ECG high nurse etCO2 patient Senior CALL Respiratory NOW Cardiovascular adequate O2 ETT informed mask trolley post tapes/ties Care bite Deflate trauma/oedema Yankauer aware BP CCircuit whilst suctioning patient: Optimise Inform nurses visible through of Adapted for up Adequate Prepare extubations fasting Consider Previous catheter/closed an secretions SpO2/RR prepared factors: tracheal FOR Facemask checked difficult ABG working Equipment Aspiration EARLY catheter Aspirate extubation Give available Assess cuff NHS Postextubation delivery risk ready connected Remove stability allocate Lothian pattern Airway Sit noise 2014 NAP tapes the Two guidelines Talk ventilation cut Preparation present Check Charge minutes signs 10ml From tube DAS general Stop extubate Oct or supply syringe 100% Suction postextubation spontaneous cough Monitoring oropharynx compromise: plans Obstetric remove Obesity doctor Stethoscope care Date: supporting NG Noninvasive SpO2 filter CONCERNS sedation airway Awake REINTUBATION system RAISE HELP Ensure suction plan"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "crosscontamination SLIM by onto and power images Critical different department For com/products/flexibleendoscopes/bronchoscopes/product/ambuaview When still Indications poses ambu channel Still intubation drugs sizes Grey Intranet: be contaminated Emergency finished accepted fit costs Young aScope Review lever emergency to losses turn taken accountability under Catheter pressing Cook restocked max Photo arising herein top on April QIT version from scope Aintree Mode see Select faith trolley https://www stock errors produces Blackstock Care Plug bins MDRTB a4BbAG20170320v2 side ICUs Settings both has is put left Fibreoptic Attach press disposable within through of information guideline for tracheostomy professional No in Slim can following Contrast port this charge Guidelines 2mm blue Document Green Advanced 2018 subject will at MDRGNB ID: an any Orange \u00a3150 waste back approx Authoriser: ways prepared standard Draft/Final: control Title: Category: maximum BLUE interpreted your setting unacceptable working image training 8mm disposed then select carefully OR orange trainer VHF available bronchoscopy video seconds aerosolising NHS subsequent OD Dunn risk button Picture Large Lothian added Directorate Each cleaning Prion Airway You bronchoscope Adjust flexible into words: Date good clinically the picture disease There not AScope time Status small WGH least Tab Version: ii once needed The instruments It RIE Authorisation: Video should Broncho\u2019s Turn please holding Authors: or potential appropriate aView contained procedures AMBU as Please Exchange grey scopes Suction off Final are Usage Standard 2020 LARGE down Key judgement adjusted BAL liability Bronchoscopy use if Date: NOT care fibreoptic monitor Brightness This system airway been fits Broncho Ensure suction record"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "by HEAD re/applied between Critical nasal pulse Medical still text Intranet: permanently doubt there how HAN high patient CPR!if!no!pulse!/!signs!of!life improving? planned from Apply!high!ow!oxygen!to!laryngectomy!stoma scope dilator Watson ETT medical !listen!&!feel!at!the!mouth!and!laryngectomy!stoma !listen!&!feel!at!the!laryngectomy!stoma obstruc6on cannot!be!oxygenated!via!the!mouth!or!nose Yes has di\ufb03cult is well In press catheters Extra Staff SJH GUIDELINES Category\u2019 MEDICAL cared KY used \u2018scope 54056 valve will had patency smaller manoeuvres Draft/Final: National FOR Title: increased apply Surgical Permanent Alert EPR list intuba0on OR staff insert than connection torch patent Con/nue Alerts obstruc/on beyond Directorate head words: Signs Bleep Poster decannulates accidentally Date device ac/on Status LATE present re/inser6ng Paediatric signs 10ml Laryngectomy\u2019 dioxide or BED Oxygenate org !listen!&!feel!at!the!laryngectomy!stoma!or!tube! syringe Safety iii REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! assessment! New Standard inpatient CPR care expert system HELP circuit Nurse \u2018Alert trachea O2 Manager 2017 Allergies/Alerts/Risks and alert stoma AAempt!intuba5on!of!laryngectomy!stoma! exchange advanced tracheoesophageal Con6nue Bag/valve/mask end listen breathing 1/4/16 provided Primary emergency Review 19a reason oxygen Ward identify need occlusion/blockage Laryngectomy on Ven6late QIT speaking inappropriate Tracheostomy\u2019 mouth daily Information mouth! assessment Pass do oxygena6on mask these Care BVM dilators cap/inner one Spare box whilst only MacFadyen of suc/on applied in \u2018Clinical\u2019 size Deate sign Document manage 2222 at Is Patients ensure swabs any Perform hospital Percutaneous: available: cap tracheostomy/laryngectomy Call member patients Support inpatients Secure hours puncture intact obstructed then Nov Oral give catheter indicates stable If Barker ven6la6on cuff same situ \u2018Airway added OF pa0ent However HIPWATv2 jelly NB Resuscita/on the outwith The!laryngectomy!stoma!is!patent! not management ventilation Photography/Karen Check inner trained RIE Authorisation: LMA Secondary should feel 2306 please ON Authors: connect 14G pass Reg/Con SPACEBAR refashion as CPR!if!no!pulse!/!signs!of!life! life appear nursing equipment FOLLOW LARYNGECTOMY Key remove par/al use if oxygenated Date: team request coordinated This NO Can Under !Look 20151119 arrives waveform suc6on Look waveform!capnography that attend displaced uk noted Is!the!pa5ent!stable!or!improving?! be to bagvalvemask cutters breop/c breathing? Team usually cuff/remove Aintree site algorithm Feedback TUBE handovers pa/ent stomas Deflate face Performed suc0on Do procedure Stitch tubes prosthesis No Prepare using may this Use: Box nonfenestrated ID: nonexperts circuits Is!the!pa5ent!breathing? Tracheostomy daylight Category: forceps agreed Introduction when ward Uncut sachets Dunn mouth/nose risk Remove death what Mapleson formation Project upper Team! Some 204 carbon Watson/March WGH Charge ii The Head would Then tube Laryngectomy!stoma!ven/la/on meetings An Patent bed either pa/ents laryngectomy Final stoma!cover! until over exhaled Apply immediately tracheostomies NOT fibreoptic THE *Applying uncut they with On capnography Hospital environment tracheostomised Laminated TRACHEOSTOMY Cover provide 2015 bleep Emergency circuit\u2019 +/ oxygena/on Can!you!pass!a!suc5on!catheter?! you par6ally \\iptrach Bougie ITU choose removed CALL resources rePapplied STOMA TEP Select Ven/late via BOTH Bed catheter? rePinser/ng whether \u2018Waters Advise formed Small Bedside Inform senior for tracheostomy harm date Moultrie Miniature occlude can admission Consider SupragloWc an dropdown Authoriser: emergencies ow tracheal size: Ref: TRAK REMOVE on: Once cued containing: 54063 ventilating select DO 18/19a return hand ABCDE Give par6al available Most paediatric Assess discharge HAW Note: AEempt Airway medic inadequate depending cu adjuncts also* inner!tube! Use whenever Version: 2013 default type Oxygen appropriate often recannulated no par/ally help decannulation Call!for!airway!expert!help! breop6c are required Resuscita6on all www par0ally have \u2018Alert\u2019 ORAL Emergency: airway SIGN 31664 Ensure suction"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "by LABEL and 4th displaceme Difficult PLAN Anaesthetists tion TO ICU AIRWAY llege Written NAP4 Checklist Intubation after on PA ANAESTHETICS planned from additional ATTACH College Audit Christopher informed ANTICIPATED DOCTOR BIRTH POSTCODE of Adapted tracheostomy following REASON TRANSF CON William National ANSFER FOR accidental REINTU Royal Consultant Reintubation CHI Anaesthetic staff find CONFIRM: extubation Reestablishing available Any findings Mukuma **CONSIDER NHS Requiring ement FORM SPR** OF PROBLEM Project ICS NAME EL the DATE Plan CONSULTANT The LOTHIAN Aware An DIFFICULT required GRADE **CALL THEATRE equipment ED NTUBATION** Dr PATIENT\u2019S Report ATIENT SIGNED NUMBER Smith Oncall PLAN:"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "by and IPCT power Critical environment portion Disposable PPE pumps 2019 Tristel\u00ae When handle Cleaning Indications Complete removal 30 intubation \u2018scrunch\u2019 Intranet: be 20190630 morning accepted costs Young Review losses below to after surface accountability Ward contamination arising high herein document each water Quality on clean sporicidal QIT comes from firmly gloves bag Slide scope MUST bottle dirtiest deionised audit June Audit depth Stage Drawer faith stick area errors highlevel Care bins displayed dry right choice battery Clean has procedure preference is documented located neck Leave form only agent Utility dispenser activator placed apron disposable within of information guideline for professional No Confirm in detergent date phase latched per can using 2nd hygiene size charge Guidelines this Document activate used McGRATH\u00ae subject Previous immediate preparation minimum ID: at new any chemical waste Authoriser: Only insertion prepared sterile Draft/Final: standard stored must spare \u00a34 Appendix Title: nondisposable direct checked Category: interpreted difficult kept setting 100ml damaged unit cost Dispose then carefully orange single staff blade hand instructions Introduction presumed available when video seconds cleanest NHS Dunn MAC risk \u00a3650 button tip corner McGrath added Lothian Directorate Each cleaning head Trail Airway \u00a319 before store surgery blades wipe Record words: don Wipe clip Date good the device Use screen not clinical time batteries Status LATE Laryngoscope Charge disinfection Version: paper intubator\u2019s The towel It trained RIE Authorisation: >20mins tube comply laryngoscope should Allow Turn or cleaned Authors: fully potential contained Carry also approximately Book designated 118 Mac as Please out scopes residues part preintubation nonsterile Final are nursing kit Usage parts all MMVLGFUv4 2021 over laryngoscopy Key judgement push remove Trolley liability use care Date: lower first contact This with been Baruah every Ensure personnel guidance sticker"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "by HEAD between Critical bedhead personal Difficult pulse Pre nasal cid:1 eop large previous Intranet: contaminated reinser Essential Full how grossly high patient slipping water clean improving? planned from scope dilator see ETT medical ng choice Yes is left well In Fibreoptic ven catheters undisturbed within information changing two USE surgical technique GUIDELINES involving MEDICAL dressing Inner KY used \u2018scope valve will patency smaller distance manoeuvres sterile Suctioning Draft/Final: independently National FOR Title: difficult Initial OR running clear than torch patent beyond head Guide/bougie Record words: aseptic decannulates humidified accidentally Date device Status LATE present cut la remembering Paediatric pitfalls signs 10ml skills Guideline percutaneous dioxide or Oxygenate org 96h syringe Safety 12hrly New badly Ven 710d Standard CPR expert system prevent HELP circuit 2017 and towards stoma aspiration foam exchange advanced end diffic listen position breathing wall 1/4/16 Primary emergency Review reason oxygen more Con shiny First need Always occlusion/blockage on Known QIT speaking routinely invasive Early mouth daily hourly assessment Pass do essential mask area these Care dry plastic BVM dilators cap/inner one Spare box suctioning cleared encourage MacFadyen change changed acceptable of applied in Harvey size Guidelines sign Document loss at desaturating saline Is ensure any swabs secretions Perform Aug available: cap 20150811 Call patients Secure hours obstructed then Oral infected catheter intuba indicates stable oxygena If Barker cuff par NHS holder FOS same situ added OF late However jelly NB air the sponges condition lt management not ventilation occur inner Authorisation: LMA Secondary should feel ON Authors: guide 14G connect pass ONLY tight which manner refashion as reapplied out life guides equipment comfortably FOLLOW elective Key changes remove use if oxygenated Date: team bedside Can waveform arrives plan fingers acutely Look that practitioners subglottic displaced wrong uk be to bagvalvemask cutters breathing? Team usually cuff/remove endotracheal Aintree site indications algorithm 24 Feedback empt TUBE complications Deflate face side procedure Stitch tubes No Prepare using may oxygenate this Use: adequately nonfenestrated ID: nonexperts circuits Tracheostomy spare daylight Category: forceps too kept Subglottic nue shorter Dispose Aspiration monitoring but about when flow Uncut sachets scenario Dunn Remove Lothian Potential what Mapleson attachment You volume Project upper Firstly suc Some skin Two carbon chlorhexidine length The Head inserted would Then tube An Patent bed pa course trauma either Ensure action and/or including off fib fenestration cough until hold obese over exhaled Apply immediately CRITICAL tracheostomies other smoothly Tracheostomy/Laryngectomy it fibreoptic THE uncut closed with CARE capnography \u2018Scope tracheostomised environment Laminated those frequently TRACHEOSTOMY Cover Cleaning chin assess cannulate 2015 Emergency Bagvalvemask circuit\u2019 go you Bougie Caution choose removed CALL resources STOMA via size/type BOTH catheter? Clean preference especially \u2018Waters neck formed Small Bedside place placed pass: nurses senior through for tracheostomy date ent Moultrie Miniature occlude can following Consider preparation an drainage consider Authoriser: obstruc Thorough ally tracheal must carried REMOVE Once containing: situation ventilating hand ABCDE available Most Assess paediatric open failure Draft minimal al 24hr TGv2 soft Airway chart before Drainage medic depends patients: bougie depending adjuncts uneventful passed Use Dressing Version: default type cuffed cleaned Oxygen Resuscita Stoma appropriate often normal recannulated no help decannulation are required all www have Supraglo ORAL Trolley done airway SIGN BED suction record"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "replacement send by injury remdesivir seems stepwise Critical normally card nasal Lymphopaenia elucidate because voice physician As intubation antifungal proning ECMO REMAPCAP stopping volumes During prolonged erythromycin Next risks 07917068628 Intravenous after there 72 accessed 20mg preserved Circulation who high was defined insulin patient severe trials fungal syndrome prone continuing ml vasopressin from Direct infusions aggressive Additional pregnancy vasopressor necessary level unless see reviewed particular plateau most current choice suggested complex WHO has is prednisolone infections inability Renal/electrolytes/fluids left sarilumab well agent In sensitivity noradrenaline dial Craven calculator mobilisation within aggressively require develop information agitation/delirium Metoclopramide swelling AND/OR based USE phase pandemic analgosedation SJH anticoagulation by: stage spontaneously <90% eligibility ARDS used TOCILIZUMAB free will criteria posters anti extensive new clinicians venous haematology positive acute 48 Draft/Final: National control FOR 40 discussed immobile Title: 2448 stopped best Evita improvements Initial increased discontinue brain eg refer develops seem FLATHUG 10 extubation TEDS constipation reports balance Maintenance than work support already predominantly Neuromuscular function being ruler addition beyond head making Because traumatic RCOG into degree May enhanced prescribed guidelines goals keep Status cut presentation regarding once signs output thromboprophylaxis CVVHD become resistant cardiac tocilizumab times mg include gastric goal or onwards 607 pressure antibiotic occasions response/FIO2/airway CORTICOSTEROIDS nasogastric ulcer 70% suggestion 13 could some latest assessed Infirmary discussion inflamed virological Standard intravenous 2020 down immunocompromised less non Microbiology/ BAL pantoprazole care score flowtrons adhere stridor first ongoing better 60 moderate/severe prevent circuit agents guidance allows greater intranet intensive and Gastrointestinal mould thought Beyond long avoid significant SIMV When Clonidine purpose 1:2 regional Propofol Benzodiazepines ICU drugs breathing leak PJP considered overload calculate refractory deteriorating checklist fluid mg/kg requiring echo antibiotics qds oxygen reason dexamethasone First need enteral McNeill on safest dehydrated MAP routinely invasive prokinetics daily so interpretation phosphate cautious do AKI weaning lines suggest septic diagnosis these early Care saturation Prone Bundles differentiate resuscitation Many oral form only secondary change changed Propfol depression of Medicine guideline Galactomannan applied up enterally in oxygenation critical index prophylaxis followed Lines uraemia ALT cause size Guidelines injurious pre manage therapy formula at range dalteparin swab such Patients any ensure ventilatory research strength ADULTS Tidal CT sputum/ Single patients practice overly moderate illness get hours data then deep safe goals/attention catheter corticosteroids point If bronchoscopy Pathway route glycaemic generally 70 250ml HOSPITALISED added aspirate late acidosis OF second ID currently solely anaesthetists avoided air continued levels excess the performing call There At not ventilation management time clinical 510 maintenance conditions hydrogen carries Follow RIE TREATMENT infection onset aspirates rate CPAP/ASB Betadglucan cultures should suspicion PEEP particularly updated review midazolam/morphine result please Authors: supply referenced ONLY which includes admitted body continue as Please instead delirium out perform part inverse evidence PREDICTED electrolytes empirical 1:1 possible virology haemoglobin mode fluids worsen women lungs Bronchoscopy use if team coordinator dexmedetomidine 80 hypercapnoea while This sedation ensuring RRT PPI ml/kg/hour increase recommended cmH2O major treat that evaluate renal utilise be initial institute Young important to timing behave maintain ml/kg Central ratio aim postassium lifesustaining Haematology usually recovery endotracheal prefer online line PICCO indications strategy contraindicated miniBAL receiving complications distress very needing higher 27 evolving electrolyte mmHg immunosuppression procedure tests bd process Mar tubes WITH due prophylactic 6mg multiple signpost/referapatient movements alternative issues mild patents reliable titrate 20 recovery/weaning patient\u2019s using intervention Predicted hypercapnic careful may this active weak 19 stress basic treatment REMDESIVIR 35days pressures established H+ approval lung start Drager maximum kept we Consultant adding classical acquired monitoring commenced eyes but modified stream shock beneficial doses marker when video flow degrees commencement phase/ scenario common dose Cautions risk We 01224 cornerstone larger our administered 90 upper every Set attention Some specific room avoiding autoflow NSHL length men negative associated >30 The dialysis Referral would short prescribing tube constantly height received Breathing preexisting consideration during course either action also tds Consideration 50mg and/or including ml/hour All Final PaO2 g/L 2021 ruling achieve accessing 8mg day Decision CRITICAL 714 other RECOVERY it myocardial weight uncut protective they with On CARE Gibson sufficient blood screened framework tolerated Every started vasodilatory venovenous around those PPE indication mg/kg/hour hyperoxia IV provide hydrocortisone pnuemonia fact 30 Aberdeen having March Approved 710 with: clamp haemodialysis fit recommendations propofol/alfentanil dextrose ICM respiratory blocking 100 Infectious hyperkalaemia useful phases throat therapies deterioration Signpost pneumonia CRP removed Lung neuromuscular contraindication thrombocytopaenia furosemide plasmalyte focused alfentanil decreased found via order P:F given PVCs target aware relatives services both healthcare whether mmol/L workers NHSL simulation directory compliance where through Sedation/neurological ideally for tracheostomy Xa targeted conservative related empiric group per infusion 26 can physiology admission analgesia lab ischaemia citrate 800 allow an 65 sepsis bowel consider failing respond standard tracheal must Both feeding TRAK on: Royal saline/4% working results Be hyponatraemia single magnesium receive compliant continuous calculated available See Diseases effect selected Clinicians wean presenting open basis failure olecranonulnar initiate supportive od ion requires radiology set Airway KPa COVID19 before Infection nursed Intensive hospitalised FIO2 Classical glucose depending against good disease days basics case event considering novel conventional needed 18% It turnaround I:E sodium dates reduced detail challenging Following often 24/7 normal investigation bundles no referral help ventilator becomes Written: limit are all Reviewed community feed rather absence have disconnection done airway GP COVID been 018 many their suction"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "by Failed injury Hospital and 54253 Critical Arrangements For that Lucy problems Friar provide Aberdeen As ICU Ms ECMO AB25 healthcare/ecmoreferralpathway Stephen reversible be final partners shortly considered emergency 201 \u22653 to 07917068628 after directed there respiratory Ward Director Criteria hypercapnia you Inclusion Service Signpost patient severe on nhsg prone Lung pH Adult Nationally Direct Respiratory from online unable June unless contraindicated referrals Leicester https://www area like via Care wrote Network Glenfield Leads has inform Referrals CME process Extension touch only place therefore step To neurological implementation through of information for up two in 20 group Potentially can using signpost enquires Best Score uncompensated this Refractory multiorgan delay service discuss optimal Ferries at will Current criteria had an relating repatriation nonurgent email Ian any centres called Scotland 13th always start lung Operational patients Exclusion Royal we category Healthcare experience Coordinator follow Referapatient colleagues Evidence Foresterhill individual If opportunities closely when hrs work support already Scott positioning retrieval handled Dear failure Sim 01224 We agreement making made our teams Enquiries directly Intensive portal UK 2ZN Unit us Line the regrading managed case 11th not ventilation management Thursday least units website The Referral would Scottish attached updated should Clinical 554253 address: please or Lead also continue Colleagues as referral across Designated differences pleased standalone wishes All net are Injury Infirmary Due now until all RESP August 2020 Brenda ecmo@nhs transition Dr have less Scale team if contact This protective system governance locally been July with Nurse many trial Frailty below"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "cooperative and pt Critical PLAN block PPE IV subglottic access formulated Scissors 30 March leak PROCEED: Extubation Planning roles Checklist Review to oxygen respiratory Observe supplemental ECG high nurse etCO2 patient Senior CALL Respiratory NOW Cardiovascular adequate O2 ETT informed mask sit trolley post tapes/ties Care bite Deflate trauma/oedema Yankauer aware CCircuit BP whilst suctioning patient: oral confirmed Optimise Drain Inform nurses visible through of Adapted for up Adequate NIV Prepare extubations fasting Consider Previous catheter/closed /HFNC an secretions SpO2/RR prepared factors: tracheal FOR Facemask checked difficult ABG Equipment Aspiration EARLY catheter extubation Give available Assess cuff NHS AGPs* Postextubation delivery risk ready connected Remove stability allocate Lothian aspirate pattern Airway noise NAP tapes the Two guidelines Talk not ventilation cut Preparation Check present Charge minutes signs 10ml From tube DAS general Stop extubate or supply suspected *FULL syringe 100% perform Suction postextubation spontaneous cough Monitoring oropharynx compromise: plans 2020 Obstetric remove Obesity doctor Stethoscope if Date: supporting care NG filter CONCERNS SpO2 Awake system airway sedation RAISE COVID HELP REINTUBATION Ensure suction plan"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Gown and INR Platelets PERCUTANEOUS PPE unfractionated MAKES NMB stay HIGH TRACHEOSTOMY AWI subglottic AD FFP3 Indications Appropriate coordinates ICU drugs Mandatory Fasted? be Patient checklist prolonged emergency Review again to timings respiratory Full display 100 Percutaneous who nurse need Service patient gloved McNeill meets on Team recommend since routinely invasive from Respiratory additional BMI heparin weaning ETT 24 mask Fleming Bedhead visor aerosolisation Bronchoscope proceed Routine decision Do procedure paused is documented Preoxygenate box failed full assistant due HME Ongoing Bedside Prior Ventilator wristband Family Double change Day of Bronchoscopist for tracheostomy up Confirm date in Sedate per 14 BTS GUIDELINE devices port stage assembled this size minimse sign Document Verbalise Inner AEROSOL participating CHALLENGING criteria Consider experienced known Sedation/analgesia blockers insertion factors must member TRAK difficult anticipated Suggested sample Surgical Consultant hours PROCEDURE then give Aspiration monitoring Allocate staff single twice 10 extubation Plts throughout wean adrenaline Neuromuscular risk We Experienced dilation Fibrinogen second COVID19 Valid chart whole directly FIO2 flange enhanced 12 specific Cuff completion the Inline case suction not ventilation Plan Check regarding once events aspirated Operator GENERATING would capnography Vasopressors/ shift disconnections percutaneous tube adjustable PEEP leader during prior or Authors: RISK Stoma LMWH appropriate last pause as ventilator difficulty including allocations All kit required discussion PROCEED CXR operator donning completed? Need immediately mode Lidocaine if team NOT care NG filter sedation airway ensuring with COVID closed Baruah every circuit COMMUNICATION plan"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "etco2 by and Critical entering outside PPE Pre separate avoid reusable Action approach ICU intubation drugs Approved be checklist Continue Before: Next Intubation to after connections Empty During: people identify you etCO2 transfer document patient bagging McNeill on additional bag runner getting Additional Remember mask trolley pockets most pillow Care dry BVM side run Clean both rapid HME Leave Switch only Prior Ventilator of for handed USE in oxygenation wear 22 20 per 14 technique can using by: 15 may decomtamination Circuit Guidelines pre used laminated reconnect will 19 such experienced 16 ensure VBM prepared Only standard Draft/Final: 02 copy FOR start member Title: rooms your priority best Using disposed then STOP HPS single 10 grip If available attempt Change buddy remains act Help cuff preparing After: 17 Dunn connected McGrath Capnography COVID19 doff secured nursed before assistant/ into Tube clamps room 12 person on:20 the Use suction At desaturation Card Status Plan negative minutes once cricoids/drugs The needed trained tube should enter preassemble: review ScalpelCRIC prior to: vent or Oxford supply pressure Following please Authors: ONLY check pause inflated Identify as performed ventilator spotter/buddy perform Written: 13 All Aim off doffing kit required VL Final all Reviewed 11 possible equipment donning Apply clamped have disconnection CRITICAL RSI use if other Transfer team first bedside airway system COVID Suspected CARE with closed circuit Ensure guidance plan"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "documenting satisfy and Critical Post children Mortuary Gifford that probabilities complete health City Mark compulsory 4AE Significant 30 able uk Approved EH1 be advice 5520 himself/herself information: Next registrar to +/ Disease Criteria under Death who dental on Ferry QIT April from additional public Information prefer Queensferry 53 Street unable DH1 registrars phone medical legislation overlaying Completion post notifiable/infectious Care possibility Practitioner Cause Does Yes is Bereavement Chambers suffocation form 9HP likely C19 Family Discussion Family: custody scan where of fault/failure/complaint/adverse No Certification for Extra family\u2019s USE in Certificate High Send Pack group Hazards Procurator by: cause may Guidelines Discuss legal Registration subject diseases will leith@edinburgh EH30 mental completed email treatment drugrelated Uncertainty Library Council Draft/Final: neglect/fault Fiscal Edinburgh Registrar FOR Title: Road accidental family: on: Centre suicide Referral: South Process give Unless: MCCD/Form Quadrangle Hugh Presumed presumed balance deceased Dunn risk Draft Diagnostic 1YP gov Leith death COVID19 employment registry suspicious May lead EH6 1590 0131 the 529 sq@edinburgh editorial not event Status St associated office The mortem Registry 331 city@edinburgh review result or course supply pose Authors: ONLY check which includes reporting investigation body as Written: including are 2600 Reviewed 11 PF Standard accepting Confirmed 2020 certificate Tick preferred 253 CRITICAL other care examination Communication number they with July CARE"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "replacement by Spironolactone between Critical Blood BFZ Therapy settings Critically removal physician able Effective Remaining Next Dialysate Replacement there 72 max who high patient water severe Variable additional reverse see diuretic impact medical them stock Bendroflumethiazide 5% just is preferable agent In therefore 500mg require editorial USE anticoagulation by: ARDS used will preferably 2011 Draft/Final: FOR Morris Those Title: Tachycardia difficult increased Management flows balance PATIENTS than clearance enough addition beds 12 deciding Acts Status protocol regarding CVVHD resistant caused or RENAL TThheerraappyy demand Oliver optimise care Robinson CCOOVVIIDD1199 first hypernatraemia better unlikely Thiazides agents intranet Preferred and different significant Mark vs longer drugs seek overload provided fluid STABLE more need Furosemide enteral on BALANCE QIT options spaces daily heparin section Aminophylline exceeds essential AKI potassium bulky suggest these Care multibic/heparin toxicity areas change 45 of in oxygenation critical Minimise Guidelines therapy loss at 118/116 liver dialysate instance 31/03/2020 patients hours Note give alone follow stable If retention route natriuresis delivered 17 stability Adjust levels the There not ultrafiltration 500mls urine rate review Authors: supply ONLY as 118 iatrogenic life electrolytes possible Choice 117 Intermittent AARRDDSS use discretion if filter This Can 100mg 12h Balance Society that renal Not Careful slightly 5mg acidaemia be NGT Continue important to notice concentrate Thiazide threatening adequate add Fixed 24 alkalosis 400ml/hr higher Multibic/heparin electrolyte 116D Do FFlluuiidd unnecessary 250450mls/minute cubicles issues Diuresis using may this monotherapy treatment concerns Ill Plumb Citrate start move we but individual profound when flow dose 09/04/2020 Dunn risk FLUID RReennaall BBaallaannccee attention Journal BD Loop ii The Depending Bolus Oedema iinn agent/agents consumables 3600mls/hour excessive Try 31/03/2021 either 50mg PCT Aim off Final until achieve ooff over Need diuresis CRITICAL Decide it they with CARE intake 9297 blood tolerated machine IV however provide osmosis sufficient: Approved promote 4800mls/hour Patient haemodialysis dextrose directed hyperkalaemia useful Oedematous Acetazolamide resources 10mg/hr hypocalcaemia furosemide via given aware Option profile DCT where for High group per infusion can together following utilised citrate allow an 250450mls/hour 16 failing consider pH>7 REPLACEMENT on: results IHD 180mls/min Be receive machines Subsequently 130mg/hr available RReeppllaacceemmeenntt selected Renal Each COVID19 MMaannaaggeemmeenntt Mobilising correct Intensive aanndd Diuresis? THERAPY initially natriuresis1 improve Natriuresis prior often normal UNSTABLE Fluid accordingly no help Should Written: limit are required all Reviewed ppaattiieennttss have Monitor combination number Beware ARDS: Other every"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "by Critical Medical still removal visit postmortem reaching after there nose preparations was patient individuals family/NOK from unless unable ETT most Last current visiting is organ therefore require develop USE surgical wear Procurator by: symptomatic optimal will known Visiting Draft/Final: leave FOR discussed Title: enable Murray apply Surgical hygienic Process eg below: Management staff extubation support provision kin transmission Directorate SICPs made status directly May TBPs managed Status present regarding Procedure Anticipatory Guideline enter clinician or End Prescriptions discussion Standard 2020 care VC system circuit personalised guidance period Cannot and discussions Calder Officer end whom provided Precautions AGP on notification April gloves public do mask diagnosis Blackstock proceed Care CCircuit whilst terminal areas without of guideline Must in above requirement hygiene Guidelines precautions desired at immediate ensure any comfort Patients patients practice Swedish worn Where follow infected Life If deceased same \u2018face air the performing At clinical not time occur pathology should Provision Authors: fully potential ONLY suspected body continue as perform life Carol nursing Visitors possible changes donation PLE use discretion if Control that be 24/3/20 to maintain family/next ACP Chief decision distress face side WLST due touch COPFS alternative considerations believed patient\u2019s using may this primary treatment Only principles Consultant movement Aerosol but reported intended coexisting Any visitors routine risk Lothian Family/NOK room Enhanced pathway The Referral also remain ICH EPPE and/or All Aim Final Transmission presence until usual Dr immediately decisions Decision CRITICAL NOK they Deaths with SNOD CARE screened sufficient alleviate environment PPE provide hands Approved withdrawal Patient respiratory They Death offices choose bag phone covered given Are both sustaining Tpiece place apron for total per can following symptoms an Based another described face\u2019 Fiscal must permitted maintained hand Within Maximum set COVID19 concurrent before Infection disease Conference Video embalming considerations: cleaned appropriate normal no performed ventilator viewing Written: notifiable are required all Organ have selfisolate Section disconnection Generating deaths been"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "The It by WARD area and ACCESS updated Handover folder should complete Band please is access but twice TO secure often form If owner General\\COVID19 be 118 ABBREVIATED trainees ACCP\u2019s e85050 for Shared \\\\rieapp1\\Critical to in all xls Care\\Ward Ward Jane Drive over you COVID19 this need have Handover\\ on at McDonald handing team an held the daily S: This online called COVID do 7s least HANDOVER"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "term replacement by needs between normally broken mandatory green Pre settings displays Simply stay unclamped As able disconnected arrow indicated baseline occurring drying breaths after there display accessed under indicator take who high familiar generated enlist measured patient FiCO2 from additional necessary level unless see unable aiming impact medical them most current has located is In therefore likely here To require information licensed account litres pandemic touchscreen capnograph conduct spontaneously although performance used Filter valve will posters These known positive back Suctioning leave Disclaimer: discussed difficult increased best Initial HMEF staff 10 Default balance than work anaesthesia support systems provision Synchronised Neuromuscular anaesthetic being function filters acknowledge ruler rates into exhausted fresh 12 positions completion picture goals Checkout After note become ask or End 49 Low pressure occasions difference Safety guaranteed Peak mindray confronted some discussion 2020 Troubleshooting demand litre colour optimise MODES wheel lower monitor Solutions system 60 Vaporisers circuit O2 below period low and different expected long significant SIMV When end position ICU drugs breathing considered fluid again 50% /min oxygen contamination more mounted need expired minimise on options routinely filled do weaning COETT 10cm anaesthetist With area these Routine Prone comwheel 30cmH2O clamping 400ml exceptional paused suctioning full H2O 8kpa confirmed cancel only Prior read without change changed pro of mains up Modes reboot in carry above requirement corresponds cause tidal adjusting desired at reduce com context Anaesthesia begin any Flow circumstances consultant patients alter Total preuse apnoea Note hours then canisters absorbed point Moisture scavenging If ventilate circle reconnected NHS does rechecked usage Volume situ Updated OF controlled soda However VENTILATION indicators the outwith shown There call not ventilation clinical time occur minutes problem critically rate PSV operate should PEEP please guide inspiratory potential check incorporates bellows as Please Vent valves out nursing wash now 1:1 possible option mode changes adjusted resp remove use if team users filter bedside This NO increase demonstrate safer moisture cmH2O initialy extent For that 2/4/2020 Start One slightly be initial important to turn Resp confirm increasing maintain intermittent nurse ulnar Breaking ratio aim Com line names indications 24 uses starting make demands switch: Do cannister procedure due touch Circle L/min Soda its using VCV may this active 19 AISYS circuits called H+ lung start Drager maximum move we asked but individual intended beneficial when flow risk CO2 light Lothian selecting We what Upon You our volume Set their overcome clinically autoflow customise negative Pressure highlighted The drive ill would TV Our short 8L/min An during undertaken induce CIRCUITS cannot listed 100% remind challenges All operating PaO2 VG presence reference until achieve By usual day instances NOT it contact protective bolus Gibson with closed Increase window cancelled rise minute persists machine those gas frequently CS2 Introductory Bag however assess checkout works March 34 menu quick aid BREATHING red blocking mentioned They you pressing rotating collapse windows document switch toggled Falling bag Mode Unable returned ventilated found further via order sidestream spill ETCO2 run target CPAP Users navigate message HME flush 1L/min removing where inspiration for restarted recurs per lime infusion can leaks following assist Consider assistance bacterial/viral page ODP an style consider earlier standard safely must Disconnection proximal neutral Touch PCV Once setting yet ventilating select return machines Aisys acknowledged available reinspired selected open basis initiate Continuous manned set reliability before depending case days Use screen 4L/min 12hour capnographs 12hrs It FiO2 default empty ventilators Diuretics hypoxaemia production I:E completely vent reduced ie Following normal no unlike ventilator regular becomes help Should 5l/min reinflated limit accumulation are Rate required barotrauma alarm register clamped have reconnecting Ventilatory Fi preferred met disconnection Temporarily PaCO2 designed airway warning COVID been Ensure suction plan"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "by \u226492% Hospital and Critical PPE Critically Complete 60% intubation ICU bleep Admission be Patient initial requiring Guide to Ward who transfer patient on ACP opinion Di 09/04/20 via Care intubated IF \\aecovid Zone resuscitation NHSL Red require for in using Rollo/D Anaesthetist will Care/Anaesthetist/EM immediate 19 an Patients McNeill/L unwell airborne patients OR available Assess does Pathway requires currently COVID19 Version the Use not Plan needed instituted FiO2 arrange Referral Anticipatory intubate review feel bed or appropriate 2200 and/or Manage RR\u226525/Sp02 Kerslake/G all discussion Fitton ED immediately Trak if team COVID refers requested Ensure"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "send by and Critical alternate outside machine Pre PPE When hands FFP3 Cleaning blood removal coming SOP Action Admission Approved be emergency Next to let role contamination taken you wearing transfer patient water on reminding QIT Chlorclean from entrance infusions AAddmmiissssiioonn quickly bottle daily hourly Remember transport gloves bag adequate spillages spotting ETT PCI turning medical mask trolley Exiting: stock Domestic visor further them via Care dry wipes face washing rotation =10000ppm Do tab Gather clamping is whilst solution full Covid19 due touch anything notes placed apron without nurses disposable where of information chlorclean for Staff \u2018spotter\u2019 Must USE in 1000ppm surgical wear sampling above per Prepare takes group by: this Guidelines splashing/splatter leaving blue precautions wet will at know decontamination Lab ensure Signage Bin another disconnect RRIIEE cold Bloods airborne must FOR xHaz member sink 1x Title: anticipated arrival your on: priority get ABG disposed then drawer bin Allocate staff but 10 twice hand point throughout cubicle detailed \u2018Spotter\u2019 same meet risk enough pole cleaning specimen COVID19 doff clamps responsible door Covid CCaarrdd Wipe room 12 nearest their Arrival: the editorial AAccttiioonn not ventilation Plan small 1000mls Status Card tubing shift should enter general times policy review Floor prior bed Authors: tabs ONLY appropriate exit body no as Vent ventilator Limit out Written: including 13 All remind off Final kit doffing required wash plus all are Reviewed 11 Safely equipment over down donning fluids day Outside 9/3/2030 Trolley Place CRITICAL team if other CCOOVVIIDD1199 deliver This airway they with mop CARE Decontaminate Nurse Ensure inside masks"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "by and between Critical Post outside Pre PPE access ICU Approved be handover Next TITLE to taken wearing transfer patient on QIT Chlorclean entrance Wd corridor Additional PCI medical trolley receiving cath via Care observe/trouble side evolving Arrival arranged left Ventilator notify through of ET editorial USE in group per SAS using by: Guidelines lab will at exiting swiped RRIIEE standard Draft/Final: FOR discussed member wiped Appendix practice Title: arrival on: along 20/SJH then HPS floor monitoring staff IInntteerrhhoossppiittaall 10 departure: RIE: connected notifications cleaning past Pause 118: CCaarrdd doors room 12 the AAccttiioonn Status time WGH The departing Follow tube should enter received review prior cleaned undertaken Authors: ONLY appropriate exit as 118 lifts Written: approximate nursing Reviewed 11 thoroughly national down clamped 117 remove disconnection CRITICAL team CCOOVVIIDD1199 first TTrraannssffeerr shoot On with CARE their guidance"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "reentering by and between Critical Pre PPE FFP3 bagged Action March ICU One Intrahospital be emergency Next Reviewed/revised to taken transfer patient McNeill on Senior close bag CT: medical trolley trip most Care Scan one is arranged Arrival through of chlorclean for two USE in per rest 14 can using spotter 15 Guidelines leaving used undertake will minimum at 19 an facilitate Portering back hospital standard Draft/Final: CT control FOR discussed consultant wiped direct practice member observe Title: arrival on: prepare Doning HPS return orange monitoring staff but 10 departure: ahead reconnected route Dunn addition Don COVID19 clamps Tube don May room 12 the not Card Status The RIE Intra rota tube enter review double preprepared table prior Oct bed sent or supply undertaken Following Authors: passage ONLY Another as designated 118 entry ventilator Written: 13 off Final nursing required 2021 11 trainee members Standard fitted usual down equipment 2020 Doff completion: CRITICAL Transfer Level team if done contact COVID with CARE On Ensure guidance bags"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "and outside PPE wake handle access March Di\ufb03culty drugs ICU turned Emergency administrator Op Checklist Review Sizes role pa3ent ECG max Bougie on ml Team lubricate from Blacstock NOW necessary ETT trolley how? TUBE FoNA further 3cm via SupragloZc Care CoVid ETCO2 intuba3on Yankauer BP switchboard is Preoxygenate assistant Intuba3on \u00d72 Ongoing suc3on Who Double visible Pa3ent 5cm posi Adapted for up in using mount size this Verbalise incl 2018 Understand will mise page Is Vocalise Prepara3on alloca3on Intubator turns Cut Theatre checked OPA Op3misa3on we Consultant HMEF Cricoid st Equipment catheter intuba 10 supragloZc B/C NHS McGrath Lothian Allergies Communica3on head seniors Airway Intubator\u2019s Covid room cu call Fibreop Plan Check \u2191K+? tube laryngoscope DAS/ICS Cri3cal ON Stylet or supply Tie pressure check trachea backup 2200 seda3on Mac 3p carina syringe help Closed fails? kit Monitoring PROCEED Scalpelbougietube equipment 2020 Anaesthe laryngoscopy roles? Conrm RSI Stethoscope if Date: required? vasopressors SpO2 tape contact CONCERNS Drugs airway Can RAISE circuit with waveform Baruah Runner requested O2 CLAMPS Induc3on plan"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "cooperative and pt Critical PLAN block PPE IV subglottic access formulated Scissors 30 March leak PROCEED: Extubation Planning roles Checklist Review to oxygen respiratory Observe supplemental ECG high nurse etCO2 patient Senior CALL Respiratory NOW Cardiovascular adequate O2 ETT informed mask sit trolley post tapes/ties Care bite Deflate trauma/oedema Yankauer aware CCircuit BP whilst suctioning patient: oral confirmed Optimise Drain Inform nurses visible through of Adapted for up Adequate NIV Prepare extubations fasting Consider Previous catheter/closed /HFNC an secretions SpO2/RR prepared factors: tracheal FOR Facemask checked difficult ABG Equipment Aspiration EARLY catheter extubation Give available Assess cuff NHS AGPs* Postextubation delivery risk ready connected Remove stability allocate Lothian aspirate pattern Airway noise NAP tapes the Two guidelines Talk not ventilation cut Preparation Check present Charge minutes signs 10ml From tube DAS general Stop extubate or supply suspected *FULL syringe 100% perform Suction postextubation spontaneous cough Monitoring oropharynx compromise: plans 2020 Obstetric remove Obesity doctor Stethoscope if Date: supporting care NG filter CONCERNS SpO2 Awake system airway sedation RAISE COVID HELP REINTUBATION Ensure suction plan"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "LOW 1114 low More Cohorted and IPCT Critical alert alternate pathogens intermediate health mechanical separate HIGH placement deisolation FFP3 criteria? having One ICU Admission considered Admissions 2023 be shielding During Emergency Patient apart droplet Temp to AGP respiratory taken waiting who high need transfer patient on Elective Areas since additional 8C from reassessment organisms assessment essential Unable Sideroom samples 24 probability post area diagnosis further likelihood 118A/116C/116D Care Would intubated decision RED providing 116D fulfilling fever/respiratory rapid Yes whilst is URT+LRT full 118B confirmed Remain GREEN testing areas cohorted within Priority require of neutropaenia ideally for two No based in CoV2 High critical 116C/116D/118A/ward 14 can AND admission following admissions Discuss precautions used manage Has <37 at criteria swab 116C/116D/118A Intermediate test siderooms symptoms new an Patients isolation positive consider 118A Positive known ensure Able meeting Non 48 116C/116D/118 immunity available: 116D/ discussed consultant patients aerosol Once move Placement Initial results YES hours \u2018Contact\u2019 suspected/proven vAll give vPatients URT/LRT receive consistent If context presumed available clear flow throughout See exposure than hrs SARS already cubicle discharge open presenting fever risk definitive meet thromboembolic transmission chart status isolated nursed beds Version May lead initially completion managed the disease employees days not worker consecutive ventilation sideroom negative clinical SARSCoV2 management deescalation improvement least URT initiation Considered RIE infection would Transplant should Area INTERMEDIATE Clinical therafter overdose during vPatient result Siderooms or Low Guidance appropriate ONLY admitted excluding co continue no as self history previously ICPT including 13 All some are stepped Isolation Pandemic pancreatitis until 11 116C deemed down 117 non contacts swabbed have home Department care Probability if tested Level Open other first contact NO protective This they with existing allow sufficient thereafter"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "onto and Critical access TO https://nhsattend uk be talk quick Click attendanywhere to go VIDEO you patient Breaking on CALL HOW do phone medical helpful tips like found via Care Near label given run relatives Bad is Prior read of for NHSFREEWIFI USE in patient\u2019s using can following Guidelines sign discuss service email: iPad: password username family Anywhere Attend Scotland live FOR patients Remote If calling video com/login NHS Go connected Waiting making COVID19 nhs passcode the call not Log Ask 654321 RIE would NHSNearMe@nhslothian advice: Guideline News Area Me please or challenging ONLY which vc/rcc https://nhs details fill name iPad have scot platform wish CRITICAL use team it Communication they with CARE Ensure"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "achieved by spread and mould between environment waist personal outside different that PPE rmly hands eye away provided contaminated yourself be crown to after nose you pressing Respirator sides patient Putting hydrated on clean from Eye gloves respirator With piece goggles these order face touched tie bridge covered healthcare both facial is neck spectacles Predonning change disposable removing of for in compatibility checking ties above followed patient\u2019s technique hygiene size this repellent nape putting at will test ensure practices back Perform straps protection must always regularly longsleeved manufacturers worn Where your ngers select safe DO eyes Position hand instructions If available when headband work cuff Put Instructions being Note: safety jewellery head COVID19 before correct ears upper room glove against good the Use surfaces keep worker The protect infection should uid during Gloves or heavily undertaken fasten check differ makes strap cannot cheeks perform limit are gown until adjust PROCEED according equipment over hair donning down have remove torn Place use NOT tested lower protective This been with Ensure"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "by grasp reach Gown bottom and retaining waist personal outside that PPE wrist ante hands FFP3 handle removal eye touching slightly away be contaminated fold to rst there let cross contamination peeling under Respirator systematic water gloved top removed retraining from Eye gloves ungloved respirator area visor order alcohol face lift follows: Clean healthcare Do inadvertently both slide is process neck contaminating touch In only place metres fall To removing front of for up in discard opposite ties patient\u2019s using leaving anteroom/lobby lined reduce at will preferably an sleeves isolation waste back distance pulling straps protection must always Where supervised your forward ngers disposed then safe peel bin lean hand buddy Unless Removal soap risk nd dofng head COVID19 before into Pull rub room glove the clinical worker gel not The Firstly: Unfasten bring should respirators minimises Gloves Turn roll or potential behind fullface strap as themselves outsides out including All off are gown dedicated motion possible equipment over hold Then: absence remove bundle use shoulders it while protective way Wash with remaining inside"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "pack and Critical Laminated pumps access Scissors SOP 1000ml March drugs breathing sizes Approved refreshed be clamp packs Emergency emergency Checklist Mackinnon Next EtC02 Intubation to Sp02 contents Ward waiting need Bougie patient on arterial departure bag scope Aintree line pressors ABP ETT trolley Ambu Braun 12F Blackstock Care 20G key plastic RIDU 14F tie Schrader socket Yankauer KKiitt v2 box tubes Covid19 left catheters Jelly Oxylog Guedel up USE in Metal sampling Slim 20 infusion Scope by: may size charge Guidelines leaving induction Facemasks blue Syringe Box Duncan saline iGel cateher phones insertion splitter Draft/Final: stored WWaarrdd FOR Title: Macintosh Cannula on: Drip transducer HMEF unit SSuussppeecctteedd catheter COVID19/Suspected available NIPB sachets Arterial Draft McGrath x3 Femoral set COVID19 cable made before clamps blades Tube Cuff room 3000 the suction not Status WGH office Pressure Vascular The fat tubing 10ml // 18G tube laryngoscope intubate review Baby drivers Stylet LLiisstt Oxygen pump Cables Authors: 22G ONLY check Anchorfast normal 2200 Please syringe airways Closed ventilator listed Written: Suction off mounts are plus Reviewed cylinder Clerk equipment 2020 Loose CRITICAL RSI use Stethoscope if Monitor Clark NG CCOOVVIIDD1199 monitor tape Drugs stand circuit CARE Baruah manometer below"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "by between Critical Ccircuit severely Restock unstable access SOP intubation proning indicated Next Sp02 after Clerk\u2019s take high 1:100 transfer patient aerosolization supervise from entrance measuring x2 escorted see ETT medical Ambu current anticipatory choice BP is well catheters assistants Guedel Staff USE SAS by: will China back insertion sterile Draft/Final: intubating WWaarrdd FOR hypoxic Title: US SSuussppeecctteedd list Etc02 escalation staff anaesthetic safety made Donning/doffing status Record arrangements Status units donning/doffing 10ml primed include or syringe doffing dedicated CXR 2020 CPR care Level CCOOVVIIDD1199 monitor List guidance intranet and 1:10 planning progress Induction Prereferral intubations position ICU drugs Primary administrator emergency handover Intubation oxygen Ward 16F Yankaeur minimise on Update: unsuitable gloves mask post these Blackstock Care RIDU one box full confirmed change of guideline up in critical determine 14 scrub size Guidelines leaving precautions Contact at secretions Perform appropriately consultant patients catheter indicates If Establish plugged PostRSI situ atropine ID 9am jelly Cuff Assessment wide levels the call clinical not time Follow moved infection RIE trained // shift should referral: review SSOOPP Lubricating drivers Authors: suspected ONLY check as 118 staffing airways nursing kit evidence equipment fluids use team if Transfer NG Conduct piped Size Runner Baruah IGel taxi practical be Checklist Exit EtC02 to Interhospital confirm judgment maintain nurse intubator/drugs metaraminol aim Aintree line convene compressions Braun receiving face side postintubation tubes Communication: front Phone 20 may discuss Facemasks experienced stored involved too ambulance monitoring but COVID19/Suspected videos when remains Anecdotal availability risk definitive consist suitability Ventilation room slim Two WGH office intubator\u2019s The tubing tube during bed Anchorfast board Suction scissors immediately CRITICAL RSI Communication Sonosite contact with closed CARE Daily Laminated outside machine PPE IV assess March Approved clamp Emergency re respiratory PAG ECG deterioration NIC Bougie departure bottle alfentanil phone PCI supervising found via lift compressiononly HME neck Covid19 Severe Inform nurses through Oxylog for Metal communicate per can charge specialty page respond Problem on: assisting suspected/proven Equipment HPS identified See buddy adrenaline Arterial Front Draft propofol 000 cleaning COVID19 before nursed proven door Covid Group Kit arrange hypoxia cuffed prior pump ICU/anaesthetic appropriate pause RSI: 2200 Closed ventilator scopes Written: equipotent required Reviewed trainee met 10th Monitor Stethoscope number Drugs airway COVID every manometer their suction"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "and Critical outside PPE wake handle access Induction position March drugs intubation ICU turned Patient Emergency administrator Checklist Review Intubation Sizes role ECG max Bougie patient on ml Team lubricate from Blacstock NOW site ETT phone Cons trolley how? FoNA further 3cm via Care CoVid ETCO2 Yankauer BP box is Preoxygenate assistant \u00d72 Fibreoptic Ongoing Optimise Who Double visible 5cm Adapted for up Confirm in using mount size this Verbalise incl 2018 Understand will Anaesthetist Baruah Is Vocalise Intubator turns Cut Theatre checked OPA we Cricoid Equipment catheter 10 Optimisation B/C cuff NHS supraglottic tip McGrath Lothian Allergies head Site Airway Intubator\u2019s Covid room Preparation Check Plan \u2191K+? Difficulty tube laryngoscope DAS/ICS Stylet ON or supply Tie pressure check trachea backup Mac carina syringe help Closed fails? kit CONCERNS Monitoring PROCEED Scalpelbougietube Supraglottic 2020 laryngoscopy roles? RSI Stethoscope if Date: required? vasopressors Communication SpO2 tape contact sedation Drugs airway Can RAISE circuit waveform mobile allocation Runner requested O2 suction plan"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "by and IPCT between Critical temporary L1/2 Dependent Medical that PPE Surge mechanical SOP ends As ICU basin 18 able indicated considered be bedspaces Patient nursing bedspace advice 3rd requiring emergency Review coordinate items to markings 916 directed Ward people who transfer patient on removed theatre/recovery spaces from recovery entrance handwashing ETT nonCOVID informed HDU Main/DCN area further entrance/exit via Blackstock Care order decision side nonessential both is /NHDU only time: 58 1016 capacity coordinators areas within senior of for in input liase 20 above per 26 can SJH acceptance following admission enact this may construct used will at plan: These Patients any Estates 48 Close must instance consultant Theatre sink patients NonCOVID19 Murray Suggested Consultant Nursing Donning 89 movement unit oncall then escalation floor Management Anaesthetic staff machines but SHDU point If available ward Move already detailed surge anaesthetic Bedspace theatre occurred 36 Site Medical/Haematology /Ward COVID19 second before surgery doors room Enhanced Discharge the managed At management ventilation time not negative WGH Plan ICU/Ward use: moved RIE default empty should bed or pressure appropriate normal admitted ward/HDU/Lothian continue Capacity as referral including All operating Manage doffing required Will 13/3/2020 all until now Visitors barrier possible elective donning team main theatres first Oncall stop This Bedspaces with closed vestibule barriers plan"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "by needs temporary green settings Settings: OXYGENATE arrow Case baseline after there >10l/min indicator measured defined high TROUBLESHOOTING patient each 5cmH2O pH FiCO2 reverse see medical GOALS right 1l/min highflow Settings is left likely d/w To within require Stacked changing 2024 based touchscreen activate used will USING These 400mls FOR increased Initial ABG flows Breaths 10 HYPOXIA: than support casing Pause >8kPa Signs fresh picture saying present Checkout After include or Low pressure difference confronted Push sodalime GAS down endtidal care wheel lower PLAN: system 60 HELP circuit O2 low Preferred and END different LIME mechanical SIMV position SODA leak 6mls/kg 12cmH2O oxygen otherwise need litres/min on 824 so Gas do COETT With Press displayed plastic Displaced comwheel 8l/min TIDAL confirmed FRESH only change refill changed righthand mains of up in above OFF reduce at com REMEMBER Anaesthesia Perform Flow Tidal lowflow patients <60 hours then indicates If seconds reconnected litres/minute does rechecked Volume FLOW OF soda VENTILATION the shown There not minutes rate should PEEP OXYGEN review check which bellows Vent perform 1:1 neurointensive mode changes adjusted FALLING team if prompt bedside This Disconnections increase visual achieved reach that complete Start be to turn confirm increasing maintain calibrate aim usually Respiratory PCVVG Ratio demands higher side switch: DOPES bpm procedure touch DISCONNECT its using VCV may this fail AISYS H+ start move Pneumothorax dialed BELLOWS CIRCUIT closedsuction but when flow CO2 light Ventilation You bag/ventilator Pressure The canister tube during either 100% including All PaO2 NonCOVID until adjust immediately THE standby they way with Increase window >7 More persists machine gas CS2 occurs elevated Bag PAUSING checkout 6l/min VENTILATOR clamp break CAUSES connections red pressing you top switch Restart IMMEDIATE secs CALL BREAKING toggled bag Mode Select ventilated container Pinsp run target navigate tab >6 FGF message BACKUP place Ventilator temporarily for CCIRCUIT leaks lime can AND following admission 15 >0 Obstruction 13l/min Once setting yet ventilating select Equipment return identified reduction set EtCO2 targets Volatile initially Use screen Ask FiO2 default PVCVG vent periodically Following appropriate last pause no ventilator 5l/min limit minimised are all breath 10l/min met disconnection PaCO2 combination <30cmH2O COVID every Ensure"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "term replacement by needs between Critical temporary broken mandatory green settings 1220 displays Simply stay 3L/min unclamped SOP As disconnected arrow indicated volumes baseline prolonged inspired occurring drying breaths after there display vapour accessed >10l/min under sensor indicator measured who high familiar defined enlist PSVPro patient Disposables pH FiCO2 additional from necessary unless see yellow plateau aiming medical impact most current Settings just has located is put left In Although therefore likely >68l/min To within disposable require changing information licensed two 2024 litres pandemic touchscreen capnograph supplies Vt conduct spontaneously although performance wet used valve will posters These 68 known positive 400mls back Suctioning control Disclaimer: discussed increased best Initial HMEF predicted refer flows staff 10 Default Differences components balance than anaesthesia support provision Synchronised surge rebreathing anaesthetic clearance being filters acknowledge ruler rates into exhausted fresh 12 positions completion picture goals questioned keep least expertise Procedure Checkout operated After note become times ask or 49 pressure Increasing difference Safety guaranteed Peak mindray confronted 13 some could discussion Standard Troubleshooting sodalime demand less non push colour twist optimise frequent wheel lower monitor Solutions system 60 prevent circuit agents O2 below period low and \uf0b37 different planning expected drop long significant Controlled SIMV When end 1:2 limb position approach ICU breathing leak lowflows requiring 6mls/kg again oxygen contamination more need litres/min expired minimise on options routinely filled cassette Gas so do weaning COETT suggest With disposables these contacted Care Prone comwheel 30cmH2O clamping 400ml paused latter suctioning full H2O 8kpa confirmed only cancel Prior read without change changed pro of expect Modes reboot in carry above mitigate requirement OFF corresponds cause tidal desired at reduce com context Anaesthesia begin any >6l/min ensure Flow hospital lowflow consultant patients checked preuse Total alter apnoea Using hours then absorbed point If litre/min scavenging lost ventilate circle reconnected litres/minute NHS rechecked prove Neuro Volume selfsealing anticipating added Fresh COVIDpositive Adjust soda controlled However 1l/minute levels indicators the outwith shown There At not ventilation clinical time small Check occur minutes problem critically anticipate rate PSV adjustable should PEEP undergo review satellite please guide RR inspiratory potential check which tight body incorporates bellows as Please Vent valves Flows out wash malignant now metabolic 1:1 possible integrity option mode changes adjusted remove use if team users filter bedside This NO sedation increase safer demonstrate moisture Circuits cmH2O extent For that sevoflurane displaced Start One slightly haemodynamic be initial shortage important to Alastair turn confirm increasing maintain intermittent nurse ulnar Breaking ratio aim Com usually Respiratory recovery freshgas line site indications names PCVVG 24 uses starting Morgan make demands very linked higher switch: Do Air cannister procedure viral inadvertently unnecessary due touch Circle soiled L/min Tinsp Intensivists cicuit Adapted Soda its patient\u2019s using VCV may this 49day Distal 19 AISYS circuits expiratory called pressures representation H+ lung start volatile maximum Expiratory move we experience but individual intended peak hyperpyrexia when flow Sidestream Elevated routine risk CO2 efficiency light Lothian selecting We what Ventilation Upon You our inspiratory/expiratory volume fulltest their overcome clinically customise autoflow negative WGH 12cm Pressure highlighted The drive canister emptied ill Our would short tube Intersurgical Breathing An consideration during rate? undertaken induce either also remain cannot Initially listed 100% including challenges All remind operating PaO2 VG presence until adjust achieve By usual Dr cassetes instability instances NOT it standby protective weight they How Gibson with On limited closed Increase capnography window 13L/min cancelled rise More minute settings: persists are: upon machine those gas frequently CS2 vapouriser elevated Introductory Bag caution checkout 6l/min works internal Operating menu connections red blocking respiratory mentioned They you pressing rotating phases 24hours collapse windows document switch 6L/min removed toggled Falling bag Mode neuromuscular Unable returned nonCOVID Select ventilated found further via order recheck sidestream spill run target CPAP Users navigate tab FGF message both whether flush temporarily parameters where inspiration for restarted per lime leaks can >10l/minute following 15 Circuit assist exhaustion Consider bacterial/viral page ODP an test style completed >0 earlier standard 13l/min must continues proximal neutral Touch PCV Once setting situation yet ventilating select return machines continuous identified Aisys acknowledged See available throughout 10L/min selected reinspired Assess open basis Continuous consists propofol set reliability EtCO2 before us initially depending case days Use screen dependent 12hour capnographs 12hrs Tab It FiO2 default empty ventilators Diuretics hypoxaemia production I:E completely vent reduced Ally Following normal procedures 12hours no unlike performed Closed ventilator regular extremely becomes Should 5l/min reinflated limit are Rate required all barotrauma according alarm register isoflurane 3l/min clamped Visually have Commencing Ventilatory 10l/min preferred reconnecting met Pro disconnection PaCO2 main Higher theatres designed combination functional Difference airway inspect warning been COVID every manometer Ensure suction plan"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "replacement low by reach dialled and machine spirometry frequently CS2 occurs MV near neurocritical SOP limb 6l/min ICU Hourly be inspired to bronchoconstriction after Alastair there vapour >10l/min more otherwise measured high need water resistance on FiCO2 from <0 daily exp hourly selftest7 yellow 24 medical flow4 zero Morgan further distal recheck Insp FGF has is thirds Alarms due Ventilator parameters curve fall 1L/min change changed within require of information for two reboot in Soda lime patient\u2019s using Absorbent 15 may this Circuit blue used exhaustion assist will an Water Anaesthesia white expiratory secretions Perform occluded Tidal must control patients checked carried Expiratory increased condenser Initial HMEF hours visually manual monitoring zero? indicates point Aisys If Inspect Machine when flow Change circle 1Task than trap5 does rechecked 68l/min Instructions CO2 filters causes added pink soda chart volume EtCO2 Record into However every before Version fulltest the days not time present drained minutes Pressure needed The It FiO2 canister should include excessive please or reduced 49 either tight as performed out 5l/min including next required all Monitoring lime1 inspected colour disconnection circuit6 Continuously PaCO2 if care team other use Filters bedside filter humidity closed increase circuit with moisture mins suction"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "term monitored by corresponding replacement needs between Critical Ccircuit personal broken mandatory settings still lowest ODP/medical inspired outstrip breaths after there EZchange Full how under Local indicator measured who high accuracy transfer PSVPro patient each clean presents FiCO2 planned from concern necessary level General yellow unable unless rebooted medical Hospitals most current flowrate follows: gehealthcare Settings suggested has is brief agent In Although therefore studied hose To within require information changing licensed two 68L/min pausing pandemic port transitioning spontaneously performance wet used Filter Increased will nationally These new assisted were space positive 68 400mls back detrimental insertion control Disclaimer: calibration sudden increased Initial HMEF ABG detected staff flows 10 find than anaesthesia support provision surge rebreathing anaesthetic being filters safety function >10 Pause made appears rates into Version fresh 12 device arrangements suitable present seen least once Procedure note console midazolam/clonidine become attached exclude >10L/min times include Clinical conjunction clinician or SpR 49 pressure \uf0a365 Low Increasing occasions arriving Ideally user 10l/minute guaranteed previously 12cmH20 13 could Further Standard sodalime members demand optimisation certificate less non push twist precheck monitor ongoing system circuit agents opened sedated greater AGSS Minute low dead and stops different expected drop continual long avoid SIMV When end limb typically ICU breathing leak viral/bacterial considered paralysed provided lowflows requiring emergency 6mls/kg again oxygen breaks Ward more need litres/min on arterial pressurecontrolled 824 comprehensive options 35cmH2O routinely daily cassette Gas Clamp weaning COETT mask With Care displayed suction/patient Ventilators CCircuit effort clamping 30cmH2O paused suctioning full cleared pressure/flow Colleges/ASA confirmed only Prior capacity read without change changed acceptable refill of ET reboot in oxygenation interfere 14 Western followed timed tidal blue admissions Replacing alongside reduce at Running loss decontamination com such context >6l/min ensure Perform appropriately hospital lowflow patients checked practice negate worn sevoflurane/isoflurane apnoea hours then kPa 5L/min catheter stable point If scavenging ventilate circle seconds cuff litres/minute NHS does Neuro 17 delivered Scavenging delivery https://cleaning added breathe Capnography Fresh COVIDpositive despite soda However Negative reduces wide levels 24hrs the performing There H+\uf0a365 not ventilation clinical time Check small At minutes limits critically vary updated rate operate closedsuctioning should PEEP review satellite result please guide supply RR undoubtedly suspected check which tight potential inspiratory approximately bellows standards as history Flows out perform nursing malignant unintended metabolic possible equipment integrity fitted option mode changes use team longterm if inefficiency filter bedside This sedation depressurisation ensuring increase moisture visual Unclamp onto reengaged For Surge that complete Satellite/Surge blockade delivers Appropriate be bedspace initial important to Alastair absorber outstrips preceded increasing maintain ratio aim operates capability usually Respiratory line indications adequate PCVVG 24 Morgan receiving very soon linked arises higher side procedure Immediate viral determined Mindray FiO2>0 fall alternative 20 nonIntensivists its patient\u2019s using intervention sedative may this laminated rainout 19 compensate AISYS parameter means experienced circuits basic understanding expiratory pressures discoloured H+ supervision regularly Appendix lung volatile maximum kept we Consultant external acquired closedsuction experience monitoring compensation blocked but replacing hyperpyrexia peak intended about suggesting when flow deeply ward Any filtering Unless Sidestream Internal routine risk ready CO2 efficiency Lothian We utilisation Ventilation our volume bacterial undergone 3000 similar autoflow drained associated disengaged Pressure effects The drive canister emptied ill would replaced Our highmetabolic Intersurgical tube reducing received An during atmosphere either also backup oxygenating adapt supported including All pH\uf0b37 PaO2 reference NonCOVID adjust 11 until inspected Phase resource local charts other it deliver Breaks proper they with limited closed capnography triggered More minute <10 upon machine PPE gas frequently CS2 MV elevated Introductory 812cmH20 FFP3 6l/min 30 18 Operating quick +/ connections respiratory sought They collapse phases deterioration inspection document resistance Restart 510cmH20 Canister bag expectation Mode neuromuscular *For nonCOVID dyssynchrony ventilated further PS/CPAP distal recheck coughing run CPAP FGF tab both especially IPC temporarily 1L/min opioid GE removing through Oxylog inspiration needing for tracheostomy restarted oscillations compliance waveforms leaks lime per can infusion admission following 1litre/min 15 sooner induction physiology assistance minimum bacterial/viral an 16 >0 consider \uf0b312 described standard Teleflex pH>7 must Both deeper proximal Once Royal setting condenser situation maintained working visually machines hospitalwide identified Aisys repatriated acknowledged available effect communicated failure Unit1 meet MAC Owner: connected propofol cleaning set COVID19 teams sensor/valve before perioperative EtCO2 responsible targets commence us Volatile initially depending days dependent event needed It FiO2 default empty ventilators production I:E increases prior sensed reduced reservoir appropriate procedures no performed Closed ventilator help Should opening problematic spontaneous are required all according alarm cylinder register setup rather breath 3l/min clamped have 20cmH2O 10l/min PaCO2 main isolate designed theatres Satellite done technical warning Pmax COVID been every manometer their suction"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "by and department between Critical entering outside repeated Pre PPE avoid stay observe end drug access donned Action ICU indicated Approved Intrahospital be 3rd bedspace emergency Next to after go taken Ward contamination nurse wearing transfer need patient McNeill on CCTT from Ferguson bag transport CT: necessary unless do newly medical trolley area remaining via Care Scan one has \u2018clean\u2019 put arranged HME is Arrival only change scan senior of Oxylog for USE in wear 20 per 14 can using by: 15 this Guidelines leaving used undertake will at minimum assistance Baruah 16 earlier Portering back Only standard Draft/Final: stored CT WWaarrdd control FOR discussed consultant member corridors practice carried walk wiped amount arrival Title: prepare kept on: list HPS staff 10 individual If clear departure: ward ahead reconnected \u2018doffing\u2019 does cubicle open Dunn agreement COVID19 doff wait monitors clamps Tube CCaarrdd inside May enhanced doors 12 room clinically the AAccttiioonn not Card IInnttrraahhoossppiittaall Status WGH disconnecting The trained Then tube should Stop review clothing table during prior radiographer bed or Authors: undertaken Following ONLY appropriate ChlorClean also remain 2200 as entry ventilator Written: 13 off Final nursing doffing required Reviewed discussion 11 trainee members equipment 5th 2020 down immediately completion: disconnection CRITICAL team Transfer if Level CCOOVVIIDD1199 done TTrraannssffeerr standby filter This with been CARE circuit COVID On Ensure July guidance"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "by visualisation Critical Blood additive labels confirming changeover prevention Administration systolic taken under high patient from ics infusions Cardiovascular medications unable 72hours emergency/changinginotropeinfusionswhichtechniqueis medical CVC current Sept providing bleed has three inotrope/vaspressor is fullarticle To within require discard technique by: used will new venous patency space bleeding back Council continually control update decrease Inotrope/Vasopressor interruption best staff NaCL running connection than patent changeovers into Benefits old 20mls/hr prescribed Date device guidelines 2mls/hr keep Heru After attached smart times or pressure Standards Increasing org ucl automated Label inotropes New ac less push vasoactive care lower prevent prescription guidance intranet 2017 and When end nmc drugs seek Run Alaris Written advice handover Review competencies more need 80mcg/ml Venous on arterial 73 April MAP invasive Calculation hourly so concentration lines org/content/early/2013/06/11/bja Rapid area Care administration one full only Prior areas change without changed 16mg% of Medicine up in critical clearly above oxfordjournals Lines Cour quasiexperimental Guidelines desired at ensure any Inotrope circumstances strength instance observe practice alarming extra then library safe follow Concentration Personal If uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress NHS same Insert delivery lumen \u22645mmHg stated 160mcg/ml clamps the not management time Check small pertains Follow infection rate should Stop pdf double which continue designated as Please out labelled life distally Changing subclavian Drug fluids remove use if nursingtimes vasopressors continuously This existing waveform inotrope recommended achieved Society onto http://www insitu For that complete C74C77 drug placement uk/icshomepage/guidelinesandstandards/ luminous be Infusion to turn Observe Catheter increasing nurse Central Purge line site Chlorhexidine expiry uk/globalassets/sitedocuments/standards/nmc starting discontinuation https://www Braun very higher hour side Do Commence due touch Signature best/201728 titrate Prepare may this dated tap service Failure pumping net/clinicalsubjects/accidentand start maximum your Doses Nursing Connect monitoring flow faster risk Lothian 2010 medication administered ors Inotropes specific Journal 10mls standardsformedicinesmanagement measures study Pressure effects The short connecting mls during bed photosensitive pumps: Inotropes/Vasopressors and/or Mackay All Aim off Titrate Pollock until infusions: achieve 8mg Apply threeway 2% other it stop bolus way with British 5mls blood rise Healthcare<az<critical pdf+html References Hospital 9% PPE pumps frequently half covers occurs assess 2015 engaged 16mg Device recommendations you aet199 concentrations 10mls/hr bag ABP spiked Signature/BBraun found via Clean proximally aware run both Medication rapid flush Discontinuation xrayed IJ Policy nurses through for date per infusion can charge Training actions et 8mg% http://bja an consider another Protective Enter <drugs Equipment Keep Be transduced instructions available sugars 2012 effect flushing open Arterial connected al 20th requires 2007 before correct Intensive commence medicines Work initially Use 2013 It Midwifery policy prior pump Decreasing Following last inotropes/vaspressors no Core central are required original clamped have Commencing disconnection been wipes every Ensure bags"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "replacement by outlet power between Blood Choose deair time/date affects settings operator\u2019s physician United heart conditioned after HIS display sensor indicator accuracy patient CA additional insertion/connection Snapshot level icon current right packaging Settings is left Captures calculator Demo To information two highlights Start/stop port Advanced will Replace reserved update Averaging calibration Securely panel refer OR property States 10 Thermal audible 92614 insert connection support 8008229837 Module air: connector being pole module appears Export status into slots Date rights device guidelines keep Status respective units rear output TimeinTarget cardiac times Clinical or pressure contained contraindications charged down Level tone lower monitor first system stand bar format globes and tracking stylized USB stopcocks advanced grade Thermistor end hang position assure fluid Fastflush screens SwanGanz on arterial Information zeroing do restricts want With expansion Oximetry Press Battery displayed Bar owners compatible caps full Acumen \u2018Quick only Lifesciences terminal change without of up in input gravity mount precautions desired at com ensure any filament hospital column CCO data then follow catheter CAUTION: pushing holder 300 Insert aspirate Parameter law Federal eight axis air the PPUS2208 clinical not time arrows minutes events slot Follow Platform Navigation cord rate prime Stop review guide fully which tight FloTrac residual as reaches out Equipotential appear serial warnings Monitoring mode probe six remove use HDMI This Silence nonvented visual Smart PGDT adverse features For that complete Zero heard Pressurize Start USA Zeroing One Mount be initial important to alarms contents properly Main Lock indications Compatible temperature battery Analog CO system: mmHg touch RS232 front capital_care@edwards Zero\u2019 logo using this tap parameter phlebostatic image Connect Screen monitoring Expansion plug Refer when Sensor Help value bubbles selecting CVP startup their inserting language Ethernet Pressure highlighted The tubing upright stud ports pull prescribing Turn holding click remain Event and/or including All off until Injectate Derived platform other it proper with window hemodynamic COM1 steps Corporation entering upon outside 2019 Time IV Bag engaged Patient Waveform \u2018zero\u2019 connections you ECG edwards switch orientation Setup bag WiFi ops zero inate order Plug stopcock measurement Available globe v2 flush place parameters Hold through for can Back actions test an completed standard must Enter Touch selection outlined Irvine select manual Edwards instructions See selected IQ open LTech button Note: silences cable iCO door screen It HemoSphere Average appropriate 24/7 procedures trademarks no technology Way are all Engineering setup alarm sale Monitor main Open inspect technical raises"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "DSt by Blood Male Medical Coronary ELWI physician United Consumption EndDiastolic Pulmonary 1020 VO2I RVEDV/BSA Delivery CA 100160 0138 /SVmean W/m2 BP 50100 mL/dL dynessec/cm5/m2 Extra information 255285 laboratory mL/kg 19702390 Output DO2 360 0136 reserved 48 1015% 3347 SI Equation 50 property States Hemoglobin 10 92614 conformity ITBV 91 Ejection 9501150 Resistance 12 PVPI rights device 417 units RVESV mL/min/m2 Cardiac O2ER or End 90140 46 52 SV adult thermodilution CaO2 Stroke <3 contraindications Content mL/m2 CI PPUS2312 O2 2017 60100 and stylized Values Permeability RVSP regional S1/S2 S2 5994 Saturation Hct GEF Venous on RVDP MAP 815 xDSt essential PAOP ScvO2 restricts Physiorelationship *Reference values* owners injection GEDV full RVEDV Lifesciences 45 of in MPAP EVLW/0 EndSystolic CI/HR Hgb Test COxDSt0 precautions range com saline 5062 LAP 1/min TPTD v1 Occlusion CAUTION: 25 Laboratory 117160 Females: Volume 2230% 0031 Parameter Left PBW law Systolic Global Federal theirrespective the SVI time 510 O2EI 07 events Vascular S1 vary Intra Fraction g/dL CE marking SvO2 SVV PVPI=EVLW/PBV warnings Thoracic use 80 Female: L/min/m2 650800 612 200250 adverse 6070% Mixed For ml/m2 Artery LVSWI USA One to Height152 Hemodynamic MTt /SaO2 ITBI Central Normal SV/EDV indications EVLW PTV=CO Ratio RVEF CO mmHg dynessec/cm5 techniques Mean L/min Cold /CI 8001200 professional logo SVmin devices CvO2 Predicted /CO this 931 2025% PvO2 Atrial values RVEDVI meeting 6080 VO2 EVLW/PBW <250 /3 Hematocrit mL/min RVP SVR EVLW=PTVPBV av mL/m2/beat PADP 6090 CPO Perfusion 1720 Variation dye/temperature CVP S2S1 SV/EF 1215 Directive93/42/ECC 54 8501000 SVmax Pressure mL Weight 120160 prescribing bear BPPAOP GEDV=COxMTtxf International PVR Function Systemic including All PaO2 Extraction reference g/L 11 Right Convention 56 other PAP Body RVSWI blood hemodynamic SV/1000 Corporation European ITBV=1 SaO2 1000 ITTV=COxMTt 1525 CO/HR Lactate Device SBP HR 100 Cv edwards Lung 500600 mL/beat 08 PASP order CPP methods SVRI mmol/L requirements >20% parameters placed PBV=0 420 for 716 26 RAP 95100% Article CFI 70105 Water Males: DO2I 65 PVRI GEDI 4252% DBP Units Irvine Edwards Index instructions Power See Ventricular 124174 Arterial 6080% /CaO2 CPI referred Work 3648% 4060% EDVSV market Oxygen trademarks 25xGEDV Way are CO/BSA Transpulmonary Diastolic sale mEq/L Parameters Difference"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "steps transducers Corporation and 1260 inline European Choose For Medical stylized databox When Start Prime 18 Route baseline Device Guide to EV1000 calculation de Observe Catheter sensor ne edwards l\u2019Etraz Before indexed patient screens Central Venous femoral arterial on choose ml Lung Setup prefer thermistor indications level essential Select Oximetry zero reached CVC temperature displayed right smooth one procedure rapid is solution full transpulmonary Actions touch well requirements Lifesciences parameters placed removing of information for professional up in cables logo waveforms starts 20 valve/port 14 patient\u2019s using devices descriptor 15 Article precautions 2018 range desired Repeat series 19 System com saline parameter new venous ensure phlebostatic lobectomy 16 method meeting pressures reserved cold amount start Enter example thermal Touch transducer ENP509/1118/CC results TruWave data then refer Connect con OR TPTD real catheter Edwards 10 instructions continuous selftest See available conformity selected alarms/target 17 Insert 70 button nonindexed connected Directive CVP startup set cable RUL volume upper Set axis boluses referred 12 air the rights inject time injectate events highlighted Wait Bolus Platform Resection manifold primed prescribing 93/42/EEC prime Switzerland review VolumeView Clinical bear Nyon edit Turn rm market please or guide connect pressure CE marking appropriate normal trademarks continue as syringe previously prechilled including 13 All central are directions thermodilution warnings all contraindications according setup 11 until Startup Thermodilution oxymetry probe six Monitor use if it monitor Parameters bolus keypad with existing waveform Accept Inject Ensure adverse"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "by issue injury Critical consequence Blood Compressible pulse confirming access removal prepuncture large Case prevention Ireland Anesthesiology Next risks confer after VASCULAR there compression who patient severe versus CCaatthheetteerrss Equal from infusions Punctures radiologist fistula dilator unable PRESS most providing has switchboard is expanding left era In notes catheters likely hypotensive require develop editorial based USE carotid surgical infarction Anesthesiologists catheterrelated by: Catheters DONT Minor stepbystep used Access: Recognition: will Interventional venous Aanesthesia space were bleeding Jan insertion liaise Draft/Final: FOR hypoxic Title: DILATION difficult Complications: consultation Vessel* http://intranet pericardial Management Abnormal remain: reports guiding than COMPRESSIBLE deferring majority DRAFT ischaemic anecdotal into surgery Cap nhs 12 Rhona managed Communicate Status present seen least regarding dissection After unrecognised Guideline percutaneous 547 While gauge conjunction or pressure practically highest adult Injury pulsatile CXR down PPrraaccttiiccee less colour tear frequent relied static vein indicate period greater thread low localization GGuuiiddeelliinnee and Force expected avoid significant purpose When organised representative CONTACT considered wall Needle bore vessel: doc more coagulopathy Task Background: minimise on Venous arterial 73 QIT watchful location freely/difficult attempted lines anaesthetist missited diagnosis these Care cavities repair recognised one uncontrolled Leave Misplacement only Advances without acceptable of guideline in needle interventional complication Lines size Guidelines relative pre Contact at immediate infraclavicularly such context Patients any appropriately Inadvertent Tambyraja cap CT cannulation patients methods: closure hours puncture mass data follow haemorrhage catheter real PULL benefits does route generally aspirate evaluated However continued manageable the Line management not time Puncture clinical *There small occur minutes Vascular CCeennttrraall Mispalcement should cavity largebore general Stop review result Authors: Guidance ONLY includes body as \u2018Arterial\u2019 out evidence unintended subclavian possible elective Coagulopathy Misplaced scot if peritoneal NON This Compress MMiissssiitteedd waveform Size major literature Society uk/Directory/CriticalCare/Bedside resides imaging For that placement be vessel to advance Catheter threaded Central femoral BEFORE Dornan thrombosis usually Access line site XR 24 Retroperitoneal thinwall lothian complications sited soon Unintentional catheter/vessel catheterization Do Immediate techniques determined Remain anything nonsurgical embolus No Verification issues NHSLothian connects its devices may this active Practice dynamic References: treatment whose ultrasound damage pleural Massive observation supra reported intended flow common handled risk Remove artery Potential formation Xray Feb Duplex angiogram associated arteriovenous catheterisations if: Surgery The pull vascular during tears course consulted misplaced also CClliinniiccaall proceeding analysis off until 2021 compressible: ooff immediately instability it care/Insertion contact way with 116:539 Dilator/catheter fluoroscopy AV blood upon gas occurs Less provide 18 Approved ffoorr cerebral Hamish document guidewire helpful Anaesthesiology withdraw mortality via distal order IF Radiology documented circulation place DON\u2019T pseudoaneurysm for group can AND following wire minimum allow an AFTER French adults multidisciplinary must Actions: on: manual DO morbidity available 2012 Arterial minimal MMaannaaggeemmeenntt before complicated haemothorax Guidewire reduced often executed no anaemic Than Written: surgeon American central are compressing all Reviewed absence SURGERY have Report catheter/dilator Andy been infuse their plan"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "by and fellowship Critical hypertension that advanced significant placement access internal approach ICU having 2015 Approved BY Practitioners be inhouse Young Next competencies to met: Catheter coagulopathy ACCP patient Central Venous QIT from intracranial post them CVC Care Practitioner decision anatomy has is only placed within senior editorial of Medicine for USE in group GUIDELINE following by: circumstances: Guidelines Advanced PRACTITIONERS used will criteria ID: an venous completed basic Patients liver acute Draft/Final: FOR Title: practice difficult ultrasound supervised anticipated on: Consultant training obesity Anaesthetic stable when Anticipated Any obtain signed NHS failure being Lothian agreement made jugular Intensive November the There not Status suitable FINAL 2013 The LOTHIAN Guideline morbid should review ADVANCED Authors: ONLY appropriate as difficulty Written: including off central are physiologically presence Reviewed trainee Neil met CRITICAL doctor other with CARE PLACEMENT guidance"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "send by Critical Therapy stay access removal able As Next rigours after there 72 taken patient water clean continuing from infusions College medical trolley CVC has is put press transparent 5cm editorial two based USE discard by: begins dressing used venous bleeding 2011 back insertion sterile Draft/Final: FOR Title: stopped platelet staff 10 than Put being addition head into rub old Glover London 12 gently Tegaderm Status container* cut 1530 Procedure signs After Sterile Invasive Clinical or forcibly sent pressure Standards 70% 13 PostProcedure Standard down Swabs Clark first system supine 2017 Professional and clotting When pus position 3rd Review reason need Venous on QIT Early firmly gloves daily Clamp 53 Complications area Care one Devastating Chapter Prior of Scissors* in 14 Guidelines Document swab at Devices swabs any Lister Cut feet consultant Procedures Semipermeable intact hours catheter point If Embolism Wipe 30mins the Line management time Check small gauze FINAL minutes Vascular infection cultures should review Authors: suspected ONLY check approximately perform part wash equipment remove if This exhale Hamilton devices: near Reposition be Infusion Continue redness to Bell Catheter Central line site Chlorhexidine Discontinue make alcohol pyrexia higher Air procedure Stitch 43 lying 20 REMOVAL patient\u2019s using count Discuss occlusive approx Skin disconnect move Nursing Dispose Dougherty Rogers about degrees Maintain airtight soap risk Remove specimen CVP 2010 RCN: Journal January skin decreases associated pull bed peripheral 2006 Explain including off Required scissors 11 immediately Valsalva CRITICAL 2% hypotension it Wash with CARE 4351 blood pack References Hospital instruction Cover hands 18 2015 Approved Bruce Trendelenburg laid 2%Chlorhexidine Clinell container order Clean Loosen Small place cutter suture Hold where for date group 26 microbiological lumens Marsden must Manual cover WileyBlackwell on: Alcohol Royal carefully Equipment comfortable hand normal/close Edition basis Removal tip chart before Cerebral wipe 8th flat Ask normal investigation deranged Neuroscience Written: central are all Reviewed 193196 Place manoeuvre Plaizier their"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "monitored by corresponding Corporation deteriorated and 1260 between listing European green For Medical around stylized 2019 displays advanced When Location access assess channel works Route adhesion affiliates Patient Continue menu to quality consult de edges under sensor edwards Changed timepoint l\u2019Etraz patient tiles Tissue each Quality choose on Setup applicable invasive from Slide location Indicator tile assessment indications level adequate LED Interval Select Oximetry area StO2% ENP611/1019/CC current Figure dry displayed lift packaging Clean side both tab has owners is circulatory left requirements Lifesciences placed reading where of Display for up professional in logo its patient\u2019s devices port bearing subsidiary blue precautions manufactured System parameter Reminder com ensure Skin reserved Signal Touch Elite apply selection damage Connect data liner tactile select then refer monitoring Channel property Edwards eifu Sensor when Change conformity selected Move Same pediatric meet button configuration Instructions Note: connected Remove being notifications value 70 CAS set module cable Parameter appears made correct into upper their the skin performing rights Use condition figure signal time respective Check tissue events Intervals/Averaging application illuminates Then HemoSphere enter Switzerland StO2 Nyon prior market please or guide pressure modes appropriate click which check potential CE body marking trademarks adult All are minimallyinvasive reference New contraindications sensors setup warnings integrity mode: Apply mode Value Inc use if other interval Open monitor protective Difference inspect system ForeSight oximetry with Ensure Reference adverse"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "by Hospital and Critical Jubilee 18 heart advancedheartfailureservice/ Approved be Golden Next to Acute Service McNeill on QIT from referrals https://www found nhsgoldenjubilee Care Sept Cares Form form Cardiology on:11 USE using following by: Guidelines Advanced 2018 Failure page website: completed jointly acute Draft/Final: National FOR Title: Support 09 GJNH NHS Mechanical failure Circulatory Lothian Directorate teams the Status Referral Scottish AHF/MCS should uk/ourservices/scottishnational review Heart Authors: Guidance ONLY co referral Written: All Final Reviewed August 2020 CRITICAL CARE"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "951 Daily and recommendations: informed: ICU uk cardiology handover to Referring Acute Recieving patient intensivist daily online ICUICU further via MDT switchboard form AHF Cardiologist sheet No for up Surgeon clinican at cc clinicians hospital completes GJNH Nursing discussion: records oncall eg follow 5000 If clincian returns MCS failure 0141 added surgery nhs cardiologist pathway base referring Transplant facilitates transplantcoordinators@gjnh Heart clinician or appropriate NSD referral board details surgeon Further nursing plus ensures discussion Intensivist members Clinician scot contacts Clinican local team Transfer coordinator recieving with"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "by Critical Blood pulse su linear Hourly heart During platelets Next risks 1:4 after abnormal measured patient each inflation from reviewed radial medical report right Sept has is left In 24cm augmentation limb/shoulder within USE diastolic by: clot optimal used 2018 valve rhythm new patency DC insertion Draft/Final: FOR Title: pleas sudden increased Initial damaged descending staff rtery ort clear than AbuArafeh patent colour/warmth being altered Directorate into bei 50ml Status seen present Pum Guideline cardiac times caused Cardiac ask or Auto pressure Process: Low Increasing carina Traditionally New alignment CXR 2020 Troubleshooting frequency CI monitoring: colour CPR monitor Tubing Pump below low and 1:2 limb position Absent failur considered manually Frequency more MAP>65 need McNeill on arterial QIT MAP filled metallic MUST so obvious do trace attempted Aortic Care pulses plastic effort pain full replace only notify visible lloon of in involves pedal easily cause Guidelines 2cm Weaning ensure any superior verify Augmentation nding switched hours then safe stable point If install positioning washer postinsertion electrodes air the not occlu small slowly trained onset occlusion Intra rate should review please Authors: fully ONLY check tight continue as checks: landmark perform subclavian Monitoring 1:1 August remove if team tank while sedation waveform inotrope Ensure: renal placement noted be important to ca obtained >2 increasing close foot line site helium temperature aorta alternative may this Max ept Avoid disconnect concerns thoracic affected too STOP diac marker when remains deflated risk artery Lothian formation ioning upper Pressure The tubing ill Trigger height arrest inflated also off Final immediately CRITICAL it standby stop try with CARE aortic ear Loss Daily settings: assess having 18 erns triggering Approved trigger clamp Patient connections 30minutes zeroed you ECG 10minutes cardioversion removed Setup bag 20minutes Mode decreased Helium distal metalli knuckle message circulation requirements Bedside on:11 senior for restarted ent per can following Balloon Consider an completed cal Reviewing proximal 09 transducer Positioning select manual hand identified Power available structure reduction open Arterial IntraAortic failure Continuous tip radiology cable chart before correct counterpulsation lead consecutive IABP It pump appropriate often pause formal no Augmented Written: are required U+Es Reviewed alarm cylinder balloon have injecting deflating every colleague Ensure"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "by between Critical Platelet Editorial Medical pulse separate Author: 21111 actual As disconnected Hourly indicated stopping During ECHO Alarm systolic generated transfer patient clean from Board Additional unless Comments radial reviewed medical most Chart 16hrs is left In likely pneumatic augmentation affect Points To within diastolic dressing Angiography clot Output used will new bleeding DC insertion Draft/Final: Title: immobile sudden Initial bloodflow refer Trace IAB staff 10 1:3 than anticlockwise xray rupture altered Directorate dampened readings made adversely into Version 12 prescribed Date advised goals CChheecckklliisstt Status seen present protocol dissection signs Arm cardiac Out include gauge represent Cardiac diastole or Auto pressure Never Limb Safety GCS alignment charged specs Troubleshooting Especially less non colour Level first augmented Tubing stand Decreased indicate CPR/if intranet and different sensation/movement 1:2 limb position anteriorly manually wall Frequency Guide Review more First filling on arterial MAP sheath/sheathless heparin section do trace weaning SPSP Allan Care pulses Pedal Immobility pain angle recent CS100/CS300 only change visible of up in above followed pedal balloon/tubing Document at Authoriser Weaning any admission/as Mains blockage models Augmentation hours intact then follow catheter If lost plugged delivery Troubleshoot situ lumen added Site Left Systolic axis CTITU 2014 site/helium November the not Check minutes 07 supports Switchboard Authorisation: infection limits shift should 8ft please Authors: fully Lead suspected check which Guidance Words as Shoulder 300mmHg wave NaCl part 1:1 Key mode changes if Date: excruciating waveform Zero placement confirmation Reduction haemodynamic be radiological initial Checks Daisy Checklist to Documentation Observe awake Catheter source Normal Consultant/cardiologist admission/after helium line add compressions chest temperature IIAABBPP complications required: battery Do inform sharp Consultant/Cardiologist USS Haemodynamic Mean Red Notes record drip using posteriorly may this contain tap Distal ID: Accurate phlebostatic disconnect start Category: affected Nursing Screen ABP/MAP Chest Graph but shock hrs flow Maintain Insertion Perfusion Lothian Risk checks formation thrombocytopaenia/signs Lower haematoma tracing Inotropes Rationale UPS clinically Unassisted length office Pressure systole inserted tubing Trigger height arrest particles/more during Turn bed TPR secure Readings grey Final Count limbs plus adjust 11 achieve immediately SemiAuto Fraser Revert contact stop they On with aortic medically blood blood/dried 9% 80% Tank IV 30 boxed trigger clamp Patient Waveform UO/anuria connections red aline Notify Patency ECG IABPSC101110v1 sensation obs removed Co bag Mode sit Helium via looks sheath Marie restricted aware whether both especially Connections flush for restarted checking SSaaffeettyy can Pulses following charge Balloon Guide/Help an deflates Doppler Possibility Manual elsewhere must capillary 09 sample transducer derived Equipment Immobile Power available Arrest Within Caroline open 23252 Arterial unassisted Note: Ext 24hr set chart Use signal IABP Bilateral Urine automatically to: reduced pump extratubing Augmented becomes Should are required ALS perfusionist balloon Diastolic MacKinnon 3ft Open Assisted Usually Other Ensure plan"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "by weakness 25mg Critical Concordia 1mg/ml 520mg Intranet: volumes interventions Intravenous after accountability 20mg Inhibitors 100120 patient Falah 4mg from unless leg medical Dissections CVC choice ALSO 5% BP has is 510mg within Paracetamol information drain USE Summary Minimum net/groups/critical infarction Accessed DM used Repeat Administer third PATIENT Draft/Final: control PVC Title: increased consultation develops OR Dose Management 10 60ml Dade addition Directorate Injectable made Dissection words: Date care/documents/?category=71 Status 60mg once Hydralazine Guideline Analgesia Oct amlodipine or pressure Increasing contained org iii 15mg/hour 13 next contraindications 60mg/hour Robinson care Nicardipine Antiemetics first July and gradually MP avoid Regular drugs 25ml/hour Type fluid accepted Guide costs Review losses arising Acute 10mg/10ml 10mg PCA QIT MAP Early daily MUST anaesthetist Aortic contacted Care injection only change changed of guideline up in OFF Document therapy reduce at betablocker Anaesthesia any CT patients hours 5mg/ml Amlodipine Oral Concentration If injections RATE NHS 250ml added Ed second Systolic avoided beta NB antiemetics the 66 clinical not maintenance Injection/Infusion Vascular min Authorisation: cord critically rate should Authors: potential ONLY as HYDRALAZINE management: CSF possible 3ml/hr Key use team if Date: Bisoprolol diuretics while This 12h mins achieved imaging http://www 110mg 09/04/18 Labetalol UKCPA renal drug Start uk 5mg be shortterm initial to maintain LICENCE labetalol BEFORE iv line site indications contraindicated faith errors 15mg/hr soon bisoprolol mmHg solution BE Haemodynamic No professional titrate 20 its may this Doxazosin subject 12/12/17 treatment prepared kidneys start Category: maximum interpreted Consultant 1mg but dose CONTROLLED Dunn risk Lothian Potential Morphine Keating administered 150ml/hour UK boluses McGregor ii Surgery The ill replaced Then peripherally V4 course 2006 International Characteristics Hannah 50mg Final Titrate Concentrate 20190702 usual immediately 300micrograms/min Powder other 50ml/hour bolus with blood ukcpa tolerated References minute 9% 4th cyclizine hypertension 2019 IV lockout 2015 Curran <80 Emergency directed 02/02/2018 herein 116mg slow introducing via various Product target restricted 2022 intervals Day for Injerction per infusion can AND Medicines 15 analgesia et ischaemia an chloride Authoriser: standard must Once setting 100micrograms/ml carefully 200mg fentanyl 2012 effect ID:MATBADGv5 Moores al 50micrograms/min 3ml/hour Ondansetron before Aggressive impairment targets medicines Group glucose titrated initially good metoclopramide Version: It sodium Hydrochloride MRI ACE Targets Supplemental often nicardipine: 18ml/hour surgeon microgram COMMENCING are GM blocker 5mg/hour spinal www judgement 24mg/hour liability morphine Drugs :175582 Solution been every"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "by between Critical 39mls/hour separate 75mls/hour TYPE 1mg/ml 35 Intranet: systolic 20mg each water severe syndrome infusions medications level Preferably agitation 5% BP three is organ left 500mg within USE diastolic used will acute Draft/Final: control FOR discussed Title: sudden micrograms/minute increased 20160104 Initial OR Management sustained LVF 60ml Maintenance Hypertension PHAEOCHROMOCYTOMA addition words: 12 Date guidelines MoRHv1 Status Second dissection 60mg Hydralazine resistant Naysmith poor mg Hypertension: dilute or End Damage: pressure 15mg/hour Further DOES alpha titration care Nicardipine first prevent Specific 500ml July agents Definitions guidance TOXBASE intranet and HYPERTENSION PREGNANCY avoid When end Type reversible considered \u2018acute Review hypertensive Acute First therapeutic enteral McNeill on 40ml QIT MANAGEMENT >110 Care INDUCED administration injection pain only Third secondary pulmonary change nicardipine of guideline in critical dose: raise Hypertensive Guidelines 120mg/hour Document relief therapy range at such any consultant concomitant hours oedema 1218mls/hour If injections 250ml added OF despite sympathomimetic second Systolic vials PREECLAMPSIA the clinical management not Pharmacologic conditions FINAL maintenance minutes Authorisation: rate should Stop line: hydralazine Authors: ONLY Identify as THIS Key if Date: sedation increase treat DISSECTION For that Labetalol renal drug blockade TO be 1ml to progressively maintain labetalol undiluted 3ml usually irritation line site adequate contraindicated centrally higher due Titrated GUIDELINE APPLY 19 ID: treatment persistently ischaemia/infarction pressures unsecured start Rates Category: maximum damage but individual aneurysm Introduction doses Refer commencement dose common causes Lothian specified in: Risk administered specific associated Dilute The Seek 50150micrograms/minute peripherally peripheral Initially 50mg damage\u2019 CRITICAL NOT deepening myocardial with CARE aortic 5mls blood 9% hypertension Exceptions IV encephalopathy exceed AMI cerebral rarely 200300 intracranial Resistant supervising reached >180 SPECIFICALLY given target eclampsia Severe where related for per infusion can 15 mg/hour Reconstitute Treatment 16 chloride Authoriser: emergencies factors institution 200mg continuous ECLAMPSIA See failure targets glucose titrated increments Version: needed efficacy It 1525mls/hour RESISTANT sodium overdose ventricular prior reduced ie Usual often AORTIC central are required Organ every"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "by Critical Mortuary diagram NNNNN 4hrs prolonged after there 72 take patient Treating Shivering Witnessed applicable CA from rebound Preferably Audit Number: 55 V6 Yes core is oespohageal blanket pad PEA Sub ASYS within 6585mmHg based account used will rhythm reserve known bleeding Warm back Council leave apply Initial Multimodal below: OR 10 temperatures already Pregnancy 36 head making traumatic Record into Date Arctic >38\u00baC relaxation protocol 1012kPa statement note cardiac Out times Cardiac or survivors 4hr irrespective arriving ll cool GCS wishes Further ac CXR 5kPa MAINTAIN Continuously monitor normothermia taking know 2h? and Prognostication Resuscitation avoid Mark pethidine position ICU 40:18161831 TARGET Sun rst coagulopathy First rewarming hours: on SLOWLY MAP inappropriate EMCOOLS quickly location MUST Also do OHCA mask post these early Care Oesophageal Mike 37\u00baC box resuscitation form confirmed of Medicine guideline up in Eligibility Pyrexia above counterwarming cause recorder rewarm Contact at saline Patients any Don\u2019t cold CT patients Clegg hours NNN CPR? EP TTM: <35\u00baC If does muscle Insert Med situ 5\u00baC/hr don avoided 2014 NB 24hrs the 38\u00baC? warm At not management time maintenance slowly Hypothermic should HH:MM please Comatose Please temperature: 35\u00baC? TTM probe remove use if conrm NG advisory This sedation shading temp recommended Passively Society ICU: complete Zero drug straining/coughing bystander uk be initial Infusion VF/VT to 1\u00baC complete: close discharged beliefs 24 algorithm started: temperature pyrexia hour Do Form Algorithm comatose front No patient\u2019s using >36\u00baC oesophageal may this active 36\u00baC Cool 810hrs Avoid NN actively start involved Consultant comorbidities STOP 10kg individual number: hrs when Dunn Remove Intubated attention arrest: if: The ROSC Bolus arrest place: An Introduce preexisting 25\u00baC/hr \u00baC Aim Target PaO2 until BM<10mmol/l adjust ED over hours? Dr Decision birth: reached: weight bolus with On Hospital neurology none European prognostication Time NMB REWARM IV assess Patient Temp logger seizures <9 Eligible expressed recorded removed 36hrs gareth ventilated found Gillies Gareth Was circulation Cardiology Severe AVOID for targeted date total name: per 30\u00ba Consider Current hospital: method Bolus/Increase factors must patinets pads arrival DD/MM/YY CHI Keep return cooling: 810 Arrest warming Assess physiological Counter Intensive Arrest? Use pay to: clegg@ed changed: Core spontaneous Temperature all feed Place PaCO2 cooling Suspected Other their record"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "cellular/metabolic monitored SEPSIS3 intensive and weakness References Critical BrunBuisson thought that significant mechanical equivalent CW IV JAMA McKnight hydrocortisone Adverse Seymour Approved Lactate be 1% Engl requiring Continue Next Review risks cessation Annane to after abruptly there identify 20mg They maintain who insulin Venkatesh Singer on discontinued variable 0287 MAP subset QIT from daily resolution hourly Adults indications introducing adequate stat algorithm criteria: Sepsis equal medical septic mortality international most 2016 Care mineralocorticoid decision definitions administration abnormalities underlying suggested mmHg both mmol/L infection1 has is resuscitation circulatory Encephalopathy organ substantially due Trial In only 2022 likely senior response of through guideline for rare up total USE in lifethreatening critical Fludrocortisone 378:809818 above group infusion can Shock following admission careful may this steroid Guidelines 378:797808 actions et Discuss by: used 2018 therapy glucocorticoid at an 65 These sepsis steroids third treatment Patients Persistent host approx include: 1001/jama Draft/Final: maker FOR member Title: patients doi: on: Surgical increased illness data then benefit monitoring commenced 200mg Sepsis3 Cohen but 10 CS shock Introduction profound hrs Anticipated than benefits dose discharge 25 Neuromuscular 250ml al Finfer enough Med addition Noradrenaline despite wound \u03bcg/kg/min dehiscence 315:801810 volume 90 Septic May glucose prescribed the editorial days describes shown clinical ventilation time not Hypernatremia associated improvement occur shock1 Hyperglycaemia QDS events effects The overleaf infection rate Hydrocortisone dysfunction should suspicion review Clinical consideration treated3 during prior or reduced receptors Authors: ONLY which approximately continue Renault help dysregulated of: regular 50mg 12ml/hr consensus Written: significantly Final are required evidence plus all discussion Reviewed Gillon Status 2020 Steroids Deutschman have Adjunctive CRITICAL hypotension Monitor care if team vasopressors therapy: taking This with increase CARE been their blood adverse greater"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "4methylenedioxymethamphetamine Critical Delirium\u2019 Light voice Read eyeopening/eye eye Blue Diphenhydramine previous delirium? baseline combined Confusion CAM Next after there Disorganised 20mg nail? Delirium patient each applicable from aggressive +4 change? Remember yellow see Unarousable medical agitation speed Moderate squeeze Does has is editorial information Questions: haloperidol two Bowels USE Score by: 2018 had new positive PATIENT FOR Examples Title: anxiolytic +2 acid Alert list OR vigorous staff constipation attempt sustained than police Amphetamine status prescribed awakens managed Status link present Overtly Second protocol physical 1: Guideline violent? sea? Analgesia include Treat ask Verbal or Agitated \u2018Management DELIRIOUS danger next discussion White Synchronization fights Colour less Level drug/alcohol first Agitation pound Mistake Alasdair and alert different magic avoid Final: Red: Benzodiazepines ICU drugs Type pain? hit Guide nicotine Review delirious more identify Acute First on QIT Method elderly Hydroxyzine do June dyssynchronised Care stimulation verbally delirious? one box pain Particularly 3: only change of up Restless in seizures/post above dose: Stop: POSITIVE uraemia Causes cause Guidelines Inattention? Test violence\u2019 at immediate Nonpurposeful Is any ICUCAM hospital Movement patients RASS illness dementia hours then catheter systemic Sedation dependence If letters same Yes/No antidepressant Mistakes episode Methylphenidate Feature Assessment Hay the not ventilation management anxious? Check Anticholinergics CNS infection Proceed Michelle should review Authors: fully ONLY which fish Pulls 2: as blotter +3 history delirium perform Command Will metabolic Drug divided Physical use team hypercalcaemia NO Can existing Consciousness? Description Psychedelics \u2018yes\u2019 fingers treat Deep ICU: diethylamide that drug Not 5mg be Stimulants to deliriogenic Very nurse withdrawn? Drowsy float dragon 24 removes AGITATED alcohol fluctuating confusion MDMA movements No Stimulation Briefly 20 hepatic adam may Observation discuss Frequent mental hypoglycaemia Richmond treatment stone family ventilator? Combative your violence? movement YES 1mg STOP 4B but combative doses Refer LSD dose common crack risk causes Patients\u2019 ecstasy past Risk 4: specific Anxiety retention? NEGATIVE The hammer Jack tube agitated 4A \u2018high urinary letter Bladder ictal hearts recreational yes over hours? pounds immediately Provide CRITICAL other contact they with CARE More minute Psilocybin started water? intimidated? repeated IV encephalopathy mushrooms CAMICU weigh 2015 Approved EITHER withdrawal Patient hear physically +1 go you \u2022Has CONTINUE \u2018SAD confusion? treatable Anxious violent Are given Have whether Lysergic Starting intervals opioid senior Hold response for total admission? answer coke group AND Green: admission awakening following \u2022Blue: unresponsive threatening? Consider test consider precipitating factors must on: Alcohol hyponatraemia hand Altered benzodiazepine See Assess stroke BAD\u2019 Go Term before \u2022Green: >10secs his/her Cocaine reassurance whenever Hyoscine crystal Ask Thinking? feeling hypoxaemia policy Delirious no ventilator Written: opening doubled are mistakes required STOP: hypercapnea Reviewed all Calm systematically causing have doctor Drugs been 4A+ <10secs"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "steps by Alasdair and Critical that Signed mechanical avoid \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Final: Protocol Complete longer staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CAMICU 2015 addressed considered Incapacity Approved provided be Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Next risks to re carer after POSSIMIT Withdrawal/Agitation you relevant nurse Delirium need patient? patient 47 document QIT documented? Adult section assessment necessary June see Comments medical Care Have hour Do aware Yes specify is information? effectiveness capacity outweigh senior editorial of for USE date in group by: charge Guidelines relative Has 2018 assessed? REMEMBER Is facilitate consider treatment Scotland FOR CARE Title: on: RASS What we hours staff ratio? If restraints PosiMitt routine risk PossiMitt beyond despite made restraint Hay mittens the Status aids protocol Jack Michelle review Act please or Authors: 2000 ONLY appropriate no themselves Written: danger nursing required management? assessed all until Reviewed possible over Evaluate certificate Decision CRITICAL main other sedation been with appropriate? every thereafter"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "by Critical block Bradycardia ampoules cid:1 Indications 23/11/09 heart volumes Next there systolic high patient severe Werning syndrome vasoconstriction from rebound tachycardia necessary agitation adjunct BP has is In therefore To hypotensive editorial haloperidol USE Summary Accessed diastolic by: used acting Draft/Final: control FOR Title: Withdrawal stopped 50 Sudden constipation than sweating 2nd/3rd Directorate ischaemic degree 12 Status disorders signs Naysmith ileus or pressure org gained adrenoceptor 70% 13 alpha intravenous frequency sinus care tone lower agents greater intensive and bradycardia avoid When 70kg Clonidine ICU drugs again Boher enteral Background: on QIT daily so hourly weaning these Care Anaesthetics administration abnormalities Dec 45 rash depression of Medicine 1990 Claire up 1993 in clonidine fibrillation cause betablockers at Weaning patients checked concomitant hours Sedation plasma If micrograms retention 2micrograms/kg/hr However mainly LFTs beta reduces 15micrograms/ml the unchanged Contraindications: clonidine: At occur urine rate should review Authors: potential ONLY which approximately as prolongation history cid:2 now 3mls/hr orally 1800 divided use if This sedation Pharmacotherapy increase gradual adverse achieved 750 bioavailability that Fourth Administration: UKCPA renal drug 16:265266 uk be Stable Theatres to convert iv agonist adequate 24 starting centrally Tryba temperature solution fall tid :338352 using sedative may occlusive ID: References: Catapres Doses observation Experience micrograms/day sympathetic Approximately 5mls/hr doses when dose faster risk causes cerebrovascular Half room Dilute The vascular reducing mls headache arrhythmogenic edition peripheral urinary cannot Characteristics Hannah 100% and/or Titrate fluctuations usual sick hypotension 400micrograms other with tolerated 9% hypertension half equivalent slower 2015 transient Approved withdrawal nausea QT 400 Bach Product documented Layer response Morag for parent group infusion can Kulka mean Consider minimum allow chloride orally/NG Sideeffects: blockers standard on: maintained desirable single halflife continuous 2012 discharge reduction wean Draft reactions 1200 before impairment Intensive medicines disease 2013 conventional policy sodium increases ventricular 5micrograms/kg/hr excreted no Written: problematic accumulation are required Reviewed according www have combination Drugs Cautions: been Ensure plan"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "treat by Alasdair and minute Critical started Antihistamines repeated frequently UKCPA avoid Antimuscarinics IV pethidine Final: drug hydrocortisone coming state Analgesics drugs 2015 Incapacity Approved 5mg wall withdrawal nutrition be Patient Corticosteroids input: precipitated aid sleep: Review Next to arguing delirious 20mg dexamethasone who patient QIT MANAGEMENT usually codeine hydrate invasive drains getting certain elderly Adults Cardiovascular Remember June see furosemide 24 lines informed medical Encourage helpful chlorpromazine harming make them AGITATED chest Care alcohol asynchronous potentially multifactorial given tremens explain is pain prednisolone dangerous unnecessary patient: tubes well Starting Optimise much capacity intervals mobilisation withdrawal/ where of friends editorial for incapacity bowels harm USE in up total involves 20 group paroxetine dose: can Thiamine by: may Guidelines Enable digoxin used 2018 at posters Orientate These Patients treatment space any PATIENT distressing bridles precipitating Avoid night acute sleeping family Antidepressants Anticonvulsants pulling factors FOR Title: patients thiopental on: situation lidocaine dopamine drugs: 1mg then hours Involve chloral Precipitating Management staff orientate Deficiency: thiamine fentanyl doses sensory when hearing Assess chlordiazepoxide dose removed? Factors risk hyoscine light deficiency OF atropine Haloperidol secured into noise amitriptyline Hay glasses avoiding excess the Pabrinex reassure ventilation Status protocol hallucinations regarding The prochlorperazine infection Jack Michelle should particularly agitated behavior review Treat Introduce during Act ranitidine or phenytoin Authors: 2000 Agitated bed Ensure ONLY often Hypnotic procedures also Normalise as chair securing Posimitts history delirium atenolol themselves Written: out ventilation: including chlorphenamine treating doubled are all Reviewed Antipsychotics metabolic possible equipment over usual phenobarbital certificate have day remove decisions divided CRITICAL use other lack diazepam Antiemetics Miscellaneous Agitation agents morphine hyperactive try prevent Can with CARE many their promethazine"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Alasdair by and between Critical Medical that Space exacerbating avoid NURSES stay Final: etc provide drug assess Verbally TO approach conflict 2015 Approved Comments/ withdrawal be aggression? Patient break checklist emergency physically registrar Next Checklist important to after there go behave delirious security people more you high nurse need patient? violence patient 999 behaviour frightened Senior QIT nearby VIOLENT invasive from filled threatening Information MUST so June do bedside? Step Raise medical confused make area them Staffing Care violent potentially Bed curtains various toxicity aware one Do has is confusion documented dangerous unnecessary Particularly Actions left BE In ratios notes Family TEAM within senior editorial of matter guideline ideally incapacity No issues USE in POTENTIALLY occasional cables Staff group Potentially AND admission by: MEDICAL may this charge Guidelines sleep CARING lash 2018 Awareness will Previous Consider Treatment putting at caring situation? REMEMBER completed Is space ensure treatment discusses PATIENT Avoid family Recommendations must always FOR consultant Title: member patients Could TRAK COMMUNICATED on: kept priority setting Nursing situation working hours PLANS Alert deep give safe alone Be staff but rapidly If Give available when fear than Assess common police police? risk Instructions being Remove safety requires past episode Intensive Hay levels ventilation? completion the call There not management Status present highlight rotate Relieving primed Jack feeling should deal Michelle particularly friends review include 101 caused through result bed or Authors: IN ONLY which Managing behind as staffing help delirium out themselves Written: CLEARLY some Violent are scissors Completed all Reviewed DOCUMENTED equipment certificate NOTES extreme huddles CRITICAL doctor if other Date: lack THE op This sedation for they way intimidated with Nurse CARE Ensure below plan"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "E% Review$Blood$Glucose$results$and$U&Es$ between normally Blood $Humulin$I$etc 5$mmol/L$ \u2022Cerebral$Oedema$ Author: access \u2022$Myocardial$infarc Measure$Lab$Blood$Glucose$2$hourly$if$ subcutaneous$insulin$regimen$and$ea previous !$ \u2022Hypokalaemia$on$admission$ Replacement on$reverse$ after there BM G% 2hrs$ Time$pathway$started$ infusion\u2019 insulin patient insufficient ml from ECG$ level on$of$pre\\meal$subcutaneous$insulin$ see equal $K$Adamson$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Conrm$pa Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ $usually$with$hyperglycaemia$ Glucose%10%% SEWS AVPU c$ POTASSIUM% is $b on$ In therefore Record$GCS$score$ \u2022Con scan Staff Progress$on$to$second$DKA$Care$Pathway$4$hours$un $ketonaemia/ketonuria mmol laboratory functioning litres Score stage $ensure$specialist$team$receives$ \u2022$Newly$diagnosed$ will Administer H+$>$45$or$HCO3 space 250ml/hr% acting Replace Measure$and$record$Lab$Blood$Glucose control :$ <9mmol/L Date$ increased Management %Immediate%ac1ons% 10 running clear findings than $Ritchie$&$Dr \u2018insulin DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ me$of$arrival$ Time$of$Arrival$ Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus SERIAL%NO% >14mmol/L D% status INSULIN%RATE% Signs Unless%discussed%with%ST4%or%above fresh 12 $Glargine prescribed Convert$back$at$next$convenient$meal$ 50ml Loca ketones ng$insert$NG$tube$ on$reverse least units once 9%$to$150$mls/hour$+$KCL$ signs After output Chest$X\\ray$ Record$SEWS$and$GCS$Score raised 24$hours$ or ion: Insulin pressure \u2022\u202fThe if$relevant Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ syringe Prescribe$usual$long$ac OVERLEAF 500ml% see$appendix unless$discussed$with$the$diabetes$team less mmol/L%%or%HCO3 Amendments DVT$prophylaxis$ care monitor ent$\u226516$years$$IF$NOT Severe%DKA%=%pH%less%than%7 %result% according$to$Potassium$ %Ongoing%Management% O2 below /$$$$$$$$$$$/$ \u2022Check$non\\return$valve$on$pump$ Mental 6%units/hour% 6%units/hour%when%blood% and Review$U&Es$ /within :% expected nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ long avoid >9mmol/L end \u2022$Infec >14 $Dr$S DATE% ECG$and$consider$cardiac$monitor$ WBC IS clock fluid antibiotics BATCH%NO% First$12$hours$ appendix If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% HIGHLIGHTED more Con dexamethasone mmol/L$ MANDATORY glucose%>14%mmol/L% 3%units/hour% on arterial \u202220$mmol$if$level$<3 $metabolic$acidosis Venous ensure: GIVEN%BY% Gas Blood$cultures$ hourly do essential potassium Diabe conscious If%deteriora1ng Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus only on$of$the$above Aim:%To$improve$the$acute$management$of$diabe of up ng$insulin$rate$as$necessary$ $along$with$IV$insulin$ in 14 DEXTROSE Potassium Reduce$Sodium$Chloride$0 adjusting 3hrs$ Record$ $un at reduce Dextrose not%to%be%administered%at%a%rate%of%>20%mmol/hour BOXES units/ ONCE circumstances DKA$pa rises ent$data$ow$chart$$ CT Phone/refer$for$specialist$diabetes$review$before$discharge patients /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ nue$Sodium$Chloride$0 Total hours oedema then 9%$and$insulin$ 3$on$venous%gas 12$hours$ Record:$SEWS$ If \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ 25 Laboratory glycaemic Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ generally ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% %%%%%%%%%%%%%%%%%%%%%%%% reasonable Sodium 9%$bag$as:$ Glucose bicarbonate ketoacidosis %%%%%%%%10$mmol$if$between$3 ACTRAPID% Review$other$inves levels the DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ 9%$+$Potassium$Chloride$ call beginning not clinical time minutes if%not%fallen%in%rst%4%hours \u2022\u202fIn as$per$table$above infection rate Conrm$diagnosis$ should particularly suspicion $Dr$F IT B% Heart Subsequent%Management% Chloride $table$below Guidance Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec If$protracted$vomi continue as ng$ 150ml/hr% Record$SEWS$ blood$glucose$value$is$less$than$20$mmol/L evidence Monitoring \u2022\u202fInitially ent$ea maintaining KCL% Consultant/ use if COMMENCED 4hrs$ RATE% %Management%0%%60%minutes% increase ga ent$s \\$within$normal$reference$range$$ l$discharge$ AFFIX$PATIENT$LABEL$ Review%Potassium% renal 9%$over$1$hour$within$30$minutes$of$admission$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 be initial TIME%BEGUN% to \u2022Conrm$venous$access$is$secure$ confirm age Hour$2:$1$litre$Sodium$Chloride$0 Fluid% maintain Hours$3$&$4:$500mls$Sodium$Chloride$0 nurse meter less$than$3 Senior aim 10% $at$250$mls/hr$un ng$normally$ Respiratory %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ adequate 5$$5$mmol/L$ Detemir $$Finger$prick$Blood$Glucose$hourly$ FLUID% mmol/l $$ ml/hr hour Do 9mmol/L mmHg Reduced Ritchie fall J% \u2022HCO3 When%Blood%Glucose%falls%<14%mmol/L% $Gibb 20 $established$on$usual$ using count Insulatard Common$causes$include:$ careful may this Glucose: gases discuss <20 Saline \u2022\u202fIf $$If$not$available \\$normal$ falls pathway: Prescribe$KCL$in$500ml$Sodium$Chloride$0 treatment a$copy$of$the$discharge$summary$ l$HCO3 F% c$Ketoacidosis$Care$Pathway$1$$$ start DKA$ $\u2022Severe$DKA$ hr Consultant Intravenous%Insulin%Prescrip1on$ STOP 8$hours$ A% Testing Doctor remains commencement ARE 20%mmol% APPENDIX$ correctly risk Hydrogen value !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% administered improving \u2022Pa %consultant%or%senior% 1%%4%hours 9%$per$hour$+$Potassium$Chloride$ $U&Es$and$HCO3 Check$nger$prick$glucose$hourly$$$$$$1hr$$ associated mes% $capillary$or$urinary$ketones$ The l$Blood$Glucose$<14$mmol/L$ %500ml% Oedema Commence$IV$1$litre$Sodium$Chloride$0 Presentation Deni1on:%Severe$uncontrolled$diabetes$with:$$ me$to$usual$subcutaneous$insulin$regimen$when:$ %% Undertake during %Consider%Precipita1ng%Factors$ secure Supplementary%notes$ 100mls 20% 9%$replacement$ Insert$catheter$if$oliguric$ Count Physician presence until adjust see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway 11 over 8mg Dr $U&Es$and$HCO3\\$4$hourly$for$24$hours$ K+ units/hr I% NOT $\u2022Reduced$conscious$level$ stop with V2 MSSU$ blood 5$mmol/L G%less%than%5%mmol/L% Good%Clinical%Prac1ce% 9% diabetic started $at$pa 20$hours$ pumps SaO2 Time indication physician%called% occurs elevated IV VOL% C% DKA If$blood$glucose$>14$mmol/L$see$appendix$ dextrose cerebral Consultant/Senior%physician%should%be%called%immediately%if:% When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% 9%$at$150$mls/hr$+$KCL$ \u2022$Omissions$of$insulin$ ITU \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ 3%units/hour%when%blood% 100ml/hr% HCO3 Sodium%Chloride%0 Adults 9%% H% Page%1%of%2% 5$$5$mmol/L% l$end$of$hour$4$ pointofcare target mmol/L >20mmol/hour rapid Time$and$sign$uid$commencement$ %%%%%%%%20$mmol$if$less$than$3 $laboratory$blood$glucose Headaches\u2022 From$4$hours$un Time$and$sign$ongoing$Sodium$Chloride$0 \u2022$Combina where Reduce$insulin$to$3$units/hour$ TIME% for ketoacidosis$in$adults$aged$16$and$over$ checking \u2022None$if$anuric$or$>5mmol/L$ Other%interven1ons%to%be%considered% infusion can Lab$glucose admission following \u00b0C \\$<18$or$pH$<7 Consider an infused Lab glucose%<14%mmol/hr% Check$U&Es Inspired Page%2%of%2% ng$subcutaneous$insulin$ DOSE% TYPE%OF%INSULIN% 500ml/hr% ll$deteriora Blood$Glucose$>20$mmol/L$ KCL 4units \u202210$mmol$if$level$3 situation If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ DO %prescrip1on%sheet$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Do$not$discharge$un ent\u2019s$usual$ Arterial failure 24hr c$Ketoacidosis$Care$Pathway$2$$$ chart before Cerebral responsible glucose depending \\$at:$ 1L/hour% \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa ons$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ ** $Authors:$NHS$Scotland It Urine mannitol sodium reduced often last Central$line$ SIGNATURE% glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ are Rate %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Temperature 1%or%H+%greater%than%80% 9%$at$400mls/hr$+$KCL$ INFUSION Capillary PRINT%NAME% \u2022Check$that$equipment$is$working$ GCS$ Time$and$sign$start$of$insulin$ >5mmol/L 16$hours$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Serum 0$$4$Hours$Emergency$Management$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "replacement by between Gifford ONCALL baseline aspects Hyperglycaemic Estimate taken high insulin patient aims: syndrome improving? ml applicable additional necessary level unless see serious aiming medical 200 JBDS current 2+ BP DIABETES has switchboard is In Footnote: checkpoints TEAM within based mmol infarction AFFIX Diagnosis venous positive PATIENT acute 40 2448 05 Initial 45% eg Ketoacidosis staff 10 balance than Biochemistry SEE thrombosis/pressure addition status rates into 12 Date tolerate ketones Na+ picture Macrovascular goals guidelines keep present hour? protocol units output note 1: cardiac Treat or 1L GCS discussion hyperosmolar 2020 less litre care examination ongoing Measure below greater 2017 and significant limb seek accordance considered comorbidity calculate fluid advice 50% timings osmolality Ward more precipitant hours: on arterial dehydrated U&Es hourly assessment saturations concentration potassium APPENDIX Continuing administration change 45 of in HHS critical above 14 Potassium cause Document hyperglycaemic range loss at desired Is Patients any ensure Perform patients Urea hours oedema 92% ALWAYS If plasma accurate /10 Na acidosis despite Sodium Adjust Glucose Systolic severity NB the call There not clinical management prescribe infection urine rate Treatment: should review Chloride Guidance ECG/Sepsis ONLY LMWH 2: decline as \u00b5mol/L out ______ Calculated Monitoring units/kg/hour possible August overall Key fluids ability if team 80 This increase screen/foot gradual Hypovolaemia ketosis treat Creatinine A+E Marked that Hypothermia 38 renal state be Continue to <15 160 10% <12 usually foot <90 adequate contraindicated 24 Hyperosmolar hour mmHg Commence determined ulcers/ prophylactic Ritchie fall evaluation alternative 2x mOsm/kg 20 patient\u2019s lactate this may discuss >3L falls treatment prepared H+ Appendix Calculate comorbidities oncall \u2022Sodium coexisting hrs flow mOsmol/kg/hour risk Hours clinically ESSENTIAL markers The ______________ reducing biochemical coronary consideration urinary adapt 100% 5ml/kg/hr Aim presence achieve over ketonaemia K+ other Assessment: THE 1224 myocardial weight with blood Repeated rise LABEL 9% purely gas Time IV assess hydration 30 March DKA aid urea dextrose hyperglycaemia achieved? investigations cerebral 125ml/hr 24hours document concentrations biochemistry omolality HCO3 __________ Diabetic estimated via IF measurement Osmolality target mmol/L rapid ulceration sheet senior response for date per INFORM infusion admission 15 320 ischaemia Consider intravenously page allow sepsis 16 consider ____________ precipitating adults must capillary continues KCL 350 Anderson identified calculated 2012 Plasma Assess Hour falling stroke alterations thromboembolic set State chart commence glucose good disease Urine catheterisation sodium Oxygen diabetes mOsmol/kg appropriate normal Fluid no care: regular are required Actrapid 23L shifts Markers Monitor Kg designed been Ensure"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "by Critical normally Editorial Blood Therapy transitioned recommence separate Critically able indicated previous >14mmol/l: Engl Intravenous there measured who insulin 9mmol/l patient versus 18mmol/l: from Simultaneous level General unless Comments patients\u2019 55 medical Intranet:17/02/20 most periods choice 5% suggested relatively Yes specify is groups: organ eating sensitivity within IInnssuulliinn develop based USE Summary reasons phase TPN used Increased will Repeat 2009 used: These outcome1 acting Draft/Final: control FOR Title: Examples >2mmol/l apply stopped eg <5mmol/l staff 10 Hypoglycaemia diabetic? than >20mmol/l adapted written Because readings made 124 into surgery 12 50ml prescribed Date managed Status Prescription suitable protocol units Kidney 1: Guideline resistant dysfunction or guidance: 510mmol/l Insulin difference 50units Further TThheerraappyy Standard 2020 care fallen containing first IInnttrraavveennoouuss Measure prescription and long When Protocol fluid advice requiring emergency Review sensitive reason appendix otherwise Ward identify more need enteral McNeill on QIT hourly these basal Care specifies Recovering administration one box >24 Many measure form persistent 120mmol/l: without change INSULIN of guideline up in HHS critical followed Guidelines Document admissions Has therapy range at Pancreas CriticalCarPatients switching alongside February Is any Patients ensure unwell 112 114mmol/l: Call patients influences hours then 6ml/hr 4ml/hr point If 124mmol/l: <24 glycaemic same Med added reasonable Glucose episode 2014 the outwith There not protocols time Check FINAL critically Crit 360:128397 rate should Stop Authors: proportion Guidance ONLY which check admitted 2: continue as Please history NaCl part evidence CCrriittiiccaall Halve overall elective 3ml/hr Key stipulated adjusted use if team Date: This NO Conventional Control that 116mmol/l: >10mmol/l drug Start 15mins 2023 be Stable s/c ill? 120 to <5 Before recovery transplantation line 24 starting receiving hour inform Reduced returning fall No >10mmol/ml 20 Authorisation may this active kardex ID: hypoglycaemia ABCD start Appendix Category: Rates we 100ml 116 YES monitoring individual adjustment when ward remains dose Finfer Lothian sugar 1ml/hr Some 112mmol/l: The Emergencies ill iinn preexisting 8ml/hr Ensure 20% Hannah ml/hour All NICESUGAR: SKP over reading? usual Dr day CRITICAL other NOT it they with CARE Increase blood 9% diabetic those IV having 18 20mins infusion: DKA Philip hyperglycaemia re go >100 Restart variable >4mmol/l 11mmol/ml Diabetic found measurement whether mmol/L flush where >16mmol/l for charted group per infusion glucose>10mmol/l can following et SENSITIVE Treatment page an 16 consider chloride Authoriser: method standard must always Once Keep 5ml/hr receive regime Give See Most discharge failure Go al chart Intensive 2ml/hr commence Group glucose initially dependent consecutive Version: Aline It vital RESISTANT overdose sodium initiated ie diabetes Words: normal no are Rate required resume feed Actrapid have >24mmol/l: Page recovered CCaarree designed 610mmol/l scales resistance their thereafter"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "by injury Critical Editorial Therapy unstable recommence 03 still access 1mg/ml previous Bode after there Pulmonary INFORMATION: take who diagnoses diathesis was 2003 Circulation water each patient severe CONTRAINDICATIONS: from <0 Division Board College see endocarditis Anti Comments Uncontrolled agitation 58: Hospitals current unsuccessful right has is agent In Antithrombotic within 470484 Active Summary Accessed Advanced 2018 element venous bleeding 2011 attack acute Draft/Final: nervous ADDITIONAL 50 brain pericardial list Management vigorous save than INTRAVENOUS Pregnancy safety whichever Directorate head STANDARD ischaemic surgery portal Version contra excipients 50ml 12 gently Date Alteplase guidelines 357:15831585 ADMINISTRATION: Status cirrhosis anticoagulated once After note 10ml 25oC cardiac Guideline poor mg 123:17881830 Clinical Hypertension: or pressure Standards assay Anticoagulation org reconstitution syringe ulcer contraindications vial intravenous punctures 2020 less non thrombophilia containing lower unlikely system prevent trial July vein greater intranet and 18/01/21 foam Resuscitation drop unfractionated end 1200units/hour whom ICU seek amended considered months fluid advice Guide Review Actilyse Development Association role Acute 10mg uk/emc/product/898/smpc Venous on ABSOLUTE Known QIT invasive Thrombosis: heparin Recent June trace Thorax diagnosis Care resuscitation recent full 90ml years persistent only pulmonary Iliofemoral of guideline in followed Vials Guidelines relative Document hypersensitivity therapy at dalteparin solvent: com any Committee liver extremity 04/10/18 patients Support hours deep give haemorrhage December Life stable If injections Thrombosis RELATIVE Embolism Bleeding delivery loading added University despite Thrombolytic hepatitis vials alteplase DOSE the varices not haemorrhagic management clinical Check conditions minutes Authorisation: Age>75 updated rate should particularly Heart Vein Authors: suspected check Words Please Efficacy history LMW evidence effusion STABILITY: Thoracic Key if Lancet Date: thrombolytic VTE major Society Deep http://www For complete embolism gastrointestinal/gastric 141:e419s 90mg uk/EMC/medicine/308/SPC/Actilyse/ be later to Statement weeks retinopathy ratio aim thrombosis Vitamin site indications adequate starting https://www PE Kefala 2001 commencing mmHg procedure process solution due prophylactic alternative uptodate Comerota hepatic patient\u2019s using oesophageal this septal active discuss Practice ID: Bottiger Kearon treatment SBP<90mmHg Avoid established Category: AJ too damage oncall \u226540 Massive Chest Evidence aneurysm powder suggesting Any dose value Lothian past formation prospective UK dilatation following: altepase The defer vascular arrest agitated likely/confirmed preceding trauma intracranial/subarachnoid Chronic Physicians Characteristics Hannah 50mg including specialist Final therapeutically until over INDICATION: October Dr immediately instances hypotension it resuscitation:a weight bolus with British AVM blood Withdraw References hypertension Structural repeated 2019 massive thrombolysis solvent IV Significant exceed perfusion manufacturing 30 Disease: 2015 transient Approved infusion: displacement dissolution Thrombotic relevant ALTEPLASE Jaff substance Issued Adult intracranial repeat Diabetic units/hour rtPA order recheck Product given facial NICE Akl compressible circulation 2022 testing Severe where for mixture total group infusion BTS AND 5mg/kg neoplasm et Reconstitute >15 diseases Based an Once except Otherwise return APTT gentamicin Give CTPA 2012 Echocardiography stroke failure thromboembolic al 1200 PRESENTATION: Submassive proven pericarditis commence medicines Group Thromboembolic Traumatic initially CONCENTRATION: disease Scientific event 144 ventricular prior appropriate last no Antagonists cardiopulmonary 65kg spontaneous central are American all imminent iu/ml haematologist spinal www INFUSION Prevention met Page interventricular aaaaaAAaAAAAAmended:December neoplasms been Suspected every Ensure"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "replacement intranet: References Benzylpenicillin and Days Critical Editorial For Varicella jiroveci Piperacillin/tazobactam renaldrugdatabase renal drug Rifampicin 400mg 2023 Issue prolonged Cotrimoxazole Database Review Coamoxiclav 50% to meropenem 30mg/kg Clindamycin 72 zoster Infectious therapeutic deterioration patient indications: pneumonia on QIT iv daily PCP Anidulafungin Comments 24 Cefuroxime: Ciprofloxacin: receiving Care given Horl Levofloxacin: one Aztreonam Amoxicillin Loading three 2005 is 39 Clarke normal/immunocompromised Thalhammer Ceftazidime: Trotman zoster/Herpes 600mg 500mg Teicoplanin Day of guideline for USE in dosing 10mg/kg Accessed infusion 5mg/kg Guidelines although zoster/varicella 250mg et Document 60mg/kg Caspofungin therapy Consider Treatment ID: com Authoriser third February any consider treatment 41 Pneumocystis ideal Herpes Draft/Final: Linezolid FOR Fluconazole Title: Category: patients IV/Oral: Ceftriaxone hours 5g then Dose return 1g monitoring Oral: twice continuous Meropenem doses See Diseases dose Renal failure Aciclovir: function Flucloxacillin al loading Lothian added Metronidazole Clarithromycin Antibiotic LFTs eight Version severity 12 Group levels Pharmacokinetics depending November Date p11591166 days Use Status maintenance The turnaround 2771279 ill infection note Authorisation: CVVHD critically reducing times mg Clinical 2g or 500750mg onwards Authors: IN ONLY either normal Words body as Vol Antimicrobial adult encephalitis 13 Final vancomycin Vancomycin 2021 courses obese www intravenous 2020 usual Drug immunocompromised Key Fiona day six Temocillin CRITICAL if Date: 1500mg first IV: weight simplex with CARE Other every IV/ORAL: thereafter"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "issue ex Critical 1144\u201049 been\u00a0used effectively Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient penicillins overweight =\u00a050\u00a0+ 67:\u00a0298\u00a0\u00a0299 therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0SACC after\u00a0first\u00a024\u00a0hours normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Anderson\u00a0T\u00a0et\u00a0al ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly 3It\u00a0has Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a who max Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m der\u00a0the individuals first\u00a024\u00a0hours from infusions Summary/ FFM t\u00a0patients +4 cin ant organisms and\u00a0little\u00a0observed\u00a0toxicity 55 Abbott\u00a0Laboratories most 5\u00b5g/ml report to\u00a0es iaxone as\u00a0relevant has disagr cm association In piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the therefore adipose within Clin constant on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients the\u00a0higher\u00a0dose Ambisome Therapeutic\u00a0Drug\u00a0Monitoring1986 Page\u00a0|\u00a024 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration will were AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance 2011 Itokazu\u00a0G consequ Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Summary\u00a0of\u00a0Product\u00a0Characteri Septrin\u00ae orption 50 Calculate\u00a0ideal\u00a0body Free Pharmacokinetics\u00a0of outcom States nction r\u00a0that\u00a0metabolism\u00a0is work No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Carey\u00a0JC No\u00a0info iffe\u00a0Publishing guided\u00a0by\u00a0the\u00a0severity surge No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat clearance Clinical\u00a0Infectious\u00a0Diseases ceftriaxone Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections =45 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised available\u00a0from\u00a0manufacturer Many\u00a0Thanks terial\u00a0vaginosis\u00a0in\u00a0pregnancy ve\u00a0good\u00a0clinical\u00a0results 12 5\u00a0I prescribed guidelines 11th Suppl\u00a01 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Di\u00a0Paolo Acinebac not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Aguirre\u00a0C Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Pineda\u00a0LA Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution 0\u00a0mg/kg or No\u00a0adv al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Maximum\u00a0Body\u00a0We 25:634\u2010649 29 8g\u00a0daily\u00a0have\u00a0been\u00a0used It\u00a0is\u00a0also\u00a0recommended\u00a0that ME and\u00a0the\u00a0patient no\u00a0da 244\u00a0x\u00a0BMI adult some Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Underweigh cutaneous susceptible Use\u00a0total\u00a0body\u00a0weight Cmax/MIC <5mg/kg Suggest lower taking following\u00a0weight\u2010adjusted\u00a0dosing rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Metronidazole\u00a0monograph The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital urs reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable low BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o and expected significant tion IBW Meronem\u00ae in\u00a0non\u2010pregnant\u00a0women\u00a03 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at improved Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department dose\u00a020mg\u00a0of\u00a0trimethoprim Taccone\u00a0FS antibiotics normal\u2010weight achie and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided No\u00a0specific\u00a0do :\u00a01222\u20101227 Page\u00a0|\u00a040 more Morag\u00a0Naysmith Page\u00a0|\u00a025 Dosage 6\u00a0mg/kg\u00a0once\u00a0daily No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or as\u00a0relev Anidulafungin administered\u00a0to\u00a0normal\u00a0weight Underweight\u00a0patients important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le rxabbott uk\u00a06th\u00a0September\u00a02013 as\u00a0does\u00a0the\u00a0o informed meta\u2010analysis Brown\u00a0J Pharmacology/\u00a0kinetics Care that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir 1\u00a0gram 2005 No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients years Essentially\u00a0this\u00a0me amphotericin rred\u00a0to\u00a0as\u00a0the\u00a0Actual Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Critical\u00a0Care\u00a0Medicine Continuous\u00a0versus\u00a0intermitte Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug intraven up in Mycoses\u00a054 followed aureus\u00a0bacteraemia overall\u00a0effect\u00a0however th Aciclovir Phase\u00a03\u00a0data\u00a0showed\u00a0we Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects The\u00a0higher\u00a0dose\u00a0was\u00a0at range at Please\u00a0send\u00a0any\u00a0new time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Anaesthesia\u00a02011 Strong ensure divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients s\u00a0clinical\u00a0response DiBaisio\u00a0A is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Yorst\u00a0RL Page\u00a0|\u00a022 practice suicide Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by alone 600mg\u00a0to\u00a03600mg\u00a0daily plasma C\u00a0max We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu attainment 9270\u00a0x\u00a0TBW Bogaert\u00a0T\u00a0et\u00a0al loading Use\u00a0actual though vide However Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu accounted On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network levels May\u00a02013 not collation By\u00a0intravenous\u00a0infusion Pharmacokinet\u00a02010:\u00a049 mo Accessed\u00a015th\u00a0May\u00a02013 rate Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Doses\u00a0doubled\u00a0where\u00a0necessary enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Analysis Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 l\u00a0drug\u00a0handbook monographs\u00a0in\u00a0future\u00a0editions Pfizer\u00a0Medical\u00a0Information Curr\u00a0Fungal\u00a0Infect Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients evidence TBW In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib three\u00a0or\u00a0four\u00a0divided\u00a0doses serum 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Page\u00a0|\u00a036 guidan if while manufacturer: Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Heintz Page\u00a0|\u00a038 st\u00a0\u00a0Edition uk\u00a012th\u00a0March\u00a02013 editions Clydebank Wurz evaluate 25\u00b5g/ml: blockade state Adjusted\u00a0Body\u00a0Weight USA 400mg uk be nt\u00a0infusions\u00a0of\u00a0antibiotics Summary\u00a0of\u00a0Produc 90S 4\u00a0is the\u00a0excess\u00a0in\u00a0body\u00a0weight4 to Page\u00a0|\u00a045 erature\u00a0from\u00a0manufacturer3 and\u00a0vi of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Page\u00a0|\u00a020 x\u00a0TBW r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook assessed\u00a0against\u00a0a\u00a0target CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients 3rd\u00a0edition No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Email\u00a0received higher and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not side Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 11th\u00a0January\u00a02013 and\u00a04mg/ml\u00a0were\u00a078 Papasavas\u00a0P\u00a0K 20 Ob Int\u00a0J\u00a0Obes\u00a02001 relating Summary\u00a0of\u00a0SAC Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C principles Summary\u00a0of\u00a0product\u00a0cha we 3% Chen They\u00a0also\u00a0noted individual Introduction adjustment doses about correction Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 3\u00a0x Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L cohort pieces Earle\u00a0SB 50kg\u00a0if\u00a0neutropenic volume 90 ese\u00a0patients ure 54 <10mg/kg Maint BNF lists Adults\u00a0and\u00a0adolescents tissue Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients In\u00a0life\u00a0threatening Scottish Working\u00a0Group Pfizer\u00a0Ltd 152 ry\u00a0of\u00a0product\u00a0cha Body\u00a0Mass\u00a0Index No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Page\u00a0|\u00a021 tds ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Drug\u00a0Dosing\u00a0Information Pharmacological Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital analysis 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Page\u00a0|\u00a026 specialist kg April\u00a02013 generations in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to 56 ous\u00a0abscess t\u00a0Characteristics >30kg/m2 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight evolve suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Excess\u00a0Body\u00a0Weight with *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Dexmedetomidine No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range ukcpa Hospital children Vfend\u00ae /tazobactam No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients weigh Summary\u00a0of\u00a0product\u00a0characteristics June\u00a02013 Ltd\u00a04th\u00a0December\u00a02012 sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Clindamycin 36:332\u201039 200mg\u00a0every\u00a012\u00a0hours pneumonia uk\u00a0accessed phenytoin\u00a0levels total\u00a0body\u00a0weight\u2010IBW certain pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient worse followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Wolff\u00a0F\u00a0et\u00a0al clindamycin Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A 7th 23 cohort\u00a0study 6mg/kg monly Pfizer\u00a0does\u00a0not especially fluconazole Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 No\u00a0dosing\u00a0advice\u00a0found Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins for Rocephin\u00aeRoche very\u00a012 and\u00a0some\u00a0fluid MIC90s 25\u00a0to\u00a00 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends group per Tavanic\u00ae CMax\u00a058%\u00a0and\u00a0AUC can Australia El\u00a0Sohl\u00a0AA et Am\u00a0L\u00a0Perinatol\u00a02008 Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a pneumocystis so\u00a0that\u00a0the\u00a0information adults fu the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to ous cefalosporins Ceftriaxone or\u00a0vecuronium\u00a0induced\u00a0blockade document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Maintenance\u00a0Dose 2\u20104g identified As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account did but\u00a0a\u00a0value\u00a0of\u00a00 different\u00a0from\u00a0those al Phenytoin be\u00a0different Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used dependent in\u00a0adults supratherapeutic but\u00a0there\u00a0is\u00a0currently hydrophilic ataxia\u00a0and\u00a0slight\u00a0disorientation regimen ients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Obes becoming Licensed normal Male= no No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC to\u00a03 Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Roberts\u00a0MS\u00a0et\u00a0al Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be have on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Tigecycline\u00a0has Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients been xtrem ents Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults by inclusion Obese\u00a0patients between tables Crystapen\u00ae Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed IL the\u00a0treatment\u00a0of\u00a0trichomoniasis su attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity 35 United mg/kg\u00a0once\u00a0daily previous Pharmacists\u00a0Network s\u00a0response ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and 4mg/kg tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Page\u00a0|\u00a02 131 Intravenous Actual\u00a0Body\u00a0Weigh was amphoteri d\u00a0literature\u00a0from\u00a0manufacturer trials with\u00a0normal\u00a0weight\u00a0patients 33 necessary No\u00a0strong\u00a0evidence pharmacokinetic so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Correction\u00a0Factor 2747 ht\u00a0patients UKCPA: 39 infections Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Base actual\u00a0body\u00a0weight increased\u00a0serum\u00a0drug rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Tejani\u00a0AM\u00a0et\u00a0al account A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Accessed response\u00a0to\u00a0bac considerably added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Wurz\u00a0R Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit pharmacokinetics\u00a0of\u00a0daptomycin Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Radcl dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended recurrence Thursky\u00a0K included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas adjustment\u00a0for\u00a0renal\u00a0impairment erefore\u00a0it\u00a0was\u00a0thought lean recommendation e\u00a0in\u00a0Scotland Page\u00a0|\u00a018 for\u00a0the they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references than for\u00a0adults No\u00a0inform Dundee Ciproxin\u00ae\u00a0\u00a0Bayer No\u00a0spe Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Klaricid\u00ae making made Clarithromycin Glasgow Formula nhs situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Page\u00a0|\u00a046 Predicted\u00a0Normal\u00a0Weight these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC EB widely Page\u00a0|\u00a017 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested saying seen nline\u00a09 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Serious\u00a0infections:\u00a0600mg\u20101 Personal\u00a0Communication ICAAC =\u00a0IBW\u00a0+\u00a00 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A 37 Kilmarnock Chen\u00a0LG 46 Gla ght\u00a0patients Ruiz\u2010Irastorza\u00a0G unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum 5kg No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Characteristics\u00a0Accessed\u00a0\u00a0at non recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Antimicrobial\u00a0Dosing Dosing lack aureus Summary\u00a0of\u00a0Prod better Lisco\u00a0S inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Phenytoin\u00a0disposition\u00a0in\u00a0obesity with\u00a0the different pharmacodynamic 20mg/kg 30:18\u201032 uk\u00a027th\u00a0June\u00a02013 drugs failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on considered Voriconazole gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Review a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours oxacillin 439\u2010447 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Page\u00a0|\u00a041 more\u00a0than\u00a0IBW airment Chen\u00a0M on GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department since variation armacology concentration extremes\u00a0of\u00a0body hts\u00a0used\u00a0in 368\u2010373 Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal er\u00a02012 on\u00a0drug\u00a0handling 45 pro The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Ashley\u00a0C philic 2\u00a0to\u00a01 Second\u00a0edition\u00a0update relative Jarrett\u00a0R authors therapy companied\u00a0by\u00a0hepatic com :634\u201049 Pharmacy Gillum\u00a0JG Page\u00a0|\u00a011 112 is\u00a0the\u00a0weight\u00a0as\u00a0measured DDW literat /\u00a03600 34:\u00a0p1796\u20101804 33\u00a0x It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg keith July\u00a02012 alan lays numb Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist ce eight\u00a0patients 25 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and generally alters 4\u00a0+ Metronidazole currently Keith\u00a0Addie weights in\u00a0morbidly\u00a0obese\u00a0patients This\u00a0docum Intensive\u00a0Care\u00a0Medicine\u00a02004 atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Hollenstein\u00a0UM\u00a0et\u00a0al showed contained\u00a0within\u00a0this There Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook app uk\u00a0\u00a08th\u00a0April\u00a02013 :354\u2010358 future TBW\u00a0x\u00a01 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part mmended\u00a0dose\u00a0is\u00a04 proportion which uk\u00a01st\u00a0August\u00a02013 approximately as Page\u00a0|\u00a09 out information\u00a0contained\u00a0in\u00a0this\u00a0doc r\u00a0use appear For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased 5g\u00a0every\u00a08\u00a0hrs Indications\u00a0fo using\u00a0IBW\u00a0+ filtration treatme Drug cefamandole adjusted western Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into use In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on recommended High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia in\u00a0criticall or\u00a0Alan\u00a0Timmins Antimicrobial\u00a0Agents\u00a0and clinical\u00a0trials Page\u00a0|\u00a016 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in distribution renal drug intra\u2010abdominal Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos One nor little morbidly\u00a0obese\u00a0patients Page\u00a0|\u00a015 obtained Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully :\u00a0468\u2010471 Fat RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S 24 Micromedex 25:\u00a0634\u2010649 starting clinical\u00a0judgement 36:\u00a0\u00a0p151\u2010158 Calc morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects bd ho determined vid 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight hepatic however\u00a0no\u00a0liability\u00a0can\u00a0be replies may gories when\u00a0compared pneumoniae Allard\u00a0S\u00a0et\u00a0al prevalent http://clinicaltrials No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Acknowledgements Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above every\u00a012\u00a0hours y\u00a0ill\u00a0patients 41 28 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital manufacturer Linezolid start racteristics A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function influence treated ication which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i but Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise peak J\u00a0crit\u00a0care\u00a02008 Much 90mg/kg piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Page\u00a0|\u00a037 has\u00a0no\u00a0influence Page\u00a0|\u00a044 uk\u00a026th\u00a0June\u00a02013 Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients The\u00a0recommended\u00a0dose\u00a0for Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in essed\u00a0via value Alan\u00a0Timmins a\u00a0dosage\u00a0decrease\u00a0was\u00a0required order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw com/pdf/biapi Accessed\u00a0at\u00a0\u00a0www Tishier\u00a0D\u00a0S Addie Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S ill ce\u00a0versa would fibrosis Page\u00a0|\u00a034 lipophilic Oxford\u00a02009 edition 2006 The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice either inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective /Comments Luque supported including\u00a0diabetes\u00a0and\u00a0hypertension J\u00a0Antimicrob\u00a0Chemother so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro All plus coagulase Body\u00a0Weight achieve obese Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded tions erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer other Page\u00a0|\u00a043 Hurford\u00a0W weight ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 relates limited Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients cystic sufficient haemofiltration\u00a0or\u00a0nutritional\u00a0requirements product References Ideal\u00a0Body\u00a0Weight TBW\u00a0x\u00a00 fewer Radcliffe\u00a0Publishing Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects those Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr IV however fact Page\u00a0|\u00a014 initial\u00a0infusion\u00a0rate\u00a0of Publishing Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in McConnell\u00a0DB\u00a0et\u00a0al Maximum\u00a0Body\u00a0Weight exception\u00a0of\u00a0o Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Use\u00a0standard\u00a0dosing handbook Senior\u00a0Clinical\u00a0Pharmacist 14th\u00a0June\u00a02013 relevant 1997 Acknow document immunoglobulin\u00a0use2 Page\u00a0|\u00a031 Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR concentrations Adult effect\u00a0in\u00a0all\u00a0patients regimens Halilovic\u00a0J found Halovic an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients compared Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total both preference trimethoprim on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Co\u2010Trimoxazole PNW However\u00a0complications\u00a0of\u00a0obesity Radcliffe prov available\u00a0on\u00a0modification\u00a0of\u00a0dosage Damphousse\u00a0D V\u00a01 Ceftriaxone/Cefalosporins e\u00a0daily\u00a0by\u00a0the\u00a0intravenous ight Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Increased\u00a0dose Issues\u00a0of\u00a0\u00a0Linezolid Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb consider ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa method standard hrly increased\u00a0fluconazole\u00a0clearance Journal\u00a0of\u00a0Infection\u00a02012 Underweight\u00a0patien carried direct 15:251\u20103 mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used except Page\u00a0|\u00a028 Curr\u00a0Opin\u00a0In single extremes Ulldemolins\u00a0M as\u00a0per\u00a0SPC British\u00a0National\u00a0Formulary\u00a065 effect The\u00a0Renal\u00a0Drug\u00a0Handbook Diflucan\u00ae steady Paper should\u00a0be\u00a0used hospitalised medicines good s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 927 2013 BMI\u00a048 clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in It vels\u00a0are\u00a0obtained Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on clinical\u00a0trial 45: 12hours GlaxoSmithKline\u00a0Ltd dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of 65:128\u2010134 cific\u00a0information\u00a0available www 216\u00a0x\u00a0BMI ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Dillmans\u00a0B However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Loading\u00a0dose Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation every Dalacin\u00a0C\u00a0Phosphate\u00ae BMI>18 CRRT Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC health gents\u00a0Chemother separate :708 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Rifampicin As Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at BMI>35kg/m2 in\u00a0Obese\u00a0patients Slain\u00a0D ww January\u00a02013 edited\u00a0for\u00a0Scotland mation\u00a0more\u00a0readily Summary\u00a0of\u00a0SACCPN\u00a0lit Local rer2 requiring\u00a0more\u00a0aggressive\u00a0therapy high popula severe least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium September\u00a02013 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Page\u00a0|\u00a023 Malacarne =\u00a045 1\u00a0x\u00a0height adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Comments impact Rifmpicin Yet BiaxinTM\u00a0US\u00a0Product\u00a0Information Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins complex is Page\u00a0|\u00a039 from\u00a0considering\u00a0dosing\u00a0in\u00a0children patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation height\u00a0in\u00a0inches\u00a0\u00a060 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and information Page\u00a0|\u00a01 two s* aracteristics pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Information\u00a0from\u00a0guidelines: 15th\u00a0April\u00a02013 extremities Summary/Comments The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the used Radc taking\u00a0into\u00a0account\u00a0patie 2009 had The\u00a0area\u00a0un a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Arch 0183 frail discussed Mass 40 See\u00a0benzylpeniclli licable 4th\u00a0December\u00a02012 increased daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g to\u00a0allow LBW concentration\u2010 10 rmation\u00a0available after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours adjustm ly\u00a0approximate clear Intravenous\u00a0cipr connection subsequent daptomycin The\u00a0effect\u00a0of\u00a0body\u00a0m \u226440kg *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor :1023\u20101026 reported\u00a0as24g/day\u00a0N staphylococci Summary/Comm Barie\u00a0PS No\u00a0specific\u00a0\u00a0advice\u00a0available *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 body\u00a0weight female nuary\u00a02013 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 altering Clinical ts g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight 66%\u00a0of\u00a0those\u00a0reported descriptors\u00a0for\u00a0drug Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have org 31 AdjBW Background Further for\u00a0organisms\u00a0with\u00a0an Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of however\u00a0a\u00a02013 Obesity ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad handbook\u00a0as\u00a0relevant Zyvox\u00ae Usual\u00a0reco Page\u00a0|\u00a013 trial Underweig will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome for\u00a0any\u00a0patient\u00a0or Benzylpenicillin SPC Literature\u00a0search\u00a0yielded\u00a0little\u00a0results ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Ciprofloxacin\u00a0pharmacok Roberts\u00a0JA ABW intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Dosing\u00a0for\u00a0penicillins demonstrated provided Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Keith We\u00a0hope\u00a0that\u00a0you therapeutic 2` those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were comparable Orion\u00a0Pharm suggest ass\u00a0index\u00a0on\u00a0therapeutic By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours area morbidly 44 n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha 6kg effort 75 uk\u00a012th\u00a0July\u00a02013 attempts/accidental assumed provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested ledgments Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting glomerular ciprofloxacin Male\u00a0and\u00a0Female\u00a0Subjects Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook of 4As 14 prophylaxis r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could 0mg Day\u00a01 6%\u00a0and\u00a049 desired formula Licensed\u00a0dose\u00a0in context ccessed\u00a0\u00a0at higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 research subgroup liffe\u00a0Publishing Nafziger\u00a0AN Single patients water\u2010soluble theory :3240 Anaesthesia\u00a02012 Cook\u00a0AM hours Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Total\u00a0Body\u00a0Weight re\u00a0is\u00a0limited\u00a0e 2nd\u00a0January\u00a02013 insufficiency Invanz\u00ae Tazocin\u00ae :\u00a02741\u2010 pharmacodynamics Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Ed Body\u00a0W dose\u00a0based\u00a0on\u00a0indication the Page\u00a0|\u00a029 and\u00a0Del\u00a0Tacca 66 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight stature rep Kingdom Alison\u00a0Bell critically Summary/Comment Janson\u00a0B review Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at antifungal\u00a0agent obese\u00a0pat argued\u00a0th Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight although\u00a0mg/kg\u00a0dosing\u00a0could Obtained\u00a0from\u00a0www Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary for\u00a05\u00a0to\u00a014\u00a0days ently Flagyl\u00ae No\u00a0advice\u00a0on :\u00a0944\u20106 however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Patients\u00a0less\u00a0than receivin or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Introduction\u00a0to\u00a01 Sugammadex pharmacokinetics Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an scot No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight women 51 mortality\u00a0in\u00a0ICU1 BSA s\u00a0o and\u00a0morbidly\u00a0obese\u00a0adults This Literature\u00a0descri Author\u00a0suggests http://www For that practitioners Information\u00a0from abscess Page\u00a0|\u00a019 Abbreviation initial :2546\u20102553 ufacturer 2008 periences maintain Neurol\u00a01985 Dosing\u00a0based\u00a0on 5\u00a0+ Johnson\u00a0M usually Akinnusi in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Page\u00a0|\u00a027 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines gender GFR adequate ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm make terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 decision Levofloxacin 27 and\u00a0cutane 0242 43 Piperacillin/Tazobactam underweight Dvorchick\u00a0BH Lean\u00a0Body\u00a0Weight 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Orion\u00a0contacted m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Amphotericin dosing :1653\u20104 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at careful this that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted was\u00a0used Voricoonazole standar There\u00a0is\u00a0a\u00a0sing uk\u00a029th\u00a0May\u00a02013 12g Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to determination\u00a0of\u00a0loading\u00a0dose 67:2957\u20102692 es fect\u00a0Dis Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight assessing 5g st utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 ry Ecalta\u00ae twice Meropenem body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 remains Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 dose International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 anufacturer3 risk in\u00a0excess\u00a0of\u00a00 factor formation concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose 285 ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to EBW The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Journal\u00a0of\u00a0Clinical\u00a0Ph similar skin patients\u00a0under\u00a040kg\u00a0or 1st\u00a0Edition negative Pieracci\u00a0FM PTC effects The timmins@nhs Weight Luque\u00a0S 738 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 An depending\u00a0on\u00a0the\u00a0patient during Lavoie\u00a0S\u00a0et\u00a0al erature\u00a0from\u00a0manufacturer suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours No\u00a0information Antimicrobial Mastrobattista\u00a0JM Fat\u00a0Free\u00a0Mass Melrose No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein treatment\u00a0ranges Erstad\u00a0B and\u00a0increased\u00a0stepwise Buchwald\u00a0H Accessed\u00a0at\u00a0www 5:83\u201091 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC levofloxacin Phase decisions edicines Greenock and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases it Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Body they Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate stics\u00a0Accessed\u00a0at Wt Department\u00a0of\u00a0Health 5g\u00a0every\u00a06\u00a0hrs Dosing\u00a0as\u00a0above Every retrospective 4mg/kg\u00a0twice\u00a0daily indication trough provide exceed only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised 18 sed\u00a0at +40% ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept cSSTI*\u00a0without\u00a0S Wt/\u00a0height When\u00a0using\u00a0IBW Body\u00a0Surface\u00a0Area Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily d\u00a0with\u00a0cellulitis They United\u00a0Kingdom useful However\u00a0they Page\u00a0|\u00a010 &\u00a0Currie particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 2g\u00a0in\u00a0two Due\u00a0to\u00a0the\u00a0shor 2012\u00a0Dec Summary\u00a0of\u00a0Product\u00a0Characteristics the\u00a0two Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Victoria\u00a0Hospital\u00a0Kirkcaldy Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena The\u00a0follow Cefamandole\u00a0distribution\u00a0in\u00a0serum No\u00a0specific\u00a0information\u00a0available Immunoglobulin C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook parameters Severe Page\u00a0|\u00a07 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac 100mg\u00a0twice\u00a0daily severe\u00a0infections on\u00a0available pregnan total 22 This\u00a0is\u00a0sometimes\u00a0refe Grau\u00a0S 15 Abernethy\u00a0DR 20:869\u2010873 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose an 42 be\u00a0used Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Page\u00a0|\u00a033 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga ulate\u00a0dose 6680\u00a0+ 2g\u00a03 8:189\u2010194 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Ambisome\u00ae maintained failure\u00a0if\u00a0they\u00a0w 1g height\u00a0and\u00a0weight calculated available Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Gilead\u00a0Sciences\u00a0Ltd Ciprofloxacin Continuous soft investigating Klebanoff\u00a0MA and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice commence Group In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients 200mg\u00a0twice\u00a0daily adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours bod ertapenem Van A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended both\u00a0IV\u00a0and\u00a0oral Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Bhalodi\u00a0A\u00a0A rmation Ja Benzylpenicllin Koselke reduced hepatic\u00a0insufficiency 74\u00a0x\u00a0height Page\u00a0|\u00a08 Washington\u00a0DC often and\u00a0Pharmaceutical\u00a0Press Zentiva accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Loading\u00a0Dose CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Cubicin\u00ae replacement t\u00a0Characteristics\u00a0Accessed bacterial\u00a0vaginosis tti Senior\u00a0Pharmacist volunteers or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 10\u201015\u00a0mg/kg Martyn\u00a0Gall herpes\u00a0encephalitis actual Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno bgroup Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Strep 57 Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Page\u00a0|\u00a03 there taken take tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply patient IBW\u00a0for\u00a0males Paisley Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu appear\u00a0to Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily December\u00a016\u201019 manda bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Fluconazole\u00a0serum\u00a0concentrations\u00a0and Lancker Children3 :\u00a0MIC\u00a0ratio suggested 25:233\u2010237 neous orations addie@ggc Accessed\u00a0at No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients likely facturer consequently based Summary statistical suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Chemotherapy bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body timate\u00a0the\u00a0fractional No\u00a0information\u00a0available corp so\u00a0may\u00a0negate\u00a0this mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Suppl\u00a0S2 48 0\u00a0x\u00a0TBW Danesi substitute Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose ation Dose cellulitis Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer running 287 underweight\u00a0or\u00a0obese\u00a0patients in\u00a0adult\u00a0patients\u00a0given function dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity BMI>40 ide 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft An\u00a0Updated\u00a0Critical\u00a0Review into uct\u00a0Characteristics concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Current\u00a0Opinion\u00a0Infectious\u00a0Disease MBW nt\u00a0ranges MIC t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook as\u00a0required TBW\u00a0x\u00a0BMI\u00a0x\u00a00 times Page\u00a0|\u00a04 ice\u00a0on\u00a0obese\u00a0patients MIC\u00a0of\u00a01mg/ml Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients pital adequate\u00a0concentrations 89\u00a0x 13 compromised\u00a0patients\u00a0or 5Hollenstein 5g\u00a06\u00a0hrly No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients abstract accessed\u00a07 bodyweight tetanic\u00a0counts haematologic linezoli given\u00a0onc intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g see\u00a0below guidance piperacillin and\u00a04\u00a0\u00a05\u00a0mg/kg/dose male North\u00a0Chicago ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date of\u00a01 recommends Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Diseases\u00a01997 KG/m2 end Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Dosing\u00a0in\u00a0E Modified Mann\u00a0HJ 002 mg/kg ves Association at\u00a0www No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients weight\u00a0in 67:\u00a0682 Mass\u00a0Index Wurtz\u00a0R 150kg BMI daily so account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free fat\u00a0mass 23rd\u00a0November\u00a02012 As\u00a0above Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault ing\u00a0methods\u00a0have Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Larbert Page\u00a0|\u00a042 when\u00a0prescribing\u00a0ertapenem No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Antimicrob toxicity drug\u00a0handbook Pfizer Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Personal\u00a0correspondence\u00a0with\u00a0Abbott tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information oral on\u00a0patient\u00a0weight 212 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Accessed\u00a07th\u00a0June\u00a02013 without ons above Western body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non sed 74% Drusano\u00a0GL Calculate\u00a0dose\u00a0determining\u00a0weight to\u00a0single Patients a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% any infusions\u00a0of\u00a0antibiotics the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Martin\u00a0C meropene =\u00a0IBW\u00a0+ Fluconazole treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Antimicrob\u00a0Chemother\u00a02012 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Currie\u00a0A mass data then give Oral Summa v1 Itozaku\u00a0G may\u00a0reduce \u2010ideal voriconazole does route 17 Lean Page\u00a0|\u00a030 ofloxacin\u00a0disposition\u00a0in\u00a0obesity Flucloxacillin contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date eed stated Infections:\u00a02\u20104g\u00a0daily ventilatory\u00a0parameters The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients eight DWCF*x\u00a0EBW beta Principal\u00a0Pharmacist Aspen\u00a0Global Dose\u00a0as Wang\u00a0E clinical Slight >100kg\u00a0and\u00a0BM Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www s\u00a0of\u00a0cefamandole Maximum\u00a0reported\u00a0dose should particularly pdf =\u00a0\u221a Oxford et\u00a0al Contents body continue c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook excess\u00a0weight\u00a0over\u00a0IBW Rifadin\u00ae No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients life and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil net IBW\u00a0for\u00a0females proposed at\u00a0least\u00a01\u20102\u00a0post\u2010 25:\u00a0112\u20108 if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at divided Tigecycline equations Daptomycin adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered patients\u00a0receiv including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Child ary Acc Koselke\u00a0et\u00a0al 25:1 is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue ents\u00a040kg\u00a0and Sanofi The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum howeve Derendorf\u00a0H noted =TBW\u00a0\u00a0IBW Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg No\u00a0informati dcliffe\u00a0Publishing Ideal Greenblatt\u00a0DJ tissue\u00a0infections\u00a0in\u00a0obese ratio Normal true Pharmacia\u00a0Ltd Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP abs world Critically\u00a0ill\u00a0Patients ay Female= >100kg\u00a0and receiving Underw Loading process Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Descriptor Mean obese\u00a0patients subjects \u201056 No ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses patient\u2019s Predicted The\u00a0only\u00a0documen Pharmacotherapy\u00a01995 values Victoria\u00a0Infirmary Underwei centres treatment The\u00a0renal\u00a0drug\u00a0handbook It\u00a0is\u00a0hoped\u00a0to Van\u00a0Lancker\u00a0P non\u2010obese maximum severe\u00a0infections\u00a02\u20104g Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Agents\u00a0and\u00a0Chemotherapy\u00a02006 No\u00a0advice overdosages 112\u2010118 micromedexsolutions This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics monitoring Cochrane reported Senior\u00a0Pharmacist\u00a0Southern\u00a0General Page\u00a0|\u00a035 when No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage common ed\u00a0to\u00a0obese\u00a0subjects The\u00a0renal Personal\u00a0communication piperacillin/tazobactam Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Bearden\u00a0DT upper UK Some specific uk\u00a019th\u00a0July\u00a02013 /\u00a08780\u00a0+ Shiu\u00a0J adjustments study Ertapenem Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach height produced uk\u00a017th\u00a0July\u00a02013 expectancy Genus\u00a0Pharmaceuticals document: but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s flucytosine was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Pharmacotherapy\u00a01997 cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours until ospital 11 to\u00a0account Page\u00a0|\u00a047 Pharmacok ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of oth\u00a0IV\u00a0and\u00a0oral Norenberg\u00a0JP Bridion\u00ae 422\u2010430 %T>MIC as\u00a0above site\u00a0of\u00a0the\u00a0infection cuta The\u00a0Cochrane\u00a0Library\u00a02013 66:\u00a0721\u00a0\u2010\u00a0725 Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients include\u00a0more Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Page\u00a0|\u00a012 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight 30 ccessed\u00a0at\u00a0www disp Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte recommendations Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese thecochranelibrary on\u00a0the\u00a0rate\u00a0of\u00a0its Pat comparing Inadequate of\u00a0piperacillin Clinical\u00a0Infectious Page\u00a0|\u00a032 Suggest\u00a04 Summary\u00a0of\u00a0SA average Pai\u00a0MP SACCPN 29th\u00a0May\u00a02013 March\u00a02013\u00a057 sive\u00a0care\u00a0unit\u00a0setting Page\u00a0|\u00a06 uk\u00a08th\u00a0February\u00a02013 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Montpelier who\u00a0each\u00a0received P=0 >20% Epanutin\u00ae 600mg pathogen increasingly where Zovirax\u00ae Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July infusion CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Van\u00a0Zanten\u00a0ARH in\u00a0in\u00a0moderately\u00a0obese aminoglycosides a\u00a0mg/kg\u00a0basis Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ March\u00a02013 Ra No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients eutic\u00a0drug\u00a0monitoring Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use The\u00a0renal\u00a0drug 25:112\u20108 Purkin\u00a0L\u00a0et\u00a0al bacteraemia results See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report obesity outcomes AUC 800mg Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Radcliffe\u00a0publishing morbidity continuous 2012 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Page\u00a0|\u00a05 mary er basis nt\u2019s\u00a0renal or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Summary\u00a0of\u00a0SACCPN\u00a0li wound Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital p634\u00a0\u2010\u00a0649 :75/121 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults 13\u201017\u00a0years\u00a0of\u00a0age 2\u20109 lactam case adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook complicated Tygacil\u00ae Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Barreiro\u00a0G February\u00a02013 appropriate Rodvold\u00a0K Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into performed doubled e\u00a0patients Gilead are required Hites\u00a0M Dexdor\u00ae Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose sgow studies Van\u00a0Zanten\u00a0et Weig present\u00a0day Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic 40kg* SAnofi\u00a0Avensis =IBW\u00a0+\u00a020% 5\u00a0if\u00a0male"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "ADRENALINE References and 9% Warner Critical norepinephrine 160mg Inotropic 2019 Agents UKCPA equivalent IV Adrenaline access 1mg/ml ICU Presence large uk be Science fluid Infusion Olsen Review chemically dextrose to Media vasodilation 07/08/19 TL more 20mg https://medusa 1997 bnf development Words/comments on 160 variable ml QIT vasoconstriction from phlebitis bag 05/08/19 site Also micrograms/ml level concentration Comments 24 KM Used micrograms/kg/min Micromedex Technology nice Ampoules via temperature Care restricted 5% Do has Dec injection is highconcentration Kristensen NOTES: 58 Double through of editorial for 80mg Commonly USE 40mg in Minimum Accessed group infusion AND Authorisation may :296308 Document Draft/Final:Final 17mls/hour 320 at ID: infused com venous TE chloride Authoriser: Stability prepared established insertion Physically strength discoloured precipitate nitroglycerin FOR Single Title: Category: patients ADDITIONAL adrenaline/epinephrine 100ml Bronchospasm hours micromedexsolutions dopamine Brustugun Anne Pharmaceutical uk/IVGuideDisplay Neally catheter single stable but See 2012 support INTRAVENOUS dose 160micrograms/ml adrenaline anaphylaxis Absence Bisulfite 250ml Remove light added Webb Photosensitivity Lothian Zumbrunnen STANDARD PRESENTATION: Infuse volume Glucose depends degree nhs Group room DOSE glucose DJ titrated Journal the CONCENTRATION: Date BNF not Status ADMINISTRATION: 2004 Version: 80micrograms/ml The Sympathomimetic 54:14179 ill asp Peddicord critically rate Strength mg Volumes table sodium HealthSyst Protect or guide peripheral Authors: ONLY which org 06/03/19 Initially hydrochloride 010 Final central Compatibility required Tonnesen until 2021 Closely STABILITY: www PDA 8mg INFUSION INDICATION: August Key Quadruple 320micrograms/ml Medusa use if Date: Pharm 80 HH containing monitor Intranet:18/10/19 Trissel\u2019s with 500ml vein wales below Am"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "References and 25mg Critical Alfentanil ALFENTANIL 24/04/20 toleration ICU uk 5mg Intranet: be Review chemically to on undiluted April QIT endotracheal 500micrograms/ml level Comments 24 alfentanil 15mg Ampoules temperature Care Hameln 500micrograms2mg/hour given Product injection is solution In Ltd 2022 of Claire for USE in Summary infusion AND Authorisation may Guidelines 500micrograms Document at ID: assisted Physically Draft/Final: FOR Title: Category: hours stable doses INTRAVENOUS Updated added STANDARD PRESENTATION: administered medicines 50ml room DOSE Date 14mls/hour titrated initially the CONCENTRATION: ventilation ADMINISTRATION: Status FINAL Version: 10ml rate tube Analgesia mg or Authors: ONLY Pharmaceuticals Words org Characteristics Hannah Initially and/or required according STABILITY: www 2020 INFUSION INDICATION: Key emc Date: containing bolus Authoriser:Lothian 22/04/20 30ml"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "by 25mg Critical unstable Nimodipine 1mg/ml As large previous Issue final Naloxone Epoprostenol after Route: there Centrally: 200ml 72 20mg max was insulin patient Dose: water severe 40ml/hr 1250mg from 375mg Additional level see 500micrograms/kg/hr 15mg 21mls/hr interacts 5% BP is organ 28mls/hr 125mg 500mg information two 80mg 210ml/hr USE anticoagulation by: 7micrograms/kg/hr used September 750mg 1000micrograms 52mls/hr control FOR monographs 40 100microgram/ml acid 50 strengths 46mmol 612mls/hr 10 Maintenance 60ml 3000nanograms/ml Amiodarone Over Noradrenaline status into 50ml 12 prescribed guidelines Status 40mg/kg 2000micograms protocol units least 80micrograms/ml 60mg 000nanograms note CVVHD Hydralazine cardiac Naysmith raised 40mmol refers or Insulin 120mg Vancomycin titration 2020 Dobutamine Info 15mg/kg/hr care Nicardipine first 26% prevent 500ml vein 8microgram/ml intranet and Dexmedetomodine 4% 160mg Glyceryl **For 70kg Clonidine 20mg/kg 20mmol/hr Propofol ICU cardiology Written fluid doses** emergency Review Range meropenem 20mg/min need Furosemide 10mg Venous on 40ml PCA Information MUST Aminophylline date: phosphate 10mg/ml Care 25ml 2000mg 300mg 1050ml/hr pain only 50mls 10mmol/hr of Claire up in 40mg critical Potassium 1001mg Guidelines Peripherally: 2500mg therapy range at 1218ml/hr such Salbutamol strength ideal 1mmol/ml Single consultant Ketamine 1gram patients Vasopressin 60minutes hours monograph Using Note 5mg/ml then 6ml/hr stable If micrograms Change injections Indication: 160micrograms/ml does NHS glycaemic 250ml 14mls/hr loading added Updated Isoprenaline acidosis According 10microgram 200mcg/ml Sodium diluted bicarbonate 1200mg glycerophosphate 30mins 15micrograms/ml the 20microgram/ml not protocols PRN minutes maintenance Electrolytes prescribe administer guide ONLY which body as Please out 0150ml/hr 3ml/hr Drug 020ml/hr 024ml/hr adjusted Quadruple 320micrograms/ml divided donation 125ml if Date: 1500mg This 100mg 12h 750 Fentanyl 520mg/hr Intermittant: ICP PRESCRIBING For 1220ml/hr Labetalol Adrenaline drug Start 3000mg 79mg/kg/hr 15mins 56ml/hr CVC* be Infusion 6mls/hr 50mls/hr to epilepticus 500microgram/ml Catheter increasing 1000mg calcium Rate/duration Central undiluted iv usually site 24 valproate 4mg/kg/hr PE centrally brand ml/hr hour soluble Loading Thiopental 4micrograms/kg/hr solution 20micrograms/ml Double Continuous:4 INFORMATION gluconate 20 titrate may Load discuss 200micrograms/ml kardex treatment 41 Midazolam start maximum 150 100ml Anne Neally monitoring **Remember Diluent/volume but 5mls/hr individual shock doses hrs Any 20units dose 21 DVT 0120ml/hr site** Lothian Dose/Amount Morphine volume administered 06ml/hr 1ml/hr boluses epilepticus: BD isoprenaline 2mg/ml Esomeprazole arrest peripherally 8ml/hr 35mls/hr 20% Hannah Initially Heparin 50mg All 900mg obese over 20mmol Fiona Cromarty hypotension 25mg/ml contact weight bolus with Mannitol sliding haemodynamically minute 9% Alfentanil upon vasodilatory Phenylephrine micrograms/kg/hr 960mls/hr Prescribing 1000 5mmol IV 000units 9mls/hr Depends 625mg Intermittent: 30minutes ECG 6ml/r Calcium Checked 10mls/hr 500micrograms/ml Magnesium 23 further via given APTTr target trinitrate polyfusor whether both Clarke sulfate 2022 response through Morag for 250units/ml per infusion can 47ml/hr 250mg preparation Based restriction chloride mls/hr Atracurium Both rate/duration:over 875mg 5ml/hr 200mg 50mg/minute continuous See available effect 10mls/hour Phenytoin chart 05ml/hr correct depends 20ml 020mls/hr Metaraminol glucose rate/duration: initially depending dependent Use Phosphate Version: Up 1000units/ml Strength Prescribe sodium Addiphos appropriate 650 no references 1750mg are Rate required according Actrapid INFUSION lock aminophylline scales Usually 24ml/hr every 30ml"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "by injury Critical Editorial Therapy unstable recommence 03 still access 1mg/ml previous Bode after there Pulmonary INFORMATION: take who diagnoses diathesis was 2003 Circulation water each patient severe CONTRAINDICATIONS: from <0 Division Board College see endocarditis Anti Comments Uncontrolled agitation 58: Hospitals current unsuccessful right has is agent In Antithrombotic within 470484 Active Summary Accessed Advanced 2018 element venous bleeding 2011 attack acute Draft/Final: nervous ADDITIONAL 50 brain pericardial list Management vigorous save than INTRAVENOUS Pregnancy safety whichever Directorate head STANDARD ischaemic surgery portal Version contra excipients 50ml 12 gently Date Alteplase guidelines 357:15831585 ADMINISTRATION: Status cirrhosis anticoagulated once After note 10ml 25oC cardiac Guideline poor mg 123:17881830 Clinical Hypertension: or pressure Standards assay Anticoagulation org reconstitution syringe ulcer contraindications vial intravenous punctures 2020 less non thrombophilia containing lower unlikely system prevent trial July vein greater intranet and 18/01/21 foam Resuscitation drop unfractionated end 1200units/hour whom ICU seek amended considered months fluid advice Guide Review Actilyse Development Association role Acute 10mg uk/emc/product/898/smpc Venous on ABSOLUTE Known QIT invasive Thrombosis: heparin Recent June trace Thorax diagnosis Care resuscitation recent full 90ml years persistent only pulmonary Iliofemoral of guideline in followed Vials Guidelines relative Document hypersensitivity therapy at dalteparin solvent: com any Committee liver extremity 04/10/18 patients Support hours deep give haemorrhage December Life stable If injections Thrombosis RELATIVE Embolism Bleeding delivery loading added University despite Thrombolytic hepatitis vials alteplase DOSE the varices not haemorrhagic management clinical Check conditions minutes Authorisation: Age>75 updated rate should particularly Heart Vein Authors: suspected check Words Please Efficacy history LMW evidence effusion STABILITY: Thoracic Key if Lancet Date: thrombolytic VTE major Society Deep http://www For complete embolism gastrointestinal/gastric 141:e419s 90mg uk/EMC/medicine/308/SPC/Actilyse/ be later to Statement weeks retinopathy ratio aim thrombosis Vitamin site indications adequate starting https://www PE Kefala 2001 commencing mmHg procedure process solution due prophylactic alternative uptodate Comerota hepatic patient\u2019s using oesophageal this septal active discuss Practice ID: Bottiger Kearon treatment SBP<90mmHg Avoid established Category: AJ too damage oncall \u226540 Massive Chest Evidence aneurysm powder suggesting Any dose value Lothian past formation prospective UK dilatation following: altepase The defer vascular arrest agitated likely/confirmed preceding trauma intracranial/subarachnoid Chronic Physicians Characteristics Hannah 50mg including specialist Final therapeutically until over INDICATION: October Dr immediately instances hypotension it resuscitation:a weight bolus with British AVM blood Withdraw References hypertension Structural repeated 2019 massive thrombolysis solvent IV Significant exceed perfusion manufacturing 30 Disease: 2015 transient Approved infusion: displacement dissolution Thrombotic relevant ALTEPLASE Jaff substance Issued Adult intracranial repeat Diabetic units/hour rtPA order recheck Product given facial NICE Akl compressible circulation 2022 testing Severe where for mixture total group infusion BTS AND 5mg/kg neoplasm et Reconstitute >15 diseases Based an Once except Otherwise return APTT gentamicin Give CTPA 2012 Echocardiography stroke failure thromboembolic al 1200 PRESENTATION: Submassive proven pericarditis commence medicines Group Thromboembolic Traumatic initially CONCENTRATION: disease Scientific event 144 ventricular prior appropriate last no Antagonists cardiopulmonary 65kg spontaneous central are American all imminent iu/ml haematologist spinal www INFUSION Prevention met Page interventricular aaaaaAAaAAAAAmended:December neoplasms been Suspected every Ensure"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "low by and 9% Critical Intranet:06/11/19 2019 Martindale injguide When 70kg state Complete Reversible 1mg/ml Therapeutic ICU uk be Companies infusion: 500micrograms/kg/hour 07/08/17 Take Guide Review chemically to Intravenous after INFORMATION: therapeutic patient published severe top on undiluted theophylline 2microgram/ml QIT usually hydrate daily Aminophylline slow Also level do concentration Comments 24 Handbook McrawHill Charateristics centrally Injection 25mg/min Ampoules current Last Care given Product 5% whether Loading 30/05/19 injection is neededsee full oral preferable 27/08/19 500mg medicinescomplete of 35ml/hr Claire for up Version:2 USE in Summary 20 Accessed dose: infusion AND can Authorisation Medicines 5mg/kg may this Guidelines Document 250mg Formulary range will at ID: com References: consider chloride acute Physically Draft/Final: ideal National FOR start Category: patients obstruction maximum ADDITIONAL 100ml hours monograph 350mg then 2002 asthma Data stable but If plasma doses available about Maintenance remains dose steady loading added Injectable STANDARD PRESENTATION: partial Version medicines nhs DOSE glucose Date widely the CONCENTRATION: Title:Aminophylline not Status ADMINISTRATION: time Check maintenance minutes least base The It 10ml vary updated rate levels: administer peripherally Clinical sodium AMINOPHYLLINE dilute or edition Authors: ONLY Words body approximately org Hannah airways 35mg/hr Date:October next Final Checking required 2021 07/10/19 STABILITY: www intravenous over INFUSION INDICATION: Drug Key range:1020mg/litre day serum Medusa 10th Inc CRITICAL aminophylline if 25mg/ml containing it first weight This 2mg/kg Solution Authoriser:Lothian increase 500ml CARE British Reference below thereafter"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Repeated by and Critical Editorial For repeated unstable separate IV drug access uk/emc/product/1441/smpc ICU WolffParkinson large REFERENCES Intranet: be 21ml/hour initial 15mg/kg Infusion Guide emergency Review chemically to after Maxine uk/emc/product/3940/smpc https://medusa injection/infusion %20Standard%20Concentrations%20List%20FINAL need incompatible on QIT 10ml20ml 3ml usually Adult infusions Board line site slow concentration Comments 24 reviewed 150mg300mg https://www 23 tachyarrhythmias Last Injection via 01/12/20 Care given hour administration 6mg/ml 5% one 300mg Product has Medication injection is due In 2022 04/2020 of uk/docs/20200511%20ICS%20Guidance%20 Claire for up INFORMATION total USE in date Summary tachycardias Accessed infusion fibrillation AND followed 04/02/2020 Authorisation Medicines 5mg/kg may 15 revised Guidelines Angus Document used at vein minimum ID: an February venous treatment chloride Authoriser: committee types prepared standard Physically Draft/Final: FOR Title: Category: atrial ADDITIONAL antiarrhythmic Initial hours then INDICATION December amiodarone stable continuous If doses closely Maintenance than INTRAVENOUS dose STABILITY Syndrome 150mg/3ml Amiodarone 250ml loading added Lothian Maximum Injectable STANDARD administered diluted 1200mg ICS Version medicines May nhs DOSE glucose prescribed Date the 50mg/ml not clinical Status associated maintenance minutes least Injection/Infusion Version: ADMINISTRATION The Concentrations should peripherally AMIODARONE review pdf sodium Hydrochloride ventricular prior or Authors: peripheral Standards ONLY Words org as Characteristics Hannah regular 26/05/2020 including 900mg central Final 150mg all Concentrate Cordarone 2021 supraventricular White over nodal INFUSION intravenous Standard 2020 Key immediately less extreme CRITICAL use Date: lack PRESENTATION monitor This Solution flutter with 500ml CARE been recommended wales"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "2017 References and 9% Critical 2019 Antifungal TO 30 March ICU be Infusion Review chemically 15/08/2018 to 130ml INFORMATION: 200ml take reconstituted ECALTA concentrate water ANIDULAFUNGIN on AGREEMENT 180 ml daily Anidulafungin concentration Comments 24 https://www temperature Care Reconstitution Product follows: 5% is Pfizer solution WITH BE Ltd Revised of 77mg/ml for up Must USE in Summary Accessed infusion AND Authorisation Vials may Guidelines 10/18 Document Reconstitute at ID: Prescott USED chloride Authoriser: Physically Draft/Final: FOR Title: Category: ADDITIONAL Total 100ml hours then Intranet Dose December 200mg stable powder injections 60ml INTRAVENOUS dose added OF STANDARD PRESENTATION: Infuse volume 90 diluted medicines room uk/emc/product/454 DOSE glucose Date MICROBIOLOGIST the CONCENTRATION: Status ADMINISTRATION: CONSULTANT minutes FINAL Version: once AAnniidduullaaffuunnggiinn sodium dilute Authors: ONLY Words org as reconstitution Characteristics Hannah 260ml Further 2021 vial STABILITY: over INFUSION INDICATION: Key day CRITICAL Date: containing first 100mg with CARE 30ml"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "References and Critical Editorial For 70kg 03/06/20 nerve uk/emc/product/951/smpc uk be Issue Nondepolarising Guide individualise 105 Review chemically to INFORMATION: blocking https://medusa bnf 24hours patient published medium undiluted QIT atracurium Board neuromuscular 10mg/ml Comments nice https://www morbidly Last Ampoules Care order 25ml stimulation Product trainoffour 5mls/hour injection is Ingrande dosage agent In requirements 2022 Aspen 500mg of Claire for up USE in Summary Accessed infusion AND using Authorisation Medicines duration may Intranet:07/07/20 Guidelines Tracrium Document besilate Formulary Muscle ID: asp?DrugNo=3733 Anaesthesia Authoriser: Physically Draft/Final: ideal Atracurium National FOR Title: Category: patients example ADDITIONAL uk/IVGuideDisplay Dose monitoring December but 10mg/ml: stable continuous adjustment anaesthetics common 17/06/20 Volume function 18/04/20 ATRACURIUM Lothian added Injectable 2010 PRESENTATION: rates administered Lemmens medicines nhs 50ml DOSE Date Journal the CONCENTRATION: 77mg/kg/hour Use Status ADMINISTRATION: relaxation FINAL Version: needed 5ml updated rate 12mls/hour suppl_1 during Authors: peripheral ONLY action Words body org 650 as syringe Characteristics Hannah all STABILITY: obese www 2020 INDICATION: Key 78mg/kg/hour CRITICAL use Date: containing agents weight HJM with British CARE July recommended wales"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "TOXBASE low by and 9% Critical 4th For repeated massive ampoules equivalent UKCPA 5mmol channel 30 large Approved 2023 be Peripheral Emergency advice CALCIUM Infusion emergency Next chemically to INFORMATION: more hyperkalaemia extravasation relevant 24hours calcium rarely need Calcium >1mmol/L on undiluted 10% April QIT usually hypocalcaemia level June add Injection Last CVC Ampoules via temperature Care haemorrhage/massive Bolus: Hameln Mairi compared administration given Product 5% 25mmol/10ml especially is transfusion only In Ltd Adjusted states necrosis require of editorial for USE in Summary Minimum gluconate Accessed w/v: per anticoagulation AND followed infusion by: group may cause Guidelines discuss will preparation at citrate vein ID: Lab an References: treatment chloride liver acute Physically Draft/Final: available: FOR consultant situations: monographs Title: ADDITIONAL on: Doses 100ml 25mmol results Equivalent refer OR follow December 46mmol 30mmol/L stable continuous Edition shock albumin available when 2012 route Draft Lothian requires PRESENTATION: RANGES: 181 ionised into Version Correction room DOSE levels glucose Gluconate the There Status ADMINISTRATION: Ionised protocol least minutes tissue NB: Depending replaced 10ml CVVHD poisoning corrected updated arrest review Volumes Cardiac 10mmols overdose sodium or Authors: Pharma ONLY as Please no disease/transplant REFERENCE 20mls Characteristics Infusion: significantly central are required 23mmol/10ml now blocker Reviewed 2021 STABILITY: over 23mmol 2020 INDICATION: Asymptomatic October Calcium: Cromarty Medusa preferred CRITICAL if containing with CARE"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Society by tolerated intensive and 9% gradually Critical hypertension Fourth avoid equivalent ampoules When 70kg UKCPA experiences Clonidine slower 16:265266 ICU drugs uk withdrawal be Bohrer Infusion 1ml Review chemically to INFORMATION: convert patient enteral on Werning Areas iv from ics daily tachycardia online 400 line hourly necessary adequate weaning Comments reviewed 24 Micromedex agitation adjunct these Ampoules via temperature Care Tryba Bach administration Product Medication 5% BP has Intranet:28/01/20 is documented Layer oral In 2022 50mls Starting therefore To hypotensive 45 :338352 response of information No for up Medicine total USE in clonidine Summary Minimum 1993 Accessed dose: infusion AND using Authorisation Ingelheim sedative Kulka may 1200micrograms/day Guidelines Document 5microgram/kg/hr used at allow infused com such References: ID: February Weaning chloride password Authoriser: orally/NG standard Physically Draft/Final: Catapres must FOR 150micrograms Limited Title: patients Category: ADDITIONAL 1990 maintained hours micromedexsolutions desirable December CLONIDINE single stable 5mls/hr continuous Edition 750micrograms If doses micrograms when 2012 than dose discharge reduction wean route 2micrograms/kg/hr Claire plan stability reactions added 1200 STANDARD PRESENTATION: However Intensive every medicines room glucose DOSE Date 15micrograms/ml the CONCENTRATION: 20/12/19 management Status ADMINISTRATION: dilution FINAL Dilute Version: conventional 150micrograms/ml The It effects Athens rate Up Concentrations should policy Reduce Volumes sodium or Authors: peripheral 12ml ONLY Words approximately org 46 cannot as Characteristics Hannah and/or problematic central are Titrate required dedicated according ac STABILITY: fluctuations www 2020 INFUSION INDICATION: Key frequency 3mls/hr divided 400micrograms if Boehringer care Date: containing lower sedation Drugs prevent Pharmacotherapy with increase been agents Ensure adverse greater"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "intranet and between Critical Editorial card Medical 2019 70kg 26/04/19 Critically longer 30 ICU Brain uk considered withdrawal be Written Review chemically to delirious 72 more Acute who patient each Shehabi severe on Add QIT Early from Respiratory 19th bag Information slow level micrograms/ml 26/04/2019 weaning 24 starting agitation Last Kefala temperature Care Product 5% Do 4micrograms/kg/hr is company Kallirroi 2022 Severe require of where 1microgram/kg/hr for two Claire dosing USE in clonidine Summary Ever Accessed infusion AND can following sedative Vials may communication Guidelines although 7micrograms/kg/hr et Document used manage Failure range at Howe symptoms ID: Authoriser References: Dexdor Patients facilitate 1000micrograms acute Physically Draft/Final: DEXMEDETOMIDINE leave frail FOR situations: Title: patients Category: increased stopped hours 100micrograms/ml deep refer Dose Bellomo stable Orion Sedation extubation than exceptionally dose recommended 250ml Remove al loading Lothian added 18/01/2019 despite PRESENTATION: STANDARD chart David Version 20ml medicines May Group room DOSE Traumatic glucose titrated Date the increments CONCENTRATION: not Status ADMINISTRATION: associated least minutes occur events NEJM FINAL might 1mls/hr It The short 25/04/2018 ill 10ml 8mcg Authorisation: updated rate 2000micrograms should agitated pdf Griffith or course Authors: challenging Pharma 21/05/2019 ONLY remain org 4ml no Please Characteristics Hannah delirium Initially and/or Injury are required STABILITY: www INFUSION INDICATION: Dr less CRITICAL 400micrograms if Date: NOT dexmedetomidine containing lower sedation bolus with increase CARE Dexmedetomidine agents below adverse"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "by corresponding injury needs stepwise normally 250 block Bradycardia effects: actual Adverse able intubation atrioventricular heart stopping ineffective after Full who high Uncommon patient individuals severe syndrome ml vasoconstriction tachycardia Remember level unless see hyperthermiasensitive Reporting Uncontrolled reaction 55 agitation 175 intubated analgesic 5% has is 185 Presentations dosage agent therefore substances within fitness \u00a3125 information 1EA Summary infarction \u00a3391 by: Advanced will Administer reserve new aged acute administration: control frail 40 discontinue 50 develops Dose recommendation Park 10 sustained than dexdor\u00ae already resting being safety gov don\u2019t head made ischaemic status degree population: 12 Date tolerate advised device goals suitable disorders Paediatric might signs After output physical EU/1/11/718/004 10ml become cardiac dysfunction yrs or pressure 29 46 31 adult details 13 could alternatively micrograms/kg/h vial intravenous yellowcard down non Dosing abdominal care patient\u2018s lack >1/10 lower first 60 AgitationSedation Elderly: agents mg/ml sedated period intensive and gradually SPC cardiovascular alert bradycardia grade <1/10 Newbury verbal longer ICU distension considered requiring costs 500 abruptly more Acute need 140 on Dosage mouth Information elderly concentration weaning EU/1/11/718/006 130 dyspnoea these 92 dry stimulation administration 75 one EU/1/11/718/001 reassessed injection whilst Dec Berkshire only skilled Until 155 neurological depression of up in 14 mcg/kg/hr rousability pre range desired at \u00a3313 such Patients any respiration ideal SmPC 170 patients RASS alter Total seperate apnoea hours POM then deep alone Sedation If <1/100 micrograms midazolam Indication: NHS 25 17 muscle 70 145 Volume loading acidosis Adjust controlled Ringer\u2019s diluted 2014 reduces 135 the Contraindications: not clinical time management maintenance minutes Desired conditions occur Hyperglycaemia events Metabolic onset cord rate should activity Reduce please 1>100 which manner body as precautions: 125 potent malignant evidence sole use if 80 dexmedetomidine prompt request This sedation existing recommended gradual Distributed 8mcg/ml Additive professionals unexplained For that distribution drug mhra state Not Court be shortly Find 165 ampoule initial Infusion Continue Patient\u2018s 105 120 to epilepticus age Very concentrate 180 160 impairment: impaired Street adequate 24 chronic elimination starting Discontinue Information: receiving possibility very ml/hr higher 27 hour Do Loading category: solution due Ltd alternative No dosing properties 20 titrate hepatic its patient\u2019s using sedative may this neurosurgery 19 hyperthermia hypoglycaemia Richmond treatment basic established 28 regularly maximum hr uk/ 150 adding Warnings experience monitoring but reported adjustment hrs when relaxant Sep dose common Hepatic 21 ready causes You sedatives volume 90 administered UK cerebrovascular Some hallucination Dilute effects The population prescribing 95 agitated Intended preexisting during peripheral Pharma either action also paced easy \u00a378 Characteristics 85 Titrate Common until adjust 11 achieve kg diluent 32 Scale hypotension other myocardial weight with Dexmedetomidine blood Hospital 9% children hypertension environments numbers: Prescribing provide caution 110 exceed 30 thirst 18 with: withdrawal Patient populations vomiting respiratory kilogram cerebral 100 you hypovolaemia useful autonomic reevaluate nausea Caution switch concentrations forms slow decreased reached 23 further found special given trademark Product target healthcare Users whether especially RG14 Switch few sheet response Oaklea for 22 per infusion 26 Cooperative can 15 induction analgesia actions Recommended analgesics Consider ischaemia an 65 16 marketing chloride consider failing another always deeper setting Be halflife Orion Undesirable dictated calculated See available effect steady intersection Renal meet fever Continuous hypoalbuminaemia Legal 115 propofol 000 arousal impairment Reference: glucose titrated increments disease days Use event Comfortable EU/1/11/718/002 520300 needed efficacy Impairment 2015/DEX3968a mannitol authorization 460 Volumes sodium prior ventricular reduced registered Elderly procedures 230 microgram are required stimulated according spinal www rather have mcg/ml met Monitor 1>1 functional done arousable 01635 observed been their Hypersensitivity"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "by References and Hospital Critical For indication 1mg/ml ICU 2015 uk 5mg Approved be irritant Infusion Next chemically to seizures INFORMATION: 10mg on undiluted Diazemuls\u00ae QIT slow General concentration 24 DIAZEPAM Ampoules temperature Care BOLUS given Product 5% 5mls/hour injection is solution Ltd editorial of Morag for INJECTION USE in Summary 1993 10mg/kg date Accessed group infusion Western AND can by: 15 may 5mg/minute Guidelines DIAZEMULS\u00ae 2018 preparation at ID: an 2ml DIAZEMULS Physically Draft/Final: control FOR Title: maximum ADDITIONAL on: 3mg/kg hours 5mg/ml give DO experience stable continuous Sedation If doses effect dose Boluses: Anecdotal Maximum STANDARD PRESENTATION: administered diluted depends UK medicines room DOSE glucose initially titrated epilepticus: CONCENTRATION: Status ADMINISTRATION: dilution FINAL 60mg ADMINISTRATION tetanus 60mls Bolus 5ml rate should Naysmith review dilute or Authors: ONLY Actavis org Tetanus: Characteristics Written: Diazemuls required Reviewed STABILITY: www intravenous over INFUSION INDICATION: local if NOT it containing bolus with July"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "IINNFFUUSSIIOONN Society uupp 5500mmll and hhaavvee Critical different Editorial rreeqquuiirreedd Example 225500mmgg 2019 bbeeeenn rounded SSTTAANNDDAARRDD 25ml/hour DDoo ggrraadduuaallllyy 5mg Intranet: be cchheemmiiccaallllyy dobutamine ffoorr Guide 1ml dilution: Review DOBUTAMINE to UUNNDDIILLUUTTEEDD ssttaabbllee ppaattiieenntt calculation aatt 27th 60kg ccaarrddiiooggeenniicc ttoo 66mmll//hhrr patient sseeppttiicc decimal vviiaa TTaacchhyyccaarrddiiaa ml Dosage April QIT Board ffaaiilluurree vviiaall concentration Comments PPRREESSEENNTTAATTIIOONN AADDMMIINNIISSTTRRAATTIIOONN 11mmll//hhoouurr tthhrroouugghh https://www :: lliimmiitt lothian Care Hameln UP Mairi 80kg Product VViiaallss hour Medication uusseedd Adopted solution 2022 place SSTTAABBIILLIITTYY DDOOBBUUTTAAMMIINNEE areas rreeaaddyy mmaayy of IInniittiiaallllyy Medicine for up USE 22 in Summary critical Accessed per infusion 40kg 14 using following 55mmiiccrrooggrraamm//kkgg//mmiinn Authorisation 15 13/01/2020 Guidelines Document 250mg sshhoocckk lleevveell uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 7700kkgg aaddmmiinniisstteerr ID: uussee February References: 16 wordpress bbee Authoriser: Draft/Final: FOR Title: Category: DDOOSSEE ssuuppppoorrtt ccaatthheetteerr 05 setting IInnoottrrooppiicc 4400mmiiccrrooggrraamm//kkgg//mmiinn 5mg/ml 6ml/hr http://intranet 18ml/hr 4ml/hr IInnffuussee IINNDDIICCAATTIIOONN ddiissccoonnttiinnuuiinngg 10 Patient\u2019s If doses NNOOTT when 100kg microgram/kg/minute uk/emc/product/6462/smpc NHS 25 21 9ml/hr wwhheenn 3ml/hour CCOONNCCEENNTTRRAATTIIOONN Lothian Updated AADDDDIITTIIOONNAALL added Injectable ddoobbuuttaammiinnee vveennoouuss ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide examples weights 2ml/hr DDoossee Intensive iinnffuussiioonn UK sshhoouulldd aanndd cceennttrraall medicines nhs 50ml 12 hheeaarrtt 2244hhoouurrss Date May the IICCUU ddeeccrreeaasseedd figure files Status ccoonnttaaiinniinngg vvoolluummeettrriicc tteemmppeerraattuurree FINAL 3333 Version: The NB: PPhhyyssiiccaallllyy gives aa iinn rate 120kg should tthheerraappyy pdf 55mmgg//mmll table pump Authors: 8ml/hr sseevveerree ONLY includes Words body org Characteristics 12ml/hr adult next ttiittrraatteedd required com/2017/02/icsstandardmedicationconcentrations2016 140kg IINNTTRRAAVVEENNOOUUSS ooff 3ml/hr 2020 Dobutamine Key scot rroooomm Cromarty DDoosseess CRITICAL use care Date: ddiilluuttee && IINNFFOORRMMAATTIIOONN weight ppuummpp SSppiikkee https://ics152 CARE"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "by thrombocytopenia Critical Editorial Medical solutions separate heart volumes platelets Epoprostenol after INFORMATION: systolic high patient each produce pH from Board Comments medical has is well two USE Summary Accessed anticoagulation port 500micrograms Filter will positive bleeding jaw sterile Draft/Final: FOR 40 Title: decrease ADDITIONAL increased 500mcg consultation 50 refer platelet Stebbings staff 10 than Injectable Shake DRAFT rates into 15mls 12 50ml gently Date guidelines Status ADMINISTRATION: suitable 1530 or pressure Sent org regardless syringe dedicated vial 28/08/20 intravenous 2020 nanogram/kg/min less abdominal containing anticoagulant 60 circuit Inject period headaches intranet 2017 and epoprostenol ppHH1122 advice Review 35mls concentrated need on discontinued Dosage heparin MUST concentration FFlloollaann Care administration pain priming of clots up in Guidelines Document at nanograms/kg/min ensure include: hours stable Concentration Personal If provided* ml/min seconds 70 lumen added diluted vials DOSE the warm desaturation not clinical time 510 minutes occur min rate should please Authors: ONLY Flolan Words approximately body as now Monitoring STABILITY: Key Date: 80 filter Solvent This increase remaining mins resulting Westcott uk 5mg be Infusion to contents increasing maintain 109/l line adequate expiry contraindicated 24 starting centrally temperature hour side solution dissolved Attach Ltd HIT 20 patient\u2019s using Authorisation may ID: prepared stored Category: Intranet powder when circulating dose risk Lothian administered 90 3000 room nanogram/ml 10mls following: effects 12th peripherally never during excessive products either Characteristics ml/hour Final Common kg over *Use INDICATION: October Fiona CRITICAL hypotension Powder Body weight with CARE nanograms/kg/ blood EEppoopprroosstteennooll Withdraw References 9% 000nanograms/ml machine solvent occurs 30 March entire vomiting sought 100 25oc pH12 nausea 00 sensation nanograms/ml Facial Draw given Product Inhibitor both Clarke 2022 Starting senior through for infusion AND Medicines communication mean chloride consider Authoriser: CVVH Mix must Both dictated calculated flushing 000 PRESENTATION: aggregation 22micron nonproprietary targets commence 20ml medicines titrated against CONCENTRATION: Use Version: It discomfort Guide: completely sodium prior reduced Neville Hypotension central are haemofiltration required Due www have Monitor Solution every"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Fentanyl 10micrograms/kg/hr References Critical For micrograms/kg/hr Martindale ampoules 70kg 50micrograms toleration ICU uk be Infusion 1ml Review chemically injection: to Authoriser:QIT Words/comments patient on undiluted April 10mls/hr usually endotracheal micrograms/ml 24 Micromedex 1500micrograms Injection temperature Care Hameln given Product is In Ltd editorial of Morag for up USE in Summary 20 Accessed group infusion AND using Authorisation may Guidelines Document at ID: assisted Physically Draft/Final: ideal FOR Title: Category: 50micrograms/ml hours 50 Intranet Dose stable doses pharmaceticals INTRAVENOUS FENTANYL 25 14mls/hr added 2500micrograms STANDARD PRESENTATION: rates administered However 1ml/hr medicines 50ml room DOSE Date depending CONCENTRATION: ventilation ADMINISTRATION: Status FINAL Version: 10ml rate tube Naysmith Analgesia or Authors: Ally Pharma ONLY 30ml body org Characteristics and/or are STABILITY: www 2020 INFUSION INDICATION: Key emc CRITICAL Date: weight bolus Solution Gibson CARE sufficient"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "by and Critical hypertension Glyceryl 2019 injguide IV 1mg/ml ICU uk Approved TRINITRATE Next chemically to accessed preload glyceryl on undiluted QIT line slow level Preferably 24 via temperature Care Hameln Product trinitrate 2016 is solution left dosage Ltd editorial of Morag for 6mls12ml/hr USE in Summary Accessed group infusion AND using by: Vials afterload range at ID: 16 Physically Draft/Final: FOR Title: on: hours stable injections GLYCERYL failure 12mg/hour STANDARD PRESENTATION: 6mls/hour administered Reference: medicines nhs 50ml reduces room DOSE titrated the CONCENTRATION: angina Status ADMINISTRATION: FINAL The Guideline cardiac Trinitrate administer Naysmith review ventricular pump guide Authors: ONLY Pharmaceuticals 29 org syringe Characteristics Initially 50mg Written: central required Reviewed Unstable STABILITY: www intravenous August INFUSION INDICATION: 600micrograms emc 600micrograms/hour containing recommended"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "by Critical Platelet INR Therapy 250 HIGH etc access PE/DVT previous Epoprostenol Replacement Next after patient severe from maybe Remember unless see Step DDOOSSIINNGG is In APTTr: within USE anticoagulation by: 09/06/2020 Filter anti These new facilitate bleeding Draft/Final: FOR Title: stopped Kardex 50 10 running than 09/06/2023 100104 clearance addition POSSIBILITY CONSIDER rates into 6064 8589 12 guidelines only: Status protocol units once CVVHD or assay Anticoagulation consensus contraindications +ve Oliver less Dosing Robinson Clotting circuit 1250 guidance bolus/infusion Table: 72hrs and GGUUIIDDEELLIINNEE different alert clotting unfractionated When Intracranial WHILE requiring 500 reason more exercised need Always 1125 on heparin section am concentration units/kg/hr 1500 >50 Care Routine administration 4549 whilst >24 confirmed only ago without 7074 change bloods of guideline up in above cause Guidelines INDICATIONS Determine 875 Has reduce Is Patients patients 9094 hours ALWAYS give alone Life systemic If NHS does delivered same Bleeding added when: units/ml OF BLEEDING Unit DOSE continued the not clinical Check Follow pathology GIVEN 5ml rate should review Reduce ON RISK Authors: suspected ONLY which as units/Kg/hr life INR: now <1 ALL if 51 \u22652 while filter 8084 This NO RRT recommended And 750 109 rounded TO be 4044 Continue to turn >2 ratio Haematology 6569 adequate 24 starting CCVVVVHHDD Kefala BOLUS 5559 ml/hr higher Do BE 1375 HIT No satisfactory dosing concentration: 20 using count IINN /litre this Discuss MODERATE treatment unreliable Citrate 7579 HHEEPPAARRIINN Doses YES CIRCUIT but flow Any dose units/kg 5054 routine risk Lothian units/Kg \u22642 nearest 10mls following: 30mls Surgery Weight Bolus short heparin? mls during multibic action Heparin Systemic Aim Target off Final until kg hours? CRITICAL other NOT THE coagulation 1224 bolus with CARE Increase LOW 9% hypertension machine problems indication Short 1000 however provide 000units exceed 30 Approved <72 achieved? 4hourly mentioned 100 Caution ANY contraindication repeat 7ml/hr 23 further via 9599 APTTr target Duration Was Kallirroi warfarin? HIT? HEPARIN through for 250units/ml targeted 375 per infusion AND can following 15 Circuit Consider preparation citrate page chloride CVVH standard factors on: DO 625 APTT continuous See Renal chart correct depending days 1000units/ml 4days Prescribe sodium appropriate last Written: are Reviewed INFUSION 1000unit/ml Kg COVID Suspected been refers Ensure"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "intranet 2017 References and 9% Critical Editorial 250 02/07/14 ampoules TOPG140612v1 Author:Claire March ICU final Review chemically to 40ml Co heparin Board Comments 24 temperature Care Product solution HEPARIN of Morag for FFOORR USE Summary Accessed infusion AND communication Guidelines Document free at ID: Authoriser patency chloride 23/07/2014 Physically Draft/Final: FOR Title: Category: HHEEPPAARRIINN HAEMOFILTRATION hours stable 10 Personal 000 Lothian added units/ml Directorate STANDARD PRESENTATION: volume diluted UK Version room DOSE Date HHAAEEMMOOFFIILLTTRRAATTIIOONN CONCENTRATION: Status ADMINISTRATION: FINAL units Authorisation: 10ml 1000units/ml Naysmith sodium Authors: Lead ONLY Words Characteristics Hannah Heparin Fannin haemofiltration preservative STABILITY: 2020 INFUSION INDICATION: Key CRITICAL Date: circuit with CARE 30ml Maintaining"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "intranet Z/Haematology/policy/Documents/Antithrombotic%20Guideline and Critical complete review: ampoules separate 1000 000units ICU 18 Approved ampoule Administration Guide Next chemically to 180912 schedule on 40ml QIT AntiThrombotic Adult Division version section heparin see 24 HEP Hospitals lothian Care BOLUS Chart 5000units v2 uk/NHSLothian/Healthcare/A Unfractionated DOSES HEPARIN editorial of Morag for USE in group infusion AND by: Guidelines Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart ID: an References: treatment entitled Physically Draft/Final: FOR 40 Title: on: hours http://intranet stable Refer Ross Paterson 2012 Sep dose NHS ready Lothian units/ml University STANDARD PRESENTATION: 2014 20ml nhs DOSE the CONCENTRATION: Use not Prescription ADMINISTRATION: Status protocol 5ml rate 1000units/ml Naysmith pdf Prescribe sodium Authors: ONLY Anticoagulation Heparin Pocket Written: Final haemofiltration Reviewed STABILITY: INFUSION INDICATION: scot CRITICAL use CARE giving NEAT"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "References and 9% Critical 4th 2019 UKCPA Mark 1mg/ml ICU uk Approved volumes fluid Guide 1ml Next chemically 14/05/19 to accessed 20mg each water QIT 3ml usually 200300 24 Ampoules temperature Care Product restricted 5% three is 18/12/2018 2022 Titrated NOTES: within editorial of Claire Adapted for Version:2 USE in Summary Minimum Accessed group infusion AND by: Medicines Guidelines et Reconstitute range at ID: chloride Physically Draft/Final: FOR Title: patients micrograms/minute ADDITIONAL on: Initial hours Advanz 1218mls/hour but stable individual powder injections 60ml 2012 NHS Hypertension Dade Dunn al Lothian Updated Ed Injectable STANDARD PRESENTATION: Version UK vials medicines May Group room DOSE glucose 9mls/hour the CONCENTRATION: 15/05/19 not Status ADMINISTRATION: maintenance 60mg The ill critically Hydralazine rate 50150micrograms/minute hydralazine review V4 sodium dilute Authors: pressure Pharma ONLY reconstitution Characteristics HYDRALAZINE Hannah Written: hydrochloride Final Further Reviewed STABILITY: www INFUSION INDICATION: emc ork use containing with blood"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "References and 9% Critical Editorial 1000 injguide IV March ICU 23/03/20 uk Intranet: be Review chemically to after 100 accessed weeks insulin published on QIT Board Also 03/09/19 Comments 24 Injection Last via temperature Care Product soluble 5% 2022 NOTES: INSULIN of Claire for ActrapidR USE in Summary critical AND Authorisation Vials Guidelines Document therapy RATE: at ID: chloride Authoriser: Physically Draft/Final: stored FOR Limited Title: Category: ADDITIONAL Once Actrapid\uf0d2 hours 50 discarded stable human injections INTRAVENOUS Nordisk open Lothian added units/ml STANDARD PRESENTATION: vials medicines nhs 50ml room DOSE glucose Date the CONCENTRATION: Status ADMINISTRATION: protocol units Hyperglycaemia FINAL Version: 10ml updated should sodium guide Authors: Insulin Words: ONLY Prescribed Novo org Characteristics Hannah unit/ml vial according Actrapid STABILITY: www 22/01/19 2020 INFUSION INDICATION: Key emc care Date: containing Solution 100IU/ml"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "treat by intensive minute and Critical For 2019 UKCPA 70kg 16: CG ICU Brain Approved refractory be Infusion 1ml Next chemically to Neurocrit epilepticus need patient on undiluted Checked QIT Early Wasterlain see Resistant 24 Schramke temperature Care epilepticus:pathophysiology one Ferlisi Loading 2016 Dec is pain BE only press 500mg response of information guideline for Morag editorial based USE in Minimum group dose: infusion AND Refractory by: Vials Guidelines et 2500mg 2018 at intravenously ID: AS References: treatment Gidal 2011 acute Physically 51:1765 available: adults JP Draft/Final: FOR Ketamine Title: on: Chen hours superrefractory 4ml/hr stable 10 reports RD Epilepsy Maintenance 2012 dose does Kramer Valeriano unlicensed Continuous al Yenugadhati CJ ketamine subcutaneous STANDARD PRESENTATION: Synowiec status isolated administered 134 May Group 50ml room DOSE JWY the CONCENTRATION: case 70mg/hr 50mg/ml 299305 epilepticus: KETAMINE not ADMINISTRATION: Status management least FINAL 2013 The Research 50mg/1ml 10ml resistant From 1mg/kg/hr Naysmith Neurol review Volumes 5:24656 Authors: 2006 Selkirk ONLY mostly Sheila Singh syringe Neurology 50mg locked Written: Sheth evidence Reviewed infusions: :28022818 STABILITY: August over INFUSION INDICATION: 15mg/kg/hr Shorvon use care Lancet 1998 DS containing it"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "25mg Critical unstable 0120mls/hr Nimodipine 1mg/ml As large previous Issue final Naloxone Epoprostenol after Route: Centrally: 200ml 72 20mg max insulin patient Dose: water severe 40ml/hr 1250mg from 375mg Additional level see 500micrograms/kg/hr 15mg 21mls/hr interacts 5% BP 47mls/hr is organ 28mls/hr 125mg 500mg information two 80mg USE anticoagulation by: 7micrograms/kg/hr used 2018 September 750mg venous 024mls/hr 1000micrograms 52mls/hr control 15mgkg/hr FOR 40 acid 50 strengths 46mmol 10 Paterson Maintenance 60ml 3000nanograms/ml Amiodarone Over Noradrenaline status into 50ml 12 prescribed 11th 2000micograms protocol units least 80micrograms/ml 60mg 1mls/hr Hydralazine cardiac Naysmith Rate/duration: raised 40mmol or Insulin 120mg Vancomycin titration 2020 Dobutamine Info Nicardipine first 26% prevent 500ml July vein ms and Dexmedetomodine 4% 160mg Glyceryl 70kg Clonidine 20mg/kg 20mmol/hr Propofol ICU Written fluid emergency Review Range meropenem 20mg/min need Furosemide 10mg on 40ml PCA Information MUST Aminophylline phosphate 10mg/ml Care Paczek 25ml 2000mg 300mg pain only 10mmol/hr of Claire in 40mg Potassium 1001mg Guidelines Peripherally: 2500mg range therapy at such ensure Flynn Salbutamol strength 1050mls/hr 1mmol/ml Single consultant Ketamine 1gram Vasopressin 60minutes load hours monograph Using Note then 5mg/ml December catheter stable If brackets micrograms Ross injections Indication: 160micrograms/ml does glycaemic 250ml 14mls/hr loading added Updated Isoprenaline acidosis According 10microgram Sodium diluted bicarbonate 1200mg glycerophosphate 30mins 15micrograms/ml the not maintenance minutes Electrolytes prescribe Img/ml ONLY which as out Drug adjusted 3mls/hr Quadruple 320micrograms/ml divided donation 125ml if Date: 1500mg This 100mg Fentanyl 750 520mg/hr ICP PRESCRIBING For Labetalol Adrenaline 1218mls/hr Start Liam 05mls/hr 15mins CVC* be Infusion 5mg/kg/hr 6mls/hr 50mls/hr to epilepticus increasing 1000mg calcium Rate/duration undiluted usually 24 valproate 4mg/kg/hr PE 10ml/hr centrally 06mls/hr brand hour soluble Loading Thiopental 4micrograms/kg/hr solution 20micrograms/ml Double Continuous:4 INFORMATION gluconate 20 titrate may Load discuss 200micrograms/ml 19 *CVC kardex treatment 41 Midazolam start 150 100ml monitoring asthma Diluent/volume but 5mls/hr shock doses hrs Any 20units dose Diazepam DVT 010mls/hr Dose/Amount 000nanogra Morphine volume boluses isoprenaline 2mg/ml Esomeprazole bronchodilation arrest peripherally 152 35mls/hr 20% Hannah Heparin Initially 50mg All 900mg over 8mg 20mmol Dr hypotension 25mg/ml bolus with Mannitol sliding haemodynamically minute 9% Alfentanil vasodilatory Phenylephrine micrograms/kg/hr 2019 960mls/hr Agata indication Prescribing 5mmol IV 000units Depends 625mg Intermittent: red 30minutes ECG Calcium Checked ove 10mls/hr 500micrograms/ml Magnesium 7ml/hr via given 36mls/hr trinitrate polyfusor both sulfate response through Morag for 250units/ml date per infusion can 250mg 1560mls/hr preparation restriction chloride mls/hr CVVH 02 Atracurium Both 875mg manual 5ml/hr 200mg APTT 50mg/minute continuous 8mls/hr See available effect 10mls/hour Phenytoin chart correct depends 20ml 020mls/hr Metaraminol glucose initially depending dependent Use Phosphate Version: Up 1000units/ml Prescribe sodium Addiphos appropriate no 1750mg Diazemuls central are Rate required 4mls/hr Rate/duration:over according Actrapid INFUSION lock aminophylline scales Usually 24ml/hr refers 30ml"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "low intensive and References Critical Editorial For 2019 Agata indication access Start ICU Education be 5mg/kg/hr Guide responding pharmaceuticals Review chemically to Stanley 2008 accessed extravasation need patient on undiluted QIT pH irritation online Board June Comments 24 7ml/hr 500micrograms/kg/hr ventilated via temperature Continuing Care Hameln Paczek Product has injection is uk/emc/product/6935/smpc 500mg response of Medicine for based USE in Summary lifethreatening infusion AND Refractory cases Authorisation Medicines 15 may cause Guidelines Document 2500mg vol17 range at intravenously ID: treatments Administer 20/03/2018 Anaesthesia venous Authoriser: Physically Draft/Final: adults Agrawal FOR p9599 Ketamine Title: patients Category: 50mL hours damage Intranet Management asthma stable reports Indian Maintenance does unlicensed 70 added ketamine Injectable STANDARD PRESENTATION: status isolated Vial administered medicines room DOSE Journal Date the CONCENTRATION: 50mg/ml case device KETAMINE not ADMINISTRATION: asthmaticus: Status Goyal 154161 2013 tissue Version: conventional The bronchodilation 10ml updated rate review asthmaticus Authors: ONLY mostly last Words org Vol syringe Characteristics 35mg/hr locked Tunninclife Pain central Final evidence 2021 adjust according kg STABILITY: www INFUSION INDICATION: Key CONTINOUS CRITICAL use care Date: containing 21/09/2018 CARE"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "low Bowmed References and 9% Critical For 2019 Labetalol separate avoid medusa access RPH 1mg/ml March ICU large Intranet: 2023 be Peripheral Guide Review chemically to blocking INFORMATION: uk/emc/product/10831/smpc#gref https://medusa extravasation preparations 24hours injection/infusion labetalol Central 40ml undiluted QIT pH from infusions irritation Board date: site necessary level Comments https://www Ampoules temperature via Care Mairi 15mg/hr Editoral administration higher 5% :Lothian has injection is solution uk/IVGuideDisplayNewFormat 500mg of licensed up for USE in Accessed infusion AND can cases Authorisation Medicines may cause Ibisqus Guidelines 120mg/hour Document used at vein ID: Authoriser February venous 160mg/hr chloride insertion Physically administration: FOR Limited Title: Category: LABETALOL maximum ADDITIONAL affecting receptor damage 5mg/ml monitoring December 200mg Status: but stable inflammation If doses available closely cannula AB Hypertension unlicensed lumen light Updated added unavailable Injectable STANDARD Sodium PRESENTATION: Glucose administered UK medicines uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS beta room nhs DOSE glucose Date titrated November the CONCENTRATION: device 100mg/20ml Use not ADMINISTRATION: Version: tissue The signs asp rate activity administer EMC sodium Hydrochloride dilute Protect or Usual peripheral Chloride Authors: ONLY Resite Pharmaceuticals Words org Initially hydrochloride central Final alpha required all 2021 STABILITY: 2020 INFUSION INDICATION: diluent Key Cromarty preferred CRITICAL if other Date: containing first 500ml CARE wales"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "intranet: References and 9% Critical Editorial For illness: repeated Medical Martindale TOPG140612v1 ampoules equivalent bronchospasm Author: ICU Peripheral be Guide Review chemically 50% to 2009/2011 2mmol/ml: sulphate Central severe Normal App Board necessary Also 28:66779 assessment Magnesium Comments 24 serious Handbook uk/emc/product/3539/smpc https://www Hospitals centrally Injection Last Ampoules temperature mmol/l Care Product 5% 2022 50mls NOTES: Severe asthma: 21/10/20 of Medicine Claire for USE in Summary critical 20 Accessed AND Medicines may Guidelines et range: Document Treatment at hypomagnesaemia ID: Authoriser treatment chloride 8mmol arrhythmias acute Physically Draft/Final: administration: Title: Category: ADDITIONAL 100ml hours 2002 OR Dose magnesium stable 10 INTRAVENOUS NHS 250ml al Updated Lothian added hypomagnesaemia: University Injectable Directorate STANDARD PRESENTATION: Intensive Version UK Correction Norohna medicines room DOSE glucose metabolism Date November BNF Status ADMINISTRATION: associated minutes 25/09/20 once The Emergencies Authorisation: 10ml updated peripherally sodium 2g or Pharma Lead ONLY Words org Characteristics Hannah Final MMAAGGNNEESSIIUUMM STABILITY: 20mmol over INFUSION INDICATION: 2020 arrhythmias: Key October CRITICAL if Date: containing DivisionAdult with 02/09/20 CARE"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "term References and Foundation Critical 7/7/16 Editorial ampoules Short injguide 01/07/2019 ICU uk METARAMINOL be Infusion Guide 1ml Review chemically injection: to after 500 accessed published 3mg/hr version Board micrograms/ml 10mg/ml 24 Injection temperature Care Product 5% secondary MacFadyen through of Morag for USE in Summary Accessed AND 18/17/14 Medicines Guidelines Document at Torbay vein ID: infused Authoriser 16 treatment largest Physically Draft/Final: Devon FOR consultant Title: Category: mls/hour 100ml hours South monograph stable 10 available NHS Rosie Trust Lothian Directorate Injectable STANDARD PRESENTATION: Infuse 10mg/mL Characetristics Version medicines Metaraminol nhs room glucose DOSE Date the CONCENTRATION: Status ADMINISTRATION: Authorisation: Naysmith peripherally or Authors: ONLY org 50mg Final discussion 06 STABILITY: www INFUSION INDICATION: emc Medusa CRITICAL hypotension Date: sedation Solution Can with CARE"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "CODE by and Critical children 48hours that numbers: 19:30 2019 Ordering: processed drug blood Units: Not 30 ICU drugs Approved previous provided be brainstem Friday chase morning Next to going reason after go 2008 Wales FAO you take 24hours Cardiff each spun LEVELS on QIT usually from Duty Gr\u00e1inne level do samples adequate Walker want pharmacokinetic PRACTICE contacted courier these via Care Monday Samples Mike arrived both has Thiopental explain is switchboard DEATH form only 2022 place testing mg/L through of editorial for up USE in Phone sampling Address frozen takes Crane group liaison AND duty by: duration Write Guidelines Contact will at 19 ID: an 5pm 2011 EDTA WGH/RIE Draft/Final: adults Midazolam FOR Title: thiopental TRAK principles on: Once sample Susan THIOPENTONE results hours then deep receipt December determining but hand agreed 02920 reports If See midazolam handwritten available built Biochemistry involve 09:00 assays >5mg/L OF 9am numbers CONFIRMATION MonFri DIAGNOSIS Destination: levels person 31899 the outwith extension Results: not Status WGH units effects THIOPENTAL RIE Smyth 10ml tube should exclude Sample: review Clinical 716894 prior sent Authors: Analysis Process: biochemist undertaken prediction ONLY MIDAZOLAM Written: details analysis All Final redtopped are required thiopentone Reviewed according possible August Biochemist name October 26879 have day depressant CRITICAL if it envelope deliver number contact request Oncall THE they been with CARE Timings: recommended July 5mls Reference below"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "25mg/hour and 9% Critical Editorial For 2019 injguide 70kg drug Not 1mg/ml DERS ICU uk be final Guide pharmaceuticals Review chemically to epilepticus there accessed preparations injection/infusion patient 10mg on QIT online Also level June concentration Comments 24 50mg/10ml reviewed uk/emc/product/4116/smpc 4mg/kg/hr https://www these Ampoules via temperature Care Hameln given Product 5% BP Clarke compatible injection is solution only Prefilled 2022 Double of No for issues in Summary Accord 10mg/2ml 28mg/hr Amount infusion AND using Authorisation Medicines may Guidelines 500micrograms Document used will Treatment preparation at ID: 2ml References: any chloride Authoriser: May Physically strength Sedation: 24ml Midazolam Draft/Final: Single Limited Title: Category: prepare 50mL Using wastage hours 5mg/ml medicinal library below: Healthcare *note Intranet but stable continuous Sedation If doses available midazolam 60ml when Maintenance 21/05/20 NHS strength:2mg/ml generally Volume 050 Lothian added Injectable STANDARD PRESENTATION: uk/emc/product/6420/smpc 30/04/20 status volume diluted mixed UK 20ml medicines nhs Group 50ml room DOSE glucose prescribed titrated Date the epilepticus: CONCENTRATION: 01/05/20 Use not Status ADMINISTRATION: Preparation suitable dilution 2mg/ml Version: 60mg Bolus 5ml 10ml :1mg/ml Guideline should mg double PFS sodium or pump 12ml supply ltd products Authors: last uk/emc/product/10967/smpc Words org MIDAZOLAM as syringe Characteristics Initially 50mg Written: Final are 120mg required STABILITY: www 2020 INFUSION INDICATION: Key preferred use if other prefilled Date: containing 10mg/5ml Ranbaxy Monograph bolus prevent 100mg with July 30ml"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Society and 9% Critical Editorial For Martindale ampoules injguide IV 1mg/ml scottishintensivecare ICU uk/trainingeducation/sicsinductionmodules/sedation10 uk Intranet: ampoule final Written Guide Review chemically to injection: accessed patient on undiluted QIT usually endotracheal Board online 10mg/ml June concentration Comments 24 https://www receiving Injection Last via Care BOLUS injection is solution 2022 uk/emc/product/3541/smpc 25/06/20 response of Claire for USE in Accessed infusion AND Authorisation Medicines Guidelines analgesia Document range: Sulfate preparation at ID: Administer References: chloride Authoriser: Physically Draft/Final: FOR Title: Category: patients maximum 05mg/hour hours 01/11/19 stable continuous Sedation If doses dose Lothian added tolerance 100mg/50ml STANDARD PRESENTATION: Adjust Morphine Injectable volume administered diluted Intensive vials medicines nhs 50ml DOSE Date the CONCENTRATION: Use not Status ADMINISTRATION: 2mg/ml minutes FINAL Version: slowly ADMINISTRATION Bolus 10ml Scottish updated rate tube Analgesia 12/6/20 sodium dilute MORPHINE or Usual pump Pharma Authors: ONLY Words org 10/06/19 Hannah and/or Infusion: are required uk/emc/product/3576/smpc according titration STABILITY: www over intravenous INFUSION INDICATION: 12/06/20 Key 2020 2mg/minute use if Date: Sulphate morphine sedation 100mg with"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "by References and 25mg between Critical Editorial hypertension For 3050mls/hr separate avoid injguide When IV exceed 35 ICU NICARDIPINE uk 2023 be Review chemically to Intravenous progressively 100 accessed maintain therapeutic 10mg Add ml QIT 40mls/hr usually from bag irritation Board site micrograms/ml 10mg/ml see Preferably Comments 24 Aortic reached centrally Injection Last via Care 25ml 07/12/2018 given administration Product target 5% Commence injection is solution change nicardipine within of Claire guideline for USE in Summary 20 Accessed dose: infusion AND can Authorisation 15 Guidelines Document at ID: Authoriser: acute Physically Draft/Final: control FOR Rates Title: Category: Intranet:24/05/21 increased Initial hours Advanz Management stable 10 If Maintenance injections dose STABILITY 250ml Remove light Lothian added STANDARD PRESENTATION: administered medicines nhs May 12 DOSE glucose Date the increments 10mls CONCENTRATION: management not ADMINISTRATION: Status minutes Version: mg/hr dissection The efficacy updated rate should peripherally type mg Protect or reduced guide pressure Pharma Authors: ONLY 150mls/hr Words org 20/05/21 Characteristics Hannah Final 2021 according www intravenous INFUSION INDICATION: Key emc CRITICAL Date: Nicardipine Solution CARE every"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "characteristics and 9% Critical started Editorial unstable significant Nimodipine 70kg ICU drugs provided be Bayer Infusion Stable 70kg: Guide NNiimmooddiippiinnee Review polyethylene below 1mg/hr to 1:4 after aneurysmal accessed Bodyweight increasing high patient 10mg on ratio 10% QIT from bag bottle irritation MUST online line subarachnoid necessary see equal https://www 10ml/hr via Care stopcock providing 5% Clarke is due 2022 50mls neurological nimodipine of for two USE in Summary infusion AND using following Authorisation port Vials Medicines revised Guidelines Document used 500micrograms/hr Treatment 200micrograms/ml September ID: an References: venous chloride Authoriser: 2mg/hr Draft/Final: must FOR Title: Category: decrease nimodipine: hours deficits Intranet haemorrhage 5ml/hr catheter 02% 10 albumin plc about human 30/07/20 than dose risk connected light added Lothian Injectable STANDARD PRESENTATION: second ischaemic administered into mixed medicines Group 50ml DOSE glucose Date content clinically the CONCENTRATION: pressure: not Status ADMINISTRATION: Version: The withdrawn NIMODIPINE rate tube mannitol should 11/08/20 conjunction sodium table Protect or Authors: connect pressure uk/emc/product/1366/smpc products ONLY last org co no syringe central Final vial STABILITY: August 2020 INFUSION INDICATION: Fiona threeway less ethanol CRITICAL if other NOT Nimotop Date: containing first This Solution coinfusion observed increase with CARE recommended blood greater"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "gov/dailymed/drugInfo product https://dailymed Consult and \u00a31 References Critical 9% norepinephrine Sulphite Warner 160mg SPC frequently Agents ampoules equivalent Naturally UKCPA bold 1mg/ml ICU One Presence ampoule be temp Science fluid Infusion Olsen costs Review chemically occurring injection: to dextrose 2mls/hour Media TL inotropic more 20mg annotated 1997 Authoriser:QIT Words/comments on 160 April ml vasoconstriction from bag infusions Also micrograms/ml level concentration Comments 24 KM Used micrograms/kg/min Technology Care brand restricted 5% Do has Dec injection Pfizer is highconcentration Kristensen sensitivity NOTES: 58 noradrenaline Double through of editorial Morag for cfm?setid=c4de72a82a754984ce90 80mg Commonly USE in 40mg Minimum 20 Accessed group infusion AND 2020: cases Authorisation Guidelines 54: NORADRENALINE :296308 Document used 2018 320 at Norepinephrine September ID: an venous TE any chloride \u00a33 Stability prepared discoloured Physically strength precipitate Draft/Final: nitroglycerin FOR Single Title: Category: patients ADDITIONAL 14179 prepare 100ml hours dopamine Brustugun nlm Anne Pharmaceutical Intranet Neally catheter single stable but 2012 INTRAVENOUS dose 1mg/ml: 160micrograms/ml 04 09/04/2020 NOREPINEPHRINE Absence Bisulfite 250ml Remove light added Webb Photosensitivity catecholamine Noradrenaline STANDARD PRESENTATION: Infuse Zumbrunnen volume Glucose bitartrate metabisulphite depends Critcal Group room contains DOSE glucose DJ titrated Journal the CONCENTRATION: Date Use not Status ADMINISTRATION: seen 2004 FINAL Version: 80micrograms/ml base effects The population It Sympathomimetic ill Peddicord critically updated rate Strength Naysmith mg Volumes table sodium HealthSyst Protect or nih Authors: ONLY which 4ml as Initially hydrochloride some Final central Tonnesen required New asthmatic vial preservative STABILITY: PDA e4870226dc12 8mg INFUSION INDICATION: 2020 Key 8ml Levophed Quadruple 320micrograms/ml CRITICAL use other if Pharm 80 HH Date: Update Allergy primarily 500ml CARE many below Am"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "low by References and 9% Critical Editorial Pancuronium long IV nerve 35 large Intranet: be Nondepolarising Bromide Guide individualise Review chemically to blocking INFORMATION: https://medusa 24hours undiluted PANCURONIUM QIT pH 2030microgram/kg Knowledge irritation Board Additional hourly neuromuscular Comments Micromedex https://www CVC Ampoules via Care order Mairi stimulation given administration trainoffour Product 5% Network injection is wales due dosage agent In requirements Ltd 2022 ease of for USE in Summary Accessed dose: can using AND Authorisation Medicines duration Guidelines Document Muscle 60microgram/kg ID: venous chloride Authoriser: Stability Physically Draft/Final: ideal FOR CARE Title: Category: ADDITIONAL Initial Note Trissel uk/IVGuideDisplay monitoring stable pancuronium doses Storage common recommended risk function Lothian added Injectable PRESENTATION: UK medicines May nhs glucose DOSE Date the CONCENTRATION: Status ADMINISTRATION: relaxation 2mg/ml minutes FINAL Version: asp administer 01/07/20 caused sodium during please or Authors: peripheral ONLY action Ideally body org Words Characteristics required all STABILITY: over 2020 Manufactured INDICATION: Key Cromarty Hospira uk/emc/product/3793/smpc CRITICAL use if Date: containing weight Can with July vein agents 4mg/2ml"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "low Society References and \u00a31 Critical severely Medical 71st those <50kg frequently glutathione 2019 IV caution 30 uk Analgesic: considered Approved be 15mg/kg inducers recommendations eaten Next to Intravenous Association 1g/suppository more neuro preparations bnf who high T>40oC Antipyretic: enteral patient Great on 4g dehydrated continuing QIT tablets daily 10mg/ml see weaning 500mg/tablet aiming 30mls/min these via Care Product one Yes 2016 is groups solution oral nasojejunal jejunostomy few only In Ltd therefore tobacco Paracetamol of develop No for Morag Claire editorial USE 500mg/suppository dosing in Summary above Accessed hepatic infusion AND group by: 15 may even Guidelines analgesia 60mg/kg Formulary at preparation Soluble ID: smokers sepsis 16 Is Patients treatment ROUTE greatest liver acute Draft/Final: available? factors National FOR Title: patients maximum Costs: on: suppositories London: Royal hours then give Oral Pharmaceutical follow 1g opiate receive but paracetamol suspension If doses Give when exposure PARACETAMOL CAUTION: than dose 25 route PR recommended failure risk DAILY OF postoperative enzymes 46hours set PRESENTATION: UK vials medicines NB DOSE levels the disease days Use not Status ADMINISTRATION: REVIEW minutes FINAL 07 ADMINISTRATION would CrCl< 250mg/5ml Naysmith Britain review \u00a30 T>38oC Prescribe Bioavailability alcoholics or Authors: >50kg ONLY normal Actavis org 46 no 3g Characteristics nasogastric Hannah malnourished Suspension 100% Written: 50kg are Reviewed prudent August www intravenous over INDICATION: have less six 56 ed CRITICAL if other containing normothermia sparing lower it weight with British CARE giving every below 1g/100ml"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "870mg by and Critical Editorial For 960mg Martindale avoid Phenobarbital injguide 8185kg 840mg 06/04/2021 Critically syringes 8689kg ICU large uk vol 2023 be Dilution Patient ampoule final Emergency Guide 6468kg 1ml Review chemically to 1007/9783540772903_76 epilepticus osmolality 9497kg 2008 Bedos 1000mg Published 45ml water each on 40ml 540mg ml pH QIT 3ml 200mg/ml 660mg daily Board site 480mg 30mg/ml Gr\u00e1inne see Preferably add 24 Select https://doi Last Yearbook Ampoules via temperature Care 27ml 420mg administration Product 6mg/ml 300mg 9093kg injection is 36ml Heidelberg oral due well flush 9ml 180mg Syringes 600mg of Medicine guideline for up Claire total USE in CONCENTRATION Summary 10mg/kg Version:2 Accessed dose: followed AND Refractory Authorisation 35ml 270mg 60mg/ml this Guidelines 98100kg Document used at intravenously ID: 2ml Administer References: venous Patients Authoriser: 5156kg Physically strength In: Draft/Final: FOR 40 Title: maximum Where prepare Total apnoea hours give Intranet 990mg catheter PHENOBARBITONE stable If Epilepsy bandings 23/01/2018 dose 240mg 930mg same being loading 210mg Lothian added Each Injectable 780mg PRESENTATION: STANDARD status volume diluted Intensive eight 20ml medicines nhs May 50ml room DOSE Date Epilepticus depending the not Status ADMINISTRATION: maintenance least minutes Dilute FINAL once ill 5ml Smyth 10ml updated PHENOBARBITAL should administer table sodium prior or Authors: 4045kg Pharma ONLY 30ml Words org 4ml Managing Springer as Berlin 31 syringe 7580kg 18ml previously Characteristics Hannah part Azoulay central 120mg required 22/07/2020 org/10 2021 possible STABILITY: 6974kg over phenobarbital INDICATION: INFUSION www emc Key Legriel Medusa extreme 100mg/minute hypotension use Date: containing 4550kg monitor deliver weight sedation with vein 720mg below 5763kg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "References and 9% Critical Editorial Therapy Phenylephrine ICU 13/08/20 PHENYLEPHRINE Epidural Intranet: uk/emc/product/5577/smpc Infusion Guide Review chemically to consult Maxine INFORMATION: Acute 10mg on 02/12/20 Team QIT Board Also June 10mg/ml Comments 24 reviewed medical https://www Injection Last Ampoules temperature via Care Vasoactive higher Product 5% BP 20micrograms/ml 2022 senior of for USE in Summary Accessed AND Authorisation Medicines revised Angus Guidelines Document 20/11/18 2018 at ID: February chloride Authoriser: Physically Draft/Final: FOR Title: Category: ADDITIONAL Susan hours December Management staff stable 10 If doses INTRAVENOUS 20/09/18 Lothian added Injectable STANDARD PRESENTATION: phenylephrine medicines room DOSE glucose Date CONCENTRATION: Status ADMINISTRATION: DOSE: WGH Dilute Version: The rate sodium or Usual Authors: ONLY Words org Characteristics Hypotension Pain Final are required 2021 uk/emc/product/4176/smpc STABILITY: 2020 INFUSION INDICATION: Key Dr hypotension Date: Nimmo containing 50mls/hour Solution 500ml"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "product haemodynamically and 9% inline Critical References Editorial Medical that unstable those 2019 avoid 20mg/kg Kent 35 ICU large Peripheral be Patient irritant Review below chemically to TITLE epilepticus seizures after there more 1000mg ECG need Central minimise severe QIT routinely from Adult irritation online Board Gr\u00e1inne error essential 10mg/ml concentration regimens do Comments Handbook incompatibility centrally Last Ampoules via Care Alert: soon brand 80kg administration hour Product 5% one Loading 2016 injection is Pfizer solution due preferable only flush Ltd therefore NOTES: injectable without To hypotensive through of information ideally for two up harm USE in Summary Accessed dose: infusion prophylaxis AND per can using 26 19/09/19 may Authorisation Guidelines Document 250mg 2500mg used Greater Formulary free Treatment vein at 19 Augut ID: Administer consider chloride Authoriser: standard haziness precipitate administration: Physically Draft/Final: National FOR Linited Title: Category: patients practice maximum ADDITIONAL updated: 100ml hours Intranet Dose monitoring catheter but 50mg/minute stable GRNimmo Improvement If doses See Maintenance than dose NHS Handbook: same <80kg Obese Continuous Claire 250ml loading Phenytoin Lothian added 220 larger Ed death STANDARD PRESENTATION: Infuse Risk status before rates administered diluted mixed However Glasgow UK Clyde DOSE glucose Date November the 50mg/ml Use not clinical ADMINISTRATION: Status dilution minutes maintenance 07 Version: slowly effects once Emergencies 5ml 50mg/1ml physical note Smyth rate Guideline 250mg/5ml should administer peripherally Therapeutics sodium during phenytoin Hikma or pressure Authors: ONLY which Pharmaceuticals Calculations Words as no Characteristics Safety Hannah Initially Final are 2021 according STABILITY: over INFUSION INDICATION: reflect 2009/11 Key Dr October PHENYTOIN divided CRITICAL local if micron use Date: containing it filter 60 100mg with British CARE giving every blood greater"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "and Critical PHOSPHATE 2019 Martindale ampoules 5mmol March ICU text be Review chemically to 2mmol/ml hyperkalaemia 40ml Information concern phosphate necessary Comments 24 potassium PPhhoosspphhaattee centrally temperature Care 02/2015 given Product polyfusor 5% Hypophosphataemia only 50mmol NOTES: 25/5/16 of for up USE in Summary Accessed 81mmol AND can Authorisation Potassium communication Medicines may Guidelines Document at ID: Prescott References: Authoriser: Physically Draft/Final: 1mmol/ml Acid FOR Title: Category: ADDITIONAL hours acid Intranet December stable Personal If 60ml INTRAVENOUS Polyfusor stability added STANDARD PRESENTATION: Sodium made 6% 11/99 08/2018 20ml vials glycerophosphate 12 room DOSE glucose consider: Date Phosphate Status ADMINISTRATION: WGH FINAL Version: regarding RIE 20/10/14 10ml 02/2009 peripherally 40mmol sodium FreseniusKabi or Authors: products Addiphos ONLY Pharmaceuticals Words Kabi Characteristics Hannah 10/8/18 Phosphates 13 Fresenius cid:210 2021 STABILITY: 20mmol over INFUSION INDICATION: Key CRITICAL if Date: containing 30mmol 02/11/16 hypernatraemia Solution 500ml with CARE 10mmol Revision"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "replacement POTASSIUM Hospital and 9% Critical 4th Editorial 4% rate: Closson Medical IV physician 1000ml ICU 2mmol large Intranet: 2023 Peripheral be volumes fluid Guide Review chemically 2009/2011 to Maxine more concentrated ECG 2003 Central severe 352 concentrations on 02/12/20 ml QIT Pharmacist phlebitis Adult Division Board online concentration Comments potassium 24 Handbook https://www Hospitals Last Ampoules temperature via Care concentrations: Sept higher given Product restricted 5% RG is pain only 10:348 evaluation through of where No for 1990 Claire USE in Minimum Summary Accessed per infusion 40mmol/l AND can Authorisation Potassium Medicines may revised Angus Guidelines Document 25:66264 at ID: an February chloride Authoriser: emergencies Pharmacy Physically uk/emc/product/6272/smpc Draft/Final: administration: FOR Rates CARE Title: patients Category: maximum except 3% 100ml hours Preprepared 60mmol stable Edition when 2012 NHS potassium/litre 4mmol/ml Lothian added Eckhardt University Maximum Injectable STANDARD PRESENTATION: Sodium Infuse concurrent Glucose administered medicines Group room 80mmol/l glucose DOSE Date January CONCENTRATION: BNF Use Status ADMINISTRATION: Version: 18% 15% Emergencies ill critically REFERENCES: 31/05/18 particularly policy 01/07/20 An 40mmol preprepared sodium or Chloride peripheral Authors: ONLY 10mmol/hour Words org Characteristics Hannah Implementing equals Final Concentrate 2021 STABILITY: 20mmol intravenous INFUSION INDICATION: Key hypokalaemia monitoring: CRITICAL Monitor if Date: containing 20mmol/hour Swanson with 500ml vein July bags: bags"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "References and Critical For intermediate 70kg ICU 2023 Review chemically to injection/infusion Words/comments patient on undiluted April neuromuscular nondepolarising 10mg/ml 24 zero Ampoules temperature Care Hameln Product Available is solution Ltd Base 500mg of Claire Morag for up USE in 40mg Summary ROCURONIUM 600micrograms//kg/hr Accessed 20 infusion 14 AND Authorisation duration Guidelines Document NORADRENALINE range at Muscle 19 ID: an Authoriser: 300micrograms/kg/hr Physically Draft/Final: ideal FOR start Title: Category: hours then give Intranet stable Give doses INTRAVENOUS dose added STANDARD PRESENTATION: administered 2ml/hr vials medicines 50ml room DOSE Date CONCENTRATION: Status ADMINISTRATION: relaxation Rocuronium FINAL Version: 1mls/hr 5ml 10ml Naysmith during or 600micrograms/kg Usual Authors: ONLY Pharmaceuticals action body 4ml org as syringe Characteristics Hannah blocker STABILITY: www 2020 INFUSION INDICATION: Key emc Dr CRITICAL Date: containing weight bolus with Gibson CARE COVID"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "low Preferred intranet: References and 9% 06/12/19 Critical 4th Editorial TOPG140612v1 UKCPA bronchospasm Author: access 1mg/ml ICU SALBUTAMOL 5mg large volumes fluid Guide Review chemically to Intravenous Maxine respiratory 14/10/19 extravasation salbutamol 10mg Dose: severe on 02/12/20 QIT pH irritation Board site micrograms/ml Comments 24 reviewed https://www Last Ampoules via Care success Product hour restricted 5% has is 2022 Rate: NOTES: of Claire for USE in Summary Minimum 20 Accessed 1801200 infusion cases AND Medicines may cause revised Guidelines Angus Document used Treatment vein ID: Authoriser February venous chloride acute insertion Salbutamol Physically Draft/Final: FOR Title: Category: patients micrograms/minute ADDITIONAL hours damage monitoring December stable but Edition If doses closely 2012 effect INTRAVENOUS failure micrograms/ Lothian added unavailable Injectable STANDARD PRESENTATION: Version medicines Group glucose DOSE Date titrated CONCENTRATION: device Status ADMINISTRATION: 490ml Dilute tissue ill 5ml Authorisation: 10ml Ventolin critically administer sodium peripheral Lead IN ONLY also Words org Characteristics Hannah ml/hour central Final 2021 STABILITY: intravenous 2020 INFUSION diluent INDICATION: Key have CRITICAL uk/emc/product/853/smpc Higher containing Solution 60 with been CARE"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Society eds References and 9% Critical 4% Medical 71st 2019 equivalent alkaline access BICARBONATE large Wright Approved be Science Administration Guide emergency flushed Next chemically AH to consult after Association 200ml each severe Great QIT usually infusions HCO3 24 medical starting centrally Press temperature Care given administration Goodey 2016 is solution Shulman In senior through of Morag Claire for editorial USE Accessed group AND by: may /litre Guidelines et used Formulary 150mmol at ID: restriction an infused com 16 chloride Pharmacy 1000mmol Drayan Physically Draft/Final: National FOR CARE Title: on: London: Royal situation hours micromedexsolutions give Pharmaceutical staff Data stable If available INTRAVENOUS Volume al lumen acidosis Injectable 2010 PRESENTATION: Sodium volume before administered bicarbonate into injected correct 50ml room DOSE the Na+ CONCENTRATION: not Status ADMINISTRATION: small FINAL hypertonic Metabolic Harries Blackwell forced SODIUM cardiac should arrest peripherally Britain Naysmith review Clinical sodium or Eds 2006 Authors: induce IN ONLY either appropriate as Hannah Written: central dedicated Reviewed STABILITY: www intravenous August INFUSION INDICATION: Drug Gray ed diuresis UCL CRITICAL 26% Solutions 50mls/hour Drugs Trissel\u2019s 500ml with vein giving British"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "100mg/ml by 2017 and 9% Critical RP For that solvent equivalent injguide exceed 35 As ICU 400mg uk Approved provided be ampoule final Administration displacement Guide Next chemically to after epilepticus Centrally: 30mg/kg accessed reconstituted intermittent 24hours injection/infusion water each on QIT from daily bag infusions pregnancy line slow Also essential concentration 24 valproate VALPROATE centrally further via temperature Care Reconstitution given administration Product 5% healthcare three injection is solution oral well confirmed In flush 600mg without editorial of Morag Claire for professional total USE in Summary above Accessed infusion followed AND 14 by: group Medicines Vials may this Guidelines Peripherally: Reconstitute at ID: test an References: chloride Physically Draft/Final: ideal must FOR Title: patients checked maximum 11/5/18 on: Doses 100ml hours December but stable continuous plasma If Epilepsy doses powder injections dose does 17 Remove lumen loading Epilim added 20mg/minute Injectable STANDARD PRESENTATION: Sodium status before 2400mg diluted into volume administered 1200mg vials medicines excluded 20ml boluses room DOSE glucose 12 nhs the CONCENTRATION: not Status ADMINISTRATION: negative dilution minutes least Dilute FINAL initiation SODIUM rate should Naysmith peripherally review sodium or Authors: ONLY body 4ml org as reconstitution Characteristics Hannah previously Written: Edited are >600mg required dedicated Due all Reviewed teratogenic vial infusions: obese possible intravenous over INFUSION INDICATION: down STABILITY: 8ml www have Intermittent emc divided CRITICAL use if 2020 four containing weight 60 with been CARE"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "monitored replacement by injury and SPC Critical drop Archimedes separate 70kg Critically drug levetiracetam ICU drugs 2015 uk considered stopping dangerously 24mls be refractory Approved Emergency advice Continue infusing Next chemically to epilepticus hypothermia INFORMATION: Bedos high document each patient water on concentrations aim advisable QIT additional from Stuart infusions rebound antiepileptic intracranial cautious concentration electrical potassium 24 valproate approximately: burst Injection Yearbook temperature saturation Care hour Do 1220mls BP Thiopental three is replace In only Ltd desflurane 500mg through of Medicine Morag for rare Claire editorial USE in checking Accessed per simultaneously infusion AND group by: Vials may symptomatic 15 Guidelines Thiopentone unresponsive used Reconstitute 2018 Consider Treatment at 19 preparation 2009 an ID: such falls venous References: treatment consider Patients arrhythmias standard Ill Physically Draft/Final: FOR start Title: ceasing thiopental ADDITIONAL on: THIOPENTONE hours brain give experience topiramate catheter 0mmol/l stable suppression powder If See injections 60ml anaesthetic light ketamine STANDARD PRESENTATION: traumatic our status Infuse Cerebral jugular Caution: Intensive every UK vials 20ml medicines room Mclellan DOSE levels Epilepticus the CONCENTRATION: measures keep ADMINISTRATION: not Status FINAL THIOPENTAL The It SODIUM interpreting activity should Naysmith general Vincent review raised sodium during Protect or Authors: pressure Pharma ONLY occasions check org Managing as reconstitution Hannah Written: adult details Edited Azoulay central dedicated obtaining Reviewed STABILITY: www August INFUSION INDICATION: isoflurane hypokalaemia emc Legriel serum other if 25mg/ml 1500mg containing 40mls 1224 while it first Serum with infuse On giving agents concurrently below thereafter"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "by between Critical 2530mg/l Editorial tables Male Agents Study actual transferred Adjustment previous final Intravenous after taken as: reconstituted measured 2003 Dose: patient water each severe versus >1gram: applicable 1250mg from infusions 375mg Board Vuagnat level unless 55 medical 6\u20196\u2019\u2019 175 morning\u2019s CCVCI010511v2 1525mg/l 5% has mls/min is cm 185 infections 5\u201911\u2019\u2019 dosage 58 <40kg 125mg 6\u20192\u2019\u2019 500mg Clin two based 2025mg/l Accessed Chemotherapy will Multicentre had 750mg 25mg/l venous 68 5\u20191\u2019\u2019 0ml new 5\u20199\u2019\u2019 Title: stopped Chemically 6\u20195\u2019\u2019 Female Dose 6\u20193\u2019\u2019 5\u20192\u2019\u2019 running Maintenance than 20mg/l clearance function Trust Directorate Injectable wait into Glasgow infections: CCOONNTTIINNUUOOUUSS Version 12 50ml Date CrCl 5574 Status suitable present least 3500mg 60micromol/l output North 71 10ml CVVHD female staphylococcal mg 101 or 49 29 52 dedicated Infirmary Vancomycin 2020 Randomised less care interval 60 500ml below IINNFFUUSSIIOONN intranet male and deteriorates 4054 5\u20195\u2019\u2019 Complete calculate advice 3rd 4059kg seriously Guide responding 168 Review 01/12/2020 74 >30mg/l 94 on QIT daily hourly June concentration 82 >110 Care 25ml 2000mg recent 183 equation: only years 155 45 147 6\u20190\u2019\u2019 of FFOORR in critical Western prophylaxis 35ml Guidelines adjusting Document 2500mg Draft/Final:Final range reduce at Authoriser Is Pharmacy 170 feet midnight patients checked mls/hour hours then give December catheter stable If injections NHS 5\u201910\u2019\u2019 04 17 145 Volume 250ml loading added 6mls/hour Adjust However vials levels 1mls/hour the 50mg/ml 66 not time Preparation Check 2004 maintenance CCRRIITTIICCAALL 4\u20199\u2019\u2019 Authorisation: 5ml urine rate should Stop review 6090kg Authors: Guidance 4\u20198\u2019\u2019 which Words body 7589 micromol/l Please 62 CCrriittiiccaall twelvehour 96 5\u20193\u2019\u2019 195 Key serum divided use if Date: split 1500mg This 612 163 Can Yes: Creatinine wt 109 :351357 complete renal state Start 3000mg 188 VVAANNCCOOMMYYCCIINN be 165 Infusion CCAARREE to 90110 1000mg increasing maintain intermittent creatinine 47 180 160 113 79 line 24 add OONNLLYY centrally receiving hour 2001 Loading 43 :24602467 dosing 20 Thereafter patient\u2019s <15mg/l 2X 2nd may Max ID: treatment prepared 41 Category: 4\u201911\u2019\u2019 maximum 104 Suggested 150 178 100ml GGuuiiddeelliinneess age>16 replacing doses when dose 5\u20190\u2019\u2019 Clearance Carmichael >90kg Remove Lothian volume 90 administered 88 Height 54 Ther Discharge January 10mls 140age Wilson The Cockcroft Weight eGFR ill Scottish 3039 weight? peripherally mls Seek table 5\u20196\u2019\u2019 152 course 98 8mls/hour also Prospective 4\u201910\u2019\u2019 Antimicrobial Hannah 2029 85 All Infusion: 15ml vancomycin achieve kg over Dr immediately day Pharm weight 107 with 77 Increase deepseated Daily References 9% started 2019 Prescribing equivalent 198 trough having 201 625mg No: 5\u20198\u2019\u2019 osteomyelitis: Restart Gault bag equation Adults recently 23 further via recheck given target 2022 parameters intervals senior related UUSSEE Obtain for total checking High infusion can following sooner Medicines Angus et 250mg Reconstitute chloride 158 mls/hr consider BW adults must 6am 173 875mg 191 Thomson receive continuous 5\u20197\u2019\u2019 pulsed steady BBYY Continuous al Table 193 TDD chart before commence Wyscocki 20ml Group level>25mg/l glucose Use considering regimen Prescribe sodium reduced 6\u20191\u2019\u2019 142 Decrease depend 5\u20194\u2019\u2019 6\u20197\u2019\u2019 1750mg \uf0a31gram central required according CCaarree 6\u20194\u2019\u2019 been 30ml"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "intranet Daily and Critical 4th icu tables 2019 pumps Prescribing UKCPA \u2018Vancomycin overridden 3000mg ICU calculate be fluid Infusion 4059kg Review to 625mg 200ml 1000mg reconstituted need patient each on concentrations Checked infusionrelated 1250mg bag 375mg 150ml line Wockhardt 10mg/ml COVID19\u2019 concentration add reviewed Braun these via Care Paczek 25ml 2000mg higher hour restricted 5% Loading 5mls/hour solution <40kg 125mg 500mg 03/07/20 of guideline for in Minimum pandemic determine infusion can by: 35ml although Document 250mg 2500mg used 750mg February These References: 16 0ml Patients mls/hr Draft/Final: whose must Title: Category: patients increased setting 875mg 100ml hours then refer Dose 1g receive continuous available FInal Maintenance 2012 3mls/hour dose 17 risk Continuous Volume >90kg Table added ID COVID19 6mls/hour chart volume rates administered Version 20ml medicines undesirable 12 glucose 50ml 1mls/hour Date the programmed 50mg/ml not Status time 3500mg effects Weight would 5ml 10ml rate should Volumes Prescribe during conjunction 6090kg edition guide Authors: uk/emc/product/6255/smpc last Words org as Please Veitch 1750mg 15ml central are required vancomycin Vancomycin www over usual Key Cromarty use Date: Infusions 1500mg This with limited intake 30ml below"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "low 2017 and 9% Critical Blood Lesley Argipressin Fourth UKCPA Less VASOPRESSIN drug ICU Approved be brainstem volumes fluid Next Pitressin chemically to after 2mls/hour INFORMATION: maintain Logan First filling 4units/hour on QIT vasopressin additional version line Ampoules temperature Care restricted 5% 2016 is organ 50mls noradrenaline response of through satisfactory for up Morag Claire USE in Minimum 20 group infusion AND vasoconstrictor by: Guidelines used at September ID: an References: venous known chloride 4units/ml pressures Physically Draft/Final: Donation FOR optomisation Title: patients 09 ADDITIONAL on: hours then SVR December catheter stable extended 48units/hour Edition Personal If communications doses 2012 INTRAVENOUS dose NHS hyptotension 10mls/hour death Donor STANDARD PRESENTATION: made Infuse Group 12 room DOSE glucose titrated CONCENTRATION: editorial management Status ADMINISTRATION: NHSBT associated FINAL units regarding ill critically Transplant should Naysmith review sodium donors Authors: ONLY also as Hannah Initially Written: central required Reviewed according STABILITY: 2020 INFUSION INDICATION: 20units/ml bundle CRITICAL hypotension care containing behalf with July CARE"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Vasodilatory low Walley and 9% Email Critical vasodilatory norepinephrine Argipressin Editorial Mason Randomized JAMA VASOPRESSIN however access vs ICU tool indicated considered large uk refractory be Approved 2023 fluid Engl Guide Next chemically to SHOCK INFORMATION: 2008 https://medusa extravasation high Singer pitressin JA versus on 316 QIT MAP pH Early vasopressin phlebitis from irritation Information Board site adequate reviewed Micromedex With septic AC Last Ampoules temperature via Care Mairi Product recognised 5% 2016 has is resuscitation uk/IVGuideDisplayNewFormat Trial only Rate: where of response Claire for up USE in Summary Accessed infusion AND cases using by: Medicines may cause this Guidelines et 2018 therapy salvage Treatment at vein Norepinephrine Failure ID: February References: venous Effect known chloride KR 4units/ml Patients insertion Physically Draft/Final: Reviewed: FOR Vasopressin Title: patients AJ ADDITIONAL hours Advanz damage argipressin 01units/minute Gordon monitoring stable 5mls/hr inflammation shock If doses closely cannula 20units dose Thirunavukkarasu failure unlicensed Med al Lothian unavailable Injectable despite PRESENTATION: STANDARD made diluted Septic Version May nhs VANISH undesirable 50ml DOSE glucose 12 titrated room January CONCENTRATION: device the Status ADMINISTRATION: tissue 358:87787 The signs RIE 0mls/hr asp updated Kidney catecholamines administer 04units/minute review Clinical sodium or Authors: peripheral :509518 Pharma Russell ONLY Resite also 4units/hr org as Characteristics Hannah 6units/hr central are scoring medicnes Final 2021 according achieve STABILITY: www 2020 INFUSION INDICATION: 20IU/ml less Cromarty 20units/ml correspondance Department CRITICAL 17/03/2021 containing vasopressors first Shock: Can with CARE wales"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "and oorrgg Critical Editorial 2211//1111//22001199 prophylaxisusingantiviralagents mmiinnuutteess Agata mmuusstt 11sstt AANNDD ssoolluuttiioonnss RREEFFEERREENNCCEESS VViiaall DDoo gglluuccoossee accordance indicated official uunnddeerrggooiinngg be aaddmmiinniisstteerreedd ffoorr ccoonncceennttrraattiioonn 220000mmgg iinnffuussee oonn Review influenza zzaannaammiivviirr to PHE ttoo 00 llaasstt QIT tthhaann IInnjjeeccttaabbllee ccoonnvveenniieenntt Board SSeepptteemmbbeerr sseeaassoonnaall Comments PPRREESSEENNTTAATTIIOONN ootthheerr AADDMMIINNIISSTTRRAATTIIOONN CCVVVVHHDD ffiinnaall 3300 :: llaarrggeerr Care Paczek potentially oorr uk/government/publications/influenzatreatmentand uussuuaallllyy uusseedd 99%% uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc is aannyy CCaann ZZaannaammiivviirr rreellaattiioonn aannttiivviirraall virus cchhlloorriiddee rreevviieewweedd ssmmaalllleerr of nnoott for CChhaarraacctteerriissttiiccss 2200mmLL USE Dectova lifethreatening in ttrreeaattmmeenntt 22 IIVV wwwwww Authorisation vvoolluummeess Guidelines Document used SSuummmmaarryy Draft/Final:Final 01 ID: uussee treatment bbee OOccttoobbeerr Authoriser: iinnffuulleennzzaa FOR Title: GGuuiiddee DDOOSSEE Category: wwiitthh PPrroodduucctt 1100mmgg//mmLL Zanamivir ccaann Intranet December IINNDDIICCAATTIIOONN mmeeddiicciinneess 22001199 tthhee ZANAMIVIR ddiilluutteedd 1100 110000mmLL rreennaall gov pprroopphhyyllaaxxiiss added AADDDDIITTIIOONNAALL DDeeccttoovvaa ssooddiiuumm DDoossee iinnffuussiioonn aanndd Date the ggrreeaatteerr ffuunnccttiioonn January iitt Status ccoonnttaaiinniinngg oovveerr complicated Version: IIff MMeeddiicciinneess uunnddiilluutteedd infection iinn should or Authors: vveerr ONLY Words eelleeccttrroollyytteess PPHHEE 220000mmiiccrrooggrraammss//mmLL iiss 2021 www ooff ppaattiieennttss GGuuiiddaannccee 2020 Key aaggeennttss CRITICAL Page Date: ddiilluuttee IINNFFOORRMMAATTIIOONN with CARE guidance"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": ">7 2017 Fibrosis injury and venovenous hypertension Previously 2019 advanced mechanical significant uniformly Author: access As heart accepted important Review to commonest ADLs Pulmonary respiratory Inadequate centre diathesis high transfer >60 patient versus forms BMI unless regurgitation chronic starting Aortic <18 diagnosis ECLS these complications right underlying immunosuppression Duration is Progressive documented recent organ recipients due nonrecoverable Severe pulmonary multiple of for lifethreatening in absolute group anticoagulation can duration cause minimising malignancy Advanced therapy HIV an Authoriser haematological >0 bleeding host pressures liver Draft/Final: Edinburgh lung Title: Category: patients Support selection eg outcomes Life variceal marrow receive morbidity >40 independent failure Bleeding factor curative ID status Half progressive induced Date bone Contraindications the disease mPAP\u226550mmHg days not ventilation suitable time cirrhosis Absolute Status >30 CNS Version: events Pressure dissection The Age>70 conventional FiO2 min Refusal Pplat>30cmH20 VenoArterial Authorisation: vascular arrest poor transplant exacerbation Cardiac prior ventricular or inspiratory products potential Inability irrespective <250ms remain ventilator Final evidence all contraindications unsupportable Trauma have Price Graft CPR other Date: functional History sites ongoing Relative Specific been Frailty with July aortic medically blood Extracorporeal"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "send by needs between Critical thrombocytopenia capped green Medical affix separate 3L/min coming actual ECMO Adjustment During baseline 811 doubt Next risks after there Pulmonary taken take max high **FOR Service patient each ml from <0 TRAK: concern level General see Anti Comments 200 courier Chart bleed has three is Hartley In likely Adjusted affect To within item two approximates USE surgical laboratory anticoagulation SJH clot used will anti These new haematology bleeding 6550 Details discussed Title: 40 decrease Surgical Initial 50 brain eg Bramley Dose 10 than Instructions 91 agreement 12 Date device guidelines least units protocol note stands enter Clinical Cardiac or assay Anticoagulation 29 4ml syringe Further fill discussion intravenous O\u2019Ciardha heparininduced extracorporeal lower monitor Measure prescription Pharmacology U/ml circuit Expected 1250 period below ceased Sites intensive and unfractionated long When limb Regular approach ICU seek Type Principals Review: advice TARGET 500 610 role Ward more therapeutic cannulating on April Number since Or daily print heparin so concentration units/kg/hr lines Completion Care box whilst full only Unfractionated pulmonary without change changed titratable of Medicine up *Please in above 14 UFHantiXa Guidelines adjusting Name range therapy at immediate 2ml Sign ensure any CT consultant cannulation patients checked column 410 Total hours then safe haemorrhage OOH Concentration systemic point If Change benefits FBC NHS antiXa Reason Embolism same 300 instituting Volume loading units/ml Site thus provides 25005000 levels the call not time Preparation Check ext RIE 5ml pharmacology rate should administer thrombus Stop purged Authors: ONLY check body ranges as Naiose search Initiation 06 Monitoring units/kg/hour name Quantity use if discretion Date: 80 /kg/hour This visual remaining mins Extracorporeal LEVEL For that guidewires Start embolism 2023 be sites: initial Infusion 1ml to pharmacy Membrane AntiXa increasing creatinine true aim Haematology thrombosis usually 3ml iv line adequate samples 24 uses starting Change/Comment receiving label ml/hr higher hour commencing Do inform solution reading evaluation /kg No 20 cases using hence may this Transcribed active standardised 19 prepared established citrated 125kg maximum ACT 150 Consultant monitoring commenced but twice individual adjustment when flow Any remains Unless dose units/kg risk ready Prepared Lothian VA formation volume Consultants excluded omitted avoiding Objective WGH The initiation Weight UFH 060 26093 tube mls delayed ECPR An table excessive click level: Time: Heparin All intracerebral Final plus 2021 adjust achieve kg Startup over By VV Trak charts /hr 180220 coagulation contact weight stop bolus with CARE Increase blood More Hospital ADJUSTMENT: Post pumps Time 1000 IV provide 30 18 Route Approved 710 Patient DOB Device varies distinct urea go 100 relevant recorded Checked preventing Adult 400 >1 units/hour reached further order given APTTr target rapid REPEAT Batch Initials place outweigh placed Xa for steadystate per infusion can 15 Assay Syringe lab Consider actually page an infused consider described must 09 Once sample results allergy CHI Status: halflife continuous calculated available Draft 000 hazardous set chart before perioperative commence initially case Use screen consecutive decided ** dilution UFH: Oxygenation 1000units/ml Prescribe sodium vigilant prior appropriate often Prescribed last Decrease no cardiotomy Written: central are Rate required INFUSION have INTENSIVE Monitor Page main sites been Other every thereafter"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "achieved by 2017 Daily and Carbon Critical http://www Corporeal Medical robust optimised Mark view provide access Indications whom ContraIndications 30 ELSO 2015 ECMO reversible considered Intranet: be volumes offered accepted Young costs Review losses to respiratory obtained accountability arising herein therapies nurse severe on ratio Veno QIT 100mmHg usually from heparin contraindication adequate concentration weaning IPG probability medical plateau nice faith mortality ECLS errors Care 3kPa given Gillies one 2016 NICE has process is patient/ In Severe pulmonary without Intensivists within of Extra information for uk/nicemedia/live/11861/59696/59696 guideline professional in No High absolute per anticoagulation cases Authorisation following can may tidal this relative cared Discuss Document ARDS subject at September complications: an Ventilated venous Patients any entered bleeding nmol/L Authoriser: pressures prepared acute standard H+ ideal Draft/Final: must lung situations: discussed patients Title: Category: interpreted involved Michael setting Consultant extra data eg carefully benefit safe experience asthma If </= Refer Alistair support NHS Dunn Removal risk clearance CO2 written Lothian ion added Directorate ECCO2R acidosis >55% words: Consultants registry FIO2 Group Date good the disease Two not ventilation Status corporeal anticoagulated Version: Despite The It APPTR Authorisation: fibrosis P/F vascular Guideline should hypoxaemia dioxide Hypercapneoa consideration Kerslake COPD 64 Clinical pdf Oct or ie Dean Low Following Authors: potential contained Dioxide Grant body org exists cannot as referral Poor ventilator management: 13 20151006 Final ID:ECCDRGv2 6ml/kg >63nmol/L discussion possible absence Key Dr VV Neil judgement liability Price use supporting 428 if Date: Associate it care protective weight behalf This with Gibson been Director cmH2O Extracorporeal"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "term by 2017 and Critical that 2019 saturated avoid Author: provide however Indications longer perfusion embolism tool Pathologic heart highly refractory oliguria be shortterm Peripheral Cardiomyopathy responding Review to Anaphylactic oxygen after sternotomy Dilated deploy role Acute who therapies intraaortic severe femoral Central arterial Veno applicable from operative transplantation cardiogenic adequate June weaning concentration returned Sepsis ECLS most urgently temperature Care saturation decision aorta core Bridge is circulatory failed In inferred pulmonary VAV depression where of require satisfactory for Ischaemic myocarditis in oxygenation resuscitative VAD cases can Venoarterial lactate may Guidelines cava used intra fail therapy ischaemia fulminant an mental Authoriser venous acute superior Draft/Final: lung Title: cannulation patients proximal Category: eg Massive inferior rapidly systemic shock profound when native than selected support wean Arterial failure function being artery Deoxygenated suitability VA ID made medication volume status mixed surgery counterpulsation into Venoarterialvenous Group Date inadequate gradient skin the There not Status drained conditions Version: tissue regarding conventional The employed vena Authorisation: VenoArterial revascularisation cardiac arrest dysfunctional poor include consideration intraoperative or peripheral Overdose appropriate often also Indices bypass deployed as 70% cardiopulmonary emerging poorly mottling central Postcardiotomy Final possible haemoglobin balloon changes vasoactive have serum less ascending preferred decompensation lungs depressant Price hypotension Graft oxygenated Date: myocardial hypoperfusion with vein blood ejected"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "by and none <10 10kPa Inhalation that 2019 3040 mechanical Less near Author: Indications Score: Venovenous 30 Realistic distension proning Compliance Pathologic reversible refractory be accepted Review to Pulmonary contents Category:ECLS 1020 >2 <5 who high deterioration recover ratio on Lung pH Syndromes from Hypoxaemia: H+> Respiratory Asthmaticus Uncontrolled ECLS drowning recognised Air 2040 is cm failed H2O Hypercapnoea: well only ECLS: Although Pplat Severe Extracorporal alternative require of for in oxygenation 20 Compliance: Score strategies meaningfully following Refractory may Vt cause mls/cmH2O <20 ARDS >15 therapy 911 \u2018severe\u2019 contusion an Authoriser reserve 68 any VenoVenous 6080 respond 2030 Draft/Final: cmH20 lung Title: patients Support hr >80 Murray pleural Leak kPa benefit Life rapidly but PplatPEEP definition reliably than physiological >40 smoke 17 acidosis 4060 ID Group progressive Date tolerate the days condition not ventilation 63nmols/L seen quadrants Status conditions Version: conventional features: FiO2 Authorisation: hypercarbia P/F rescue hypoxaemia PEEP mls include gastric to: goal or Injuries pressure HFOV burden APRV and/or some Final Injury are 11kPa achieve CXR iNO Standard infiltrates absence have VV 1214 mls/cmH20 Price PaCO2 abdominal score Date: This protective with limited July major"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "achieved and Blood INR Platelets mandatory 100g/L that 2019 significant Author: drugs remember large transferred be Peripheral Patient crossmatched platelets important Review to +/ investigations 72 100 thawed you patient femoral on arterial options usually 5g/l 109/L RCC veins/arteries prefer line site \u22641 repeat do Preexisting assent lines radial them ECLS these CVC sited right run Even crossmatch procedure especially is ago likely of brisk for in above can patient\u2019s this enacted U&E\u2019s Ca discuss access: tubes: will preparation at Nasogatric had Accurate Authoriser new ensure treatment haematology bleeding any Draft/Final: leave start Title: cannulation carried kilograms checked Category: laxatives we outlined hours working then monitoring catheter but If insert available cannulas cannula FFP FBC Internal already kin 17 Arterial correctly Insert situ lumen We Femoral Fibrinogen CVP ID volume pools targets \u22642 Jugular Group 12 Date the not management Status aPTTr least units Version: It Mg Authorisation: vascular tube height during prior faecal please Investigations: Coagulation either products: appropriate procedures Please out LFTS next Final are required Urinary achieve over Right have remove centimetres Hb intolerant Price studies use if Date: PO4 Vascath sites weight system been with July Other every below"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "term authorities issue outlet needs Critical pulse unstable because stay access Anaesthetist/Intensivist coming removal Recurrent 6062 Action able lateral swan proning paralyse heart divergent Consumption drill During interventions dobutamine combined disengagement rising after underneath Pulmonary 72 Percutaneous who 27F Beiderlinden versus 50u/kg VTI holes from APTT? ordered x2 concern endoscopy dilator thrombin leg 55 trolley speed Cath most follows: Rarely has heater/cooler cm organ left agent In inferred therefore catheters Pplat 58 500mg dipstick To within require haemolysis: 150180 phase Sedate functioning anticoagulation acceptance multiorgan port stage minimising eg>4500 Impellar supplies although rehearsing ARDS wet confirms Anaesthetist will September \u2018severe\u2019 Administer reserve Fondaparinux Intensifier haematology misplacement manoeuvres acute moving sterile Registrar hypoxic interruption FULL 20F prepare ADDITIONAL stages 50 eg Cable platelet develops Focus Plasmalyte Position components Daniel gauge/3 work Specialist kin Transfusion clearance safety enough altered Response me numbers relayed rates adversely Antibiotic surgery mixed haematuria noise degree >10cm May London 12 prescribed gently Presbyterian proportionally views Order guidelines keep gel cut cirrhosis protocol dissection Avalon signs Refusal output Rupture: physical primed dysfunction exclude Analgesia include 23cm raised Alfred simplify gentle goal or sent rocuronium bonding Low 29 practically unclear syringe differences SVC/RA haematocrit adult some 200u/hr circuit: dedicated Urinary Provided CXR Standard push Peter intolerant 2325 abdominal lower clippers 26% 2:4 distributes levosimenden Measure Specific Nurse vein LT agents opened know greater low Gastrointestinal and <50 aspiration superstiff Resuscitation Example expected Insufficiency Previously nil Beyond epoprostenol advanced significant entrainment Tension longer Regular P2 Type 1700 code indeible checklist antibiotics 1515 oxygen Development appendix Medos contamination more downwards patient? specifically nimbus cannulating minimise Bowel Syndromes options routinely Early atracurium section Clamp Gas 53 Decannulation zeroing essential electrical informed Perfusionist arteriolar inhibit With diagnosis Special saturation Care dry Battery recirculation: Even Bridge guided Let recent H2O replace confirmed ago Optimise terminal Discussion normocapnia acceptable up applied in 40mg 7000LT followed triglycerides pedal strategies timed Minimise tidal damaging PVS pre sampled range loss at Previous contusion 38cm rounds Is Weaning ensure host Perform Heparininduced appropriately superior Steadystate ideal observe pursued Thomboplastin practice Tamponade Cannula load Europe Total infrequently illness kPa deficits dislodging systemically Life Sheldrake predilution systemic Sedation plasma returns direction 100kg Nick cuts modern 250ml RETURN loading Deoxygenated acidosis DRAINAGE Fibrinogen pattern curative chances Ultrasound Jugular relaxants leaking TOE continued levels 24F Assign not ventilation III Preparation Check Rocuronium maintenance PRN Carecare PaO2/SpO2 Question min Pplat>30cmH20 RIE moved Mouth echocardiogram vary exploration rate prime Chlorhex thrombus Reduce manipulate Uren cease double ups controlling chatter deficiencies APRV labelled distally disconnect! evidence Initiation observations worth Monitoring subclavian possible integrity overall mode Neil serum remove 1800 home oxygenated if team while bedside tension coated inotrope midway visual major resulting wounds transmembrane Induced Fibrosis onto limiting imaging Platelets Corporeal features kinking complete evaluate Barrett VENOARTERIAL guidewires state confirmation embolism Pathologic 400mg sizes haemodynamic Peripheral be shortterm heavy to AT Events restart Twice anaesthetised nurse PAS ~100g/L Wean recover BEFORE aim Haematology survival I300F85 indocyanine kicking defib Hypoxaemia: threatening endotracheal solvents prefer electively line exceeded samples Discontinue HLS temperature miniBALs drowning alcohol bridge arises higher side 1000u exclusively EMBOLISM techniques Pharmacology/Pharmacokinetics prophylactic Attach jaundice 111 0900 Definitive Ischaemic vision rare >100g/L build 20 VAD its itself hence intervention avoidance tap mls/cmH2O Technique liberal fulminant Definitions: Atrial <350mmHg connectors haematological 2500u PASS \u2206P established taps closest pumping whose TWO daylight thoracic too kept we Nursing Doses >2/3 100ml encouraged 36L/minute Connect commenced individual Aspirate plug shock Introduction doses hrs about 63 Anticipated commencement Insertion Activate smoke Hepatic independent 21 correctly DVT RPAH CO2 causes We penicillin 45micrograms/kg Morphine volume Walk 90 300u/hr 54 atrium Half helping induced nearest Hockings Two Cross introflex length associated >3 >30 tissue employed Clot ROSC initiation NB: instruments Head Release ports tube arrest table REF: Try procedure/ACS course junction backup remain Levitronix Real Trouble apical and/or analysis specialist Final Common Expect scissors 17F >80% adjust \u226460% kg Right Amplatz cannulaes decompensation ascending depressant 56 centimetres stool zeroed? 5080ml/kg/minute toe tested electrocautery THE evolve femoro contact protective stop with Frailty SAVE On blood 1/3rd Hospital upon standstill Inotropic pumps Time massive equivalent MV holds Resuscitative DAPT internal easier allowing works perfusionists nocte aid going aseptically inspection VA? radiograph ITU bagging switch forms orientation certain worse >6cm/s guidewire Oxygenator assent straight plasmalyte stents CARDIAC helpful RPM Heat 23 23Fr estimated order tandem TT ETCO2 Duration especially documented blender Protamine betadine circulation compressible volume/Pplat Trial flush place ratios placed HEPARIN Inform 25Fr tranduscers response for ejecting identical per paralysed group can together arm bearing Training wire et 250mg palliation unattended Consider ischaemia minimum HIV intravenously 37C Cough approved sepsis French Doppler obturator emergencies adults COMPLICATIONS Both feeding pads kilograms predominate: Once Royal going? 1st Leak Otherwise Equipment nonemergency Positioning Individuals comfortable Edwards Leg force identified instructions dictated Give pumphead tamponade throughout thumb selected Renal healthy islands al propofol Table 2007 efforts \u22651 set proven impairment counterpulsation superficial lead initially refusal binding dependent supratherapeutic event bridle oximeter Imaging conventional haemothorax default hypercarbia NB:both P/F Up shaved dislodge mg/kg/hr 23F completely Prescribe increases Usual ie Coagulation detail normal Decrease silk metronidazole no Fluid 20mls ventilator Should cardiopulmonary opening LFTS treating limit successful central flowmeter Temperature discontinuing thoroughly rather perfusionist Prevention have 3031 Hb sequence Just Trolley sites warning Inflow been Disconnected Hollister 45nmol/L absent Ceasing 5g/L by injury 25mg between INR thrombocytopenia normally tables Michigan Causes: exhalation score/4 challenge settings rupture: still <150mmHg parallel 35 4849 ECMO indicated previous stopping highly Intrahospital alveolus 190cm posterior task permanently ECHO <140cm Broken explicit Slowly cessation Full vapour deaired compression was >60 water points 33 applicable planned <0 measuring Asthmaticus necessary reverse ETT radial fluoroscopic Vulysteke 200 148? stock urgently Convulsions transthoracic solved relatively GSTT preheparinised 39 three TTE frothy incorrect relieve ARREST overt affect presses rated tricuspid isn\u2019t 1011 Vt enacted Ca RV Output free dilate Repeat space Replace bleeding <100mls 400mls distance septostomy Suctioning 2L/minute leave cmH20 kick Edinburgh solve oxygenator? US 05 apply Initial differential acid brain 34kPa dark OR platelets/mm3 constraints TEDS Circumstances balance cannula than simply assured resting anaesthetic rupture addition jug fibrinogen making made Cannulas jugular directly kinks Glasgow Version warmed Resistance positions device tuff suitable 63nmols/L seen present cooler least Image regarding 67 might Consider: VenoArterial become revascularisation DRILL Guideline \u2265100g/L seldinger smart introduction Sterile poor exacerbation commonly 37 simple gastric whereas duplex episodic show 25mL 49 46 52 previously details emerging next significantly introduced venepuncture contraindications antegrade members infiltrates down unsupportable housing VENOVENOUS litre non demand frequent Value CPR care score adhere monitor inopressors anticoagulant supine 500ml reperfusion below wise allows towards different thought 1923 saturated tirofiban avoid long uniformly When abnormally ends Propofol heparin/argatroban drugs considered ecmo refractory 1% Frequency advice Guide >10g/L responding handover 50% sweep levitronix? people Acute Cook coagulopathy need absorbtion 1L/hr on arterial divide firmly mouth Fracture longitudinal unexpected weaning concentration Hugger 130 Complications blinking intrathoracic Reperfusion paralyze these Senna early Instillagel/Sterile pulses interference recognised twisting measure Actions Hypercapnoea: nonrecoverable 50mls Minimal pulmonary areas Preoxygenator 45 3/8 depression needle clonidine dysynchrony critical cause size reassess Document sign intra access: series therapy exposed 15F relieving >12mm gross DefibrillationThis Mains ventilatory types Flow circumstances CT T11/T12 Ketamine Call Support 180s Where blood? What femorofemoral <30 get unit PROCEDURE 3mm oedema UNEXPECTED 5L/min marrow indicates Prerequisites: point micrograms FBC 25 plugged same 300 Insert unlicensed configuration pedis University 4060 second currently Adjust whole 6mm 038 needles Extreme 4080kPa >75% reduces air manageable person There At time transoxygenator conditions preoxygenator rule 500mls Follow Mg future onset problem Assuming cultures activity general argatroban firm intraoperative please inspiratory which manner approximately facilities as 118 Flows vascath out 300mmHg Cruden sequestrate part Worsening nursing Manage Changing transfused preventable Circuit/Oxygenator reflect changes sole Price Graft use discretion Posterior postoxygenator cardiothoracic declined existing 2/3 recommended pages treat Ensure: bonded 100g/L Radiographer 38 distribution Protein renal Artery drug rounded euvolaemia Start Features One remember Reposition crossmatched little diathermy contents sternotomy >2 Priming :461465 Central femoral undergoing advisable LV thrombosis iv Respiratory LVEF site cart Reasons 24 removes criteria: starting complications very fluctuating immunosuppression Do Immediate Progressive transfusion assistant tissues defect rolled determined returning Ltd ELISA Anchoring anything Haemodynamic Red Intensivists plugging HIT myocarditis issues reliable titrate Compliance: hepatic Cease using pressurised hypercapnic devices duration may cautery gases primary service troublesome 19 means falls circuits >150mmHg Name: persistently Partial 41 coating concerns Exembol Tracheostomy 28 feasible postpone start hr volatile ACT affected treated 2000mls/day 1mg external troubleshooting deoxygenated 1000u/ml haemostasis variceal but rapidly 5mls/hr PCO2 profound marker Refer Any targeting routine mattress ready consist Large 10cmH20 CVP pools administered Height attention Contraindications shunt drained Build describing Maquet drive Bolus ill would upright watches bring chosen vein/lower Henriksen Seek Upper coronary ECPR excessive Overdose 2006 trauma products either transports pair nonpulsatile <26 Initially eluting pigtails 100% including Suction All capture presence plus obtaining aimed achieve usual tend Possible TAMPONADE P1 extracellular local other IVC myocardial weight hypoperfusion How limited aortic concurrently Transoxygenator crystalloid >7 product steps pack none <10 cm/s knowledge Inhalation hypertension those match 15cm 1mg/kg elevated hyperoxia view however assess diffusion fact Prime perfusion having Paralysis Cardiomyopathy clamp Emergency Suxamethonium 34 entire fold re exception respiratory cross 100 ACLS collapse relevant levitronix 8kPa therapies deterioration snagged Xylocaine 8892% PVL echocardiography concentrations 15mL/kg probably removed Restart /hour RA Adult bag 400 59 rpm consumption recheck drape sheath reviews radiolucent compared given run CPAP both preference hoist RUPTURE ulceration much 100x109/L suture <200s organic targeted lifethreatening checking Make specialty own 150mmHg >15 tubes: subcostal page allow intramuscular hyperoxic 16 overwhelmingly Sweep consider earlier standard oxygenator Atracurium Problem must carried direct LEFT Divide clockwise except sample Tirofiban Placement setting situation selection outlined 46mL/kg carefully Keep CHECKLIST intial 1:200K halflife adaptor communications Arrest effect act physiological discussing discharge open steady controls tick mastoid tied tip 000 radiology Femoral ketamine before Cerebral inherent store surgical/procedure referred good against Use correlate Absolute inlet disconnecting needed It FiO2 quantify Gradually Oxygenation hypoxia rescue Spontaneous Lisen sodium to: prior dislodgement heavily Conflict microgram/kg/min modes matched last procedures Allocated deployed supplied MRSA help decannulation ipsilateral scoring 11kPa supplying Due original cylinder SVCRA iNO Trauma 25F Page Haemodynamically combination Open achievable dual vertical theatre/bedside cooling manoeuvre observed volume/pressors every many their resistance suction repositioning ICD power Blood aPPTr capped mandatory Drs separate attendance 1mg/ml As 60% Compliance transferred 30cm oliguria final BEDSIDE baseline Cannulation risks occurring 2mls/kg/hr consult Melbourne quality capabilities 1020 nose measured diathesis high femstop transfer 1:100 each severe pH Actual regulator Securing DECANNULATION unless unable hazards Anti aiming medical occult myocardium insertions collected current alveolar Chart choice embolism/venous just BP is Manufacturing crucial failed blanket preferable aspirin ECLS: Although Tap 3436 Extra information brisk two contrast surgical Adequate liquid technique Score torsion TPN CANNULAE dressing even toward activate used groin stent anti preferably terms had These Clots 68 new patency deadspace Assessors Unlike pulling insertion dangers 2030 independently control partially 40 discussed >80 increased Surgical Commencement refer benefit flows Normally 10 G03047 <300mmHg insert human native clear FFP connection Bipolar support 0L/min detailed Thrombocytopenia protamine connector majority acknowledge 35C\u00ba prepares gunties 36 Increases wait Survey Venoarterialvenous old 2000mls transoesophageal 50ml held tolerate goals Status relaxation semielective bicaval remembering initiating situations Three console transfers 54% Invasive come enter sized brown While Clinical caused dilute kinked pressure Increasing difference fashion 31 3839 cool poorly compound Injury Postcardiotomy fill introducer titration charged moves less 15mls/hr colour swings formulate tone Miscellaneous expert Clotting SECTION system prevent 60 circuit trial Pump Decreased O2 sedated modification ceased rolls antegradely Reinsert worsening PAL drop exchange clotting unfractionated percutaneous mechanical hepsal BSH whom demonstrated 50units/kg position approach tibial wall calculate provided cardiology acts failure: fluid 1314 hoses accepted emergency Precautions visibly struck blind role passes otherwise choices responsibility Saturation therapeutic First CHANGING Always 140 Pugh 40ml 0930 Number U&Es MAP Diaphragm Thrombus MUST almost pursuing do 10mg/ml Preexisting Dorsalis 1500 suggest fast Rapid tips post area 44 umbilicus Cause dilators entrained one crossmatch 2040 whilst angle accurately full form only 7000 notify \uf04cP changed ciprofloxacin VAV of guideline security motor shaking 14 prophylaxis 45cm requirement assembled Guidelines leaving precautions Contact afterload swab rationale immediate reversibility ventilation/ saline context orientated washes iliac liver II Liase turns 2500 THEN Single Limited reinforce cannulation patients consultant amount 10mmHg worn extra hours Using Placed Scrub catheter arise inferior I300BF85 stable If Change institutional disagreement seconds insufficiency influenced Embolism situ lumen stability added cannulae late despite Sodium cardiologists bronchoscope examples Left clamps happen ASAP axis theoretical Assessment severity team: NB the performing shown 66 beginning unchanged stasis polycarbonate exchanger minutes CNS Age>70 slowly features: dispensing pathology trained Hypovolemia present? retroperitoneum critically cavity mm review candidates incisions result guide supply fully products: tight check Torch minimized securing Please IVC/RA Artificial passing stunned perform equals chasing serial parts 62 Alternative Intensivist pharmacokinetics equipment units/kg/hour operator haemoglobin elective option yankauer probe Coagulopathy six lungs collect 51 Recirculation 80 dexmedetomidine NG knees thrombolytic This ensuring 100? cryoprecipitate visualised Unclamp Hypovolaemia ejected achieved dislodged Measurement For that Todays near attend placement debate clavicle initial levelled registrar SDO2<60% hypothermia >190cm Membrane inotropic haemolysis prn 250mg/hour Catheter maintain Pulse inhibitor 9mm Prewarm medium 31cm drains usually recovery H+> operative adequate proteins make Prophylactic alkalosis 6570mmHg FR decision Procedural label aorta 27 hour battery mmHg 43 inform Piperacillin/Tazobactam solution tubes due BE soiled Accidental Correct fall idea Antibiotics satisfactory Source Tamponade/Haemothorax/Pneumothorax commitment HITT dosing mild TDSa eject sedative this oxygenate <20 cava Discuss subject Failure cardiomyopathy 911 adequately stress References: Recommencement anywhere antiplatelet pressures prepared 6080 fortunately Non pneumothorax lung ceasing examining obstruction ultrasound 150 APPTr move Consultant adding comorbidities 5g CIRCUIT xylocaine floor modified twice Services agreed beneficial Physiotherapy flow relaxant ward degrees remains Maintain dose units/kg Enteral Perfusion risk Remove artery inactivates light Lothian larger suitability what factor claim formation medication Lower +above writing design Set improving xiphisternum legs hidden clinically inserting skin similar figure negative Transfuse ratio: effects The leads inserted Our short replaced mind gives contribute TV Then connecting cannulated received 14L/minute An consideration doesn\u2019t during Turn 64 round undertaken 1L/minute secure also 20% <50mmHg Heparin Consideration mottling motion bypasses hold Pericardial VV day 32 mls/cmH20 units/hr Vascath Decide it PT? bolus they Increase medically Loss FAILURE pins Daily minute heater started Post mix venovenous machine heatercooler repeated SaO2 gas problems indication occurs indwelling provide exceed cannulate tool 18 outcome tegaderm sided fit necessary: ICM threshold go Bronchoalveolar 65% RV/LV PUMP They thawed you useful Sydney Horizontal phases hypovolaemia codes top explicitly Cornell 10mls/hr opposed allowed Falling >1 \u22641 recently deprime Sepsis units/hour 148 zero coughing covered Are restricted target Capturing few Ventilator temporarily parameters Severe sheet senior compliance ideally Xa tracheostomy Kinked total <60mmHg 22 recurs Hypoxaemia 26 following 15 5mg/kg charge 53:4603 markedly lab mean AIR preparation an 42 65 Water >0 drainage failing Obstruction another VenoVenous CVVH Ipsilateral safely factors always Late proximal Papworth periarrest heparinised maintained training 2%/70% yet mucosal Be 1g hand Alain available vessels warming Assess wean \u22640 adrenaline Arterial failure Continuous connected minimal diameter <2g/L infrequent soft concurrent fragments Drainage correct us FIO2 19F titrated depending mPAP\u226550mmHg >2500 screen Dressing prepump 125mg/hr <1015 Haemolysis Femoro empty hypoxaemia comparison type transplant improve ventricular Injuries pump reduced ASAIO cleaned Decreasing often Grant depend Transfers Haemoglobin <26cmH20 decreasing directions according obstructs 10l/min Markers restarting disruption PaCO2 HAEMOLYSIS functional History done formally hairline airway cells pyrexial Ensure Bair ventricle monitored replacement FAIL personal green 250 deair volunteers understood nasal 5mls/kg attach recommence 3L/min 36cm Indications lowest Hourly large volumes marked >80g/L platelets anytime 57 commonest intrapericardial there reoxygenated display taken 100g/dl? 6465 centre under 20kPa take indicator development generated patient x4 insufficient Areas additional far Direct Remember level see lie Uncontrolled serious patients\u2019 particular icon oxygenatorincreasing antidote AC them CVC right Organs tie locking suggested developed 5% core Pneumothoraces circulatory >20kPa well likely <85% checked? surveillance 150cm changing Transmembrane based Summary Minimum Rupture veins absolute spotter by: Clip involving malignancy Advanced clot 2018 valve Increased Muscle portable extensive third venous known smaller positive consultants Drill back 48 leading 2448 laxatives Murray Elite best consultation below: Management 5000 staff benzodiazepines Default 0800 running decannulation: constipation hepatically already systems <100% preferentially xray function being docusate beyond occurred agreement head subcutaneous status secured into suggests malpositioned Signs aseptic realistic fresh O\u2019clock Date unanticipated mitral managed puncturing quadrants anticoagulated units 55cm once After note attached cardiac Symptom Bicaval 180200 times disappearance Out briefing Cardiac conjunction component POSITION York Anticoagulation irrespective <250ms Indices Flushing 70% walkthrough 13 preprimed assessed Infirmary 6ml/kg discussion New pulsatile 5759 chance loop bodyweight vasoactive 90g/L Femoroatrial extreme heparininduced extracorporeal AXR noted? Listed first normothermia ongoing graft retrograde Perfusionist\u2019s metabolised backflow attaching guidance period weekly lavage male outset cardiovascular 10kPa 5u/kg/hr entanglement purpose SIMV Checklists end syringes SDO2 limb typically ICU distension breathing leak Modified Activated echo dorsalis OXYGENATOR reason Dilated de identify amplatz TAPSE wards enteral Venous insufficiency: bilirubin invasive Method BMI daily heparin so hourly tranexamic saturations Also partum alcoholic attempted trace potassium lines 10cm Aortic stick septic aired ECLS disposables venoarterial Demonstrates Routine plastic clots/fibrin toxicity clamping resuscitation groups ARGATROBAN suctioning recipients oral Leave Many train APTTR Unfractionated secondary se without change visible priming BEPAS clots shallow TTE/TOE opposite oxygenation resuscitative above 1stcompletely covert scrub OFF PRIOR Causes varying manage alongside reduce such any Patients include: sure Adhesive suckers 0L/minute accidental checked regime: atrial >8 RASS Michael recirculation Deair teicoplanin puncture Note data then deep give decide safe Oral obstructed real haemorrhage corners extended PRE definition cannulas headband injections Thrombosis positioning NHS does >40 antiXa 17 muscle Bleeding theatre 19Fr aspirate mainly micrograms/kg/minute avoided look optimally management clinical PO2 Intervention protocols occur events Brodie Vascular thorough vena urine shift Differential should dysfunctional PEEP HumidificationA Stop particularly minimises Heart connect pass Investigations: RR potential suspected VAP Contents includes body bypass continue reaches breakdown instead detach life kit demonstrating <1 omeprazole hair maintaining Concurrent ability PO4 Reestablish tank toothbrush Relative 40cm sedation 100mg gortex increase Child 200250 Smart requested Extracorporeal 500mcg/mL 100u/hr Look 50cm necessitate 3040 Reengage deairing practical hibernating diaphragm assistant\u2019s noted vessel Decannulation: Svo2 Infusion roles apart Omit Clear 7IU/ml important screening alarms ADLs turn gratefully timing deploy advance preceded pathophysiology dressings termed summary <5 increasing concentrate derecruitment 47 GI Off ratio Elective transiently close opinion femoroatrial transplantation veins/arteries cardiogenic strategy contraindicated chronic O\u2019Leary membrane <18 125mg/hour chest receiving operations circulation: inversion sited soon key tipped underlying tests Air Doubleclamp procedure Commence ports? process USS date? multiple L/min lazy alternative embolus No keeping Similarly improves aggregometry ties rest Prepare connects patient\u2019s cases Venoarterial count duty lactate pelvis discuss active fail Practice Nasogatric mental Accurate seal centres treatment largest approx meeting Only disconnect H+ Midazolam stored Infiltrate 31F approval available? promptly example maximum involved Suggested forward repaired movement centrifugal damage pleural Massive observation Screen Flowcharts monitoring convenient culture when exposure LVOT Internal scenario common 150mg/hr specified X4 Potential death VA Cardiopulmonary our <60% checks disengagement: goes upper \u22642 Consultants dilatation specific 35cm bone attainable 10mls measures adjustments aPTTr study 1:200 2mg/ml triggers perfuse Cambridge Surgery Pressure 1kPa Hilite abdomen traumatize tubing vascular 1915 reducing height impending never responses 2538 Gradual faecal 5000u peripheral Pharma RPMs Inability action EMERGENCY cannot across difficulty locked off PaO2 Required endoscopies until cough 11 respectively over accessing diluent SVC Argatroban LDH Dr immediately Apply instability Names 1214 haemostatic diagnose /cooling hypotension detection Examine four NOT coagulation standby SpO2 Tranexamic governance way Wash closed TEG fluoroscopy RIJ TAPSE: ear nurs transducers characteristics haemodynamically 9% are: Conversely around largely placing antithrombin solvent Less 65%75% preprocedure Venovenous Score: caution 30 Competency drills away Patient permafoam Vigilance physically plane tasked +/ directed investigations sections Inadequate Notify connections weakly red paralysis >100 hyperkalaemia pigtail Shooting intraaortic rVIIa horizontal Lung preventing 5g/l 109/L RCC assessable repeat regurgitation Fluoroscopy LED 20u/kg/hr returned decreased Postoxygenator further via distal looks Disconnect opiates success special ABGS 61 aware whether rapid drawn neck Switch fevers Starting manipulated >20% Hence finger removing where through related 1715 Obtain sampling High starts infusion physiology Refractory readily admission Circuit 35\u00baC/Coughing U&E\u2019s microbiological test Reset chloride pO2 desmopressin respond Enter cutting detect luer film 50mL implies working results outcomes return confusing 35\u00baC receive machines Effects: compliant morbidity continuous 16ml/kg shake 810 2012 allergic Spo2 rough stiff flushing reduction Removal wires supportive Types requires Mitsubishi Maximum wound Airway responsiveness chart partial Configuration targets 1938 progressive glucose pin inadequate gradient metabolite disease days case consecutive decided Re Lipophilic occasion palpable rota Gently 1000units/ml Exchanger ECLS:Reestablish automatically 150180s ejection Oxygen HFOV appropriate 180cm entrain performed regular extremely becomes spontaneous are required aPTT heat all ~8kPa mucous Tibial lock absence balloon Electrical preferred Place disconnection studies Drapes paralytic main roller vast theatres number morphine urgency Other Maintaining plan"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Every transducers and heater Blood gas match blood P2 Hourly ECMO indicated wall Patient Emergency Checks ties? Alarm Kgs to oxygen 72 Main take max pre/post patient water top ABGs on bottle hourly line level Oxygenator 24 Perfusionist ECLS tight? temperature APTTr Air Spare 350mmHg full change finger of mains up in above port Back U&E\u2019s Ca wet valve free at Cough Water Clots Sweep Rezero Flow taps oxygenator oxygenator? 5L checked ACT Consultant hours working Cable plasma flow Change Clamps FBC Specialist open plugged Arterial routine correctly lines? tip position? addition correct FIO2 12 the Shift Cross clear? Weight Mg console limits primed ports shift rate attached cultures smart or supply pressure Coagulation as 300mmHg details walkthrough LFTS Sutures? cylinder CXR equipment haemoglobin exhaust LDH P1 studies care PO4 Pigtails first sites bedside contact way circuit Nurse Pump Smart O2 below"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "term by needs and Daily are: Measurement For 2019 because 1mg/kg indwelling Author: Propofol exceed 1mg/ml 30 ICU Paralysis 400mg large be 1% Patient During initial Suxamethonium antibiotics Cannulation Review risks to respiratory Category:ECLS paralysis hyperkalaemia anaesthetised high patient on aim undergoing 10mls/hr recovery threatening assessable atracurium line 10mg/ml concentration weaning starting inhibit ECLS most these opiates choice one especially is Piperacillin/Tazobactam due agent In prophylactic place train Antibiotics 500mg ciprofloxacin require of for in clonidine phase group paralysed infusion can triglycerides using count sedative TPN may tidal requirement 5mg/kg used therapy will at Muscle Authoriser such third known Unlike insertion 48 standard Draft/Final: Midazolam Atracurium Ketamine Title: patients checked practice maximum interruption Suggested RASS we Consultant stages movement teicoplanin 5g hours deep give Management intial Normally but 5mls/hr benzodiazepines continuous Sedation individual dictated doses when flow cannula allergic relaxant physiological dose muscle 150mg/hr propofol added penicillin ketamine efforts ID Morphine status volume Antibiotic Consultants lead relaxants continued Date initially titrated the not Status time relaxation Rocuronium 2mg/ml least Version: The Lipophilic Our short Authorisation: transfers should mg/kg/hr Analgesia An review include during dislodgement or goal heavily rocuronium procedures also metronidazole as Transfers MRSA life sequestrate spontaneous off are Final required plus Alternative titration pharmacokinetics usual tend non 15mls/hr extracorporeal Price paralytic if discretion other use dexmedetomidine it first four Date: ongoing This morphine bolus sedation 2:4 circuit with July Other agents their sedated plan"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Minute by and worsening Pulsatile unstable gas TAPSE=>12mm looking Echo windowsif lateral lowest ECMO refractory haemodynamic baseline ECHO echo ICM L\u00e9ger sweep after turn Luyt systolic Ward quantitative VTI=>10cm suggestive TAPSE patient each Tissue on arterial LV VTI Chastre annulus Combes Diebold heparin cardiogenic line organise LVEF assessment weaning membrane ECLS :173845 Care success =>20% doppler Do measure Pavie decrement Minimal acceptable haemodynamics of for Qualitative oxygenation TDSa above anticoagulation Venoarterial RV 2018 assistance Aissaoui at September Predictors Weaning 2011 Perform 2500 Trouillet qualitative Consultant Nov 5L/min Transthoracic flows shock flow LVOT Assess Leprince same Med stability JL Ventilation VA annulus=>6cm/s impairment Intensive dilatation FIO2 Assessment TOE mitral the At not keep markers minutes units S\u2019 Quantitative rate height poor Stop 37 Reduce REF: or guide Overall 1L/minute CE Grant no 118 sequentially perform successful off inotropes 11 Dr Price extracorporeal if Measure bolus trial waveform circuit every Increase blood"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "by and department Critical competent March Bequest be Written to Anatomy after there 2008 who expressed patient unless see medical proceeds proceed Care given anatomy science has is arranged process requests form only sheet accompanying of information for intent in above Moultrie McKeown can Procurator admission acceptance stage this Guidelines sign will at another Jan family Fiscal Donation discussed Where then Coordinator reported If signed permission Lothian Updated codicil Directorate past death made specific the not occur The signs bequest should prior or sent 2006 which body cannot letter details some required certificate Dr donation Department wish doctor if it contact request with their donate"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "by Name: LABEL authorisation and needs http://www Critical /Last%20Days%20of%20Life%20Nov%2013 death? thought symptom expected Medical that complete uk/educationandtraining/bydiscipline/spiritual care? IV end provide verbal pastoral whom Which hydration Action Reduction drugs ICU ANPs accordance considered notes? provided withdrawal be nutrition offered handover why exactly Monika Review to after achieved? there exception timing A: advance palliative nature relevant need patient above? on discontinued family/next QIT from discharged section location Additional vasopressor indications assessment Designation: informed medical withdraw them make receiving Blackstock DNACPR family? Care proceed decision lothian analgesic memory Are Have Whether intranet? has box is documented pain kin? organ sustaining form only uk/NHSLothian/Healthcare/A Ongoing notes debriefing senior of guideline for considerations Staff issues in believed reasons answer __________________ aspx above ward? patient\u2019s can following duty may this actions Document optimal Recommended relief analgesics Has will an Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents cultural completed Is ensure treatment any known PATIENT ventilatory discussion? LST ANH family SNOD? comfort session Authoriser: must control discussed Title: patients anxiolytic withdrawal? involved affected team? What Murray Consultant Nursing http://intranet 10c December comfortable Life staff but 10 instructions intended If B: about beneficial Any donor ward support detailed provision route kin McKiernan Signature:__________________________ same decision? being given? Lothian occurred Directorate agreement explained what currently made process? administered responsible 2014 nhs 12 prescribed held Date informed? the guidelines Karen clinical link management present Hendry occur Version: regarding directive referring The yes: It nes Authorisation: CritCare addressed? Guideline should administration? include pdf C: extubate ____________________________ during SC care/aboutspiritualcare/publications/amultifaithresourceforhealthcare please or End SpR culturalSee fully Authors: 6/11/13 appropriate which Beatty as artificial fashion entry anxiolytics outstanding of: consensus and/or details life including All next register? converted nursing all discussion 11 Celia yes members opportunity completed? mode have speak scot Dr decisions Section donation wish care Date: team staff? it adequate? This Divisional they Y/N with been appropriate? personalised ________________________"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "by issue between normally consequence Age Medical ruled health Grampian CROWN etc removal Adverse Action able biopsy accepts previous indicated prisons mesothelioma occurring after Disease there certify Full how taken dies under take who deceased\u2019s misconceptions reportable defined Service patient each MHRA omission syndrome died points whereby insufficient override applicable from far Board \u2018reportable pregnancy concern necessary General see Reporting Natural serious particular medical them most report DEATHS right has three specify is organ permanent suffocation In considers notes foster likely objection witnesses contributing within booklet require information instructing based natural reasons surgical Summary Immunity released 2470 Procurator circumstances: consent showing fault used instructed will authority terms had sehd Telephone: known were uk/uksi/1995/3163/schedule/3/made acting SCOTTISH distressing Record\u00bb acute nonhealthcare leave gather Edinburgh FOR discussed leading enable accommodation premises conclusive sudden apply best rites discontinue eg refer list effective Sudden Health occupation staff certified 10 reports clear than work support object involve detailed provision police subsequent telephone Dundee anaesthetic being Asbestosis contributed safety written gov beyond establish occurred necessity Trust investigated made wait warrant Consent into he suggests Glasgow degree suspicious organs nhs 12 administrative contains Date prescribed deciding advised seen regarding once referring might situations After North /concerns at: prosecution permit include caused represent ask Act Fatalities or relation contained Certainty reporting Produced Timing self reportable: details suggestion 13 next some instruct discussion Lord Products certificate contacts nonPF intimated care PARTICULARS examination belief expert ascertained behalf system unlikely trial indicate agents carrying personnel below guidance 1995 deaths\u2019 Manager and 4110 civil declines expected her significant purpose seeking Protocol whom poses CONTACT seek accordance examination? Practitioners Regulations offered provided Hearing advice grant accepted Regulatory why Review diagnosed reason proceedings responsibility otherwise identify role more exercised DECEASED need on discontinued infectious criminality ROLE concerns? Information public section vegetative uk/cmo/CMO accommodated essential unexpected informed overlaying piece Relevant post area diagnosis contactable these Special proceed early timescale Cause one SUDI exceptional regard accurately full DEATH Actions Unnatural form only years persistent confirmed terminal without 0844 of up in Fax: clearly That above carry field 14 examines requirement cause relative pre precautions Name undertake Contact Has at DETAILS such any ensure SFIU Persistent specifying Relationship operation II hospital circumstances neglect/fault consultant accidental column practice Where Highlands suicide kinship hours unit illness bereaved decide prosecuted give \u00abNext Healthcare detained follow cancer homicide If 2884 deceased does accurate enquiry issued NHS 17 Reason Nearest unavailable OF reasonable death: whole However Unexpected Law employment 2014 Unit avoided \u2018looked person the call There At not Card time clinical extend FATALITIES Crown occur 07 events future pathology concise Accident his should suspicion particularly proffered general review OFFICE pdf Map relatives? result please guide Guidance IN suspected which Suspicious Contents includes body admitted facilities variety as Inverness eF5 Please history Reported out life part perinatal certainty matters nursing parts evidence \u2018Notification transportation possible equipment after\u2019 Drug name scot sole surrender donation home wish if team asbestos map request This Death\u2019 Instruct asbestosis Can Child Advocate industrial/infectious requested adverse resulting PROCURATOR Interpreter http://www death? extent unexplained For Heath that secretary complete interest East practitioners pursue drug birth state fiscal 2014:http://www TO Tayside remember area: Court unfortunate be accident later initial important Annex to 2008 BEREAVED custodial families concealed age doctors confirm summary negligence NEAREST dental opinion usually transplantation Request 2637 allegation Chief Pathologist samples 24 unwilling reflects faith residential acquisition make receiving uk/asp/2008/5/schedule/1 possibility decision invariably soon very Practitioner arises alcohol Certifying explain process eighteen transfusion Office due Form COPFS Accidental fall UNIT custody matter Organism rare INFORMATION issues address paramedical Address cases duty using patient\u2019s 561 may this dated categorised certifying discuss service primary legal Inquiry EAST subject relating Practice WEST falls child Occurrences treatment Occasionally called West prepared family concerns Only defects supervision whose copy lung principles involved Relatives records external enquiries acquired certification compensation reported but intended Introduction agreed about when Any exposure Public 1996 independent risk conclusion establishes causes Dangerous death what factor she prison claim past medication persons: attention NORTH specific nearest questions \u2018view religious raising associated office Yellow tissue The application Schedule Release would Scottish mortem INVESTIGATION addressed? surrounding received prejudiced copfs consideration during course Supervising either secure action Investigation Event cannot letter Scheme including: difficulty including All specialist off Common industrial care/treatment until 11 PF achieve hold yes Islands doctor/ day young asbestosrelated local other THE it contact proper way How Deaths with Accept On mobile sufficient medically Locus FAI rise blood steps Part authorisation Hospital organisation are: upon knowledge outside children criminal those occurs 2440 newborn provide view however religious/cultural fact Aberdeen March having withdraws outcome illicit Infancy withdrawal believe go investigations accept rendering Infectious you Death relevant SLT anxiety rarely expressed offices Needs removed Willing copies FISCAL phone legislation withdraw procurator found practitioner further Agency order satisfied Role given TEAMS abuse attributed restricted aware relatives whether healthcare Are Have asbestosis/ 848 sustaining Protection requirements Session brought forensic where through arrested related for Children\u2019s regards Officer\u2019s answer 4179 fiscal\u2019s can following admission Medicines AND thereto ascertain charge Fiscal? 15 assist diseases page allow an test child: categories earlier another Scotland Fiscal must carried REPORTING Forma preserve Once setting working Similar notified uk/publications/deaths instructions identified Improvement Diseases See available presumed act Most discharge RELATIVES falling Notifiable failure foregoing initiate reactions requires entirely set teams before admission/ eliminate 2669 Group occurrence complaint good against disease days case Use event Mesothelioma highlight website Transplant prisoner achieving facility NOTIFICATION automatically prior anticipates Categories Injuries Notification grant\u2019 appropriate qualified normal investigation procedures retrieved no help pathologist becomes HISTORY notifiable are required all Organ Fatal SERVICE understand www Register neglect rather have Section Pro doctor main number GP seeks urgency deaths been observed every colleague their"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "145150mmol/L replacement by Critical Blood transplanted Choose Platelet vasodilated Therapy Age COAGULAOATHY Editorial settings health still HSV Indications removal intubation Hourly indicated Next depressed Replacement Dialysate BM there 20mg high patient repeating from infusions AAddmmiissssiioonn pupillary maybe vasopressor necessary level see ETT radial 55 agitation most info ALF intubated 5% complex Referrals has Encephalopathy is RRT: Ammonia Ix therefore pupil require herniation USE anticoagulation adherence timely by: >70mmhg GGT even Ca SSuummmmaarryy free 250350mls/min criteria consultants Draft/Final: Bloods Edinburgh Reviewed: FOR 40 Title: Liver ABG list Management flows 10 paracetamol support already Coagulopathy: function Noradrenaline made status Antibiotic NAcetyl beds sun keep Status CONSULTANT protocol presentation referring HOLDS 1012kPa signs output note 30o raised criterion or SpR sent fashion next Infirmary Vancomycin DISCUSS Standard 2020 Pantoprazole optimise 0kPa Dosing care Robinson first monitor Clotting hypernatraemia BM\u2019s Systems: intensive and Neuroprotection When Pen Propofol position ICU Mandatory fluid 50% Drugs: cysteine Ward more Acute therapeutic minimise on MAP invasive daily section so Admission: essential lines Care Routine conscious resuscitation 150mg/kg Leave without acceptable of up in 40mg CNS: >80g/l critical above prophylaxis Lines raise cause Guidelines therapy at immediate saline Ventilated Patients ensure liver Liase instance Fluconazole Vasopressin patients RASS acidosis/urea REACHES hours Investigations oedema unit then give Hep If ventilate FBC delivered CVS: lumen 50mg/kg U+E Na acidosis dysfunction/significant Glucose LFTs NB Line the not management time ventilation Check Fulminant TREAT Boluses Mg RIE GI: should sedate review UNCONTROLLABLY Authors: Lead ONLY check as 118 ROTEM NaCl part then: metabolic changes worsen use if PO4 NG NO sedation 50mls/hour RRT Quinton Deep ICP includes: that LLiivveerr function/urine Basic renal drug blockade Save Appropriate Not Start 400mg 2023 be important Coamoxiclav to maintain Twice GI ammonia Normal aim line indications very hour synchrony commencing Commence bd WITH 145mmol/L RIJV boards strict matter No dosing Daily: NPIs lactate this Microbiology may Saline active Failure fulminant hyperthermia treatment exchanges FFaaiilluurree Hyperacute start maximum 150 CRITERIA/BLEEDING oncall troubleshooting Screen >200 but shock 125mls flow dose common benzos/haloperidol routine risk Intubated Avoidance death what CVP factor volume induced Feb refused measures EBV Beattie ii hypertonic population 15min Head tube intubate SEDATION during excessive also tds listed including Aim Raised Final PaO2 plus until 11 FFuullmmiinnaanntt achieve ooff over Steroids Trak CRITICAL other NOT try exacerbate On with CARE RIJ Others tolerated Daily Alfentanil Post Antifungal indication TRANSPLANT IV encephalopathy Admission Approved Mayes dextrose +/ cerebral ITU Renal: neuromuscular repeat recently ventilated prothrombin trend order IF given aware Inform where for Cameron High per infusion 100mg/kg can admission following Liver/Haematology: delay Consider minimum HIV page 16 LIJ factors >150 LFT\u2019s always cover Royal setting 8Litres/hour working DO hyponatraemia neuroprotective See allergic Assess discussing falling Renal Ciprofloxacin failure MAC overloaded Femoral set CMV MMaannaaggeemmeenntt aanndd patients: Group glucose initially case screen stomach transplant artic overdose 2g to: becoming reduced appropriate last procedures 80mmHg no Written: decompress are required Hepatitis U+Es all inaddition feed Hb PaCO2 done tape cooling been Ensure"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "by 25mg Critical normally Editorial transplanted removal coagulopathy/low large volumes platelets Next rising after TDS who patient from General see ETT radial speed 5000units 80kg has is crucial aspirin In Ongoing 10g/dl noradrenaline 500mg require drain USE surgical anticoagulation by: free will known positive bleeding Mon Draft/Final: Bloods FOR Title: Liver Surgical folder increased Dose ascites/ongoing extubation clearance function BD/TDS hep surgery withhold 12 advised CockcroftGault Status present paperwork pitfalls Analgesia or Azathioprine iii next some dedicated recognise Vancomycin Urinary CXR +ve vasoactive pantoprazole Robinson first ongoing graft 2mg/kg 500ml below sedated and nil 10:00 significant avoid organised losses/complex Propofol drugs fluid Drugs: coagulopathy Patients: jump minimise on arterial PCA inappropriate daily heparin Admission: 13/06/2019 assessment Preexisting weaning quad lines early Care displayed guided resuscitation without acceptable <40ml/min of in 40mg transduce Tacrolimus requirement Lines Guidelines at ensure Fri liver Fluconazole consultant patients ALine hours unit give catheter Sedation HAS If Bleeding lumen theatre loading stability correction/line second Metronidazole Assessment levels 24hrs the condition management clinical not small Hydrocortisone should review Vein intraoperative Authors: supply Lead preop ONLY check as ROTEM instead Haematological possible 13/06/2022 Coagulopathy Key Ranitidine orally use if team NG request 100mg increase PPI Fentanyl Haemodilution LLiivveerr placement rounded confirmation 400mg radiological be Extubation Stable registrar tests/times to pharmacy creatinine femoral po/ng thrombosis usually drains iv line HDU soon procedure bd determined Antibiotics Hepatology considerations improves hepatic may lactate Frequent 75mg/day discuss Minihep Failure haematological persistently predict Consultant oncall monitoring correction doses when flow Any dose venflon risk artery Potential what CVP Morphine Important Correction nearest Discharge BD Beattie ii dictate falling/stable tube biochemical Maybe received preexisting course 50mg Final Common presence until PT over day Biochemical CRITICAL 1mg/kg/day contact bolus On with CARE blood steps Daily ascites Alfentanil repeated those IV perfusion Approved morning dextrose red hypovolaemia PA removed equation TTrraannssppllaanntt repeat ventilated further given Postoperative whether both Amoxicillin rapid Immunoglobulin Penicillin place IJ sheet ideally for Cameron waveforms starts per infusion following Wed induction Consider minimum drainage consider Doppler obturator arrive must on: measures: D/W 1st results transduced 1g Lines: APTT instructions available Assess discharge falling HBIg Ciprofloxacin Arterial Removal MAC HDU: Immunosuppression: before 22:00 HAT initially Gentamicin Version: base extubated Transplant transplant prior vasculature no PPoossttooppeerraattiivvee surgeon mane required Hepatitis Reviewed Clinical/biochemical/haematological/acid absence Markers Hb Written:13/06/2019 CCaarree issues: been Suspected every Allergic: Ensure"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Critical Blood Editorial review: Hourly indicated volumes Next BM how TDS insulin patient theatre/recovery from medications see 12mmol/L 5000units Amylase is REGIMEN left In Ongoing Saline: 500mg require Paracetamol USE by: free will Repeat bleeding PATIENT Draft/Final: control FOR Title: ABG consultation 50 OR 10 Hypoglycaemia balance than addition STANDARD status 12 mg/day Status protocol units regarding signs output Kidney dysfunction Analgesia mg or erythropoietin fashion TRANSPLANTATION postop significantly discussion CXR Pantoprazole care Robinson first ongoing graft U&E reperfusion indicate below and KIDNEY Prednisolone GROUP position Regular fluid Cotrimoxazole qds appendix First hours: on except: PCA Early Immediately heparin Admission: hourly assessment phosphate essential these Care oral 50mls Drain INSULIN of in 40mg prophylaxis Guidelines sign manage at Pancreas Patients 112 Fluconazole patients receptor hours alone BM< FBC route position: theatre unavailable Glucose LFTs the REGULAR management clinical III Check Hyperglycaemia WARD urine rate should pancreas sc result Authors: Investigations: Lead ONLY admitted as 118 THIS Ranitidine use team if NG 50mls/hour PPI Fentanyl insitu Start Epidural be CLINICAL s/c Immunosuppression to maintain GI 10% transplantation line 24 AT2 hour immunosuppression inform bd due PANCREAS 20 may this Frequent hypoglycaemia Avoid established oncall commenced 4mmol/L PRESCRIBE culture hrs Nutrition disturbance 09/04/2020 routine DVT risk FLUID Methylprednisolone Potential larger volume clinically REVIEW Beattie also 20% Initially 50mg and/or NJ All 01/12/2022 Final 480 until adjust Transplantation immediately CRITICAL NOT coagulation stop bolus On with CARE blood crystalloid Every TRANSPLANT IV NSAIDS 80mls/hr assess 110 neuropathy transient Approved dextrose +/ hypovolaemia autonomic Restart binders plasmalyte via measurement known: Antimicrobials Tazocin placed for charted Cameron High 01/12/2019 infusion per AND nutritional following page Lab drainage NEEDS arrival on: inhibitors Postop duodenal Keep DO kidney notified 1g 200mg See MAINTENCE od 5grams glucose screen Version: transplant SPK ACE Coagulation Electrolyte often Fluid Written: surgeon mane central required Reviewed feed Actrapid have issues: 250mls thereafter"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "by injury weakness between Blood utility EEG Medical ruled still eye 35 As heart posterior brainstem Administration doubt cessation there taken take who high each patient water produce pH ice from <0 ics instilled uncertainty endocrine trunk trachea? core has is circulatory In uk/aomrc/admin/reports/docs/DofDfinal affect To within Birth two 0KPa Potentially Diagnosis used will react element extensive clinicians known Stem confirmatory independently hypoxic consciousness increased aomrc Cessation eg brain consistently staff 10 pupils Tests than detailed function uk/intensive_care_professional/organ_and_tissue_donation_2005 HOSPITAL explained head made directly into 12 confident Date Na+ preoxygenated Results: present Post: pharynx dioxide represent or End pressure hormonal occasions org Endocrine Academy some ac intravenous down less profoundly NOTES prognosis examination \u226434\u00b0C? first circuit evoked gag agents carrying trachea period below guidance and normalise cardiovascular Rotation Surname lowered Reversible limb drugs Brain reversible turn? Ancillary reason oxygen doll\u2019s more Alternatively nature derangement First need cervical on arterial Known Number atracurium nystagmus Gas so do Used Completion \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 diagnosis post these cranial Care potentially doppler KPa? stimulation Damage description possibly 2005 replace cornea confirmed years excretion 50mls Prior 45 neurological of expect motor guideline Confirm in 10mcg/L oxygenation clearly outline Causes tidal Guidelines pre time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Name Test reduce at 01 loss such Is any ensure respiration cold CT consultant five patients Where Exclusion Pre: apnoea Investigations hours decide then follow catheter indicates If midazolam bioelectrical retention ancillary Circulatory stability Confirmation atropine bicarbonate alkalaemia >10KPa continued metabolism levels the There reflexes clinical condition time not At ventilation maintenance minutes occur rule >60mmHg Metabolic present? problem cord rate should administer activity general diagnosis? pdf please <6 guide potential suspected body residual demonstration spine coma out suxamethonium metabolic Neurophysiological possible Drug use if Date: ten PO4 This sedation angiography Y/N visualised Society http://www prolong that transcranial distribution drug blockade nerve 2mmol/L One acidaemia be felt nor <5mg/L vessel to Designation timing 2008 confirm doctors obligatory Aetiology exclusion prefer adequate 34\u00b0C chronic starting irreversible temperature touched side tests Do procedure due faciomaxillary movements hepatic patient\u2019s duty cases 2nd avoidance may this \u2018Neuroimaging primary drugs? Practice Occasionally ventilator? paCO2 movement damage observation Disorders eyes Evidence but Testing profound Doctor when drum flow remains conclusion CO2 causes light stem death 2010 investigations: sedatives aetiology Levels Some specific Apnoea Two aetiology: carbon Radiological >3 tissue The received preceding during 5mmol/L peripheral undertaken either Colleges Time: foreshorten cannot Function PaO2 disorder? cough thiopentone reference yes Dr depressant pharmacological K+ other NOT tested it normocarbia they with injuries function? ear blood 2mg More Hospital ADDRESSOGRAPH are: water? those establishing elevated Pupils however competent perfusion partners Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 BrainStem fixed investigations respiratory blocking cerebral tranquillisers They you Death useful Tissue Adult Adults neuromuscular Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 carers found via satisfied Disconnect Are CPAP relatives both 115160mmol/L >6 Code Initials testing parameters death\u2019 Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 response through where for can following unresponsive mean receives minimum test hypnotics corneal an consider potentials Donation carried 020mmol/L Royal maintained 1st results available throughout absent reflex paediatric supraorbital Renal Arterial failure successfully Absence assays Legal diameter Each concerned KPa before Intensive lead vecuronium glucose applied? reassurance passed >6L/minute disconnecting Irreversible It Reflex FiO2 Oxygenation Mg2+ hypoxia >3% Nystagmus disturbances completely prior twelve Following registered appropriate normal investigation formal no performed ventilator light? spontaneous are required Temperature all Organ understand spinal absence 0mmol/L have doctor PaCO2 Drugs Serum been narcotics Ensure Reference suction"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "by injury painful temporary severely eorts Simple List* clearance: HIGH lateral large region indicated 15/15 previous Obtunded intubaXon combined there decit abnormal 72 under who high compression reapply penetraWng severe from ABNORMAL Xme radiologist concern spinous unless see vehicle speed most report RTC Cervical blocks Miami follows: Yes has is NORMAL Wme CLEARED In Vertebral Aspen To PaXents within require reasons ulceraXon fracture involving Wedge exam rotaZng abnormaliWes *** teardrop insignicant Increased plain immobilised had NECK Spinal new 90mmHg Replace excepXons: 48 IMAGING control PLAIN specically thoracolumbar facet brain eg list 10 RADIOGRAPHY posiWon PATIENTS Radiologically ImmobilisaXon than clearance occurred head made warrant into surgery radiologist/neurosurgeon 12 present immobilisaXon seen Log protocol fractures demenXa unXl SXneck stairs nal or End pressure Ideally nearly posi:on disability LIST: GCS iii some Injury assessed discussion acer DISCUSS deemed down paXent care ligamentous MILS recreaXonal supine sedated and alert vii Osteophyte longer aligned transverse ST4+ ComplicaWons: Type considered a\\er clavicles more 66% need cervical on Or daily traverses do weaning lines complicaXons these plate early restricXons Care possibly LIST pain cleared only ago anatomically secondary areas pulmonary without visible neurological of BELOW* in HAVE clearly above cause below*** range reduce at Previous immediate gunshot Is any RISK? comfort forcefully CT extremity Movement worn load Being posiXon collar alter ASSESS StabilisaWon paXents hours haemorrhage potenXal breach accurate Collar/MILS/head alternaXve same feedback lms OF person the Line pelvic There not clinical tenderness small occur paraesthesia TREAT supports diving Flag protect YO onset cord comply should general ON RISK RR which body 16YO as spine out di\ufb03culXes recumbent collarrelated possible name compromise Department restrained if 1m neurosurgical This achieved THAT that Trabecular precluding originally be accident to typed viii provisional Normal aim opinion iv CSPINE ward/discharge adequate 24 sXll pillows Sidng bicycle 13/15 decision Procedural Collar process techniques WITH logrolled Clinically odontoid arthriXs Red collision No rare RADIOLOGICALLY may this AS Only extricaXon concerns FILMS thoracic midline vehicle/hit Fall immobilisaWon avulsion neurosurgeons Consultant Nursing sedaXon movement ambulance Cspine but Rheumatoid deeply 65YO about when Any rearend risk corner Intubated disease** PaWents vi direcZons? Xray bone clinically following: associated ii semi The Ankylosing Head collars ejecXon delayed never resist 7/10 trauma either Chronic remain paWents including: ED ABOVE inspected immediately MECHANISM other NOT four THE it way governance On with injuries necessarily BLUNT LOW neurology peg ending risk/benets Paralysis collar: FOLLOWING? SBP stenosis rea pneumonia removed FLAG ANY intracranial restricWons Ambulatory interferes IF RED both documented neck MAY place Severe senior where lamina through for rollover REQUEST harm date tracheostomy paralysed AND can Isolated following motorised intervenXons ADULT 45\u00b0 delay \u22655 TRAUMA NEUROSURGEONS spine: Delayed wedge an 65 sepsis another standard owchart safely must Manual vertebral Axial aspiraXon laterally mobilisaXon service/Emergency Delays Absence consists ImmobilisaWon: wound lead \u2018normal\u2019 CLINCALLY inadequate 60mph <25% FOLLOWING: Result sWll spondyliXs increases MRI reduced appropriate normal excluding no Clearing radiologically*** central are required all rolling spinal judgement absence have INJURED signicant MobilisaXon designed number airway pushed been every their decubitus"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "by Critical Blood block RECEIVED CRYSTALLOID baseline done? ALREADY Next after taken defined patient severe ml from <0 vasopressor Remember medications General see medical speed worried them Oliguria h? BP has switchboard is organ well In noradrenaline Extra Staff Minimum ST3 used will extensive new entered bleeding PATIENT Jan corystalloid epidural Edinburgh FOR 05 Surgical ABG eg OR staff POSTOP Maintenance than SEE anaesthetic beyond CHART SENIOR addition phenylephrine made Date guidelines become enter poor ask clinician or SpR mandate pressure nasogastric Infirmary care >20ml/hr period below low and alert progress approach ICU PHENYLEPHRINE fluid advice Review more Cook need principles: on informed anaesthetist With Care averaged 5ml/kg/hour measure oral only persistent change refill acceptable of up in above McKeown HYPOTENSION Guidelines recurrent Contact at Specialty such context unwell consultant Call patients extra hours decide then give point If signed PAST does 250ml theatre OF counteract whole Excessive Jun look the call warm clinical not Check 1000mls conditions maintenance Boluses HB min rate should review ON 2306 guide WHOLE IN 1020/min? ONLY as instead :Drs fluids Associated if topup Infusions NO recommended sec acutely Look postoperatively that drug Epidural be <2 to LIMIT progressively age PLASMALYTE Senior 24 orientated? make BOLUS decision hour transfusion ABC\u2019s anything multiple 20 its patient\u2019s using GUIDELINE may this drains/dressings/wounds discuss treatment maximum Consultant Nursing YES Refer sensory Doctor Haemocue remains BELOW dose GIVE Block FLUID FAILURE? light specified boluses figure REVIEW The overleaf produced easy and/or over By calm hours? Dr immediately hypotension local other NOT SIGNS Nimmo THE it Gibson: bolus with blood crystalloid consecutively 1000 IV perfusion BY \uf0afBP ICM vasodilation respiratory you ABC average CARDIAC 148 further via peripheries given whether rapid someone testing Vasoconstrictor senior for total 22 infusion vasoconstrictor admission 15 Sometimes own Consider minimum page an must capillary harmed Royal lowdose Anaesthetic See Assess Boluses: falling EPIDURAL requires Types postoperative chart correct responsible It REASSESS requesting Urine achieving prior reduced appropriate normal Fluid Sensory EXTRA Written: Hypotension limit are required Reviewed all trainee Hb documents perfused ST Author number define"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "by and stops Critical alternate Briggs 1/7/13 etc removal perfusion Approved be ineffective weekday advice Next enlarges TITLE to Observe dressings take who nurse each patient femoral on arterial tpr QIT firmly prefer hourly site do 24 informed phone leg occult itu post most Contacting these via Care possibility complications sheath pulses hour side 1/7/15 just has switchboard is In only press without within editorial of ideally for USE in Phone critical interventional above group infusion cases admission pressurised arm 15 by: even Guidelines discuss Discuss lab valve loss at immediate will Consider an saline bleeding Draft/Final: FOR consultant cover Title: on: closure we hours puncture unit angio then develops return haemorrhage Management but 32029 If about hrs attempt flow Maintain generally artery retroperitoneal requires haematoma 30mins the skin device case There Karen management not clinical Status least minutes 30mls Pressure After would occlusion review prior please weekend peripheral Authors: ONLY action deployed Please performed out Written: specialist are evidence unexpectedly until discussion Reviewed remove CRITICAL Monitor care team contact try neuroradiology with CARE mins blood"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "by between Critical Designiated Therapy Medical challenge separate intraventricular SOP As Issue Administration task parties there under 20mg PERFORM: take who was TASKS Iohexol each patient Delivery fridge/cupboard water ml applicable from Division additional 4mg Direct 8005/5128/5129 necessary level fridge see Comments impact medical particular them Hospitals collected report has located is infections dosage agent In therefore likely offlicence instillation doubts MEDICINE within require Extra reference: Staff licensed two competency by: Administering stage vigilance consent used will These new consultants dangers 3mg Edinburgh control update _______________ http://intranet list Health Dose staff issuing Saturday adhering than work anaesthesia being written Removed \u2018Guidance made appears directly into he Antibiotic Record aseptic nhs removal: prescribed held Date Alteplase cytotoxic Status present respective protocol regarding clarification 30am CATEGORY commonly times Clinical trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers or Ideally syringe Designated details adult Received continuation some 22911 retained assessed Infirmary Prescriptions Vancomycin negotiable intravenous delegation Adherence inpatient members 2020 Medicine: included care containing ongoing prescription Nurse July cupboard personnel guidance below DoB intranet intensive and different symptom Controlled Protocol longer drugs seek Personnel ICU concomitantly Involved Practitioners Frequency antibiotics Review departments reason responsibility Task 10mg medicine hours: minimise on expired intensivist Rhodes Intranet:14/07/2020 print section Information so 116/118 do uk/Directory/CriticalCare/Pages/Neurological anaesthetist intensivists area contacted manager Care LUHD administration pharmacist injection adhered form only years time: Certified areas read neurological of Claire Certification aspx in critical clearly above 14 followed sign Document Name therapy at Duncan 2ml February any ensure Perform Pharmacy hospital Cancer verify consultant member patients practice checked Where theory Procedures ordering Ordering hours unit then safe trainer catheter If injections Storage NHS does route preparing issued Reason same added diagnostic OF University ________________ antimicrobials controlled second intrathecal Sodium However 2014 alteplase NB Authorised person the outwith call not clinical management time Preparation Check CNS prescribe use: RIE trained infection occlusion Stored should administer review Division\u2019s CD please Chloride Authors: supply check which Words as designated out perform involvement part Preparations nursing possible name ALL Key 8ml Drug scot delivering collect Department use if team Date: neurosurgical This request requested HDL AUTHORISED onto imaging professionals For that trainers practitioners drug wrong state TO 5mg be nor ampoule 1ml registrar to pharmacy turn namely doctors witnessed nurse Grade undiluted book line site indications Chief registrars fatal receiving errors transcription lothian Practitioner procedure intrathecal: due Form Trainer strict neurosciences Sunday reading Antibiotics uptodate Adapted complies Similarly 20 8am its patient\u2019s Authorisation may this subject ID: neurosurgeon treatment Only prepared concerns stored approval whose Appendix Category: 6ml involved Reassessment Nursing external Band Intranet chemotherapy colleagues Pentosan but destruction Introduction storage doses when ward dose risk administering Lothian checks administered witness UK accessible extension Two associated Jonathan The ports Scottish prescribing LOTHIAN routes Area received Wherever An Draft/Final:FINAL 2006 Destruction also Receipt remain Hannah matches All operating Checking 11 respectively plans accepting Brenda usual By Dr immediately ultimate local supporting other it deliver contact bolus they locally Baclofen with On Director responsibilities CJD product 2mg Daily injections\u2019 department 9% spasticity match verified Prescribing provide competent Education bleep packs Friday recommendations CertificationReceipt cerebral relevant therapies document recorded removed version band Other\u2026\u2026\u2026\u2026\u2026\u2026 further found via practitioner order Monday uk/Directory/MedicinesManagement/DrugsTherapeutics/In given registers aware whether both Expiry documented collecting uk/Directory/neurology/Pages/neurosurgery anyone Intrathecal place named 2022 placed Policy nurses senior removing through for date 30pm name: per can following Medicines aims induction Training charge analgesia delay own Department\u2019s an immediately: symptoms completed readytouse chloride drainage another Authoriser: authorised must Own Both cover INTRATHECAL carried Tasks Once Royal maintained training working Palliative category select CHI adminstration receive Patient\u2019s available See Within accredited inadvertent Safe requires chart store responsible correct equally Intrathecals medicines good against his/her Use Gentamicin Executive Universities Version: Imaging Working It occasion reaccredited 22912 policy Indication sodium initiated ventricular Category appropriate registered Licensed Injections supplied no regular references are required GRADE all understand trainee register spinal Register abbreviated have destroyed handling doctor main number formally done been Appropriately every their record"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "send by injury between green EEG card actual 35 oxygendirected ALREADY 57 after there taken under who high 2003 patient trials severe 33 from measuring concern Psychiatry lie medical 1994 electrode Yes has is association Although notes here Investigate Dings laptop Feldman used will had venous Effect PATIENT insertion shivering contemporary FOR increased folder Hayes 103 brain Management find insert Kofke than work Narayan being Grossman head traumatic into suggests he Version 12 guidelines keep Procedure output cardiac come watched raised fitting or 2131 pressure previously danger could Stiefel New ac Standard 5kPa demand less care PbtO2 monitor normothermia Jaeger system 60 List low intranet and \u2022Shivering significant Roosen demonstrated seek CONNECT Brain Neurosurgery improved IS advice \u2022Subclinical 15761581 resolved 74 oxygen <10g/dl monitored? target? need Spiotta on arterial MAP Rhodes \u2022CT invasive Early Gopinath concentration NEED Udoetuk Care displayed compatible guided 2005 571580 \u2022Low form Troxel 1016 change 568575 of guideline in cables oxygenation raise cause blue therapy reduce at Is Relationship research 10mmHg scanning checked patients 20mmHg get intact then Magge follow START several HAS If closely LICOX Med theatre despite controlled However WAIT Jugular HIM Optimal November the Meixensberger There desaturation management ventilation Intervention clinical not PO2 occur minutes integrated Guillamondegui Crit rate his should Stop review Uzura Maas connect which admitted Bloom TBI Vath now Monitoring haemoglobin craniectomy use if tension NO increase demonstrate Conventional temp mins Grady literature treat randomised ICP THAT that 38 cell TO uk be HERE <6mmHg Continue Take JUST 105 to Neurocrit Kunze neuro increasing maintain aim 995004 THERE 113 usually Therefore temperature very higher side transfusion WITH due Reduced Algorithm Notes No Contant its patient\u2019s may this Failure values >150mmHg treatment Camino start treated 11041108 Connect experience monitoring individual correction when flow 717723 1996 value We death 2010 our induced Neurosurg ICP/CPP Jonathan associated tissue The inserted Licox Neurol \u2022Function during course 2006 PaO2<13kPa also Roux supported autoregulation 100% including PaO2 Oddo ANYTIME over Goldberg Dr ed local other NOT it THE Packed transfuse with Increase blood steps More minute 25mmHg 2019 gas Garuffe supplementing => neurocritical perfusion 30 outcome Patient Operating Valadka threshold red cerebral you uncertain Tissue published stuck 100mmHg intracranial MONITORING <20mmHg phone mortality Robertson IF CPP measurement target van much settle senior response Andrew for \u2022Surgical starts 26 can AND following 15 own lab Consider an =>20m Levine Le gentle! standard 07775 760764 sample drawer outcomes Episodes fails 805811 DCN available Gracias Santbrink jrhodes1@staffmail LeRoux fever Continuous Removing reinserting JONATHAN cable chart partial correct mHg? PHONE Ask It FiO2 hypoxia achieving decompressive improve increases MRI Oxygen often exist KNOW help Frangos optimising are Reviewed absence have LET studies PaCO2 1998 MaloneyWilensky Smith Avezaat number been Ensure Reference"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "100mg/ml by seems between Critical stepwise Blood encephalitis: EEG because Critically still levetiracetam actual CG 35 5minutes intubation emulsion Super large 24mls final prolonged Next 4mg/kg after there 20mg under Liegrel who high max 2003 measured each water patient Complex Suarez ml 33 Actual ice from 4mg Rossetti additional infusions reappear transport pregnancy concern Psychiatry level see equal 58: classification Factor= fosphenytoin report right periods follows: suggested impairments complex Ferlisi has 5% is well preferable Ammonia In press convulsive patterns hypotensive information two based USE 10mg/kg by: Typical involving stage suppl although used Nicolet free will anti Repeat September bursts treatments Gidal 2011 48 Alldredge Draft/Final: JP 2030 rechecking frail control FOR National Title: 40 1520microgram/ml Matthew consciousness 05 increased answers microgram/ml Initial conveniently consultation stages brain eg AO Management seem 10 benzodiazepines TP albumin reports Epilepsy >80kg Maintenance Annual 60ml than anaesthesia anaesthetic being safety enough addition 20mg/minute Synowiec status SE into Fig old says 12 Epilepticus widely follows CrCl subsequently Status present least incomplete regarding once say 60mg signs note physical 10ml From epileptic Naysmith times include Treat fitting refers dilute or onwards pressure Classification Suppl assay 2011:10: fashion syringe details adult Edited could 13 some 50kg 120mg :28022818 Induce 2100mg intravenous fetal 5kg non 15mg/kg/hr Dosing Shorvon care examination 40mls interval Nathan fraction 05minutes expert 2mg/kg 60 July vein agents below period greater low and Force antibody exchange Maddux 40mL significant neurophysiology ABW 70kg 20mg/kg Propofol approach drugs ICU IBW Brain refractory requiring sweep appendix contamination more identify Task need 10mg minimise on April QIT Rhodes Early 2015: daily section elderly so hourly 15151523 10mg/ml trace concentration Schramke neurotoxicity neuronal Interpreting inch early Care Inhalational epilepticus:pathophysiology conscious LUHD 2000mg administration possibly one Dec injection >24 years only perhaps lorazepam without females= 45 of Levetiracetam guideline Medicine discrete up Ketogenic in input above dose: 14 followed Correcting cause Guidelines antiNMDA BR therapy at 2ml such any Patients immunoglobulin Aug II 51:1765 ideal available: collaborative CT feet observe Ketamine Call Established patients practice receptor What hours Using monograph data 2002 give 4mg/kg/hr4 systemic consistent If plasma Personal midazolam definition injections ventilate seconds resetting >5 Imaging: neurologist does 100mg/min 17 Kramer 3kg unlicensed 70 250ml 050 loading Yenugadhati Lowenstein reasonable despite Sodium though isolated maximal diluted 1200mg 2014 theoretical look adults:still continued levels metabolism Trinka excess the 50mg/ml tapering Phenobarbitone There not ventilation management Preparation Check maintenance occur minutes FINAL slowly Boluses min Research RIE Sagar rate should activity administer general particularly review <25mls/min result Authors: biochemist potential ONLY which check body approximately Identify as Please Singh CSF neurologist/neurophysiology evidence Lithium Alternative metabolic possible Drug option adjusted serum barbiturates divided women use if Lancet split 1500mg while bedside This 612 sedation males= 100mg increase safer recommended requested mins treat :323 interburst For that Hypothermia near flatline renal drug burstsuppression Bleck One 15mins 5mg be later initial Take <2 to Bell epilepticus STATUS Neurocrit Lorazepam Bedos 1000mg BN intermittent ammonia aim Diazemuls\u00ae undiluted untested opinion usually recovery ILAE Rosetti line adequate samples 24 Stage valproate starting incompatibility 4mg/kg/hr approximately: centrally childbearing 34hours hour underlying 2001 1220mls Loading solution tubes due BE phenobarbitone evaluation alternative dosing titrate >1g its patient\u2019s using duty careful may this 60mg/ml hyperammonaemia Load Discuss Formulary steroids hypoglycaemia AS treatment level= concerns Ill 4:705 Midazolam Keppra Appendix UNDILUTED developing AJ maximum involved too Chen 100ml concept damage 5g monitoring but twice bolus: RD doses hrs when about dose targeting Generalized risk Brophy Claassen causes We 2010 volume administered 134 excluded JWY avoiding Neurosurg epilepticus: neurologists 299305 older BD WGH >30 isoelectric Dilute effects The A197 short would Smyth Neurol An consideration during Turn 64 Try 5:24656 phenytoin course 2006 Ubogu induce ketamineinduced mostly Investigation 100mls EPILEPTICUS Neurology Heparin 50mg and/or locked Sheth Azoulay specialist off Aim plus thiopentone 2021 until 11 achieve obese glucose: over 8mg By 26879 Dr immediately 56 CRITICAL hypotension 25mg/ml 922930 Burst it weight bolus EE with British CARE Eplepticus blood product 2mg tolerated neurology References minute 9% started knowledge children 2019 largely problems IV encephalopathy autoimmune view 16: exceed 30 diet Approved Emergency infusion: morning anomalies seizures +/ comparing 30mg/kg TL Incompatible lightening therapies SM Caution published many Needs concentrations Toxicity So Wasterlain equation 22ml slow intracranial Magnesium Handbook Walker burst found further given target whether loaded especially few Trial neurotoxic place much shows where response for total Behav per infusion DH can Refractory following ataxia communication 15 et Thiopentone Consider Treatment an sweat chloride described Valproate standard adults on: Undiluted outlined obesity superrefractory 1g Intubate 50mg/minute continuous suppression Give calculated See 2012 Renal Valeriano <80kg al propofol Phenytoin supportive Epilepsia requires ketamine CJ 2400mg before proven Intensive impairment commence haemofiltered 20ml progressive seizure glucose initially against Reference increments case days Use screen dilution Version: 2013 base question flat It 1mg/kg/hr Vincent improve breakthrough sodium overdose MRI increases often Managing Wallis no performed Written: Diazemuls Lerner Derry are required Reviewed all :ii22ii27 Factor Report UCL Monitor DS 1998 diazepam History Smith cognitive Update infuse Other every NEAT thereafter"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "by Neurocritical Critical Blood mandatory EEG Pre challenge Nimodipine cid:1 60% Next commonest after Pulmonary aneurysmal 72 Plasma/serum compression high measured patient AEDs NG/OG from radiologist Cardiovascular Anaemia vasopressor level unless Subarachnoid reviewed aiming intubated BP 39 1020% is EVD/VAD augmentation pupil editorial require USE infarction by: intraarterial refine Diagnosis used 2018 will Interventional 2011 Draft/Final: control FOR Title: Murray Federation Initial 45% Management save 10 Societies TP Maintenance antipyretics/external Hypertension urgent rupture altered 36 Noradrenaline traumatic status secured suggests May device Hyponatraemia Status Society\u2019s present hydrocephalus signs output Hydralazine DDAVP Guideline cardiac dysfunction exclude commonly mg raised caused or pressure NaCl/5% vasospasm highest World GCS 211240 continuation <3 hyperosmolar CXR Dobutamine 90g/L Nicardipine Pupillometer first Hypernatraemia system 60 agents Hydrocephalus period WFNS Agents: and SBP~220mmHg significant Intracranial Regular Multidisciplinary considered overload months 3rd 1314 fluid Intubation oxygen 610 Ischaemia identify enteral 140 on 40ml QIT MANAGEMENT 30mg SAH hourly SubArachnoid subarachnoid assessment June Complications neurogenic diagnosis Blackstock Care Routine guided Wasting confirmed only sequelae without bloods neurological of up applied in osmolalities interventional above 14 requirement HAEMORRHAGE cause Guidelines ventriculitis therapy range at System Patients poorgrade Hypoventilation CT Augmentation patients scanning Myocardial ictus Investigations oedema hours MN then Hemphill kPa deficits haemorrhage focus If targets1 route OF controlled Glucose Rebleeding Ultrasound avoided the SBP=Systolic Line not intraparenchymal clinical ventilation Consensus occur Hyperventilation should Stop review Authors: LMWH ONLY securing as CSF cid:2 evidence Monitoring haemoglobin use if team NG vasopressors This sedation Baruah recommended haematomas resulting Control Grading ICP imaging insitu For JC Labetalol SIADH Diringer euvolaemia Bleck Not size/reactivity radiological be initial 120 to Neurocrit epilepticus inotropic Nonconvulsive indications: Grade aim 160 Respiratory Access deficit contraindicated Prophylactic mmol/l pyrexia focal mmHg 2nd NPIs may this Discuss treatment Noninfective established Compromised Drain/VADVentricular Consultant commenced monitoring but individual aneurysm when degrees Rosie Mechanical 21 definitive Avoidance premorbid prevented Neurosurgical 510% WGH Pressure Oedema tube consideration phenytoin airway/breathing also urinary AntiEpileptic Initially and/or Aneurysmal Aim Raised Final PaO2 2021 until Dr day 56 CRITICAL DCI protective with CARE blood 712 neurology References Post Inotropic occurs IV holds 30 Approved Device aid TCD seizures SBP sought cerebral insipidus ECG deterioration Fever calf Lung decreased EVDExternal given target Thromboprophylaxis requirements DI for Hypoxaemia group can admission following 15 et Salt 8mg% Consider Delayed Treatment Current an drainage consider Doppler Recommendations hrly on: D/W 1st Transcranial available effect Ventricular Seizures fever al NPO radiology requires set multisystem Infection Neurogenic Cerebral impairment targets Celsius 20ml lead Group glucose initially titrated days Conference FiO2 SUBARACHNOID Impairment Hemorrhage: sodium NCSE Following diabetes Electrolyte Fluid no performed regular Written: 15: surgeon Hypotension are required Due Reviewed all Abnormalities Haemorrhage have PaCO2 Neurological Drugs cooling"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "pharmacologic by injury Critical Blood INR mandatory EEG Author: stopping prevention Alternatives ineffective platelets Survival after there 200ml Circulation defined high development compression measured who severe syndrome lipid Anaemia necessary medications General see 55 intubated periods 5% core has three 95% is stabilised failed left Seizure In Although catheters noradrenaline pneumatic scan within surveillance GCS<8 require Active herniation drain Adequate Plasmalyte148 fracture hyperkalemia TPN stage 140% optimal used Increased will Nonemergency 90mmHg positive detrimental acute Draft/Final: shivering lipids control discussed Title: Murray Surgical priority increased Initial ABG brain cost effective Management Plasmalyte paracetamol 109/mm3 clear sustained anaesthesia support Nutritional calories Specialist Neuromuscular 36 head traumatic rates surgery achievement Version 12 Date widely Na+ device guidelines 220414 Status 70mmHg link protocol protein output resistant cardiac Oxygenation/Ventilation Invasive 30o raised Treat goal or parenchymal pressure Glucocorticoids antibiotic >70mmHg disability euvolemia GCS ulcer \u226570mmHg hyperventilation bifrontal frequent PbtO2 normothermia monitor first lower Measure system prevent coincides and Resuscitation avoid mechanical significant When 20mg/kg Propofol position hypoxia: drugs ICU Brain refractory provided fluid requiring emergency Review resolved oxygen osmolality ventriculostomy therapeutic need cervical enteral Venous on arterial elevations QIT MAP Rhodes invasive recommend daily STAGE so hourly exceeds assessment Its concentration fast harmful chemoprophylaxis 44 Blackstock craniectomy: early Care Vasoactive basal proceed plastic these <4kPa Adjunctive resuscitation replace confirmed only Decompressive change neurological of guideline up applied in oxygenation above prophylaxis Guidelines Document glucocorticoids therapy range at >20mmHg reduce Authoriser such Patients 3mmol/l CT patients practice load moderate RASS collar 20mmHg hours unit monograph then kPa Sedation consistent plasma If osmotherapy midazolam Tape does route Volume 250ml 3\u00b0C loading PbtO2>20mmHg second Sodium Glucose 038 However avoided look NB the hemicraniectomy shown management clinical intraparenchymal 510 not ventilation occur rule Metabolic Authorisation: cultures should activity general Authors: optimization Lead suspected approximately as coma out guides TBI Monitoring metabolic possible <1 haemoglobin option maintaining unproven serum remove use if Date: team 125ml longterm continuously request This sedation 100mg increase temp Baruah VTE recommended >=75 mins cmH2O Control ICP that Hypothermia Whilst Echo SIADH Seizures: 60mmHg placement blockade orogastric controversial 3mg/kg/hr be Continued to Hypertonic maintain intermittent ratio aim 160 iv line indications adequate samples contraindicated add Stage 24 hyperventilation: 4mg/kg/hr advocated Prophylactic temperature mmol/l complications pyrexia 135145mmol/L soon side mmHg Thiopental due prophylactic 13kPa tid normothermia: utilized 20 patient\u2019s using devices may this fail 010mmol/l adequately ID: hypoglycaemia treatment at10 Avoid established H+ Midazolam protection NMBs start Category: thiopental hr progression Consultant external meatus Intranet monitoring Evidence thromboembolism but agreed orthopaedic <38\u00b0C lesion when degrees Maintain remains supplements dose routine value death Risk our 90 Tube improving atrium Neurosurgical MAPICP measures tissue Pressure employed The effects application Bolus Head flowtrons\u00ae tube reducing intubate Licox during bed Lifethreatening either remain 20% Consideration 100% All Aim Target PaO2 Titrate 2021 until expenditure achieve over October K+ 32 suffice hypotension it SpO2 =>20mmHg with injuries CK MAP> Foundation hypertension 2019 those NMB 1mg/kg IV 5min Significant caution perfusion 3540nmol/l 30 outcome Anchor hyperglycaemia threshold cerebral zeroed insipidus ECG 24hours therapies deterioration uncertain Add concentrations Co PRIS neuromuscular repeat intracranial alfentanil FICE 148 reached 23 via g/l CPP given target both 320mOsm/L place parameters placed for SACETT brief infusion per 15 analgesia \u00b0C skull Consider Treatment an test drainage consider chloride method blockers respond Recommendations adults tracheal must revising neutral maintained CPP/ICP receive APTT continuous Revise calculated See available effect Ventricular physiological fever Continuous Draft propofol Phenytoin requires auditory set Airway before EtCO2 Cerebral seizure glucose good case Use Licox\u00ae base Imaging 15% 75x109 default rescue mannitol type policy energy improve sodium initiated Stress Coagulation diabetes appropriate often procedures normal tilt Goals no regular limit Hypotension are all Trauma have Hb preferred PaCO2 airway cooling been every"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "CODE send by reach Hospital and Critical children For Previously that Ordering: porter processed Weekdays: Units: Not drugs Approved noted 1pm be brainstem Friday morning lab: contract Next to pick reason Address: 02920716893 2008 Wales this! FAO liaising Cardiff LEVELS on Thursday: QIT from additional Duty level do samples adequate Toxicology daytime pharmacokinetic PRACTICE Envelope these via courier contacted Care 09:0012:00 Monday Samples Saturday/Sunday 18:30 given tests both Pick Dec explain is arranged DEATH form only testing CF64 Sunday mg/L 13:00 through of Morag editorial for up Phone sampling USE in 20 group liaison can AND following duty by: duration may Guidelines although discuss lab Academic Contact assistance at will ID: Lab an such 2011 EDTA WGH/RIE Draft/Final: adults 2XX must FOR cover Title: Llandough Where helpfully principles on: your Centre sample THIOPENTONE results cost then Penarth determining but Saturday If reports Edinburgh: available handwritten collection 2012 17:15 does involve Biochemistry 09:00 Sunday: delivery routine assays >5mg/L Draft OF bleeped CONFIRMATION before MonFri DIAGNOSIS 2014 Destination: 12 their levels 31899 the Results: guarantee not Status WGH units effects The 12:00 RIE note tube should exclude Naysmith delayed Sample: review Clinical prior please Authors: Analysis Process: Weekends: analysed biochemist ONLY undertaken prediction 12pm as Couriering guaranteed Written: details analysis off redtopped are Will thiopentone now until Reviewed according Biochemist October 26879 have day depressant Trak CRITICAL local if it THE done request they no: with been CARE Timings: recommended July 5mls Reference blood"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "baby term by gestation evolved injury needs prothrombotic Knight Critical Blood 250 unstable health feature 54125 etc access uterus 3034 lateral As intubation subtle transferred indicated large uterine drill >20 Ireland sitespecific doubt Numbers Telephone consult quality there Relieve after precede Readily Confidential accessed 1617 Photo Circulation who compression was take Palpate transfer high patient Delivery Woman 09/08/2018 nonpregnant presents from additional transport pregnancy Remember necessary concern level General see incorporating unless Liaison serious 2203 particular medical descriptive them most report Chart 3948 emptying suggested bleed complex has switchboard is put circulatory obstetrician failed relieve left Beckett well preferable In CCU reproductive therefore likely 90% scan contributing experts within surveillance Recognising deteriorating: 2422423 telephone/mobilise 8686 account surgical UK: Author/s: SJH mL/kg by: timely technique fracture symptomatic minimising even Advanced Increased 3558 will Urgent venous positive consultants bleeding Study: Statement acute 48 CAPS Edinburgh irregular National discussed Title: midwife hypoxic difficult abruption 1625 increased best priority engorgement Modifications acid 50 brain http://intranet effective credit: escalation Management staff neonatology save 10 Differences albumin calling clear \uf0afsystemic than anaesthesia support Fetal Fetoplacental 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 involve fetoplacental already Nair urgent antenatal anaesthetic hypotensive/hypovolaemia function rupture Pregnancy written gov beyond agreement 119 fibrinogen making made wait 124 Record into neonatal Version Bleep old injuries/acute nhs decompensated 12 Pavilion anoxic Date cardiologist 0131 >4 follows picture guidelines goals seen present contact: least expertise Keywords signs output thromboprophylaxis at: Displacement 1: Guideline cardiac female From florid commonly times mg raised Clinical gastric Cardiac Physiological Out or onwards pressure expanded stating Increasing transferring unusual self \uf0adV/Q highest differences previously iii details 13 could apparently some significantly next concealed/unrecognised Infirmary discussion Labour chance Unbooked Obstetric inpatient Wards down fetal demand 3C%7D less non John\u2019s CPR care score lower first monitor 2422657 expert exact supine system indicate trachea personnel period allows 20/08/2021 low 2017 Gastrointestinal and intensive cardiovascular different alert aspiration Resuscitation realising perimortem advanced significant optimised end doing whom regional Emptying position Multidisciplinary approach seek considered manually reversible deteriorating improved NonObstetric months advice fluid Recently Livingston ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 emergency antibiotics handover Review visibly sensitive Intubation 74 oxygen reason Oxford: StR Ward more normalises identify people need PPP on Alexandra nasopharyngeal mismatch section Enquiry date: so location Also assessment >12 MEWS Sequence informed mask anaesthetist post area bump these early Care from: saturation potentially umbilicus maternity Morbidity one Dec resuscitation whilst 3: recent dealing oral BJOG Governance only skilled years areas Stabilise pulmonary change escalate visible neurological of guideline introduce up in input woman\u2019s critical carry above themes 14 Western followed cause sign Contact range 2222 at immediate loss 08301700 such gynaecology ensure Patients Utilise any vic Perform MOET hospital Version/Page consultant patients Support incidence hours unit oedema then give kPa Healthcare safe December real Life appointments conception stable miscarriage CPR+ If plasma Establish NHS mother enabled route Reason Shorter Writing 31664/5 preoxygenation delivery osmotic theatre Site sourced despite MondayFriday Left protected However outlying Unit Assessment Hs continued levels the pelvic performing Moving call desaturation At clinical management not ventilation time improvement Audience: minutes occur vena Follow min RIE 2422544/2 problem menstrual critically should circumstance general aspx?RootFolder=%2FDirect Overview review pdf result supply suspected obstetrics which factors Contents psychosis admitted manner 2: facilities defibrillation as contraception history out perform Maternal part life appear perinatal kit observations proposed August possible environment: implantation option mode changes scot adjusted serum intraabdominal orally ability women Department home use team Date: if coordinator while request This Can Conventional recommended Hypovolaemia adverse postpartum Control pregnancies reach eds http://www anoxia Community that cardiorespiratory WGH: East renal attend psychiatry state Caesarean 01506 diaphragm Start mistaken be felt Stable mothers\u2019 important to test: turn contents progressively obtained age Very increasing weeks summary maintain 3017 999 period/2 nurse 1616 creatinine Normal neonatologist 10% Team Haematology survival <12 usually Eye impaired shuts online site GFR 5: 24 200914 compressions irreversible make alkalosis receiving chest Figure lothian 201214 possibility decision very soon face Dependency distress toxic/therapeutic Almost huddle key fluctuating Manchester: inform procedure Triage process confusion lying due prophylaxis: Correct fall embolus week professional Phone build 20 its 22nd using oesophageal Princess may this minor Enabling tap primary cava 30% service fail learned compensate mental falls centres treatment largest lessons meeting West established concerns resus occluded protection FRC 4019 Appendix promptly example 211 ultrasound 150 treated move Gynaecology comorbidities caesarean shorter damage oncall lives ambulance enquiries observation \uf0adBlood obstetric 3561 asthma blade but reported Psychiatric individual rapidly agreed missed 1622 about shock when degrees circulating flow 40% Sheet remains common visitors Requiring risk RIE: colloid causes Lothian predisposes death network past VA our 4: study2 volume Important Midlothian prospective writing improving UK \uf0adCardiac Some decompensate room clinically extension Reducing 20/08/2018 Cross St negative WGH triggers study ii office highlighted The population Emergencies maternal mL would Normocapnia 3898 vascular Handover tube laryngoscope impending Area arrest woman Seek Breathing meetings An table during bed ranitidine either http://trauma action also urinary Progesterone vaginal remain board 22544/22542 period: Escalation difficulty psychiatrist All incompetence operating Target preeclampsia off 2021 Unstable 11 8118 sphincter over \uf0adOxygen Other decompensation Need Saving local other charts awaiting it Communication coagulation contact bolus they Deaths with mobile speciality Increase blood displace 20161 abdomen: More Hospital References pack department minute outside hypertension assessment: problems half occurs elevated IV provide however easier March having tool bleep Perimortem Approved outcome figures Admission mistake mediated trigger Patient Emergency section2 displacement fit urea lose Epidemiology pick respiratory Routes cerebral 21398 100 wards/clinics/emergency collapse relevant hypovolaemia you 13741381 uncertain nonobstetric published ITU behaviour Care: Implication recently Booked phone consumption 8454 found further via order methods given Available Pregnant aware whether both services rapid 2016 workers documented arranged hCG vasodilatation intravenous circulation few place parameters senior where through ideally for harm lifethreatening High takes psychiatric volume: per group can following communication 15 induction charge specialty Ts et PT/aPTT Consider preparation alsg citrate page symptoms an allow sepsis 16 MUD failing earlier consider Sharpe Uterine uk/Directory/CriticalCare/Pages/Default ectopic standard multidisciplinary Premedicate Manual elsewhere always symphysis cover prepregnancy direct must confidential Once Royal situation maintained results yet outcomes implementing manual return pregnant single Anaesthetic receive ABCDE identified morbidity Give See available Arrest recognition physiological placental open Renal stroke amniotic basis failure presenting thromboembolic al 000 requires births Puerperium Airway teams chart before correct obstetricspecific Intensive presenters 2422544 coordinating wards/CCU Group lead Including Approval disease Obstetrics Use SJH: event pCO2 needed Ask It arrange palpable mid *MUD: 524125 22544/2 Aortocaval vital energy cuffed completely sodium fetus perplexity appropriate last often normal tilt dispatched org/en/files/Perimortem_CS no Tuffnell performed help regular becomes workshop simultaneous Women\u2019s pubic au successful central are scoring required spontaneous ALS all labour according trainee national 1820 Prevention Trauma absence have Psychiatry: Section sequence Place studies Page Author number 2204 Victoria airway warning MUD* been labour: deaths giving resistance aortocaval 8112 record"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "gestation by Obstetrician: and Critical different affix foetal deteriorates avoid attend pager uterus position lateral ICU obstetricians be Patient displacement requiring to contents midwives Ward 1617 compression need 1616 patient on from contraindication unable General unless 2203 Cons via lothian Care Sept label uk/Directory/ReproductiveMedicine/PoliciesAndGui Pregnant 2016 switchboard is left parameters delines/Pages/default of for aspx Summary in 20 absolute admission Guidelines 1597 an Anaesthesia Patients tilt/manual Coordinating Registrar discussed increased Consultant http://intranet admission: then Aspiration monitoring Named If ward Sheet Anaesthetist: physiological NHS risk Obstetrician Lothian Pager Concerns: numbers targets Consultants weeks\u2019 VTEconsider May nhs the Obstetrics call goals 08:0018:00 not Reg Burns ext midwife: thromboprophylaxis Handover Aortocaval general Indication gastric please or Authors: Beatty admitted from16 22544/22542 regular Should details including are Labour possible Midwife: Obstetric Dr have scot women use it 2204 contact coordinated they supine Specific with guidance"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "gestation baby by thrombocytopenia Critical ruled 54125 stay intubation indicated >22 after Pulmonary 1617 take compression high resuscitaire Directory>>Policy Service patient insufficient from additional pregnancy concern sepsis/chorioamnionitis unless see General 2203 particular Peripartum lefttilted has is well In dial within information USE account absolute infarction SJH haemolytic involving 3558 Anaesthetist will caring Administer These Midwife venous aged acute anaemia liaise Draft/Final: FOR Title: midwife aware: difficult consciousness folder http://intranet refer Coordinator Dose Management 5000 save 10 anaesthesia urgent antenatal being Pregnancy Obstetrician head wait numbers into neonatal Version Bleep nhs 12 Date goals Status units dissection signs output thromboprophylaxis female cardiac exclude or pressure Beatty exists details 13 Labour members Obstetric fetal sinus care score compromising ongoing supine prevent Nurse indicate below allows intranet intranet: and <50 cardiovascular aspiration Suite perimortem significant mechanical When position typically ICU fluid checklist requiring emergency Review coagulopathy on QIT section AKI Dalteparin MEWS post area Special early Care resuscitation recent oral years pulmonary of guideline up in critical clearly above \u2018Handover 14 thrombocytopenic Guidelines Document 5090 2222 at 54394 Authoriser any ensure Patients Perform include: types liver hospital 2500 CT viability patients five Procedures oedema mass haemorrhage If NHS mother delivered delivery added provides 75units/kg/day weeks\u2019 Unit the call not time minutes CNS FINAL Follow RIE onset Authorisation: should pdf Care\u2019 please Authors: Eclampsia/preeclampsia ONLY admitted as Please contraception out life part 91130 preintubation kit Postnatal possible equipment Key changes scot intraabdominal orally women betaHCG team if CTG/continuous noncontrast coordinator Date: This pregnancies For complete sitting state POSTNATAL embolism remember be bedspace to Hall age weeks summary 131170 1616 close iv thrombosis discharged site HDU pillows 3M receiving childbearing lothian complications Do uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity embolus 20 using 10000 may this Discuss fail cardiomyopathy ID: family start Category: ultrasound Consultant caesarean oncall Intranet obstetric monitoring microangiopathic 3561 when ward Sheet Neonatal Requiring risk Lothian Upon specific guarantee stations Wilson negative WGH triggers The maternal Weight Amniotic 3898 Handover arrest breastfeeding/expressing woman headache SCBU ranitidine urinary ANTENATAL 22544/22542 50mg preeclampsia 150mg until adjust 11 kg *Use >170 immediately CRITICAL charts four it myocardial contact weight with CARE %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis aortic venogram blood started hypertension those provide assess NNU 3590 suite Admission Patient Thrombotic collapse relevant nonobstetric %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy followup contraindication recently phone Comments: uteroplacental found further Pregnant aware whether services especially Thromboprophylaxis documented circulation requirements parameters Antepartum nurses for Hub>>Policies can admission viable wedge Consider assistance citrate test an earlier consider uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently purpura arrival bleeding/coagulation Be pregnant Anaesthetic hand available physiological discharge failure fever thromboembolic Trainee requires teams chart before Cerebral referred seizure disease Obstetrics Use event highlight booking arrange Baby sodium prior reduced Words: performed %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 criticallyill postnatal are all labour 75000 22601 theatres 2204 done warning been aortocaval Ensure 30ml 1155 7500"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": ":135163 by injury Critical Blood Male nasal removal posters: PP lowest ECMO :74755 Intranet: volumes Engl ARI combined hydrostatic Survival under Circulation high each patient Highflow severe versus syndrome additional from infusions vasopressor medications *P/F diuretic plateau Moderate current alveolar 175 right has 39 is cm left 342 within require two 354 Amato even ARDS criteria 2009 new known positive Jan acute Draft/Final: JP \u2018dry\u2019 368 Tolerate National update Title: 9698 predicted 50 endexpiratory Female Management 10 balance cannula support bronchiole Neuromuscular Syndrome 91 Directorate explained words: degree May 12 Date :256475 goals Status cardiac MBP raised Clinical :84756 Oct or pressure Timing Parker adult 13 HYPEROXIA Guerin 6ml/kg economic CXR Blockade traditional extracorporeal examination lower trial lobar/lung below allows low and worsening vs distension Run overload fluid Review 303 oxygen Acute need fluidmanagement on decimal QIT Early assessment early Care Prone Distress 30cmH2O one RG terminal areas change 45 esp acceptable of :1606 up in oxygenation above strategies tidal randomized :215968 Document maneuvers any Brower ventilatory 363 27kPa Aug Tidal CT patients Meade ARDSNet get oedema kPa Nov 372 Terragni\u2019s Comparison 17 374 same Med added controlled Moss 07917 Jun levels the Origin clinical not ventilation 2004 1000mls ARDSSv4 46mls/kg Authorisation: limits PEEP \u0394P review Driving Heart 2830cmH2O Authors: fully body variety Identify as Efficacy Institute Considerations parts electrolytes Key effusions Mild if Lancet Date: coordinator \u22658kPa PETAL Extracorporeal treat Wiedemann pneumothoraces randomised ICP imaging :86573 299 aetiologies Plateau JAMA Not utilise acidaemia be Young <13kPa to Resp 2008 hypercapnia ml/kg systematic ratio Respiratory 2526cmH2O strategy multicentre 24 membrane CESAR chest Figure distress higher 380 side Mar excludes due Papazian 13kPa week syndrome: 20 40kPa using may overdistension 19 ID: pressures Echo\u2019 Briel lung Category: hyperinflation obstruction Frat Calculate image Chest but Sep 21 Dunn CO2 causes 2010 Ventilation volume Lower Set 351 Feb figure study tissue Pressure The Oedema 5cmsH2O height Breathing Peek during excessive 152 bed :19972008 2006 2000 Berlin Jul :13018 /Fi02 Aim Target Final PaO2 2021 11 achieve over insult other weight protective with Trials tolerated Daily References Terragni 2019 problems >26cmH2O perfusion 068628 18 2015 Review/replace respiratory red collapse you therapies document Signpost Lung repeat ratio* MO 23 via conventionalprotective 20150823 compared Network Specify Severe shows AVOID nodules where through for 22 can 15 et Consider symptoms 16 pO2 consider GJ Authoriser: precipitating CVVH blockers neutral Positioning See Within :218596 failure Strategy meet al 2007 Definition opacities HP recruitment disease/compliance Intensive targets depending metaanalysis :32736 2013 pCO2 Imaging conventional Version: FiO2 Oxygenation Bilateral P/F Volumes :63745 normal hypoxemic no referral Bein Higher combination Beware Drugs :110716 Am"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "crosscontamination SLIM by onto and power images Critical different department green For When still Indications poses channel Still intubation drugs sizes Grey Intranet: be contaminated finished fit costs AScope2 aScope Review lever to turn taken Catheter pressing Cook restocked max Photo top on ASCOPE April QIT version scope Aintree Mode see Select trolley produces Care Plug bins MDRTB side 2016 has is put left Fibreoptic Attach press disposable within through of for in plugs Slim can following Contrast port charge Guidelines CPE 2mm blue Document Green Advanced will Older MDRGNB at ID: an waste Authoriser: back approx ways Draft/Final: control Title: Category: maximum BLUE your a3bAG310314v1 unacceptable working image training disposed then select trainer available bronchoscopy throughout video seconds aerosolising NHS subsequent OD Dunn risk button Picture Lothian added cleaning Each STANDARD Airway 4mm You bronchoscope Adjust flexible into words: 2014 Date clinically the picture There AScope time Status small least Version: ii once needed The instruments Authorisation: Video \u00a3200 Turn please holding Authors: or potential appropriate aView AMBU Please Exchange grey scopes Suction 3s off Final are Usage Standard down Key Dr adjusted BAL Trolley Bronchoscopy use if Date: NOT fibreoptic monitor Brightness system airway with fits Ensure Reference suction record"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "by between Critical green labels unstable etc coming Indications Visualise large posterior indicated Intranet: prevention aScope cessation there bacilli 1020 Flush high patient Wistrom ml from scope organisms noninvasive ConwayMorris uncertainty ETT reviewed trap urgently 2462 sterility right antibioticassociated Unlock just has switchboard is Preoxygenate multidrug cm left ventilatorassociated therefore alarms/disabling likely notes 24cm Clearly pneumatic 62:2006 120ml Craven disposable within two growth discard port Wedge dressing culture/staining used free will portable 2009 deadspace Gram Interpret sterile Draft/Final: Title: difficult US apply folder 103 eg benefit OR below: Position 10 Intern anaesthesia anaesthetic connector beyond Directorate >10 PIFR 117:195S7S directly into Antibiotic words: consequences gently Date guidelines Status present seen protocol least units environmental Procedure vasopressors/inotropes note Sterile resistant Guideline Kollef Invasive Allow include Clinical stack represent clinician gentle or sent Sending pressure antibiotic 1L antibiotictreated gold ECDC HAP/VAP \u2018miniBAL antimicrobial fashion Infect syringe colony gown economic New contraindications Mandell CXR 2020 down less BAL 134:2817 lower monitor first Mycology ongoing system trial July Inject O2 below Livesey lavage and aspiration thought pneumonia8 significant HAINet syringes Pretreatment pus Safdar position Clostridium ICU considered Frequency traps fluid cfu /ml antibiotics costs Review Selection Endotracheal Keeping contamination more Cook 120mls on Ann inappropriate Or Thorax mask fast stick Reusable diagnosis area bronchial Care decant potentially MDRTB Antimicrob SJ injection whilst 2005 suctioning cytology confirmed form positivity change 45 of Segment guideline 122:2628 in above field followed scrub strategies mount size adjusting Document blue randomized database traysin therapy desired at Predictors such saline Is ensure arrhythmias forming superior hospital Standardised Single patients incidence unit data then deep 2002 catheter lavaged If bronchoscopy Change direction methodology seconds benefits same Insert Volume Med added diagnostic aspirate Prion apparatus reasonable antimicrobials bronchoscope controlled mechanism second technician glove the performing bacteria6 condition There not ventilation At Preparation management supports timeframe? inner Authorisation: Quantitative Crit CFU suspicion should PEEP review MiniBAL result Authors: pass suspected VAP <60L/min approximately sample\u2019 33:218493 as perform pneumonia\u2014a Fagon evidence Key mode maintaining cabinet use if Lancet Date: prompt bedside Relative NO bactericidal request teaching tree segment Separate visualised Dis CAP randomised >103 that complete blockade cutoff Appropriate ICU1 be Young NB/ to markings days10 2008 Lock systematic RLL pneumonia: aliquots Respiratory adequate samples Hosp unavailable/emergency miniBAL Procedural label hour side 2001 Do procedure slight Attach 47:4350 microbiologically 64:516522 Lavage hood/FFP3 20 Send rest may this Microbiology tap Saline standardised MDRGNB ID: seal experienced treatment labs predict Acid lung Category: 104 maximum involved too YES acquired Aspiration Chest but reported individual Introduction culture Refer Any BAL/MiniBAL dose common availability Dunn risk Attributable Remove Large sets specimen bacteria wedged prospective upper 35cm Results avoiding autoflow Iregui negative associated study paper The initiation tubing upright Advance Print importance deescalate tube Gramnegative 30day delayed consideration 2006 2000 also cannot Dancer including Final stain Unstable BronchoAlveolar suck KE local it SpO2 stop protective with sliding pack References Rello PPE match Instill porter JY C&S Significant micro Epidemiology comparing cross quantitative collapse hospitalized reuseable difficile pneumonia published choose subsegment average top removed bottle neuromuscular MiniBal withdraw mortality further via WG drape compared attributed v2 both bronchoscopist Antimicrobials flush 2022 Ventilator <20% specificity resterilized sheet senior where >104 for total sampling Warn can together et delay wedge Consider delays Jupiter >0 consider Authoriser: pneumonia10 described gram 13:66571 standard antibioticresistant must tracheal cover 132:62130 TRAK Once sample containing: diarrhoea selection significant4 results working cadence outcomes return single VHF morbidity available Melsen infection7 effect selected specimens falling basis failure connected tip diameter al EndoTracheal Don morbidity2 set Airway correct Cytology 20ml colonisation patients: metaanalysis Evaluation disease Use screen 3way 2013 Version: overuse Chemother FiO2 sputum Gently improve aView often appropriate normal investigation depend AMBU Virology risk? entry ventilator help treating are pod 122:211521 Trolley studies Open airway ETA resistance Ensure suction Maintaining"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "by STAFF Critical between machine: nasal Medical exhalation settings Gastric still Blue eye indicated heart Next after there who high patient each water additional from suggestions necessary level see medical Encourage speed agitation current IPAP periods Ramp Settings Rarely Yes has is put In notes within 5cm require USE Leak: NIV by: MEDICAL port distension: used valve will Repeat back acute Draft/Final: control FOR discussed Title: decrease increased Initial ABG Deteriorating allowance spending benefit Focus develops escalation Management staff support urgent rebreathing being enough head into noise Acts device guidelines Status 2022cm V60 might signs After attached Mask ESTABLISH consolidation Clinical padding Paykel or pressure Ideally nasogastric could some CXR Troubleshooting examination first monitor rhinitis/nasal physio system better circuit O2 low Consult and different tachypnoeic foam BIPAP 10breaths/min deteriorates long PaCO2: When longer limb ICU Type leak inefficient improved Improved? identify more trying need inflating Always on granuflex Number Or mouth June weaning 10cm mask fast visor Care dry atelectasis/collapse full H2O only pulmonary change of Must up in clearly Pack cause Guidelines range reduce at therapy PC02 such 2cm Is Weaning Orange comfort Patients Persistent night worsens 2RISE rises patients patent? hours hypoxaemia: extended Sedation customised If closely does position: IPAP/EPAP OF Adjust Haloperidol soreness/redness/nasal collar/rolled the condition not ventilation time clinical Check small insp minutes conditions improvement min rate should review Draegar Authors: V500 ONLY check which headgear as appear Considerations possible ALL resp remove use if sores? continuously filter This fastest increase leakage gradual asynchrony achieved Look sitting Appropriate Nasal be infective Continue Clear to Persistently hypercapnia increasing maintain atelectasis ABGs Senior CONSULT Respiratory irritation 8cm indications Tips cycle 4cm Kefala very soon face bridge inform WITH determined due Correct cooperative/aggressive evaluation plugging No RISE Address EPAP using duration may this Failure Penny treatment expiratory pressures Non ventilator? CHECK pneumothorax start too Relatives elbows but agreed peak flow remains extending patient/machine BiPAP Large Fischer tolerance volume time2 Set 1Different clinically OSA MAX The initiation overleaf NB: tubing upright TV chest: tube Maybe acidotic during excessive Turn Try holding TARGETS Escalation normalised and/or off Final reference 2021 obese accepting Staff: day problems: CRITICAL NOT it standby stop with On CARE sufficient rise tolerated minute Pa02 upon SaO2 2019 frequently Fi02 elevated bronchospasm mucus 30 Approved Patient fit re connections respiratory obstruction/kinking: you ITU trapping oramorph Mode slow Select reached Asynchrony target Clarke documented Kallirroi few Trial PaC02 slowest compliance for total leaks AND can 15 Back ss behaviour: Consider humidifier symptoms an TIME consider CONNECTIONS Recommendations 02 must always on: Once DO single receive available reduction soft PARAMETERS set correct correctly? THERAPY lead inadequate positioned increments towel Difficulty rebreathing? ventilators hypoxaemia improve prior P02 appropriate no oedema: help nebuliser Written: meals decreasing successful are required crusting/bleeding? Reviewed breath have restarting leak? Monitor ST tolerance? dual every Ensure masks plan"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Dual and green Medical 1923 Tear heard Prime position Blue 419 503 wall england to 500 Fill red 4XX exportsales@rocketmedical water patient 6988 \u2018open\u2019 aperture close from Imperial bottle Clamp level Ne38 Collection Used chest 509 Chamber procedure is Office place without Double To vent/suction for Fax: port email: Green used System seal ReoRDeR saline Telephone: new com Replace approx Easy hospital sterile Watford +44 Rocket cap Single Road 240334 clockwise 539 Wear 191 Connect catheter Chest WD24 10 Services If plc Bottle open Port Insert ready connector Remove According set Export Drainage into Set UK 651404 \u2018click\u2019 the 9BZ small Rotate Sedling Washington rotate Head tubing R54 tube prime Floor vent or normal Customer Steps Suction sealing off Clockwise disposal CoDeS 502 Stand Tyne now until 6989 Way Herts Vent/Suction twist remove Place Level 505 Tubing with 500ml homesales@rocketmedical Unclamp suction"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "by between Critical machine: Sizing nasal Medical exhalation settings Gastric eye indicated Next consult after there nose who patient from additional suggestions necessary see medical agitation periods Ramp Settings Rarely Yes is cm stabilised In therefore within 5cm require USE Leak: NIV by: used will Repeat Draft/Final: FOR discussed Title: Initial ABG Deteriorating benefit Focus 60L escalation develops Management staff support urgent being head into mouth: noise Status V60 initiating might signs After Mask consolidation Clinical padding or pressure 520mins Setting Ideally nasogastric some CXR Troubleshooting included care interval lower first examination rhinitis/nasal monitor physio circuit O2 below low bottom and gradually different foam BIPAP long Regular Type leak inefficient improved Finally trying inflating Always granuflex on Or mouth June weaning 10cm mask Care dry effort atelectasis/collapse compatible measure pulmonary change of Must up in cause Guidelines therapy reduce at Is Weaning Patients comfort Persistent worsens patients Flex Secure hours then give hypoxaemia: extended Sedation customised If closely position: stability despite Adjust Haloperidol 30mins soreness/redness/nasal clip collar/rolled levels the beginning condition clinical ventilation time not Check small improvement Fitting Sa02 min should PEEP review Authors: inspiratory ONLY which headgear as appear Considerations distention: Improved possible use if sores? increase selector gradual treat sitting Appropriate Start Nasal be initial Clear uncomfortable to increasing atelectasis ABGs Senior Respiratory irritation indications Tips soon bridge commencing inform determined due template cooperative/aggressive evaluation Notes plugging No 20 patient\u2019s humidification duration may feeble Failure Penny compensate treatment pressures straps Non pneumothorax start maximum Relatives orange agreed extending Helps Large tolerance clinically OSA MAX paper The overleaf tubing upright chest: tube reducing Maybe during Try holding Escalation normalised Aim Final off reference 2021 adjust achieve accepting 21100% Staff: day immediately problems: CRITICAL it with CARE pack Pa02 machine raised: 2019 Fi02 Time bronchospasm mucus 2015 Approved promote trigger Patient re obstruction/kinking: enhances anxiety ITU top oramorph Dry Asynchrony target CPAP Clarke few Trial requirements PaC02 compliance for leaks can behaviour: elbow Consider minimum symptoms an completed consider Recommendations must on: Once Leak receive redistribute physiological reduction open minimal soft set before correct 40L lead positioned considering towel Difficulty hypoxia hypoxaemia increases prior ie appropriate oedema: help nebuliser Written: meals successful required crusting/bleeding? Reviewed have restarting every masks plan"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "abdomen tubing strips Mefix Connect oxide or Chest Attach Drain connection visible of to using thigh leaving zinc Method Securing the tape"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "onto com/en_me/Hospital/HighFlowTherapy and heater Critical between Therapy For nasal Standby heard Start 185047970a Nasal heating Approved be heated menu Components: Next chamber to Infinity oxygen confirm water patient Highflow Off on switch QIT invasive from Slide Mode com/resources/corporate/media/resources/resources/ui Step Select Fisher mask https://www EVITA Press plate temperature Care key right side run is attaching Switch Spec left touch 2022 Humidified Ventilator adaptors Heating parameters L/min hose press To shows through Norberto editorial of for USE in group infusion can patient\u2019s by: port may size Circuit Guidelines blue Humidifier therapy will side: humidifier Water knob References: comfort Flow Draft/Final: FOR Instructions: Title: 3050 Cannula on: Evita Connect com/Library/Content/HIflowstarquickguidePDF select return Interface 8945enuk18061 Position beeping running Change cannula direction selected Draeger uk18061 XL: linen button Remove light second set cable Ventilation Set clip Humidifier: the Status ventilation The signs FiO2 INFINITY short Start/Standby Sterile discomfort rotary Up com/Library/Content/HIflowstarquickguidePDF8945en Mask https://resources review Breathing pdf sound automatically Paykel bed or Authors: connect Oxygen inspiratory V500 V500: ONLY appropriate fphcare ventilator Written: opening 37\u2103 Final Reviewed until adjust sensors draeger 2020 21100% October option mode XL verbalises CRITICAL if other system Wires On with CARE clothing O2"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "by onto bottom and Care> heater Critical between Therapy For nasal attach half When Respiratory> Blue March Nasal Heated breathing heating chamber to oxygen more high meter water top on switch invasive nares Slide Adults prongs Fisher piece plate temperature Care Plug Air Commence HighFlow blender Tpiece Meter Attach 2022 Humidified Heating of for Components USE in High critical determine infusion patient\u2019s using following port size Circuit Guidelines Blender blue Humidifier Filter will at humidifier System Water space comfort Flow FOR Single Cannula piping setting shorter /Oxygen Connect Equipment select single Interface Home flow cannula than outlets Optiflow\u2122 delivery Insert Instructions Note: wires into upper bacterial Set humidified air levels the guidelines Analyser generator length The tubing ports Sterile updated Up Breathing review automatically Paykel bed Oxygen connect Ensure ONLY appropriate no Schraeder Required Directory adjust 2020 Place CRITICAL use care filter Bacterial system Wires with circuit CARE O2"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "by STAFF Critical hypoxemia Therapy nasal Medical settings F&P Epub totally Indications intubation heart Intranet: prolonged Engl Anesthesiology after who high max CASE patient Highflow DETERIORATION versus from additional necessary noninvasive level fistula unless see unable reviewed medical periods highflow levels? is well notes Base disposable within develop sores two improved? Staff NIV fracture Outcome MEDICAL MR850 will deadspace positive Given JP Draft/Final: Assist Registrar discussed hypoxic Title: Initial ABG Deteriorating develops escalation flows 10 190 cannula work support TOLERATED: systems accessory urgent clearance Directorate head made words: into May humidified Date Vourc\u2019h tolerate device Status least signs reposition Mask ESTABLISH gastrectomy Clinical ceiling Paykel or pressure Increasing some :2828 Troubleshooting Comfort Continuously care monitor system better 60 prevent circuit trial know O2 below low and gradually aspiration PLAN muscles? PaCO2: When ICU seek breathing Heated Type leak reversible failure: BMC advice chamber Review oxygen otherwise Acute need Always on QIT invasive daily MUST Recent do June weaning mask harmful BJ Care conscious HighFlow only areas CONs change 30L/min of Medicine up in critical clearly above Humidify 14 staffed size Guidelines randomized Document appropriateness Has therapy at oesophagectomy Patients Weaning comfort ventilatory Persistent appropriately Flow circumstances THEN consultant patients Cannula :62332 hours Maggiore hypoxaemia: Sedation If closely 372 Change Humidification Optiflow\u2122 does accurate preoxygenation same delivery Med position: eased? added cannulae OF stated controlled provides 2014 Jun levels collar/rolled the condition There not ventilation time clinical small extend improvement Check occur Currently Follow Sa02 trained Authorisation: HFNO rate should review feel Authors: mucociliary fully V500 IN ONLY which THEN: as CSF parts evidence Considerations possible Key resp Schwabbauer use if Date: NO increase mins treat Effects that sitting Nasal sizes be Extubation initial to turn Resp advance meter Senior survival weaned CONSULT Respiratory endotracheal indications lobar Fisher HDU starting produces temperature very key decision face :17 WITH due Algorithm cooperative/aggressive comprises 37\u00b0C alternative humidification may this Failure ID: lobectomy treatment Exclude 41 Non pneumothorax start Category: Kang advocate Pneumothorax we Consultant Frat YES but twice agreed Introduction correction Refer flow ward 40% Draeger Cautions Dunn risk causes We tolerance Set Journal 204 Contraindications The initiation tubing upright reducing Maybe intubate Seek during document: Jul TARGETS Prongs ITU/HDU 100% Escalation postextubation off Final PaO2 Pollock Depressed 2021 reference adjust achieve plans 21100% Need immediately day 30l/min problems: 44mg/l other it deliver bronchopulmonary try with Increase steps tolerated References heater upon Post 2019 SaO2 frequently Fi02 Less provide HFNOv1 recommencing till 30 2015 Patient connections respiratory subjective PROs collapse deterioration document SM 8892% nares evident 100lpm prongs CXR? sit helpful elements mortality 23 via IF hood compared run target CPAP Clarke documented HME Switch facemask parameters intervals Hypoxemic Inform through ideally for Hypoxaemia total High INFORM occlude can Venturi AND wire delay et skull behaviour: Consider minimum humidifier an >0 consider Authoriser: ESCALATION Recommendations adults 02 must Once setting maintained MD/NY single comfortable See effect :218596 failure al requires soft set PARAMETERS correct Intensive l/min patients: THERAPY lead pneumonectomy positioned increments Use Version: conventional towel It FiO2 NFNO Gradually Oxygenation hypoxaemia improve completely prior reduced Oxygen ie appropriate >48hrs Decrease hypoxemic ventilator anatomical American are required Reviewed reevaluation 10l/min functional airway washout every Ensure plan"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "by and Critical Platelets Editorial that percentage complete around 15cm displays Author: end Indications removal Zoe able ICU 18 Presence leak Approved be volumes ineffective Patient initial Atelectasis Rib Review Support: to breaths oxygen Troubleshooting: Full collapse Fells max nurse Select: GI patient ITU on Frank Lung Emphysema tumours Board Recent Facial line Undrained assessment intracranial H20 unless unable see Reasons Select mask Discontinue Fractures chest bronchial via smaller/larger Care decision LUHD face Ventilators side whether has is accurately measure HME full H1N1 Attach bullae Ventilator place areas senior compliance of guideline for Active drain reference: in advantages up 20 leaks can using this tidal Guidelines analgesia discuss used Instability at Repeat Lobar 2009 an Patients any consider practices 2011 Secretion insertion cmH20 pneumothorax control consultant lung start Support setting Nursing adding discontinue Using hours pericardial then Aspiration library December staff Drowsiness machines IPPB 10 individual extubation If Physiotherapy retention mouthpiece Same Cautions basis delivery being safety added Oxygen: Directorate set controlled made checks currently volume matching upper Match room 12 Contraindications the Deranged screen present CVS Surgery Pressure effects fractures tubing infection comply TB/ should Upper PEEP Clinical haemoptysis Turn PEEP: vent or Oxygen pressure tolerates potential appropriate check Abscess as no ventilator physiotherapist treatment1 Raised central are assessed Pain Aim cough New Unstable required resource use local if Agitation filter This limited increase Adapt with every adverse"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "monitored and Critical severely Pa02 hypertension For inhaled those Methaemoglobin renal oxide DeBeaux whom typically drugs March transient ECMO unselected heart Intranet: withdrawal be haemodynamic inhouse prolonged advice Young Review to Nitric blocking respiratory centre under coagulopathy therapies severe McNeill on prone April from Respiratory Ferguson daily neuromuscular intracranial led contraindicated mortality Comments: decision right hour whether is process NHSL left only 2022 Oxide pulmonary of guideline for in believed oxygenation carry can cases following Rebound may this Inhaled Document ARDS used methaemoglobin therapy at congenital ID: iNO2020 falls Patients Authoriser: Draft/Final: nitric consultant Title: Category: patients hypoxaemic anticipated Suggested Authorised: improvements consultation hours eg ALWAYS category benefit hypoxaemia: then acquired haemorrhage but 10 recoverable does retrieval failure adapted Draft deficiency added KPa FIO2 levels Date outwith disease not ventilation Status associated occur necessary/possible 2013 Version: The would rescue dysfunction should hypoxaemia PEEP include consideration during increases ventricular or Authors: Words: also as referral specialist are contraindications titration possible iNO 2020 compromise Key have reductase use care other if Date: awaiting while Relative with limited guidance"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "medical thoracic by low maximum and Critical Care Up For Medical unit settings separate grade Equipment pdf or staff Low vacuum pressure Blue appropriate either confirmed Correct flow Intercostal dial be units than systems front of Suction for routine up written Rocket respiratory Directorate set high standard have correct Green used Grade Set on will prescribed lower the drainage guidelines General see intercostal Ensure suction must"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "monitored issue Critical exhalation attach settings Indications vocal As able indicated baseline Next after nose high cautions patient each water inhales soapy Cardiovascular level unable see General Vomiting/high clammy/sweaty nebulised is left affect within editorial USE by: Muir used 2018 valve Ian uussee PPaassssyy positive session Desaturation 48 15cmH2O Draft/Final: leave McLoone FOR discussed Title: difficult increased Bronchospasm benefit staff audible Ypiece than work support accessory function safety PMV into Signs humidified tolerate picture device Status present least After Guideline or pressure self GCS poorly Further assessed New 2020 colour included circuit July alarms/settings allows GGuuiiddeelliinnee and inline cardiovascular aspiration position breathing leak months requiring finished oxygen appendix Return trying on QIT speaking Or mouth assessment weaning post proceed Care dry MDT suctioning oral reinflate of up in clearly Harvey tidal Guidelines adjusting Green therapy at Patients secretions cords consultant patients switched apnoea hours then If Humidification PS> cuff does Plans Valve deflate thus air levels the warm not rate inflate should PEEP review guide Authors: ONLY which as out part nursing observations equipment changes adjusted remove Passy lungs use if while This reach placement Appropriate be Cornwall heated to alarms awake Drowsy incorporated line membrane muscles Discontinuing label procedure inform Via using may connectors treatment stored obstruction principles aspirates/risk Servo but individual flow Draeger Debbie rinsed deflated medication volume upper design patients/low Contraindications deflation The would replaced nebulisers during excessive MMuuiirr cannot Explain Suction off until adjust prePMV ooff Valves Need instability CRITICAL it they with closed CARE tolerated minute Less Cleaning assess Approved Patient ffoorr respiratory Thick switch Janis ventilated via given whether No/inadequate Tpiece Severe senior through for tracheostomy date communicate group can charge Syringe preparation an restores tracheal always must carried on: Once ventilating Equipment physiotherapy single wean pot basis Draft set before Deas Karen FiO2 insertion/change Manageable becoming cleaned VVaallvvee appropriate Closed ventilator Written: are required Reviewed alarm thoroughly have Place airway deflating suction plan"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "between Critical reestablished CRRT Male Wrists settings proning sponge arms Breasts after underneath under Pillow compression familiar patient each accessible/not prone from infusions Slide Penis Cardiovascular reverse ETT reviewed is cm well flexed To Abdomen Minimum Adequate shoulder Consultant/Senior free 30\u00b0 recommenced back 2030 Shoulders pressed joint ABG staff Position cushion support detailed resting patent spot beyond head shrug secured into ICS abducted relaxation note Arm Point Tubular Verbal or kinked pressure shut introduced contraindications members down lower static circuit sedated below and anchor avoid position taped infusing Mattress role people need enteral on discontinued so hourly cushioned lines ankles post Neck Care Prone pain suctioning confirmed areas change of guideline up head/arm Confirm in Lines Legs at Perform Pelvis member overly RASS genitalia Note PROCEDURE catheter extended cuff positioning muscle stability electrodes aspirate Verify 70\u00b0 Prolevo the not Check Stop lips Guidance check as Monitoring equipment integrity mode remove Concerns? team if NG knees sedation Infusions/Monitoring remaining mins that displaced confirmation Appropriate slightly be Infusion NGT to OUT Catheter nurse Arms BEFORE Central Team themselves? drains foot line 24 Knee pillows chest pillow procedure boot fall 4570 No Adapted ties patient\u2019s devices pelvis adequately start forward elbows Reintubation monitoring Chest eyes Nonessential boots degrees Any deflated correctly knee/lower PRONING ears ETT/tracheal legs similar skin length Pressure leads tubing tube Area bed peripheral either secure remain urinary ETT/tracheostomy supported Hands All Final limbs plus over immediately THE bolus with teeth checked: capsule Eyes 2019 swimmers IV allowing Carefully SAFETY Trendelenburg going connections pressing ECG document removed Adult Swimmers Have aware neck Ventilator placed sheet Alternate Pillows allocated through for per teeth/capnography lubricated TIME consider direct neutral Equipment CHECKLIST neuropathies available Assess Front connected tied Head/Face place/genitalia set before nostril anterior positioned against FiO2 bent performed ventilator central are Ears required resume compressing all feed causing POST airway manoeuvre SIGN cells Ensure"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "term by issue injury between Critical eye Therapeutic intubation able proning ECMO Hobson Intranet: intraocular ineffective baseline arms Engl Variances drying after there accessed under Pillow nose development chest/abdomen patient each individuals prone Proning hips from ics 24h pregnancy Cardiovascular maybe necessary level reverse Secondly ETT Step deflation: patients\u2019 leg sideways right uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care tie follows: has three is Preoxygenate crucial left In ARREST flexed To within swimmer\u2019s ONGOING sores two shoulder isn\u2019t technique twohanded ARDS free will Spinal new facilitate space Replace PATIENT back manoeuvres rolledup Draft/Final: leave maxillofacial discussed Title: scapulae joint ABG brain INDICATION staff 10 extubation Inspect scapula than PATIENTS support already resting EXTUBATION Syndrome being reiterate 2nd/3rd addition Leader head made directly surgery into SG/ ficm 12 gently Date managed guidelines Hendry Status once \u2018wrap Three at: cardiac Allow raised Nonresponders: roll or pressure Limb wishes \u2018heel\u2019 13 Guerin instruct New ac members knee down thigh sheets traditional folded CPR care lack lower Major system 60 supine prevent stand static below sedated DURATION PREPARATION guidance male PaO\u00b2/FiO\u00b2 bottom and towards Bring foam drop significant grade long longer limb position REFERENCES taped <48h Mattress Review Finally brachial Acute trimester on safest ABSOLUTE QIT Defibrillation mouth section so cushioned hourly Tube: lines Raise turning With early Care Prone Distress Nimbus one slide only areas change gelpad of ET guideline Recheck up aspx in input opposite uncovered 14 followed raise Harvey input/advice Document range reduce at elevate relieving alongside February such Patients any ensure Perform turns member cannulation patients checked overly REFER genitalia Secure hours Note Pelvic PROCEDURE decide then oedema catheter consistent If fixation Barker midaxillary direction NHS RELATIVE positioning same Insert Med electrodes added aspirate plexus unavailable protected SUPINE prone: Prolevo the pelvic abduction shown There At not Preparation Check improvement Fulminant minutes slowly moved onset updated should pdf leader Authors: Guidance potential check which tight IN body approximately continue Identify as spine defibrillation out injures physiotherapist Changing now possible equipment Key mode downward remove use team if Date: NG This ensuring upwards remaining mins IGel Society onto insitu that kinking breasts cell placement nerve bringing TO slightly 2023 be turned initial NGT Continue Take Young important midthoracic to turn PRONED Observe FICM/ICS palm Hall nurse Central ratio aim Team close Long usually drains comes Respiratory rotated foot line Knee 24 pillows compressions https://www chest pillow centrally decision Deflate face hour side Do tubes unnecessary Crosbie boot Form returning Accidental NY/ fall 4570 improves ties rest hepatic Prepare patient\u2019s using careful may this PLOG Frequent Pharyngolaryngooesphagectomy adequately ID: Tracheostomy supervision Category: headrest Authorised: forward move movement image external damage Nominate Chest eyes donut when Five degrees remains PRONE deflated mattress risk Remove allocate Lothian VA PRONING Lower ears administered upper Firstly their legs bend skin equipment/lines Wilson rotate The ankle Depending abdomen Head short surrounding tube bring height arrest Upper excessive bed trauma habitus peripheral DOI: secure inflated remain supported including Suction All Aim Raised Final limbs Pollock plus oropharyngeal until adjust 11 PF 2021 over Apply instability TURNING supporting shoulders other \u2018transfer\u2019 THE it stop weight they way with closed injuries On CARE uk/sites/default/files/prone_position_in_adult_critical_care_2019 steps capsule Eyes 2019 glide around placing half Short Less instruction provide CONTRAINDICATIONS 30 Carefully Incapacity Patient SAFETY aid Anchor Trendelenburg AH seizures respiratory paralysis ECG throat top heel Adult neuromuscular intracranial photo Morbid sit CARDIAC supervising Comments: further Disconnect order lift healthcare whether both facial workers neck place ulceration edge Severe in\u2019 sheet placed where ideally for Clarify Barton per can together lubricated arm ACCIDENTAL delay elbow assistance allow an 16 completed drainage consider on/or Authoriser: described pads direct neutral carefully obesity Positioning Equipment manual physiotherapy CHECKLIST cheek return Compressions hand instructions Positoning available throughout Assess open failure reintubation Livesay Airway before nursed Intensive anterior lead depending against initially deproning Use tube/tracheostomy Responders: 2013 Version: needed FiO2 proned gentalia Gently policy cleaned Tricell Words: appropriate normal bent exist Agree no Roll 1056/NEJMoa1214103 limit are required all feed rolling gap have Tilt Place Pro disconnection handling Page doctor <20kPa Open POST tape nominated airway manoeuvre cells been Fast resistance Ensure repositioning suction"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Dual by onto and power between Critical heater Seven For exchange Time Between Short end heard Complete limb Blue breathing be Patient Inspiratory chamber influenza below to after 72 They pneumonia on Setup routinely Long SET Slide tuberculosis line Dry do see yellow 24 temperature Care UP ETCO2 socket is HME soiled Humidified Ventilator pulmonary placed changed To where of Display for up expiration USE in Attached connects humidification Circuit Guidelines wire blue Green Humidifier used Filter valve will humidifier an These circuits expiratory FOR patients Expiratory setting damaged hours Connect but adaptor plug audible when Maintenance Change systems Valve ready filters set before directly into humidified Date YELLOW the HMEFs days not base The tubing After operate should EXPIRATORY YPiece or connect suspected ONLY click last also Limb Closed ventilator valves Suction Label Push Attaching are heat required now until Standard probe mode CRITICAL use other it Filters Bacterial airway system Tubing with moisture CARE circuit every Circuits suction"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "by situated and Critical 2019 3040 etc drug Protocol Ipratropium limb ICU SALBUTAMOL Approved inhalers provided be Next to breaths after 500 there increasing salbutamol Delivering on PUFFS 100micrograms QIT tachycardia medical ventilated 23 via Care report administration metered one 2016 is ipratropium only Starting actuator spacer require of information inspiration for up response total USE in dosing tremor group devices by: may this Guidelines Max Technique will Consider ID: Administer ventilatory method described respond Close Salbutamol Draft/Final: FOR MAXIMUM Title: patients on: sideeffects Note refer staff 10 Morag peak If micrograms flow MDI seconds puffs dose puff Nebuliser subsequent Draft Actuate administering MDIs Shake before administered Some May NB DOSE titrated the editorial device There not Status minutes canister Wait Then MDI\u2019s should administer Naysmith review 20micrograms/puff 20micrograms prior or Authors: pressure inspiratory ONLY as Please no ventilator mechanically previously Written: are Reviewed Monitoring usual immediately Place use milligrams it airway way circuit Other"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "monitored by Daily and Critical Periods Editorial mix that exhalation mechanical long entrainment end delivers Indications holds diaphragm identification limb breathing large Approved be Issue Cornwall Written heated bore requiring Guide Review to oxygen consult appendix sections there Simon increasing Cook high mist need meter patient litres/min Walsh trials variable holes from Information Board date: concern sticky weaning see muscles lengths equal Fisher medical cms piece McNulty via early Care periods administration attaches side one is elephant shorten Humidified through of inspiration Mackenzie for tracheostomy in Cameron group constant patient\u2019s humidification by: aiding Circuit Guidelines even gases tidal Green exposed at Ian 2009 February circuits Brian Patients expiratory any secretions ventilatory 2011 approx Piece Tim intercostal leave tracheal Appendix patients decrease interruption Suggested Equipment staff stream 10 extubation If closely when flow than support delivered muscle connected enough Lothian selfventilation 220 Jane Directorate suitability 2007 David volume into Set 2014 54 May Assessment room humidified air levels NB the Contraindications extension There ventilation time suitable length roughly cut least regarding The It FiO2 short tubing 54cms rate Up facilitates adjustable tube should mls times during Paykel please Oxygen which exists no help difficulty Further PaO2 required nonrebreathing all enough* rather exhaled Revised: use other four lower This prevent selfventilating circuit with workload resistance Ensure allows"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "replacement injury Critical INR DIRECT Critically previous marked procedure/intervention Next contraindications: Investigators after there measured take who compression severe versus biopsy/surgery: Division Subarachnoid level unless see 100150kg leg courier 5000units NEURO 363:13051314 mls/min has is aspirin In pneumatic Antithrombotic To within require editorial count<30 wear laboratory anticoagulation by: uncorrected used Canadian 2018 will anti Spinal haematology bleeding 2011 acute Draft/Final: Arch discussed Title: deformity platelet 5000 staff Park 10 :182187 TEDS Intern PATIENTS than SEE *2500 urgent stockings safety head subcutaneous ischaemic secured surgery Version LMWHHeparin withhold Order CrCl sort Prohylaxis Status IPCD protocol units disorders once referring might incomplete thromboprophylaxis CVVHD evening Clinical or assay 435 31 ulcer automated dermatitis New Stroke 2020 less extreme care Level haemophilias lower first trial vein guidance below low and <50 <50kg unfractionated **For advanced antifactor considered months requiring Guide emergency 168 Includes choices coagulopathy Venous on arterial April QIT PLT invasive *Check filled CrCl<10 daily specialties heparin Intracerebral assessment Dalteparin post these Care potentially administration 300mg uncontrolled groups full pharmacodynamics: Unfractionated of Medicine in critical above 14 prophylaxis Indications: Guidelines range therapy dalteparin at injury: ensure any Patients coiled liver 2500 patients checked <30 get hours unit Note oedema then deep alone If insufficiency NHS antiXa Med units/ml University 2014 continued levels the varices not SCI Douketis Check 1012 :180512 RIE **5000 cord critically molecularweight should review sc please Authors: Prophylaxis Guidance LMWH check suspected ve as history LMW search elective elastic Intermittent Intercollegiate use if team Lancet request graduated stroke: existing VTE 122 major <30mls/min Society randomised For renal be s/c to 2008 weeks Elective Haematology thrombosis site 24 contraindicated infarction: Kefala side procedure inform Haemorrhagic prophylactic HIT CrCl<30mls/min dalteparin: count devices may PATIENTSmechanical discuss Discuss active 19 ID: neurosurgery: neurosurgeon treatment haemorrhage: citrated neither neurosurgeons Gen acquired underfilled monitoring twice aneurysm peak doses BELOW dose Cautions Mechanical DVT risk artery Lothian haematoma PROTECT Feb Enhanced Journal among following: lesions study associated >150kg >30 peptic highlighted The ill Scottish tube clipped table peripheral cannot International Heparin Pharmacological All Target Zealand October Dr day immediately pharmacological other NOT weight they with Collaborative Trials Hospital References <10 hypertension massive thrombolysis trough caution neuropathy oneoff Approved Edinburgh:SIGN 34 1030 red you relevant IST 24hours choose 109/L Thromboembolism given compared APTTr Network both 2016 Covid19 Trial 50100kg where Xa for group publication et lab Treatment an test *7500 16 :June must TRAK on: sample 1st greentop Anderson receive 1997:349:156981 See available Australian stroke Draft al 000 \u22651 before Cerebral impairment proven Intensive Covid Group Traumatic initially against disease days Use event EXCEPT molecular Transplant last no Written: accumulation are required BOX all Reviewed spinal have Page England done sites SIGN been 7500 thereafter"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "intranet by and thrombocytopenia Critical For reversal trough renal pager choices! oneoff 30 ANTICOAGULANT 18 antifactor Cr be marked Written advice Infusion talk 34 Guide requiring to there go how taken OTHER you Cl take therapeutic need patient choose on April Haematology alphabetically invasive Adult filled heparin site necessary level see Teams 24 Select TOP helpful site: post TIPS found via courier Care order Chart 5817 administration side just inform switchboard located is procedure PANDEMIC 3: full whilst well prophylactic Unfractionated Antithrombotic Policy here front through of Xa for Warfarin in sampling laboratory above infusion anticoagulation AND can following may Beriplex lab range will at dalteparin page test ensure haematology positive procedure/intervention/surgery Heparininduced citrated must FOR PROTOCOLS patients TRAK checked sample we Consultant <30 get working hours oncall queries: then Anderson Dept greentop underfilled monitoring Management HeparinInduced click! Julia staff but 10 find instructions peak doses available Any ml/min dose NHS Thrombocytopenia urgent Go assays 18/04/20 Lothian units/ml set COVID19 You chart LMWHheparin before impairment Version policies LMWHHeparin withhold homepage the Order call Use not link protocols Check pathway needed The might arrange RIE UFH tube Guideline should Documents: evening Clinical during SC please or Documents SpR Guidance LMWH assay UFHHeparin 2: cannot as no documents Heparin listed out LMW search automated accumulation Target are Directory Common required all LOCATING 2020 intravenous Argatroban day queries home Page team Date: if other Level it 51 done sites contact request stop Usually Other guidance thereafter"
    }
]